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Dysregulated microbiota-gut-brain axis communication adversely influences neurocontrol 
systems, consequently affecting brain behaviours. It is plausible that microbiota-gut-brain 
axis signalling has a role in the control of breathing and cardiovascular function, as networks 
that govern cardiorespiratory control reside within the brainstem, a region innervated by the 
vagus nerve, a key signalling pathway of the microbiota-gut-brain axis. Cardiovascular and 
respiratory diseases are serious, potentially life-threatening conditions with limited 
treatment options. Thus, improved understanding of the underlying pathophysiology and 
novel therapeutic approaches are required. 
We performed an assessment of cardiorespiratory physiology in animal models of modified 
gut microbiota [antibiotic-treated (ABX) and faecal microbiota transfer (FMT)], and sleep-
disordered breathing [chronic intermittent hypoxia (CIH)-exposed guinea-pigs and rats]. We 
investigated if dietary prebiotic supplementation prevented CIH-induced cardiorespiratory 
dysfunction in rats. Whole-body plethysmography was used to record ventilation and 
metabolism in unanaesthetised animals during normoxia and chemostimulation. Under 
anaesthesia, cardiorespiratory assessments were performed during normoxia, 
chemosensory stimulation and drug administration. Brainstem neurochemistry was assessed 
by high-performance liquid chromatography. 16S rRNA and whole-metagenome shotgun 
sequencing was used to characterise the gut microbiota.  
ABX and FMT disrupted the gut microbiota, brain neurochemistry and intestinal integrity, 
blunting chemoreflex control of breathing. Decreased brainstem noradrenaline and altered 
gut microbiota as well as impaired respiratory and autonomic control were evident in CIH-
exposed guinea-pigs. CIH–exposed rats developed cardiorespiratory pathologies and 
decreased gut Lactobacillus rhamnosus relative abundance. Prebiotic administration 
increased short-chain fatty acid concentrations, measured by gas chromatography,  but 
Lactobacillus rhamnosus and cardiorespiratory dysfunctions were not restored. Several 
commensal and pathogenic bacterial species correlated with blood pressure parameters.  
Our findings add to emerging research exploring microbiota-gut-brain signalling in 
homeostatic systems, extending investigations to cardiorespiratory control. Our studies 
draw focus to the potential application of manipulation of the gut microbiota as an 
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Abbreviations: BBB, blood-brain barrier; CIH, Chronic intermittent hypoxia; COPD, chronic 
obstructive pulmonary disease; FFARs, free-fatty acid receptors; FMT, faecal microbiota 
transplant; GABA, gamma-aminobutyric acid; GLP-1, glucagon-like peptide 1; HFD, high-fat 
diet; HPA-axis, HFD+OSA, high-fat diet and obstructive sleep apnoea; hypothalamic pituitary 
adrenal axis; LPS, lipopolysaccharide; NTS, nucleus tractus solitarius; OSA, obstructive sleep 
apnoea; PaCO2, partial pressure of arterial carbon dioxide; PaO2, partial pressure of arterial 
oxygen; PCO2, partial pressure of carbon dioxide; Reg3γ, regenerating family member 3 




1.1. The gut microbiota 
 
1.1.1 Gut microbiota composition  
The microbiota describes the substantial community of various commensal, symbiotic and 
pathogenic microbes that populate the skin, lungs, urogenital and gastrointestinal tract.  This 
microbial community includes bacteria, viruses, fungi, archaea and parasi tes.  The 
gastrointestinal tract possesses the most extensive and diverse ecosystem and is home to 
trillions of microorganisms.  This community harbours 1000-1150 prevalent bacterial species, 
which combine to dominate the population of microorganisms (Qin et al., 2010). Recently, 
the intestinal bacterial population alone is estimated to establish a ratio of host:bacterial 
cells 1:1 (Sender et al., 2016). 
1.1.2 Gut microbiota evolution 
Gut microbiota modulation by perinatal factors: Microbiota colonisation of an infant 
commences during parturition, where perinatal factors such as mode of delivery, gestation 
age at birth and antibiotic exposure shape the maternal microbiota imprint (Penders et al., 
2006; Moya-Perez et al., 2017; Fouhy et al., 2019). Caesarean delivery leads to reduced 
microbiota richness and diversity compared with vaginally delivered infants (Azad et al., 
2013). Furthermore, premature babies have diminished microbiota diversity, decreased 
Bifidobacterium and Bacteroides abundance as well as increased proliferation of 
Proteobacteria phyla, due to insufficient gastric secretion, compared with full-term delivered 
infants (Sondheimer et al., 1985; Barrett et al., 2013; Dahl et al., 2017; Korpela et al., 2018). 
Breastfed infants are colonised with the mother’s unique breast milk microbial pattern and 
increased levels of Bifidobacterium compared with formula-fed infants (Roger et al., 2010; 
Azad et al., 2013). Vaginally delivered, full-term babies that were breastfed, born to healthy 
non-antibiotic treated mothers have optimal progression of infant microbiota (Penders et 
al., 2006). It has recently been shown that perinatal factors result in perpetual microbiota 
evolution up to four years after parturition (Fouhy et al., 2019).  
Gut microbiota adaptation: Remarkably, this diverse and highly complex gut microbiota 
community continuously evolves and adapts over an entire lifetime (Borre et al., 2014; 
McVey Neufeld et al., 2016; Kundu et al., 2017). Distinctive functional and compositional 
hallmarks are evident across various life periods, including neonatal, early -life, puberty, 
adulthood and ageing, with large interpersonal differences (Kundu et al., 2017). 
Notwithstanding the vast degree of interpersonal variation, the adult gut microbiota is 
primarily dominated by Firmicutes and Bacteroidetes (Kurokawa et al., 2007; Arumugam et 
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al., 2011). More recently, the adult gut microbiota was classified into three different 
enterotypes, Prevotella, Ruminococcus and Bacteroides (Arumugam et al., 2011).  
Furthermore, microbiota diversity and composition are influenced by nutrition, life -style, 
hormone and health status, ageing, environment, stress and medication, amongst other 
factors (Woodmansey, 2007; O'Mahony et al., 2011; Albenberg & Wu, 2014; Panda et al., 
2014; Golubeva et al., 2015; Kelly et al., 2015; Foster et al., 2017; Boehme et al., 2019).  A 
growing body of evidence now points to the gut microbiota as a potent contributor to whole-
body homeostasis in both health and disease (Cryan & O'Mahony, 2011; Grenham et al., 






1.2. Microbiota-gut-brain axis communication pathways 
 
1.2.1 Microbiota-gut-brain axis 
The gut microbiota functions in a multimodal bidirectional communication pathway termed, 
microbiota-gut-brain axis, enabling microbes to share information with the brain and the 
brain to communicate with the gut (Rhee et al., 2009). This bidirectional communication 
network includes the central, both brain and spinal cord, enteric and autonomic nervous 
systems and the hypothalamic pituitary adrenal axis (HPA-axis).  There is compelling 
evidence to illustrate that dysregulated microbiota-gut-brain axis signalling affects 
homeostatic neurocontrol systems, with consequences for behaviours such as anxiety, 
depression, social interactions and learning and memory (Desbonnet et al., 2014; Hoban et 
al., 2016; Burokas et al., 2017; Dinan & Cryan, 2017). Many of these maladies are associated 
with neurodegenerative, neurodevelopmental or biopsychosocial disorders such as 
Parkinson’s disease, autism and irritable bowel syndrome (Cryan & O'Mahony, 2011; Dinan 
& Cryan, 2017).  
The mechanisms of microbiota-gut-brain axis signalling are multifaceted and comprise 
afferent and efferent pathways (Burokas et al., 2015). Despite the vast amount of 
experimental evidence from rodent and human studies, supporting the role of the gut 
microbiota in regulating physiological homeostasis and brain functions, signalling pathways 
have not been entirely elucidated. Currently, a number of afferent (neuronal, immune 
system, gut microbiota metabolites, tryptophan metabolism and neurotransmitters) and 






Figure 1. 1 The microbiota-gut-brain axis  
The microbiota-gut-brain axis permits microbes to communicate with the brain and the brain 
to convey information to gut. A number of complex communication pathways are proposed. 
CRF, corticotropin-releasing factor; ACTH, adrenocorticotrophic hormone; SCFA, short-chain 




1.2.2 Short-chain fatty acids (SCFAs) 
Acetic, propionic and butyric acid are principal SCFAs, which are primary end-products 
produced by microbial fermentation of partially digestible and indigestible polysaccharides 
(Macfarlane & Macfarlane, 2012).  They function as major signalling mediators of host-
microbiome communication, playing a crucial role in the maintenance of physiological 
homeostasis and brain functions (Stilling et al., 2014a; Canfora et al., 2015). SCFAs are either 
utilised in colonocytes or transferred and circulated by di ffusion and monocarboxylate 
transporters (Kekuda et al., 2013; Vijay et al., 2015).  
It is widely accepted that free-fatty acid receptors (FFARs), especially FFAR 2 and 3, are 
located on an extensive range of cells throughout the body (Sina et al., 2009; Tolhurst et al., 
2012; Nohr et al., 2015; Lu et al., 2018b). SCFAs can bind to FFARs expressed on 
enteroendocrine cells of the gastrointestinal tract, subsequently releasing gut hormones 
such as glucagon-like peptide 1 (GLP-1) (Tolhurst et al., 2012).  They can cause neuronal 
activation by binding to FFARs, specifically FFARs 3, which are located on neuronal ganglia 
throughout the body, including the superior cervical ganglion (Kimura et al., 2011),  
sympathetic ganglia of the thoracic and lumbar sympathetic trunks and vagal ganglia (Nohr 
et al., 2015).  In addition, it is apparent that FFARs 2 are highly expressed in immune cells, 
suggesting immune system regulation by SCFAs (Sina et al., 2009; Smith et al., 2013b). 
Furthermore, SCFAs may directly influence neurotransmitters. For example, it has been 
shown that butyrate and propionate modify tyrosine hydroxylase gene expression in PC12 
cell lines, which can affect dopamine and noradrenaline synthesis (DeCastro et al., 2005; 
Nankova et al., 2014; Stilling et al., 2016).  
Additionally, SCFAs affect microglia, the resident macrophages of the central nervous system 
(Erny et al., 2015; Mosher & Wyss-Coray, 2015). Germ-free mice, born and raised in sterile 
environments, have advanced defects in microglia maturation, morphology and function 
(Erny et al., 2015), increased blood-brain barrier (BBB) permeability and decreased 
expression of brain tight junction proteins (Braniste et al., 2014). SCFA supplementation 
reversed these microglial defects (Erny et al., 2015), up-regulated brain tight junction 
proteins and reduced BBB permeability (Braniste et al., 2014). Of note, microglia may play a 
key role in regulating neural circuits within the brain (Bilimoria & Stevens, 2015). Not only 
have SCFAs been reported to modulate microglial activity and function in germ-free mice, 
but SCFA administration and microglia modulation has also been described in a rodent model 
of sleep-disordered breathing (SDB). Ganesh and colleagues reported reduced acetate and 
increased microglia activation in a rat model of obstructive sleep apnoea (OSA).  Probiotic or 
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prebiotic supplementation prevented the decrease in acetate levels and the augmented 
microglial activity (Ganesh et al., 2018). 
Noteworthy, under healthy physiological conditions a limited amount of SCFAs may cross the 
BBB (Stilling et al., 2014a). FFARs are sparsely distributed in the brain, thus it has been 
suggested that persistent secretion of SCFAs may result in epigenetic modulation through 
histone deacetylase (Stilling et al., 2014b; Stilling et al., 2016). For example, SCFAs 
particularly butyrate can inhibit the activity of histone deacetylases, resulting in hype r-
acetylation of histones (Waldecker et al., 2008; Kratsman et al., 2016; Dalile et al., 2019). 
1.2.3 Tryptophan metabolism and neurotransmitters 
The gut microbiota facilitates central neurotransmitter regulation by synthesising and 
releasing neurotransmitters from bacteria directly or by altering levels of neurotransmitter 
precursors (Desbonnet et al., 2010; Lyte, 2013, 2014a; O'Mahony et al., 2015). Several 
studies link the gut microbiota to the serotonergic system (Clarke et al., 2013; O'Mahony et 
al., 2015). Serotonin orchestrates modulation of complex physiological functions (O'Mahony 
et al., 2015). Interestingly, 95% of serotonin synthesis predominantly occurs within the 
gastrointestinal tract, with only 5% produced in the brain (Spiller, 2008).  
Tryptophan, which is a serotonin precursor, was increased in plasma of germ-free mice. Gut 
microbial colonisation normalised plasma tryptophan concentrations. Furthermore, the 
absence of microbiota in germ-free mice affected the central serotonergic system within the 
brain. Heightened tryptophan levels correlate with elevated hippocampus serotonin 
concentrations and turnover in a sex-dependent manner (Clarke et al., 2013). Consistent 
observations were evident utilising a probiotic strain, Bifidobacterium infantis, which 
increased tryptophan concentrations in plasma, with subsequent effects on central 5-
hydroxyindoleacetic acid, which is a serotonin precursor (Desbonnet et al., 2008).  
Furthermore, within the gastrointestinal tract, microbes including Candida, Escherichia, 
Streptococcus and Enterococcus species produce serotonin (Lyte, 2013, 2014a).  
Microbial species can also produce other neurotransmitters. Bacillus species produce 
dopamine. Lactobacillus species produce acetylcholine, Bifidobacterium and Lactobacillus 
species produce gamma-aminobutyric acid (GABA) and Bacillus, Escherichia and 
Saccharomyces species produce noradrenaline (Lyte, 2013, 2014a; Strandwitz, 2018). 
Microbial-synthesised neurotransmitters transfer through the mucosal layer of the 
intestines. However, in healthy physiological states these neurotransmitters cannot cross the 
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BBB, even when circulating within the bloodstream. Noteworthy,  tryptophan is more readily 
proficient in passing through BBB capillaries, which may sequentially initiate production of 
serotonin within the raphé nuclei of the brainstem (Le Floc'h et al., 2011). It is plausible that 
neurotransmitters predominantly influence brain function through activation of the enteric 
nervous system; however, there is paucity of information regarding signalling mechanisms. 
Of interest, serotonin can bind to serotonin type 3 receptors on vagal afferents, prompting 
neuronal activation (Glatzle et al., 2002; Raybould et al., 2003). 
1.2.4 Immune system 
Immune cells within the gastrointestinal tract play a crucial regulatory role at the host-
microbiome interface, influencing whole-body health (Macpherson & Uhr, 2004; 
Sonnenburg et al., 2006; Belkaid & Hand, 2014). Commensal gut microbes frequently reside 
in regions enriched in immune cells, which produce mucus, antimicrobial peptides and 
immunoglobulin A (Belkaid & Hand, 2014). The immune system supports a symbiotic 
relationship between the gut microbiota and the host tissue. Mucus, produced by goblet 
cells, creates the first line of defence, limiting interactions between host tissue and gut 
microbiota, subsequently preventing microbial translocation (McGuckin et al., 2011; Belkaid 
& Hand, 2014). Additionally, an antimicrobial peptide, regenerating family member 3 gamma 
(Reg3γ) has been shown to deplete gram-positive bacteria, whereas colonisation of germ-
free mice with gram-negative bacteria augmented Reg3γ expression (Cash et al., 2006; 
Sonnenburg et al., 2006).  Similarly, intestinal dendritic cells in concert with T and B cells of 
Peyer’s patches mediate immunoglobulin A production, specifically for commensal-derived 
antigens (Macpherson & Uhr, 2004). Thus, when functioning optimally, an important 
regulatory interaction exists at the luminal surface between the gut microbiota and the host 
tissue, which is vital for integrative body systems.  
The immune system functions as a principal communication pathway of the microbiota-gut-
brain axis (El Aidy et al., 2014b). Sensory vagal afferent fibres can detect cytokines and other 
inflammatory mediators and inform the brain of inflammation in the periphery (Goehler et 
al., 2000; Johnston & Webster, 2009). However, the mechanism by which the vagus nerve 
detects the presence of inflammatory mediators remains unclear. In situations of 
dysregulated intestinal permeability, such as stress, bacterial components including 
lipopolysaccharide (LPS), found on the outer membrane of gram-negative bacteria, can 
translocate from the intestinal lumen into the circulatory system. Systemic LPS prompts 
peripheral immune system stimulation and HPA-axis activation (Kelly et al., 2015; Araujo et 
al., 2017). Intriguingly, it appears that microbes within the gut can also exert effects on 
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microglia (Erny et al., 2015). As such, microglia of germ-free mice are immature; microbial 
colonisation normalised these deficits (Erny et al., 2015). Under healthy physiological 
conditions, it is implausible that immune molecules, such as chemokines cross the BBB. 
Interestingly, recent studies suggest an increased potential for chemokines to cross a 
dysregulated BBB, suggesting microbiota-induced immune modulation may directly affect 
brain function (Banks & Erickson, 2010).  
1.2.5 Neuronal pathways 
The neuronal pathways of microbiota-gut-brain communication include central, enteric and 
autonomic nervous systems, such as spinal, vagal and sympathetic pathways (Houlden et al., 
2016; Kigerl et al., 2016; Breit et al., 2018; Fulling et al., 2019). A growing body of animal and 
human studies suggest the vagus nerve is the leading and most direct communication 
pathway of the microbiota-gut-brain axis (Fulling et al., 2019). The 10th cranial nerve is the 
principal nerve of the parasympathetic nervous system, consisting of 80% afferent and 20% 
efferent fibres. It emerges from the medulla oblongata of the brainstem and terminates 
within the colon (Berthoud & Neuhuber, 2000). Vagal efferent fibres of preganglionic 
neurones arise from the dorsal motor nucleus of the vagus nerve and supply muscular and 
mucosal layers in the lamina propria and in the muscularis externa of the gut wall (Berthoud 
& Neuhuber, 2000). The celiac branch of the vagus innervates the proximal duodenum to the 
distal descending colon (Wang & Powley, 2007; Mukudai et al., 2016).  Afferent cell bodies 
of the nodose ganglia convey sensory cues from the periphery to the nucleus tractus 
solitarius (NTS) in the dorsal medulla oblongata, which projects afferent signals to multiple 
regions within the central nervous system, such as the rostral ventrolateral medulla and 
locus coeruleus, which are involved in cardiovascular control and central chemosensitivity, 
respectively (Berthoud & Neuhuber, 2000).  
Studies in mice report that administration of Lactobacillus rhamnosus modified  GABA 
receptor expression in the brain and mitigated anxiety and depressive-related behaviours 
(Bravo et al., 2011). These behavioural and neurochemical outcomes were abolished in 
vagotomised mice, suggesting vagal-mediated communication between the gut microbes 
and the brain (Bravo et al., 2011). Furthermore, oral administration of Campylobacter jejuni 
in mice, elevated anxiogenic behaviour and induced neuronal activation in the NTS, 
parabrachial and paraventricular nuclei and amygdala, which are components of the 
respiratory control and/or central autonomic networks (Gaykema et al., 2004; Goehler et al., 
2008). Additionally, anxiolytic benefits of probiotic, Bifidobacterium longum were eradicated 
after vagotomy in mice (Bercik et al., 2011b). Furthermore, vagotomy in young patients 
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minimised the risk of developing neurodegenerative disorders (Svensson et al., 2015).  
Indeed, it has been suggested that vagal afferents respond to many stimuli within the gut, 
including nutrients, cytokines, gut hormones and metabolites, and neurotransmitters 
(Goehler et al., 2000; Raybould et al., 2003; Johnston & Webster, 2009; Kimura et al., 2011; 
Nohr et al., 2015).   
Intriguingly, the vagus nerve and the NTS, its chief projection site and central ‘relay hub’ 
translate visceral information from sensors in numerous peripheral sites, such as the gut, to 
several regions involved in the control of breathing and cardiovascular function. Considering 
this and the regulatory role of the microbiota-gut-brain axis in physiological behaviours and 
brain functions, microbiota-gut-brain axis signalling has potential relevance for 
cardiorespiratory control, both in health and disease. 
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1.3. Microbiota modulation and analysis 
 
A variety of well-established methods are routinely utilised to alter the gut microbiota in 
rodent models and appropriately assess microbiota-gut-brain axis modulation in health and 
disease states. These methods include, but are not limited to germ-free animals, antibiotic 
administration, faecal microbiota transplant (FMT), diet and prebiotic and probiotic 
administration (Burokas et al., 2015). 
1.3.1 Germ-free animals 
Germ-free animals are born and raised in gnotobiotic units, which are sterile environmental 
chambers. This approach eliminates the opportunity for postnatal colonisation of the 
gastrointestinal tract (Cryan & Dinan, 2012; Luczynski et al., 2016). The primary advantage 
of germ-free animals in assessing the role of the gut microbiota in physiological behaviours 
and brain functions is in proof-of-principle studies. Furthermore, an additional benefit 
involves microbial colonisation of germ-free animals at various developmental time-points. 
Nonetheless, animals born and raised in sterile environments have various deficits, 
exhibiting permanent neurodevelopmental dysfunctions. For these various reasons germ-
free animals are often unsuitable for investigations not involving early-life microbiota 
deficiencies (Luczynski et al., 2016).  
1.3.2 Antibiotics 
There is compelling evidence that microbial patterns fluctuate in response to antibiotic 
administration (Panda et al., 2014; Desbonnet et al., 2015; Hoban et al., 2016; Haak et al., 
2019). Indeed, the ‘antibiotic revolution’ was one of the greatest achievements of modern 
medicine saving millions of lives (Brown, 2005). Nevertheless, antibiotics are not only 
beneficial but also detrimental to the host (Sullivan et al., 2001; Benoun et al., 2016; 
Gasparrini et al., 2016). The majority of antibiotics have a broad spectrum of action, affecting 
not only pathogenic bacteria but also perturbing resident gut microbes (Panda et al., 2014; 
Hoban et al., 2016; Haak et al., 2019). Thus, antibiotic overexposure using broad spectrum 
antibiotics may overwhelm the microbiome, culminating in genotypic antibiotic resistance of 
resident microbes and pathogenic bacteria (Sullivan et al., 2001). In humans, seven 
consecutive days of fluoroquinolone and β-lactam antibiotic administration disturbed gut 
microbiota assembly by decreasing core phylogenetic microbiota and microbial diversity by 
25% (Panda et al., 2014). However, antibiotics increased proportions of unknown species, 
with β-lactam enhancing microbial load by two-fold (Panda et al., 2014). Humans receiving a 
cocktail of antibiotics for one week, including vancomycin, ciprofloxacin and metronidazole, 
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displayed a perturbed microbial structure, with diminished diversity and richness 9 and 49 
days after completion of the antibiotic regime (Haak et al., 2019); 8-31 months following 
antibiotic administration microbial diversity was normalised to baseline levels (Haak et al., 
2019). In rodents, exposure to broad-spectrum antibiotics reduced bacterial DNA load by 
400-fold, altered microbial diversity and richness and the relative abundance of many 
residential microbes (Reikvam et al., 2011; Desbonnet et al., 2015; Hoban et al., 2016).  In 
rodents, many pathophysiological conditions relating to altered brain functions, such as 
deficits in memory and depressive-like behaviours, present following antibiotic-induced 
changes in the gut microbiota (Desbonnet et al., 2015; Hoban et al., 2016).   
1.3.3 Diet 
Diet directly shapes gut microbiota composition, structure and diversity, providing nutrients 
to gut microbes, via indigestible ingredients or by-products of digestion (Brown et al., 2012; 
Albenberg & Wu, 2014).  Dietary regimes provoke distinct microbial patterns within the gut 
(Brown et al., 2012; Kallus & Brandt, 2012; Murphy et al., 2015). Consumption of a western 
diet, containing copious amounts of salt, sugars and fats results in elevated 
Firmicutes:Bacteroidetes ratio, which is  associated with hypertension and diet-induced 
obesity (Kallus & Brandt, 2012; Murphy et al., 2015; Yang et al., 2015). Mediterranean diet 
consisting of whole grains, vegetables, fruit and minimal consumption of animal products 
significantly increased SCFAs and reduced trimethylamine oxide in humans, a metabolite 
linked to atherosclerosis and cardiovascular disease (De Filippis et al., 2016). Moreover, 
consumption of a Mediterranean diet reveals marked decreases in other chronic diseases 
resulting in reduced mortality (Del Chierico et al., 2014). In essence, the gut microbiota plays 
a vital role in carbohydrate, protein and polyphenol fermentation and vitamin synthesis 
(vitamin B12, B6, B5, B3, D and K). In turn, diet orchestrates a unique microbial pattern within 
the gut (Sandhu et al., 2017). 
Dietary fibres: Carbohydrates represent a substantial component of the human diet. They 
are metabolised by the gut microbiota and subsequently absorbed as simple sugars in the 
intestines (Rajilić-Stojanović, 2013). Microbial fermentation of carbohydrates generates 
energy from undigested food by producing bacterial metabolites, including SCFAs. Dietary 
fibres are specific carbohydrates or carbohydrate-containing compounds that cannot be 
readily digested or absorbed in the small intestines but are fermented in the large intestines. 
These fibres are classified based on their specific function in the plant, fibre components, 
polysaccharide type, gastrointestinal solubility, digestion site and products and physiological 
properties (Staffolo et al., 2012).  
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Prebiotics: Prebiotics are a type of dietary fibre which are resistant to gastric acid and 
enzymes and convey health benefits via upregulation of microbes associated with whole-
body health (Gibson et al., 2004; Slavin, 2013). Inulin, lactulose, fructooligosaccharides and 
galactooligossacharides are the most extensively studied prebiotics (Roberfroid et al., 2010). 
Fructooligosaccharides and galactooligossacharides are oligosaccharides present in plants 
(e.g. asparagus, garlic, banana, tomato, artichoke and onions) and human milk, respectively. 
These oligosaccharides have direct and indirect effects on overall health, including decreased 
risk of obesity, reduced levels of cholesterol, immune regulation, ameliorated mineral 
absorption, anxiolytic and antidepressant effects and reduced colonic carcinogenic 
substances (Cani et al., 2006; Sabater-Molina et al., 2009; Kuo, 2013; Burokas et al., 2017).  
1.3.4 Faecal microbiota transplant 
There is growing appreciation for the use of FMT in animal models and in modern medicine. 
FMT is the transfer of stool from a donor into the gastrointestinal tract of a recipient in order 
to directly change the microbial pattern of the recipient (Kelly et al., 2016b; Pevsner-Fischer 
et al., 2016; Zheng et al., 2016).  
Transplantation of faecal microbiota from depressed patients into antibiotic-treated rats, 
altered a number of microbial taxa and reduced gut microbiota richness and diversity 
compared with controls (Kelly et al., 2016b). Depressive behaviours were evident in 
antibiotic-treated and germ-free rodents that received FMT from depressed individuals 
(Kelly et al., 2016b; Zheng et al., 2016). Moreover, blood pressure phenotypes in donor 
animals can be transferred to recipient animals via FMT (Li et al., 2017; Toral et al., 2019). 
Additionally, mice receiving faecal microbiota from patients with irritable bowel syndrome 
had an altered gut microbiota along with intestinal barrier dysfunction, innate immune 
activation and anxiety-like behaviours (De Palma et al., 2015). Mice receiving faecal 
microbiota from autistic patients exhibited a perturbed gut microbiota and autistic-like social 
behaviours (Sharon et al., 2019). 
Intriguingly, autologous FMT following antibiotic administration resulted in rapid and near 
complete restoration of the gut microbiota in a human population (Suez et al., 2018). 
Clinically, FMT has proven to benefit individuals with Clostridium difficile infection and to a 
lesser extent patients with biopsychosocial disorder, irritable bowel syndrome and 
individuals with a neurodegenerative and immune disorder-multiple sclerosis (Pevsner-
Fischer et al., 2016). These animal and human studies suggest that FMT may be a viable 
strategy to investigate brain functions in health and disease. 
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1.3.5 Analysis of the microbiome 
Whole genome shotgun and 16S rRNA gene sequencing allow for advanced compositional 
analysis of the microbiome.  16S sequencing is a technique wherein highly conserved regions 
of the transcript (cDNA) or 16S rRNA (DNA) are used to identify metabolically active or 
present microbes, respectively.  In contrast, whole-genome shotgun sequencing is a 
technique wherein all DNA in a sample is sequenced to classify microbes that are present 
and their functional (metagenomic) potential (Claesson et al., 2017; Bastiaanssen et al., 
2019). 
Beta and alpha diversity are terms used in ecology that represent between and within-
sample variability, respectively. Multiple formulas define diversity differently, due to 
different weightings ascribed to aspects such as how rare/abundant the species are, binary 
abundance/presence, number of species and taxonomic distance between species 




1.4. Control of breathing and cardiovascular function 
 
1.4.1 Overview of cardiorespiratory control 
The cardiorespiratory control network is a highly complex homeostatic system. Exquisite 
cardiovascular and respiratory regulatory mechanisms are required to maintain sufficient 
blood oxygenation to meet metabolic demands, which is vital for whole -body health. 
Neuronal networks within the brain, particularly the brainstem, tightly regulate the 
cardiorespiratory system. They depend on critical feedback from the periphery (Guyenet, 
2006; Garcia et al., 2011). There is substantial sensory-guided modulation of autonomic and 
respiratory motor outputs from the periphery, which implement appropriate 
cardiorespiratory reflex control (Guyenet, 2014). Autonomic centres execute sympathetic 
and parasympathetic motor output to the heart and circulation (Guyenet, 2006). Respiratory 
centres transduce appropriate reflex responses through numerous efferent  pathways, 
directly or indirectly via spinal nuclei to muscles of breathing, providing superb breath-by-
breath ventilatory control (Garcia et al., 2011) (Figure 1.2). There is considerable respiratory 
modulation of autonomic outflow (Guyenet, 2014). Notwithstanding the homeostatic 
capacity governing breathing and blood pressure control, there is an extensive degree of 
evidence supporting remarkable potential for adaptive and maladaptive plasticity, which can 
occur at multiple regions within the cardiorespiratory control system, including peripheral 
and central levels (Edge et al., 2009; Peng et al., 2009; Edge et al., 2010; Kumar & Prabhakar, 
2012; Edge & O'Halloran, 2015; O'Halloran, 2016; Burns et al., 2017; Fuller & Mitchell, 2017; 
Hocker et al., 2017; Laouafa et al., 2017). Maladaptive plasticity may result in devastating 
consequences for integrative body systems (Bavis, 2005; Gulemetova & Kinkead, 2011; 
Fournier et al., 2013a; Kinkead et al., 2013; Golubeva et al., 2015; Soliz et al., 2016; Laouafa 
























Figure 1. 2 Summary of the cardiorespiratory control network, which is composed of 
sensors, central control regions and effectors. 
These components work in unison to maintain adequate blood oxygenation to meet 
metabolic demands of the body. Sensory afferent cues from the periphery, including 
peripheral chemoreceptors, pulmonary and airway vagal afferents and arterial 
baroreceptors project to the brainstem, where information is integrated and processed. 
Appropriate respiratory and autonomic responses are generated to maintain acid-base and 
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1.4.2 Neuronal networks  
The pontomedullary regions of the brainstem consists of interconnected neuronal networks 
that are vital for production of automatic breathing and for generation of autonomic outflow 
involved in cardiovascular homeostasis (Guyenet, 2014).  The NTS, ventrolateral pons (A5 
pons), dorsolateral pons (inter-trigeminal region, lateral parabrachial nuclei and Kolliker-
Fuse nucleus) and ventral respiratory column (Bötzinger complex, pre-Bötzinger complex, 
rostral and caudal ventral respiratory group), which resides in the ventrolateral medulla are 
the principal building blocks of the respiratory pattern generator (Feldman et al., 2003; 
Alheid & McCrimmon, 2008; Smith et al., 2013a). Additionally, the ventrolateral medulla 
(rostral, intermediate and caudal), lateral parabrachial nuclei and NTS are recognised to 
contain the main components of the network that generates sympathetic and 
parasympathetic autonomic outflow to the cardiovascular system. Another principal 
component of cardiovascular control is the hypothalamus, particularly the paraventricular 
nucleus (Guyenet, 2006). The hypothalamus has extensive connections with brainstem 
circuitry and predominantly contributes to cardiorespiratory regulation in response to 
environmental stressors or threats (Guyenet, 2006; Behan & Kinkead, 2011). 
Respiratory and autonomic outputs are further regulated by numerous neuromodulators, 
such as serotonin and noradrenaline, as well as excitatory (glutamatergic) and inhibitory 
(GABA and/or glycinergic) neurones (Doi & Ramirez, 2008; Ramirez et al., 2012; Abbott et al., 
2013; Smith et al., 2013a). Neuromodulators have multiple functions at various levels of the 
control network. Often the same modulator can exert differential effects on activity by acting 
on different G-protein receptors. Disturbances in neuromodulation can have significant 
impact on cardiorespiratory control (Doi & Ramirez, 2008; Harris-Warrick & Johnson, 2010). 
This network in turn phasically activates respiratory motor neurones located in the phrenic 
nucleus of cervical spinal cord and elsewhere (hypoglossal and ambiguus nuclei of the 
medulla) and modulates sympathetic and parasympathetic preganglionic outflow, which 
contribute to cardiovascular control (Guyenet, 2006, 2014).  
1.4.3 Central chemoreceptors 
Some neuronal networks within the central nervous system detect changes in carbon dioxide 
(PCO2) and hydrogen ion concentrations (pH) in brain extracellular fluid. These central 
chemoreceptors are essential in the maintenance of acid-base homeostasis. During eupnoea 
(normal unlaboured breathing at rest), the partial pressure of arterial carbon dioxide (PaCO2) 
is maintained within the physiological set-point. However, PaCO2 may increase as a result of 
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airway blockade, diving, bronchial disease and disordered breathing, among other factors 
such as disease states. Elevated PaCO2, sensed by chemoreceptors, initiates an increase in 
ventilation and arousal from sleep to maintain optimal pulmonary ventilation and gas 
exchange.  
A substantial degree of evidence suggests that the putative principal chemosensitive region 
within the brain is the retrotrapezoid nucleus (RTN), which detects carbon dioxide (CO 2) via 
signals from astrocytes, synaptic input from peripheral chemoreceptors or intrinsic proton 
receptors (Guyenet & Bayliss, 2015). Phox2b mutation in mice (born without RTN neurones) 
and genetic elimination of RTN neurones significantly reduced the ventilatory 
responsiveness to hypercapnia (elevated CO2)  (Amiel et al., 2003; Dubreuil et al., 2008; 
Ramanantsoa et al., 2011; Ruffault et al., 2015).  
Additionally, several studies suggest that a subset of serotonergic neurones residing in the 
raphé magnus may have central chemosensitive properties (Hodges et al., 2008; Corcoran et 
al., 2009; Brust et al., 2014; Buchanan et al., 2015). Impairment in serotonergic neurone 
development in mice results in reduced ventilation during hypercapnia (Hodges et al., 2008; 
Hodges et al., 2009; Buchanan & Richerson, 2010). Furthermore, pharmacological inhibition 
of serotonergic neurones (Di-expressing and Egr2-Pet1 subtype) in rodents diminished CO2-
induced ventilation (Ray et al., 2011; Brust et al., 2014).  
Of further interest, partial lesions of catecholaminergic neurones (locus coeruleus and other 
brainstem noradrenergic neurones) reduced the hypercapnic ventilatory response in mice 
(Li & Nattie, 2006). Furthermore, oxidopamine-induced lesions of the locus coeruleus in rats 
attenuated ventilation in response to hypercapnia, but not hypoxia (Biancardi et al., 2008; 
Biancardi et al., 2010). Other neurones within the brain may also function as central 
chemoreceptors, however at present there are unmet knowledge gaps in this regard 
(Guyenet & Bayliss, 2015).  
1.4.4 Peripheral sensors 
Peripheral sensors are essential components of the cardiorespiratory control network. 
Sensory afferent cues from the periphery, including peripheral chemoreceptors, pulmonary 
and airway vagal afferents and arterial baroreceptors, project to the NTS within the 
brainstem.  In turn, the NTS relays information to other cardiorespiratory regions where 
information is processed and appropriate respiratory and autonomic responses are 
generated to maintain acid-base and blood pressure homeostasis (Coleridge & Coleridge, 
1984; Purves et al., 2001; Widdicombe, 2003; Prabhakar & Peng, 2004). 
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Peripheral chemoreceptors: Peripheral chemoreceptors residing at the carotid body and 
aortic arch detect partial pressure of arterial oxygen (PaO2)(Prabhakar & Peng, 2004; 
Teppema & Dahan, 2010; Kumar & Prabhakar, 2012). The carotid body is the dominant 
peripheral oxygen sensor, situated at the bifurcation of the common carotid arteries, 
bilaterally. It receives sensory innervation from the carotid sinus nerve, which is a branch of 
the glossopharyngeal nerve (9th cranial nerve). Type 1 (glomus) and type II sustentacular 
(glia) cells form the structure of the carotid body (Kumar & Prabhakar, 2012).  
Chemoafferent sensory discharge from the carotid body is modest during normoxia (~100mg 
PaO2) (Lipski et al., 1977; Prabhakar, 2006) and within blood PaO2 range of 100 to 60mmHg. 
However, the carotid body is extremely sensitive to reductions in PaO2 below 60mmHg. 
Hypoxaemia (low blood oxygenation), which occurs for example during high altitude 
exposure and in pulmonary and respiratory disorders such as chronic obstructive pulmonary 
disease (COPD) and sleep apnoea, activates carotid body afferent discharge, through the 
glossopharyngeal nerve, to the NTS within the brainstem (Kumar & Prabhakar, 2012). 
Appropriate respiratory and autonomic outputs are evoked in response to hypoxaemia, such 
as enhanced ventilatory drive and altered sympathetic and parasympathetic activity. This 
ensures adequate oxygen supply to tissues throughout the body (Machado, 2001). 
Pulmonary and lower airway vagal afferents: Sensory fibres within the lung and smooth 
muscle of the lower airway send signals to the NTS within the brainstem, via vagal afferent 
fibres. These afferent fibres are broadly divided into 3 types: slowly- and rapidly-adapting 
myelinated stretch receptors and unmyelinated bronchopulmonary C-fibres.  
Slowly- and rapidly-adapting mechanoreceptors are sensitive to dynamic and static functions 
of transmural pressure and lung volume. Indeed, these receptors are primarily activated by 
lung inflation (Schelegle, 2003; Widdicombe, 2003). Furthermore, rapidly-adapting stretch 
receptors are also activated by irritants (Widdicombe, 2003). Bronchopulmonary C-fibres are 
polymodal, activated by a variety of stimuli, including chemicals (phenylbiguanide and 
capsaicin) and lung oedema, among other factors (Coleridge & Coleridge, 1984; Dutta & 
Deshpande, 2010; Lucking et al., 2018a). 
Each group of sensory afferent fibres has specific functions in cardiorespiratory reflex 
responses. For example, classic cardiorespiratory responses to slowly-adapting 
mechanoreceptor activation include inspiratory termination, expiratory facilitation (Bre uer-
Hering reflex) and tachycardia; rapidly-adapting mechanoreceptor stimulation results in 
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generation of cough; and bronchopulmonary C-fibre activation leads to apnoea, post-apnoea 
induced tachypnoea and bradycardia (reduced heart rate) (Kubin et al., 2006).  
Arterial baroreceptors: Arterial baroreceptors are mechanosensitive nerve endings that 
function as arterial blood pressure sensors. They are situated primarily in the aortic arch and 
carotid sinuses near the bifurcation of the common carotid artery. The carotid sinus and the 
glossopharyngeal nerves transmit sensory afferent information from the carotid sinus 
baroreceptors to the NTS within the brainstem (Guyenet, 2006). Furthermore, extra-carotid 
arterial baroreceptors found in the aortic arch and stretch-sensitive receptors of the heart 
and pulmonary vessels transduce sensory afferent cues  via vagal nerves to the NTS (Purves 
et al., 2001; Guyenet, 2006). Regardless of their anatomical location, these arterial 
baroreceptors function by transducing afferent information in a negative feedback loop to 
maintain homeostatic control of blood pressure (Purves et al., 2001).  
In essence, increased blood pressure stimulates baroreceptors, inhibiting activation of spinal 
cord sympathetic preganglionic neurones. In tandem, the elevated blood pressure stimulates 
parasympathetic preganglionic neurones, which are located in the nucleus ambiguus and 
dorsal motor nucleus of the vagus. This shift from sympathetic to parasympathetic 
dominance results in decreased noradrenergic stimulation of cardiac musculature and 
pacemaker postganglionic sympathetic fibres (Salman, 2016). In parallel, stimulatory effects 
of acetylcholine released through cholinergic parasympathetic supply to the heart has 
negative dromotropic effects, reducing cardiac pacemaker discharge frequency in the 
sinoatrial node and slowing ventricular conductance. Furthermore, negative chronotropic 
and inotropic effects occur, reducing heart rate and atrial and ventricular contractions. 
Peripheral vasodilation occurs predominantly via withdrawal of sympathetic 
vasoconstriction. This negative feedback loop lowers blood pressure (Gordan et al., 2015; 
Salman, 2016). 
In contrast, a decrease in blood pressure inhibits parasympathetic activity while increasing 
sympathetic drive. Norepinephrine is released from sympathetic postganglionic terminals, 
increasing cardiac pacemaker activity, enhancing inotropic effects and elevating 
catecholamine release from the adrenal medulla. Moreover, norepinephrine increases 
smooth muscle tone of peripheral arterioles leading to vasoconstriction and increases 
cardiac output. As a result, blood pressure is normalised (Purves et al., 2001; Gordan et al., 




1.4.5 Cardiorespiratory coupling 
Accumulating evidence supports the concept of cardiorespiratory coupling, establishing a 
unique and dynamic twinned system. Recording of sympathetic and parasympathetic nerves 
innervating the blood vessels and heart suggest that autonomic nervous system activity 
displays discharge patterns coordinated with respiratory rhythm and pattern (Adrian et al., 
1932; Barman & Gebber, 2000; Bouairi et al., 2004; Gilbey, 2007; Grossman & Taylor, 2007). 
Respiratory-related modulation of autonomic activities depends on the acid-base balance 
within the control network (Dick et al., 2004; Molkov et al., 2011). Cardiorespiratory coupling 
generates appropriate reflex responses with rhythmical oscillations in blood pressure and 
heart rate (Moraes et al., 2012).  
There are knowledge gaps regarding neuronal sources contributing to cardiorespiratory 
coupling. However, studies suggest that respiratory neurones of the ventral respiratory 
column establish connections with pre-sympathetic neurones of the rostral ventrolateral 
medulla, either directly or indirectly, through the caudal ventrolateral medulla, producing 
respiratory oscillations in sympathetic activity (Miyawaki et al., 1995; Zoccal et al., 2008; 
Zoccal et al., 2014). Additionally, the NTS has a vital role in the regulation of sympathetic and 
respiratory activity in response to peripheral chemoreceptor and mechanoreceptor 
activation.  Specific NTS neurones may underpin the coupling of cardiovascular and 
respiratory activities due to the recruitment of both respiratory and autonomic pathways 
(Costa-Silva et al., 2010; Zoccal et al., 2014). There is interest in respiratory-sympathetic 
coupling as a potential contributor to elevated blood pressure observed in animal models of 
chronic intermittent hypoxia, modelling human OSA (Moraes et al., 2014; Machado et al., 
2017). 
1.4.6 Plasticity 
Due to the considerable capacity for impressive plasticity at both central and peripheral 
levels of the cardiorespiratory control system, plasticity is now recognised as a fundamental 
property of the integrated cardiorespiratory network (Fuller & Mitchell, 2017). 
Neuroplasticity describes a persistent modification in a neural control network based on a 
prior experience, resulting in reorganisation of structure and/or function within the network 
(Mitchell & Johnson, 2003). During both development and adulthood, physiological and 
pathological factors can challenge the neuronal network’s capacity to maintain 
cardiorespiratory homeostasis (Almado et al., 2012; Kumar & Prabhakar, 2012; Golubeva et 
al., 2015; O'Halloran, 2016; Fuller & Mitchell, 2017; Hocker et al., 2017). Such challenges 
include exercise, development/ageing, inflammation, stress and chronic and intermittent 
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hypoxia, amongst other factors (Powell et al., 2000; Mitchell & Johnson, 2003; Edge et al., 
2010; Golubeva et al., 2015; Hocker et al., 2017). Adaptive plasticity, which is vital in the 
maintenance of pH regulation and appropriate blood oxygenation, may occur in response to 
physiological challenges. However, maladaptive plasticity also presents, revealing l ong-
lasting perturbations to cardiorespiratory control and deleterious consequences for whole-
body health (Mitchell & Johnson, 2003; Peng et al., 2003; Bavis, 2005; Gulemetova & 
Kinkead, 2011; Edge et al., 2012; Fournier et al., 2013a; Kinkead et al., 2013; Golubeva et al., 
2015; Soliz et al., 2016; O'Halloran & McDonald, 2018). 
Chronic intermittent hypoxia (CIH): In rodents, exposure to CIH alters cardiorespiratory 
homeostasis at many levels of the control network, including motor pathways, central brain 
regions and peripheral chemoreceptors (Fuller et al., 2000; Peng et al., 2003; Kline et al., 
2007). Noteworthy, IH may induce adaptive responses in the control system.  However, 
depending on pattern, duration, intensity and timing of IH exposure, maladaptive plasticity 
can also occur (Lane et al., 2008; Gonzalez-Rothi et al., 2015). Many classic adverse effects 
develop due to CIH exposure. These include but are not limited to, development of 
hypertension, elevated sympathetic nervous activity, augmented peripheral chemoreflex 
responses, alterations in respiratory pattern such as increased central apnoeas and 
enhanced respiratory timing variability as well as disrupted cardiorespiratory coupling (Peng 
et al., 2003; Braga et al., 2006; Zoccal et al., 2008; Zoccal et al., 2009; Edge et al., 2012; 
Moraes et al., 2013; Lucking et al., 2014; O'Halloran, 2016; Laouafa et al., 2017). 
CIH can induce carotid body plasticity, which manifests as sensory long-term facilitation. This 
promotes sympathetic nervous system activation, culminating in the manifestation of CIH-
induced hypertension (Peng et al., 2003). CIH-induced plasticity of the carotid body is 
dependent upon reactive oxygen species production by NADPH oxidase, transcriptional 
regulation of hypoxia-inducible factors and serotonergic signalling (Peng et al., 2003; 
Prabhakar et al., 2007; Peng et al., 2009; Peng et al., 2011). More recently it has been shown 
that lactate, a metabolite that is increased during hypoxia activates olfactory receptor 78 on 
glomus cells of the carotid body with resultant increases in carotid sinus nerve activity (Chang 
et al., 2015).  
Notwithstanding the effects of CIH at the level of the carotid body, CIH can also induce 
central plasticity. The NTS, which is the integration site of chemoafferent information from 
the carotid chemoreceptors, is a site of central plasticity. CIH exposure results in altered 
glutamatergic neurotransmission and second-order neurone activity in the NTS. As a result 
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increased excitatory drive to respiratory motor neurones and sympathetic preganglionic 
neurones may occur, which at least in part, could lead to CIH-induced cardiorespiratory 
dysfunction (Kline et al., 2007; Costa-Silva et al., 2012).  Central plasticity is also well-
documented in several other locations within the brain, such as the pre-Bötzinger complex 
(the major respiratory rhythm-generating site of the brainstem), hypothalamic 
paraventricular nucleus and medullary network (Moraes et al., 2013; Garcia et al., 2016; Li 
et al., 2018).  
Additionally, CIH exposure induces enhanced long-term facilitation of motor pathways to the 
diaphragm, inspiratory intercostal, hypoglossal and laryngeal nerves (Fregosi & Mitchell, 
1994; Fuller et al., 2000; Bautista et al., 2012; Wilkerson et al., 2018).  Motor facilitation of 
pathways may occur via spinal serotonin release, spinal receptor 2 activation, TrkB receptor 
activation, ERK MAPK activity, reactive oxygen species formation and synthesis of brain 
derived neurotrophic factor (Baker-Herman & Mitchell, 2002; Baker-Herman et al., 2004; 
MacFarlane et al., 2009; Wilkerson & Mitchell, 2009).  
Stress: Acute and chronic stress, which disrupt programming of the HPA axis, an efferent 
pathway of the microbiota-gut-brain axis, have a significant impact on vital homeostatic 
behaviours and brain functions (O'Mahony et al., 2009; Golubeva et al., 2015; Kelly et al., 
2015; O'Halloran & McDonald, 2018). In rats, exposure to a single stress elevated c-fos 
activity in cardiorespiratory control regions including the NTS, locus coeruleus and 
parabrachial nucleus (Jaccoby et al., 1999; Berquin et al., 2000).  
Early life stress has devastating effects on the cardiorespiratory control network at various 
life stages, which can persist into adulthood depending on duration, intensity and timing of 
the stressor.  Perinatal stress augmented apnoea (respiratory pause) index, increased the 
coefficient of variation for respiratory frequency, elevated blood pressure and affected the 
hypoxic ventilatory response during early life and adulthood compared with control rats 
(Genest et al., 2004; Gulemetova & Kinkead, 2011; Fournier et al., 2013a; Golubeva et al., 
2015). Furthermore, maternal separation leads to more variable minute ventilation and tidal 
volume during non-rapid eye movement sleep and wakefulness compared with control 
animals (Kinkead et al., 2009).  Indeed, stress, particularly early life stress dampens the 
capacity to achieve adequate ‘fine-tuning’ of breath-to-breath ventilatory control and it 
alters blood pressure.  
Stress has been shown to elevate sympathetic drive, which may contribute to the 
hypertensive phenotype evident in stressed animal models (Fontes et al., 2014). Additionally, 
25 
 
it is conceivable that disturbed excitatory and inhibitory neurotransmission within the 
paraventricular nucleus and/or the NTS contributes to the altered hypoxic ventilatory 
response (Genest et al., 2007; Kinkead et al., 2008; Behan & Kinkead, 2011; Gulemetova et 
al., 2013). Furthermore, decreased serotonin and noradrenaline concentrations were 
evident in the medulla oblongata of new born rats subjected to gestational stress, which may 




1.5. Autonomic dysfunction and aberrant gut microbiota 
 
1.5.1 Stress and aberrant gut microbiota 
It is well known that stress and the HPA axis can influence the gut microbiota (Tannock & 
Savage, 1974; Kelly et al., 2015). Chronic social defeat, crowding and perinatal stress result 
in perturbations to gut microbiota structure and composition, with increased susceptibility 
to enteric pathogens (O'Mahony et al., 2009; Bailey et al., 2010; Foster et al., 2017; van de 
Wouw et al., 2018b). Chronic sleep disruption, an indirect stress, which occurs during sleep-
disordered breathing, disturbs gut microbial diversity and composition in mice and this 
remains altered for the duration of sleep fragmentation (Poroyko et al., 2016). Chronic sleep 
disruption increased the Firmicutes:Bacteroidetes ratio, which is an index of gut microbial 
imbalance and is associated with various pathologies (Poroyko et al., 2016). This increased 
ratio was due to growth of Lachnospiraceae and Ruminococcaceae families and a decrease 
in Lactobacillaceae and Bifidobacteriaceae families, which consists of many beneficial 
species (Poroyko et al., 2016). 
In a hypertensive model with heightened sympathetic activity, gut inflammation and 
decreased tight junction expression occurred, manifesting as increased intestinal 
permeability (Santisteban et al., 2017; Kim et al., 2018; Toral et al., 2019). These changes in 
gut pathology were associated with perturbed microbiota, including changes in Alistipes, 
Bacteroides and Bifidobacterium (Santisteban et al., 2017). Similarly, CIH exposure caused 
gut inflammation, oxidative stress and decreased tight junction expression, compromising 
intestinal barrier function (Wu et al., 2016). These maladies have previously been associated 
with disrupted gut microbiota (Kelly et al., 2015; Santisteban et al., 2017). Furthermore, CIH-
exposed mice had a Prevotella enterotype and altered bacterial genera, including 
proliferation of obligate anaerobes, increased Shannon index (a measure of microbiome 
evenness) and a distinct diversity cluster compared with control mice (Moreno-Indias et al., 
2015). Similarly, in mice, high-fat diet (HFD) and intermittent cycles of hypoxia and 
hypercapnia altered the gut microbiota and gut microbiota metabolites (Tripathi et al., 
2018). Additionally, in CIH-exposed mice, elevated levels of endogenous LPS were evident 
systemically (Moreno-Indias et al., 2015). Increased LPS is indicative of increased intestinal 
permeability, which may be due to sympathetic hyperactivity driven by CIH exposure 
(Fletcher et al., 1992c; Fletcher et al., 1992d; Santisteban et al., 2017). In a follow-up study, 
CIH-exposed mice were afforded 6-weeks of normoxia as a recovery strategy to mimic 
treatment for sleep-disordered breathing. However, after this recovery period, the presence 
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of endotoxins systemically and CIH-induced gut microbiota perturbations persisted (Moreno-
Indias et al., 2016).  
Systemic stress and CIH provoke sympathetic nervous system hyperactivity. This over-
activity appears to be a cause of disrupted gut microbiota composition and dive rsity (Wu et 
al., 2016; Santisteban et al., 2017). However, considering the vagus nerve is key in the 
microbiota-gut-brain axis and vagal activity is altered in animal models with sympathetic 
nervous system hyperactivity, it remains plausible that autonomic dysregulation influences 
the gut microbiota rather than hyperactivity of the sympathetic nervous system alone 
(Mancia & Grassi, 2014).  
CIH may also have direct effects on the gut microbiome. Interestingly, hyperbaric air affects 
the composition of the gut microbiota; a decrease in obligate anaerobes and an increase in 
total aerobes and facultative anaerobes occurred in hyperoxic rodent faecal samples 
compared with controls (Maity et al., 2012; Albenberg et al., 2014).   
CIH can affect the gut microbiome indirectly via autonomic dysregulation and/or by direct 
effects on the gut microbiota (Moreno-Indias et al., 2015; Moreno-Indias et al., 2016). 
Therefore, the gut microbiota is a potential source contributing to CIH-induced 
cardiorespiratory dysregulation via altered ‘microbiota-gut brain axis’ signalling initiated by 




1.6. Blood pressure, breathing and the gut microbiota 
 
1.6.1 Blood pressure and gut microbiota composition and diversity 
Hypertension is a risk factor for cardiovascular disease and stroke. High blood pressure is an 
independent risk factor associated with sleep-disordered breathing (Parish & Somers, 2004). 
Several animal models and human studies have recently linked the development of 
hypertension to aberrant gut microbiota composition and diversity (Yang et al., 2015; Durgan 
et al., 2016; Adnan et al., 2017; Li et al., 2017; Santisteban et al., 2017; Yan et al., 2017; Toral 
et al., 2019).  
An increased Firmicutes:Bacteroidetes ratio occurs in hypertensive rodents, which was also 
evident when the hypertensive phenotype was transferred via oral gavage (Yang et al., 2015; 
Adnan et al., 2017). Intriguingly, this shift was not observed in pre-hypertensive rodents 
(Santisteban et al., 2017) and an anti-hypertensive agent, minocycline, recovered the 
Firmicutes:Bacteroidetes ratio (Yang et al., 2015).  
Furthermore, hypertensive rodents have reduced bacterial diversity as evident by a decrease 
in microbial evenness and richness (Yang et al., 2015). Similarly, decreased species richness 
and evenness and distinct diversity cluster occurred in hypertensive individuals compared 
with normotensive individuals (Yang et al., 2015; Li et al., 2017; Yan et al., 2017). Of interest, 
in the gut of hypertensive patients there was lower metabolism of amino acids, cofactors, 
vitamins and short chain fatty acid producing enzymes and higher lipopolysaccharide 
biosynthesis, steroid degradation, trimethylamine producing enzymes and membrane 
transport compared with controls (Yan et al., 2017). Faecal transplant from two hypertensive 
patients into recipient germ-free mice produced hypertension and tachycardia in the 
recipient animals (Li et al., 2017).  Remarkably, faecal microbial transfer from normotensive 
donor rats to hypertensive recipient rats decreased blood pressure in the hypertensive 
recipients (Toral et al., 2019). 
Blood pressure and short-chain fatty acids: In hypertensive rats, butyrate- and acetate-
producing bacterial taxa, such as Clostridiaceae families and Bifidobacterium respectively, 
were significantly reduced with lactate-producing bacterial taxa, such as Streptococcaceae 
and Coriobacteriaceae families increased (Yang et al., 2015; Durgan et al., 2016; Santisteban 
et al., 2017; Ganesh et al., 2018; Kim et al., 2018).  The relative abundance of lactate-, 
butyrate- and acetate-producing bacterial taxa were associated with systolic blood pressure 
(Adnan et al., 2017; Toral et al., 2019). Lactobacillus a lactate-producing genus positively 
correlated with systolic blood pressure, whereas Clostridiaceae and Odoribactereae, 
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butyrate-producing families and Holdemani and Coprobacillus, acetate-producing genera, 
negatively correlated with systolic blood pressure (Adnan et al., 2017; Toral et al., 2019). 
Additionally, minocycline administration trended towards an increase in acetate - and 
butyrate-producing bacteria (Yang et al., 2015), showing that an increase in these bacterial 
taxa are associated with lower blood pressure.  
In rodent models, propionate, acetate and butyrate administration attenuated cardiac 
fibrosis, cardiac hypertrophy and hypertension in chronic angiotensin II -induced and 
mineralocorticoid excess-induced hypertension (Marques et al., 2017; Kim et al., 2018; 
Bartolomaeus et al., 2019). Additionally, acetate supplementation decreased the 
Firmicutes:Bacteroidetes ratio (Marques et al., 2017) and butyrate treatment normalised gut 
barrier dysfunction (Kim et al., 2018), two pathologies of hypertensive models (Adnan et al., 
2017; Santisteban et al., 2017). Remarkably, probiotic (Clostridium butyricum) or prebiotic 
(Hylon VII) administration prevented hypertension in a high-fat diet and obstructive sleep 
apnoea (HFD+OSA) rat model, increasing the abundance of several SCFA producing taxa and 
caecum acetate, which were decreased in the hypertensive model. Furthermore, probiotic 
or prebiotic administration prevented epithelial goblet cell loss, mucus barrier thinning and 
microglia activation, which were evident in the HFD+OSA hypertensive model. Impressively, 
chronic acetate administration into the caecum of rats during exposure to HFD+OSA restored 
caecal acetate concentrations and prevented the development of hypertension and gut 
inflammation (Ganesh et al., 2018).  
Blood pressure regulation by gut microbiota: The precise mechanism of how perturbed gut 
microbiota and microbiota metabolites contributes to hypertension has yet to be elucidated. 
At present, sympathetic neuronal communication between the hypothalamic 
paraventricular nucleus and the gut has been proposed to be involved in blood pressure 
regulation (Santisteban et al., 2017). Remarkably, faecal microbiota transfer from donor 
normotensive to recipient hypertensive rats decreased blood pressure, gut inflammation, 
plasma LPS as well as NADPH oxidase-dependent reactive oxygen species production and 
neuroinflammation in the hypothalamic paraventricular nucleus. Additionally, decreased 
plasma noradrenaline concentrations and blunted pentolinium-induced hypotensive 
responses were evident in recipient rats indicative of reduced sympathetic nervous system 
excitation (Toral et al., 2019). This proposed mechanism may have relevance in hypertensive 
CIH-exposed animals (Li et al., 2018).  
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Furthermore, studies in the literature have recurrently identified altered lactate, butyrate 
and acetate-producing bacterial taxa in hypertensive animal models (Yang et al., 2015; 
Durgan et al., 2016; Santisteban et al., 2017; Ganesh et al., 2018). Interestingly, SCFAs have 
been shown to affect brain microglia, reduce BBB permeability, influence neurotransmitter 
production and immune system regulation (DeCastro et al., 2005; Braniste et al., 2014; Erny 
et al., 2015; Stilling et al., 2016).  Moreover, SCFAs can cause neuronal activation (Lal et al., 
2001; Nohr et al., 2015), influencing the autonomic nervous system. When considered 
together, these studies suggest that hypertension, at least in part, results from the influence 
of perturbed gut microbiota on central cardiovascular control regions. Notwithstanding the 
influence of the sympathetic nervous system, given the dominant role of the vagus nerve, 
not only in microbiota-gut brain axis communication but also in the cardiorespiratory control 
network, microbiota-mediated dysfunction of vago-vagal signalling may contribute to 
development of hypertension. 
1.6.2 Respiratory control and gut microbiota 
Not only has the gut microbiota been associated with blood pressure control, but emerging 
evidence also suggests that the gut microbiota plays a potential role in respiratory 
physiology. Stress models have revealed maladaptive plasticity resulting in long-lasting 
insults to the respiratory control network (Fournier et al., 2013b; Kinkead et al., 2013; 
Golubeva et al., 2015; Tenorio-Lopes et al., 2017). Pre-natal stress results in enhanced 
variability of breathing frequency during normoxia and alters ventilatory control during 
hypoxic and hypercapnic chemostimulation in rat offspring. Importantly, these changes 
correlated with microbiota genera (Golubeva et al., 2015). Variability of breathing frequency 
during normoxia was associated with Mucispirillum and Papillibacter; respiratory frequency 
response to hypercapnia correlated with Oscillibacter and Anaerotruncus (Golubeva et al., 
2015).  Notably, these observed associations may well be interdependent due to the effects 
of systemic stress on the microbiota (O'Mahony et al., 2011; Foster et al., 2017; van de Wouw 
et al., 2018a).  
Given the anatomical location of central respiratory control regions, the potential for 
cardiorespiratory coupling and the involvement of the dominant communication pathway of 
the microbiota-gut brain axis, the vagus nerve, in the control of breathing, it is plausible to 
consider that perturbations to the gut microbiota could influence respiratory control.  
Moreover, it is interesting to speculate that there may be a putative role for specific taxa in 
the control of respiratory homeostasis.  
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1.7. Cardiorespiratory and pulmonary disorders  
 
1.7.1 Obstructive sleep apnoea (OSA) 
Although gut microbiota composition and diversity is modified in rodent models of SDB, at 
present there is paucity of information regarding the gut microbiome and microbiota 
metabolites in SDB patients. OSA is the most common form of SDB and has overwhelming 
consequences for integrative body systems, emerging as a major health crisis worldwide 
(Garvey et al., 2015). OSA is characterised by repetitive collapse of the pharyngeal airway 
exclusively during sleep, leading to the development of episodic oxygen fluctuations 
manifesting in exposure to CIH. Compelling evidence exists for an association between OSA 
and cardiorespiratory, metabolic and neurocognitive morbidities, with CIH well established 
as the primary driving pathogenic factor behind the host of well -characterised maladies 
associated with OSA (O'Halloran, 2016).  
It has recently been shown that OSA patients fall into any of the three enterotypes, 
Bacteroides, Ruminococcus and Prevotella (Ko et al., 2019). Using apnoea-hypopnea index 
greater than 15, it was established that sleep architecture including arousal time and index, 
non-rapid eye movement phase 1, and sleep latency were altered in Prevotella enterotype 
OSA patients compared with patients with Bacteroides and Ruminococcus (Ko et al., 2019). 
It is interesting to note that CIH exposure in mice also resulted in development of a Prevotella 
enterotype (Moreno-Indias et al., 2015). Moreover, in the urine of OSA patients a number of 
metabolites were different compared with controls; 5 of these metabolites related to the 
gut microbiota  (Xu et al., 2018).  
Although much remains to be known about the gut microbiota in OSA patients, advances 
have shown that oral, nasal and lung microbiota are significantly altered in OSA patients (Lu 
et al., 2018a; Wu et al., 2018; Xu et al., 2018). Firmicutes, Proteobacteria and Fusobacteria 
were significantly different in both lung and oral OSA samples compared with controls (Lu et 
al., 2018a; Xu et al., 2018). Interestingly, 7 genera of the nasal microbiota correlated with 
apnea-hypopnea index in OSA patients (Wu et al., 2018). Continuous positive airway 
pressure, the gold standard for treatment of SDB did not alter nasal microbiome diversity in 
OSA patients (Wu et al., 2018).  
1.7.2 Apnoea of prematurity and bradycardia 
It is interesting to note that premature babies, where the gut microbiota is significantly 
distinct to that of full-term infants, often develop apnoea of prematurity and bradycardia 
(Barrett et al., 2013; Korpela et al., 2018). Apnoea of prematurity and bradycardia occur due 
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to immature respiratory centres and an underdeveloped nervous system (Cohen & Katz-
Salamon, 2005). Furthermore, there is early deprivation of neuroprotective hormones 
including progesterone, in preterm infants; the lack of progesterone may have implications 
for brain development (Berger & Soder, 2015; Bairam et al., 2019). Moreover, the gut 
microbiota is involved in early programming of brain circuits (Sudo et al., 2004; Diaz Heijtz et 
al., 2011; Clarke et al., 2013; Desbonnet et al., 2014). Of interest, progesterone 
supplementation alters the gut microbiota and increases Bifidobacterium abundance during 
the 3rd trimester of pregnancy in humans and rodents (Nuriel-Ohayon et al., 2019). Notably, 
decreased Bifidobacterium is evident in preterm infants (Dahl et al., 2017; Korpela et al., 
2018), in tandem with reduced progesterone levels (Bairam et al., 2019). Studies have 
established that progesterone has an important role in respiratory regulation during the 
postnatal period in animals (Lefter et al., 2007; Bairam et al., 2013; Joseph et al., 2018). It is 
interesting to speculate that there may be interplay between the gut microbiota and 
progesterone in the control of breathing at least during neonatal life.  
Furthermore, organisms such as Staphylococcus Aureus often colonise the infant’s 
gastrointestinal and respiratory tract and may cause or aggravate cardiorespiratory 
dysfunctions (Hofstetter et al., 2008). CIH is a dominant pathological feature of apnoea of 
prematurity and directly/indirectly influences the gut microbiota (Moreno-Indias et al., 2015; 
Moreno-Indias et al., 2016). Perhaps the gut microbiota may in part contribute to maturation 
of cardiorespiratory centres within the brain and have relevance for apnoea of prematurity 
and bradycardia. 
1.7.3 Asthma 
Several studies have linked alterations to the gut microbiota during early life with increased 
risk of asthma later in life (van Nimwegen et al., 2011; Abrahamsson et al., 2014; Arrieta et 
al., 2015). Caesarean section delivery increased the risk of developing airway sensitivity up 
to 12 years of age (Keag et al., 2018). Additionally, asthmatic children had reduced gut 
microbiota diversity at 1 week and 1 month of age compared with non-asthmatic children 
(Abrahamsson et al., 2014). Furthermore, the relative abundance of faecal Veillonella, 
Faecalibacterium, Rothia and Lachnospiracea were reduced in children at high risk of asthma 
(wheezy and atopy). Interestingly, faecal acetate was also decreased in these children 
(Arrieta et al., 2015). Reduced gut microbiota diversity was evident in asthmatic adults 
compared with healthy controls (Wang et al., 2018).   
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Not only are microbiota alterations evident in the gut of asthmatic patients but changes are 
evident in the lung microbiota. Proteobacteria enrichment has been described in lungs of 
asthmatic patients (Hilty et al., 2010; Huang et al., 2015). In patients with moderate to severe 
asthma an abundance of Haemophilus was evident (Hilty et al., 2010). Klebsiella or Moraxella 
catarrhalis species were present in patients with severe asthma (Huang et al., 2015).  
Of note, pregnant mice receiving acetate supplementation had suppressed expression of 
genes linked to human asthma and mouse allergic airways disease in offspring (Thorburn et 
al., 2015). In asthmatic children, Lactobacillus acidophilus and Bifidobacterium bifidum 
improved lung function and reduced asthmatic exacerbations (Gutkowski et al., 2011).  
1.7.4 Chronic Obstructive Pulmonary Disease  
COPD is a progressive inflammatory disease characterised by persistent airflow limitation, 
leading to the development of hypoxia. To date, there is a paucity of studies investigating 
the gut microbiome in COPD patients. Smoking, which is a leading cause of COPD, has 
significant impact on gut microbiota structure.  Smoking increased Proteobacteria and 
Bacteroidetes phyla, as well as Clostridium, Bacteroides and Prevotella (Benjamin et al., 2012; 
Wang et al., 2012). Conversely, Actinobacteria and Firmicutes phyla, as well as 
Bifidobacterium and Lactococcus were reduced due to cigarette smoke (Tomoda et al., 2011; 
Savin et al., 2018).  
Additionally, it is well-established that potentially pathogenic taxa, including Pseudomonas 
aeruginosa, Haemophilus influenza and Streptococcus colonise the lungs in COPD patients 
(Garcia-Vidal et al., 2009; Simpson et al., 2016; Wang et al., 2016). Non-pathogenic Bacillus 
species were decreased in the lungs of COPD patients (Simpson et al., 2016).  
1.7.5 Cystic fibrosis 
Cystic fibrosis is an autosomal recessive disease due to a mutation in the cystic fibrosis 
transmembrane conductance regulatory gene. Cystic fibrosis patients have decreased gut 
microbiota diversity and altered composition compared wi th healthy controls.  These 
compositional changes include increased Firmicutes:Bacteroidetes ratio as well as 
Staphylococcus, Propionibacterium acnes, Clostridium difficile and Clostridiaceae in cystic 
fibrosis patients (Burke et al., 2017; Vernocchi et al., 2018). Decreased abundance of healthy 
gut taxa including Roseburia, Bifidobacterium and Faecalibacterium were also evident (Burke 
et al., 2017). Moreover gut microbiota differences were reported between various stages of 
cystic fibrosis (mild, moderate, severe)(Burke et al., 2017). Interestingly, Lactobacillus GG 
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administration to cystic fibrosis patients promoted beneficial gut microbiota and decreased 




1.8. Knowledge gaps addressed in this thesis 
 
This area of research is undoubtedly in its infancy and currently there is paucity of studies 
investigating the role of microbiota-gut-brain axis signalling in cardiorespiratory and 
autonomic control. There is tremendous potential for microbiota-gut-brain axis signalling to 
play a regulatory role in cardiorespiratory homeostasis and dysfunction. At present, it 
remains unclear if the gut microbiota contributes to respiratory control and reflex 
responsiveness. Although a picture is emerging to illustrate that the development of 
hypertension is in part related to aberrant gut microbiota, there is a scarcity of studies 
assessing the role of the microbiota-gut-brain axis in cardiorespiratory homeostasis (Figure 
1.3). 
Exposure to CIH has been shown to affect major homeostatic control systems, altering the 
gut microbiota, enhancing sympathetic nervous system activity and destabilising 
cardiorespiratory control. However, it is not known if CIH affects the gut microbiota, 
independent of sympathetic hyperactivity. Furthermore, there is a need to determine if 
aberrant microbiota-gut-brain axis signalling at least partly contributes to cardiorespiratory 
dysfunction evident in CIH animal models. In parallel, there is a dearth of studies examining 
if beneficial modulation of the gut microbiota can improve or prevent cardiorespiratory 
dysfunctions that present in animal models associated with perturbed microbiota. These 
specific knowledge gaps amongst others are unravelled in this thesis.  
Cardiovascular and respiratory diseases are serious and potentially life-threatening 
conditions (Benziger et al., 2016).   These illnesses are leading causes of mortality and 
disability worldwide, with cardiovascular disease being the number one cause of death 
(Thomas et al., 2018). Globally more than 100 million people suffer from SDB alone 
(Organization, 2007).  Untreated cardiorespiratory conditions/diseases result in 
exacerbation of symptoms, culminating in a portfolio of pathologies. Prolonged SDB may 
result in the development of cardiovascular disease, hypertension, stroke and cognitive 
deficits, to the name but a few maladies. Currently, there are multiple and often successful 
efforts to treat cardiovascular and respiratory diseases, including but not limited to beta 
blockers, lipid-lowering therapies and continuous positive airway pressure (Thomas et al., 
2018). However, treatments are not always favourable due to ineffectiveness or lack of 
compliance (Van Ryswyk et al., 2019). It is of immense interest to further investigate the role 
of microbiota-gut-brain axis signalling in cardiorespiratory homeostasis and dysfunction in 




Figure 1. 3 The microbiota-gut-brain axis, brain and behaviours 
A number of communication pathways are proposed as potential mechanisms of microbiota-
gut-brain axis signalling. A growing body of evidence suggests vagal-mediated 
communication is the primary signalling pathway between the gut microbiota and the 
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brainstem (Fulling et al., 2019). SCFAs, metabolites of the gut microbiota, can bind freely to 
free-fatty acid receptors located throughout the body, including vagal ganglia (Sina et al., 
2009; Tolhurst et al., 2012; Nohr et al., 2015; Lu et al., 2018b). Gut hormones are released 
as a consequence of SCFAs binding to free-fatty acid receptors on enteroendocrine cells 
(Tolhurst et al., 2012). SCFAs also have the capacity to affect microglia within the brain (Erny 
et al., 2015). The gut microbiota can facilitate central neurotransmitter regulation by 
synthesising and releasing neurotransmitters from bacteria directly or by altering levels of 
neurotransmitter precursors i.e. tryptophan (Desbonnet et al., 2010; Lyte, 2013, 2014a; 
O'Mahony et al., 2015). The immune system also functions as a communication pathway of 
the microbiota-gut-brain axis (El Aidy et al., 2014b). Cytokines signal to the brain via 
numerous pathways, including detection by vagal afferent fibres (Goehler et al., 2000; 
Johnston & Webster, 2009).   There is evidence to demonstrate that altered microbiota-gut-
brain axis signalling affects neurocontrol systems, with consequences for behaviours such as 
social interactions, learning and memory, stress, eating behaviour and anxiety. Currently, 
there is a dearth of studies investigating the regulatory role of the gut microbiota in 
cardiorespiratory control. ACTH, adrenocorticotrophic hormone; CRF, corticotropin-
releasing factor; SCFA, short-chain fatty acid. Cortisol and corticosterone are released from 
the adrenal medulla in humans and rodents, respectively.  
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1.9. Thesis structure and specific aims 
 
The primary aim of this thesis was to investigate if microbiota-gut-brain axis signalling plays 
a regulatory role in cardiorespiratory and autonomic control. We sought to explore 
cardiorespiratory and reflex responsiveness in animal models of manipulated gut microbiota 
and of SDB, to uncover if altered microbiota, in the form of dysbiosis, manifests in 
cardiorespiratory impairments. Additionally, we aimed to unravel some of the mechanisms 
by which homeostatic functions are maintained or disrupted as a resul t of microbiota 
disturbances. Moreover, we explored whether manipulation of the gut microbiota via 
various methods, routinely deemed beneficial, could ameliorate or prevent cardiorespiratory 
dysfunctions evident in animal models. 
Chapter 2: Manipulation of gut microbiota blunts the ventilatory response to hypercapnia in 
adult rats. 
 We aimed to perform a comprehensive assessment of cardiorespiratory control and 
reflex responsiveness to chemostimulation and drug administration in adult rats 
following antibiotic administration or vehicle.  
 We hypothesised that there would be evidence of aberrant plasticity in 
cardiorespiratory control in antibiotic-treated rats.  
 We sought to examine monoamine concentrations in brain regions and ex vivo 
intestinal permeability in adult rats following antibiotic administration or vehicle.  
 Thereafter, in a subset of animals, we aimed to explore if manipulation of the 
microbiota via faecal microbiota transfer could normalise the gut microbiota and 
reverse or ameliorate effects of antibiotic administration on cardiorespiratory 
control. 
 We sought to assess monoamine concentrations in brain regions and ex vivo 
intestinal permeability in adult rats following faecal microbiota transfer.  
Chapter 3: Chronic intermittent hypoxia disrupts cardiorespiratory homeostasis and gut 
microbiota composition in adult male guinea-pigs. 
 We aimed to explore the effects of exposure to CIH on cardiorespiratory physiology 
and reflex responsiveness to chemostimulation and drug administration in guinea-
pigs, mammals with hypoxia-insensitive carotid bodies. 
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 We hypothesised that CIH exposure would not lead to the development of 
hypertension in guinea-pigs, supporting the obligatory role for carotid body 
sensitisation in manifestation of CIH-induced hypertension. 
 We sought to examine monoamine concentrations in brainstem regions and urine 
catecholamine and corticosterone concentrations in sham and CIH guinea-pigs. 
 We aimed to assess the effects of CIH on the gut microbiota, independent of carotid 
body sensitisation, to consider if altered gut microbiota might have consequences 
for putative residual cardiorespiratory dysfunctions in CIH-exposed guinea-pigs. 
Chapter 4: Chronic intermittent hypoxia lowers Lactobacillus rhamnosus relative abundance 
and increases apnoea index and blood pressure: Effects of prebiotic supplementation 
 We aimed to perform an assessment of gut microbiota structure, cardiorespiratory 
control and reflex responsiveness in adult rats following CIH exposure.  
 We sought to examine monoamine concentrations in brainstem regions and plasma 
corticosterone and inflammatory markers in CIH-exposed rats. 
 We hypothesised that there would be evidence of cardiorespiratory dysfunction, 
altered brainstem neurochemistry and modified gut microbiota in CIH-exposed rats. 
 We aimed to investigate if manipulation of the microbiota via prebiotic 
administration could prevent or ameliorate the deleterious effects of CIH exposure 
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Abbreviations: ABX, antibiotic-treated; AIH, acute intermittent hypoxia; BH, Benjamini-
Hochberg; DA, dopamine; Dia, diaphragm; EMG, electromyogram; ETCO2, end-tidal carbon 
dioxide; FDR, false discovery rate; FLASH, fast length adjustment of short reads to improve 
genome assemblies; FMT, faecal microbiota transfer; fR, respiratory frequency; FiCO2, 
fractional inspired carbon dioxide concentration; F iO2, fractional inspired oxygen 
concentration; Hb, haemoglobin; HVA, homovanillic acid; L-DOPA, L-3,4-
dihydroxyphenylalanine; NA, noradrenaline; OTUs, operational taxonomic units; PBG, 
phenylbiguanide; PBS, phosphate buffered saline; PCoA, Principal coordinates analysis; 
PaCO2, partial pressure of arterial carbon dioxide; PD whole tree, phylogenetic whole tree 
diversity; PaO2,  partial pressure of arterial oxygen; QIIME, quantitative insights into 
microbial ecology; SaO2, arterial oxygen saturation; SD1, short-term respiratory timing 
variability; SD2, long-term respiratory timing variability; Te, expiratory time; Ti, inspiratory 
time; Ttot, total breath duration; Vco2, carbon dioxide; VE, minute ventilation; production; 
VEH, vehicle, autoclaved deionised water; VE/Vco2, ventilatory equivalent for CO2; Vo2, 
oxygen consumption; VT, tidal volume; VT/Ti, mean inspiratory flow; 5-HIAA, 5-







Background: It is increasingly evident that perturbations to the diversity and composition of 
the gut microbiota have significant consequences for the regulation of integrative 
physiological systems. There is growing interest in the potential contribution of microbi ota-
gut-brain signalling to cardiorespiratory control in health and disease.  
Methods: In adult male rats, we sought to determine the cardiorespiratory effects of 
manipulation of the gut microbiota following a 4-week administration of a cocktail of 
antibiotics. We subsequently explored the effects of administration of faecal microbiota 
from pooled control (vehicle) rat faeces, given by gavage to vehicle- and antibiotic-treated 
rats.  
Findings: Antibiotic intervention depressed the ventilatory response to hypercapnic stress in 
conscious animals, owing to a reduction in the respiratory frequency response to carbon 
dioxide. Baseline frequency, respiratory timing variability, and the expression of apnoeas and 
sighs were normal. Microbiota-depleted rats had decreased systolic blood pressure. Faecal 
microbiota transfer to vehicle- and antibiotic-treated animals also disrupted the gut 
microbiota composition, associated with depressed ventilatory responsiveness to 
hypercapnia. Chronic antibiotic intervention or faecal microbiota transfer both caused 
significant disruptions to brainstem monoamine neurochemistry, with increased 
homovanillic acid:dopamine ratio indicative of increased dopamine turnover, which 
correlated with the abundance of several bacteria of six different phyla.   
Interpretation: Chronic antibiotic administration and faecal microbiota transfer disrupt gut 
microbiota, brainstem monoamine concentrations and the ventilatory response to 
hypercapnia. We suggest that aberrant microbiota-gut-brain axis signalling has a modulatory 
influence on respiratory behaviour during hypercapnic stress.  
Funding: Department of Physiology and APC Microbiome Ireland, University College Cork, 
Ireland. 
Keywords: Antibiotics; faecal microbiota transfer; breathing; hypercapnia; cardiovascular; 





Research in Context 
 
Evidence before this study: The microbiota-gut-brain axis is implicated in the homeostatic 
control of physiological systems; however, its potential influence on the control of 
breathing is unclear.  
Added value of this study: Chronic antibiotic administration in rats depleted gut microbiota, 
increased gut permeability, altered brainstem neurochemistry and depressed the 
ventilatory response to hypercapnic stress. Faecal microbiota transfer in vehicle- and 
antibiotic-treated rats significantly disrupted the microbiota composition, with associated 
disruptions to brainstem neurochemistry and depressed ventilation during hypercapnia. 
Brainstem monoamine neurochemistry correlated with the relative abundance of several 
bacteria, primarily of the Firmicutes phylum.   
Implications of all the available evidence: Manipulation of the gut microbiota disrupts 
respiratory behaviour suggesting that the microbiota-gut-brain axis has the capacity to alter 









There is a growing understanding of the significance of the gastrointestinal microbiome and 
its modulatory capacity in the homeostatic regulation of multiple physiological systems 
(Dinan & Cryan, 2017). Trillions of gut microbiota form a co-dependent, mutualistic 
relationship with the host, contributing to whole-body health (Bordenstein & Theis, 2015), 
through an extensive multimodal communication pathway termed the ‘microbiota-gut-brain 
axis’ (Sudo et al., 2004). Dysregulated microbiota-gut-brain axis signalling disrupts major 
neurocontrol systems affecting anxiety, pain, depression and social behaviours (Neufeld et 
al., 2011; O'Mahony et al., 2014; De Palma et al., 2015; Kelly et al., 2016b; Burokas et al., 
2017; Golubeva et al., 2017; Stilling et al., 2018). Multiple contributors to microbiota-gut-
brain axis communication have been identified, including neural pathways, immune 
mediators, bacterial metabolites, serotonin and tryptophan metabolism, host genetics and 
gut hormones (Burokas et al., 2015). There is a wide appreciation of the potential 
contribution of microbiota-gut-brain signalling to cardiorespiratory control in health and 
disease (Golubeva et al., 2015; Durgan et al., 2016; Adnan et al., 2017; Santisteban et al., 
2017; Ganesh et al., 2018; Lucking et al., 2018b).  
The cardiorespiratory system is tightly regulated by neuronal networks residing within the 
brainstem. Respiratory rhythm and pattern, generated by complex brainstem networks is 
transduced via multiple efferent pathways, directly or indirectly via the spinal nuclei to the 
striated muscles of breathing, which provides for exquisite breath-by-breath control of 
pulmonary ventilation (Alheid & McCrimmon, 2008; Garcia et al., 2011). Autonomic centres 
within the medulla oblongata (dorsal motor nucleus of the vagus, nucleus ambiguus and 
rostral ventrolateral medulla) transduce parasympathetic and sympathetic motor outflow to 
the heart and circulation. Of interest, there is considerable respiratory-related modulation 
of autonomic efferent signalling. The vagus nerve, a key bi -directional communication 
pathway of the microbiota-gut-brain axis (Bonaz et al., 2018), provides visceral information 
from sensors in multiple peripheral sites to the nucleus of the solitary tract within the 
brainstem. There is considerable sensory-cued modulation of respiratory motor and 
autonomic outputs, from the periphery, which execute efficient cardiorespiratory control. 
Notwithstanding the primary homeostatic function of the neural networks governing 
breathing and blood pressure regulation, there is ample evidence in support of a remarkable 
capacity for plasticity at multiple sites within the control network, both at a central and 
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peripheral level, which underpin adaptive and maladaptive outcomes (Peng et al., 2009; 
Almado et al., 2012; Kumar & Prabhakar, 2012; Fuller & Mitchell, 2017; Hocker et al., 2017).  
Maladaptive plasticity expressed in several stress models have revealed considerable long-
lasting perturbations to respiratory control, with deleterious consequences for whole -body 
health (Bavis, 2005; Gulemetova & Kinkead, 2011; Fournier et al., 2013b; Kinkead et al., 2013; 
Soliz et al., 2016). Prenatal stress results in enhanced respiratory variability and alters 
ventilatory control during hypoxic and hypercapnic chemostimulation in rat offspring during 
adulthood (Golubeva et al., 2015). Interestingly, respiratory frequency responses to 
hypercapnia correlated with alterations in the gut microbiota (Golubeva et al., 2015). 
Recently, exposure to chronic intermittent hypoxia, modelling human sleep apnoea, was 
shown to disrupt cardiorespiratory homeostasis, with evidence of decreased prevalence of 
protective sigh behaviours, altered autonomic control of heart rate, decreased brainstem 
noradrenaline concentration, and altered gut microbiota composition (Lucking et al., 2018b). 
To our knowledge, there are no other studies of the effects of manipulation of the microbiota 
on the control of breathing. Yet importantly, animal models of sleep-disordered breathing 
show evidence of altered microbiota composition and diversity, driven by altered diet and/or 
exposure to intermittent hypoxia (Moreno-Indias et al., 2015; Durgan et al., 2016; Moreno-
Indias et al., 2016; Tripathi et al., 2018). Thus, it appears that respiratory dysregulation has 
the capacity to alter the microbiota. It is important to determine if disruption to the 
microbiota affects respiratory homeostasis.    
Of relevance, the gut microbiota are important modulators of cardiovascular control. The 
transfer of faeces from hypertensive donors (spontaneously hypertensive rats, a 
hypertensive model of sleep-disordered breathing fed a high-fat diet, and hypertensive 
human donors) into normotensive recipient or germ-free animals leads to the development 
of hypertension in the recipient animal (Yang et al., 2015; Durgan et al., 2016; Adnan et al., 
2017; Li et al., 2017). A decrease in butyrate-producing and an increase in lactate-producing 
bacteria are associated with a hypertensive phenotype (Yang et al., 2015; Durgan et al., 2016; 
Adnan et al., 2017). More recently, it was established in an animal model of obstructive sleep 
apnoea that acetate is a key player in blood pressure regulation (Ganesh et al., 2018). 
Collectively, these findings suggest an influential role for the microbiota-gut brain axis in 
cardiovascular homeostasis.  
It is established that chronic administration of a cocktail of broad-spectrum antibiotics 
significantly depletes the gut microbiota (Desbonnet et al., 2015; Hoban et al., 2016). It is 
75 
 
also recognised that alterations to the gut microbiota can influence brain behaviours at a 
functional level (Hoban et al., 2016; Kelly et al., 2016b; Burokas et al., 2017; Stilling et al., 
2018). Thus, we sought to perform a comprehensive assessment of cardiorespiratory 
physiology in the context of a manipulated gut microbiota. We examined cardiorespiratory 
control and reflex responsiveness in adult rats following a 4-week antibiotic intervention 
period. We hypothesised that there would be evidence of aberrant plasticity in 
cardiorespiratory control in antibiotic-treated rats. Thereafter, in a subset of animals, we 
explored if manipulation of the microbiota via faecal microbiota transfer could reverse or 







2.2. Methods  
 
2.2.1 Ethical approval 
All procedures on live animals were performed under licence from the Government of 
Ireland Department of Health (B100/4498) in accordance with National and European Union 
directive 2010/63/EU, with prior ethical approval by University Coll ege Cork (AEEC 
#2013/035). Experiments were conducted in accordance with guidelines established by 
University College Cork’s Animal Welfare Body. 
2.2.2 Experiment animals 
Ten-week old adult male Sprague Dawley rats (n=40; purchased from Envigo, UK) were 
housed as age-matched pairs in standard rat cages. All animals were housed under a 12-hour 
light: 12-hour dark cycle with standard rodent chow available ad libitum.  
2.2.3 Antibiotic administration 
Rats were randomly allocated to receive autoclaved deionised water (vehicle, VEH; n = 20) 
or broad-spectrum antibiotics (ABX; n=20) in autoclaved deionised water for 4-weeks. To 
deplete the microbiota, we used an antibiotic cocktail consisting of ampicillin (1g/l), 
vancomycin (500mg/l), ciprofloxacin (20mg/l), imipenem (250mg/l) and metronidazole (1g/l) 
(Hoban et al., 2016; Kelly et al., 2016b). Water bottles were replenished every second day 
and water consumption recorded per cage. Animal body weights were monitored daily 
(Appendix Fig. A.1 a). Weight loss in the beginning of ABX intervention is a commonly 
reported side effect related to the aversive taste of the ABX cocktail. Fresh bedding was given 
to ABX and VEH groups every other day to decrease the risk of microbiota re -establishment 






Figure 2. 1 Experimental design 
Schematic representation of the experimental design employed in the study. 
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2.2.4 Faecal microbiota transfer (FMT) protocol 
Collection and processing of donor microbiota for faecal microbiota transplantation: Donor 
faecal microbiota was acquired from the pooled faeces of 10 VEH rats, collected fresh from 
individual animals by massaging the lower abdomen and promoting the passage of faeces 
from the rats. Both the collection and the transportation and processing of faeces occurred 
under anaerobic conditions to prevent loss of anaerobic microbiota. Sterile reduced 
phosphate-buffered saline (PBS; 10ml) containing 20% glycerol (v/v) was added to each 1g 
of pooled faeces. The faecal material was thoroughly re-suspended. Samples were 
centrifuged at 2000rpm for 5 minutes at 4˚C (MIKRO 22R refrigerated centrifuge) to generate 
a sediment of undigested dietary fibres. Supernatants were aliquoted, frozen and stored at 
-80°C until use in oral gavage. 
Administration of FMT: ABX rats (n=10) received a washout period of autoclaved deionised 
water for three days and VEH rats (n=10) remained on autoclaved deionised water. Two 
inoculations of donor microbiota (300µl) were administered via oral gavage to ABX and VEH 
rats, on day 1 and day 7 following the washout period. To reinforce the donor microbiota 
phenotype, the ABX rats were transferred to bedding previously occupied by VEH rats on 
inoculation day 1 and thereafter on a weekly basis (ABX-FMT group). VEH rats were 
transferred to fresh bedding adhering to the pattern described above (VEH-FMT group). All 
animals received autoclaved deionised water for the duration of the 4-week period (Fig. 2.1). 
2.2.5 Assessment of respiratory flow and metabolism in unrestrained, unanaesthetised rats 
Whole-body plethysmography: Whole-body plethysmography (DSI, St. Paul, Minnesota, USA) 
was used to record respiratory flow during quiet rest in unrestrained, unanaesthetised rats. 
This was performed at the animal housing facility of University College Cork as this subset of 
animals subsequently remained in the facility for faecal microbiota transfer and housing for 
a further period of 4 weeks. Animals were introduced into custom chambers (601-1427-001 
PN, DSI) with room air pumped through the chambers (3l/min) ensuring the maintenance of 
oxygen (O2) and carbon dioxide (CO2). Animals were allowed to acclimate for 30-90 minutes 
to allow habituation to the surroundings. Contemporaneous observations were performed 
in ABX (n=10) versus VEH (n=10) and subsequently ABX-FMT (n=10) versus VEH-FMT (n=10) 
using a pair of plethysmograph chambers. 
Metabolic measurements: CO2 production (VCO2) and O2 consumption (VO2) were measured 
in animals throughout the whole-body plethysmography protocol (O2 and CO2 analyser; AD 
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Instruments, Colorado Springs, CO, USA) as previously described (Haouzi et al., 2009; Bavis 
et al., 2014; Burns et al., 2017; Burns et al., 2018). 
Experimental protocol: Once the acclimation period was complete, a 10-15-minute steady-
state normoxia period allowed for the assessment of baseline parameters (FiO 2=0.21; 
balance N2). Thereafter, rats were exposed to a 10-minute poikilocapnic hypoxia challenge 
(FiO2=0.10; balance N2). Each animal was then allowed to recover during normoxia 
(FiO2=0.21; balance N2) to re-establish stable breathing. Subsequently, another baseline 
period was recorded and rats were then exposed to a hypercapnic challenge (FiCO 2=0.05; 
balance O2) for 10 minutes followed by a recovery period. A new baseline period was 
determined and animals were then exposed to 10 successive cycles of acute intermittent 
hypoxia (AIH), consisting of alternating periods of normoxia (FiO2=0.21; balance N2) for 6 
minutes and hypoxia (FiO2=0.10, balance N2) for 6 minutes. Following the AIH protocol, a 
normoxia period was established (FiO2=0.21; balance N2) for 1 hour. On completion of the 
experimental protocol, faecal pellets in the plethysmograph chambers were counted per unit 
time.  
Data analysis for whole-body plethysmography and metabolism: Respiratory parameters 
including respiratory frequency (fR), tidal volume (VT), minute ventilation (VE), inspiratory 
time (Ti) and expiratory time (Te) were recorded on a breath-by-breath basis for analysis 
(Finepoint software Buxco Research Systems, Wilmington, NC, USA). Artefacts in the signals 
due to movement and sniffing were excluded from analysis. A steady-state baseline period 
was averaged during normoxia to assess ventilatory and metabolic parameters at quiet rest. 
For acute hypoxic and hypercapnic challenges, respiratory and metabolic data were averaged 
for the last 5 minutes of these exposures to ensure adequate time for gas mixing in the 
chambers and assessment of steady-state ventilatory and metabolic responses. Data are 
expressed as a change in the absolute values from baseline values. Furthermore, to 
determine the peak hypoxic ventilatory response, respiratory frequency was averaged every 
10 seconds for the first 120 seconds of the acute hypoxic gas challenge. Similarly, for the 
acute hypercapnic challenge, the respiratory frequency response was averaged for each 
minute of the 10-minute challenge. For AIH challenges, respiratory data were compared 
between groups for the last hypoxia challenge and expressed as a percentage change from 
the preceding baseline normoxia exposure. Data from the post-AIH normoxic period was 
collected at 5 minute intervals. The last 5-minute epoch of the 1-hour period of normoxia 
following exposure to AIH was compared with the normoxic baseline period preceding AIH 
and expressed as percentage change from baseline as a measure of AIH-induced respiratory 
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plasticity. Comparisons were made between the experimental groups. Respiratory flow 
signals were also analysed to quantify the occurrence of apnoeas (post-sigh apnoeas and 
spontaneous apnoeas) and augmented breaths (sighs) during normoxic baseline and hypoxic 
and hypercapnic breathing as previously described (Edge et al., 2012). An apnoea was 
defined as two consecutive missed breaths and data are expressed as apnoea index (number 
of apnoeas per hour). Sighs (augmented breaths) were distinguished as breaths with double 
the amplitude of the average VT. Poincaré plots were constructed showing breath-to-breath 
(BBn) versus the subsequent breath-to-breath interval (BBn+1) allowing determination of 
short-term (SD1) and long-term (SD2) respiratory timing variability during stable baseline as 
well as hypoxia and hypercapnia breathing. VT, VE, VT/Ti, VO2 and VCO2 were normalised per 
100g body mass. 
2.2.6 Assessment of cardiorespiratory parameters under urethane anaesthesia  
Surgical protocol and cardiorespiratory measures: Cardiorespiratory parameters were 
assessed in rats under urethane anaesthesia (1.5g/kg i.p.; 20% w/v) following isoflurane 
induction (5% by inhalation in room air). Depth of anaesthesia was assessed throughout the 
surgical and experimental protocol by carefully monitoring reflex responses to tail/paw pinch 
and the corneal reflex. If required, supplemental doses of anaesthetic were given. Rats were 
placed in the supine position and core body temperature was maintained at 37˚C using a 
homeothermic blanket system (Harvard Apparatus, Holliston, MA, USA) and a rectal 
temperature probe. 
A mid-cervical tracheotomy was performed. The right jugular vein was then cannulated for 
intravenous (i.v.) infusion of supplemental anaesthetic and drugs. Next, the right carotid 
artery was cannulated and a pressure catheter inserted into the left ventricle to record left 
ventricular contractility (dP/dt max); artefacts were observed in the pressure signals in some 
animals and data acquired from these animals was excluded. The femoral artery was 
cannulated for the recording of arterial blood pressure and the withdrawal of arterial blood 
samples for blood gas, pH and electrolyte analysis (i -STAT; Abbott Laboratoies Ltd). All rats 
were maintained with a bias flow of supplemental O2 to preserve arterial oxygen saturation 
above 95% during basal conditions (SaO2; Starr Life Sciences, PA, USA). A pneumotachometer 
and a CO2 analyser (microCapStar End-Tidal CO2 analyser; CWE Inc., USA) were connected to 
a tracheal cannula to determine tracheal flow and end-tidal CO2 (ETCO2), respectively. A 
concentric needle electrode (26G; Natus Manufacturing Ltd, Ireland) was inserted into the 
costal diaphragm for the continuous measurement of diaphragm electromyogram (EMG) 
activity. Signals were amplified (x5,000), filtered (band pass; 500-5,000Hz) and integrated 
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(50ms time constant; Neurolog system, Digitimer Ltd, UK). LabChart v7 (ADInstruments) was 
used to display data in real-time.  
Experimental protocol: An arterial blood gas sample was attained following a 30-minute 
period of stabilisation. Following the stabilisation period, baseline parameters were assessed 
for 10 minutes. An electronic gas mixer (GSM-3 Gas Mixer; CWE Inc.) was used to manipulate 
the gas composition of the bias flow to administer chemostimulation challenges to the rat. 
The rats were exposed to a graded hypercapnic challenge: FiCO2=0.05 and 0.10 
(supplemental O2; balance N2) consecutively for 5 minutes each. Following a recovery period, 
animals were challenged with poikilocapnic hypoxia (FiO2=0.10, balance N2) for 5 minutes, 
followed by a 5 minute hypoxic hypercapnic challenge (FiO2=0.10, FiCO2=0.05, balance N2). 
After the chemostimulation challenges and a sufficient recovery period, the serotonin type 
3 (5-HT3) receptor agonist phenylbiguanide was administered in incremental doses (PBG; 2, 
4, 8, 16, 32 µg/kg; i.v.) to stimulate pulmonary vagal afferent C-fibres (Dutta & Deshpande, 
2010; Lucking et al., 2018a). Then animals underwent bilateral cervical vagotomy. After a 20-
minute recovery period, another blood gas sample was acquired and post-vagotomy baseline 
parameters were determined. The chemostimulation challenges described above were 
repeated under vagotomised conditions. Finally, a single bolus of 32 µg/kg PBG was 
administered to confirm that PBG-induced pulmonary chemoreflex responses were entirely 
dependent upon vagal nerve transmission. 
Animals were euthanised by urethane overdose i.v. and whole brains were i mmediately 
harvested and frozen in -80°C isopentane and stored at -80°C until required. The caecum was 
removed, weighed and caecal contents were removed rapidly and snap frozen in liquid 
nitrogen. The distal ileum and proximal colon were removed. The heart was removed and 
the right ventricle and left ventricle + septum were separated and weighed. The lungs were 
removed and weighed and then were allowed to air dry at 37°C for at least 48 hours and re-
weighed.  
Data analysis of cardiorespiratory parameters in anaesthetised rats: 10 minutes of stable 
recording were averaged (baseline data) and are presented as absolute values. For 
cardiorespiratory and EMG responses during graded hypercapnia, hypoxia, hypoxic 
hypercapnia, vagotomy and chemostimulation challenges post-vagotomy, for each reported 
parameter, the average of the last minute of recordings was determined and data were 
compared with the 1-minute pre-challenge baseline. To assess the dynamic response to PBG 
administration, data were averaged in 3-second bins and the maximal response for each 
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concentration was determined for each cardiorespiratory parameter reported. 
Cardiovascular responses to PBG were expressed as absolute change from the preceding 
baseline value. Maximum apnoea and post-apnoea tachypnoea data from PBG stimulation 
were expressed as the duration of the apnoea or tachypnoea period normalised to the 
average cycle duration determined during the baseline period preceding PBG challenges i.e. 
fold change. Cardiorespiratory responses to vagotomy and chemostimulation before and 
after vagotomy were expressed as absolute change from the preceding baseline. EMG 
responses to vagotomy and chemostimulation before and after vagotomy were expressed 
as percent change from the preceding baseline value.  
2.2.7 Macromolecular permeability in small and large intestine ex vivo  
Epithelial permeability: Ussing chambers: In a subset of animals, distal ileum and proximal 
colon were removed and examined ex vivo. Distal ileum (a 2.0 cm segment adjacent to the 
caecum) and proximal colon (2.0 cm most distal segment of proximal colon) were gently 
flushed, cut open along the mesenteric line and mounted in Ussing chambers with an 
exposed tissue area of 0.12cm2. Tissue was bathed with Krebs solution (in mM: 1.2 NaH2PO4; 
117 NaCl; 4.8 KCl; 1.2 MgCl2; 25 NaHCO3; 11 CaCl2 and 10 glucose) at 37°C with continuous 
carbogen (95% O2, 5% CO2) supply. 4-kDa FITC-dextran (4kDa, FD4, Sigma, Ireland) was added 
to the mucosal (luminal) chamber at a final concentration of 2.5mg/ml. To assess FITC flux 
through the epithelial barrier, samples (200μl) were collected from the serosal chamber at 0 
(baseline), 60 and 120 minutes after the addition of FITC. At each time-point, the volume 
removed was replenished with Krebs buffer. To exclude the potential contribution of ileac 
Na+-glucose co-transporter (Slc5a1) to paracellular permeability, glucose in the mucosal 
chamber buffer was substituted with 10mM mannitol in ileac tissue samples (Turner et al., 
1997).  
Data analysis: FITC was measured on VICTOR-1 plate reader (PerkinElmer) at 485nm 
excitation/535nm emission wavelengths. FITC mucosal-to-serosal flux was calculated as an 
increment in fluorescence intensity versus baseline fluorescence over time and presented as 
ng/ml. 
2.2.8 Brainstem monoamine concentrations 
High-performance liquid chromatography (HPLC) coupled to electrochemical detection for 
the measurement of brainstem monoamine concentrations: After euthanasia, whole brains 
were immediately removed from the rats and snap frozen in isopentane cooled in liquid 
nitrogen. Whole brains were transferred to -80˚C for long-term storage. The frozen 
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brainstem was dissected from the brain at -20˚C and subsequently sonicated in 1ml of chilled 
mobile phase spiked with 2ng/20µl of N-methyl 5-HT (internal standard) (Bandelin Sonolus 
HD 2070). High-performance liquid chromatography was performed as previously described 
(Lucking et al., 2018b). The monoamines noradrenaline (NA), dopamine (DA), serotonin (5-
HT), monoamine precursor L-3,4-dihydroxyphenylalanine (L-DOPA) and metabolites 5-
hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were assessed. Each 
monoamine and metabolite were identified by their respective characteristic retention 
times. This was determined by standard injections, which were run at regular intervals during 
the sample analysis.  
Data analysis: Class-VP5 software processed chromatographs that identified specific 
monoamines. Analyte:internal standard peak response ratios were used to calculate 
concentrations. Data are expressed as nanograms of neurotransmitter pe r gram of tissue 
weight (ng/g). 
2.2.9 16S rRNA sequence-based microbiota composition and diversity analysis in caecal 
content 
Caecal microbiota DNA extraction and 16S rRNA gene sequencing: DNA extraction and 16S 
rRNA gene sequencing was performed as previously described (Lucking et al., 2018b).  
Bioinformatic sequence analysis: FLASH (fast length adjustment of short reads to improve 
genome assemblies) was used to assemble 300 base paired-end reads. Thereafter, QIIME 
suite of tools (Quantitative Insights Into Microbial Ecology) version 1.9.0 was used to further 
process paired-end reads. This processing included quality filtering based on a quality score 
> 25 and removal of mismatched barcodes and sequences below length thresholds. 
Denoising, chimera detection and operational taxonomic units (OTUs) clustering were 
performed using USEARCH v7 (64-bit)(Edgar, 2010). PyNAST (a flexible tool for aligning 
sequence to a template alignment) was used to align OTUs. BLAST against the SILVA SSURef 
database release 123 was used to assign taxonomy. Alpha diversity was generated in QIIME 
(Caporaso et al., 2010). 
2.2.10 Statistical analysis 
For data sets with confirmed normal distribution, a one-way ANOVA with Bonferroni post 
hoc where appropriate or parametric two-tailed Student’s unpaired t tests with Welch’s 
correction where appropriate were used to test for statistically significant between-group 
differences. When the assumption of normal distribution was violated, a non-parametric 
Kruskal-Wallis with Dunn’s post hoc where appropriate or non-parametric Mann-Whitney U 
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tests where appropriate were used. Two-way ANOVA or repeated measures two-way ANOVA 
with Bonferroni post hoc where appropriate were used for relevant data sets. Microbiota 
data are expressed as median (IQR). All other data sets are expressed as means ± SD or are 
displayed graphically as box and whisker plots (median, IQR and minimum to maximum 
values). Microbiota analysis was performed in SPSS and R software environment. The OTUs 
detected only in ≤ two animals in each group were excluded from the analysis. Bacterial 
genera that were significantly different at least in one comparison were used to construct 
the Log2 fold change ratio heatmap. The 2D principal coordinates analysis (PCoA) plot based 
on Bray-Curtis distance matrices was constructed using R (version 3.4.4), R Studio (version 
1.1.453), and the “vegan” package (version 2.5.1) using the vegdist function and 
recommended parameters. For the correlation analysis between the microbiota composition 
and a large array of parameters including cardiorespiratory, neuromodulators and intestinal 
permeability, Hierarchical All-against-All association-testing (HAllA) was used (version 0.8.7) 
with Spearman correlation as correlation metric and medoid as clustering method. 
Spearman correlation coefficients were determined for a subset of associations and data are 
graphically illustrated showing individual data points. GraphPad Prism Software v6 
(GraphPad Software, San Diego, CA, USA) was used for all other statistical analysis. Statistical 
significance was set at p<0.05. Benjamini-Hochberg (BH) adjustment procedure was applied 
with the false discovery rate (FDR) set at 10% and 20% to correct for multiple testing in the 
relative abundance and correlation analyses, respectively. Adobe Illustrator CS5 (v15) was 









2.3.1 Body and tissue weights 
Compared with VEH controls, ABX rats tended to be underweight (Appendix Fig. A.1a), 
coincident with significantly reduced fluid intake during the first week of the experimental 
protocol (p=0.001, two-way ANOVA with Bonferroni post hoc, Appendix Fig. A.1b). During 
respiratory assessment in the plethysmograph chambers, manipulation of the gut microbiota 
altered faecal output per hour (p=0.04, Kruskal-Wallis, Appendix Fig. A.1c). Microbiota 







































380 ± 23 369 ± 22     436 ± 27 420 ± 24 <0.0001 0.999 0.888 0.0001 0.0002 0.004 0.0001 
RV 
(mg/100g) 
58 ± 6 51 ± 3 55 ± 7 61 ± 6 0.009 0.133 0.196 0.999 0.008 0.999 0.999 
LV 
(mg/100g) 
219 ± 14 207 ± 10 206 ± 14 208 ± 9 0.053 - - - - - - 
LV+RV 
(mg/100g) 












79 ± 3 78 ± 1 77 ± 1 79 ± 3 0.017 0.999 0.196 0.112 0.999 0.999 0.016 
 
Table 2. 1 Body and organ weights 
BW, body weight; RV, right ventricle; LV, left ventricle; VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal 
microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as mean ± SD and were statistically 
compared using one-way ANOVA with Bonferroni post hoc where appropriate, or non-parametric Kruskal-Wallis test with Dunn’s post hoc, where 




2.3.2 Baseline ventilation and metabolism in behaving rats during quiet rest 
During baseline breathing, VT, fR, and VE and VCO2 were all equivalent between groups (Table 
2.2). However, manipulation of the gut microbiota had a significant effect on the ventilatory 
equivalent for carbon dioxide (VE/VCO2) (p=0.042, one-way ANOVA, Table 2.2). VE/VCO2 was 
significantly reduced in VEH-FMT rats compared with VEH rats (one-way ANOVA with 
Bonferroni post hoc, Table 2.2). 
2.3.3 Respiratory timing variability, apnoeas and sighs during normoxia in behaving rats 
during quiet rest 
Assessments of both short-term (SD1) and long-term (SD2) respiratory timing variability 
during normoxia were equivalent between groups: T i (Table 2.2), Te (p>0.05, one-way 
ANOVA, Fig. 2.2e, f) and total breath duration (Ttot, p>0.05, Fig. 2.2g, h). Sigh frequency was 
affected by manipulation of the gut microbiota (Fig. 2.2n). There was no difference in apnoea 
index (Fig. 2.2l) during normoxia between groups (p>0.05). The apnoea index combines 
spontaneous and post-sigh apnoeas, both of which were equivalent in their respective 
prevalences between groups (p>0.05). Furthermore, the average duration of apnoeas was 





Figure 2. 2 Chronic antibiotic administration and faecal microbial transfer do not alter 
respiratory timing variability, or the prevalence of apnoeas and sighs in behaving rats 
during quiet rest 
Poincaré plots of breath-to-breath (BBn) and subsequent breath-to-breath (BBn+1) interval 
of expiratory duration (Te; a, c) and total breath duration (Ttot; b, d) for 200 consecutive 
breaths for VEH and ABX (a, b) and VEH-FMT and ABX-FMT rats (c, d). Group data for Te short-
term variability (SD1; e) and long-term variability (SD2; f) and Ttot SD1 (g) and SD2 (h) in VEH, 
ABX, VEH-FMT and ABX-FMT rats during normoxia. Representative respiratory flow traces 
(downward deflections represent inspiration) illustrating a spontaneous sigh followed by an 
apnoea (i), a spontaneous apnoea (j) and a spontaneous sigh (k). Group data of apnoea index 
(l), apnoea duration (m) and sigh frequency (n). VEH, autoclaved deionised water; ABX, 
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antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, 
antibiotic-treated followed by faecal microbiota transfer. Groups (e-h, l-n) are expressed as 
box and whisker plots (median, IQR and minimum to maximum values); n=10 for all groups. 
Groups were statistically compared by one-way ANOVA or non-parametric Kruskal-Wallis 

































50 ± 6 51 ± 8 48 ± 6 49 ± 7 0.855 - - - - - - 
VT 
(ml/100g) 




2.5 ± 0.4   2.5 ± 0.6 2.5 ± 0.5  2.6 ± 0.4 0.936 - - - - - - 
Ti (ms) 252 ± 23         264 ± 36 261 ± 26 259 ± 33 0.813 - - - - - - 
Te (ms) 537 ± 96 557 ± 86 527 ± 101 565 ± 132 0.844 - - - - - - 
Ti  SD1  
(ms) 
29  ±  9 24  ±  7 28 ± 11   24 ±  6 0.484 - - - - - - 
Ti  SD2 
(ms) 




2.7 ± 0.6 3.3 ± 1.0 3.2 ± 0.7 3.0 ± 0.9 0.414 - - - - - - 
VCO2 (ml/ 
min/100g) 
1.6 ± 0.3 1.8 ± 0.2 1.8 ± 0.2  1.7 ± 0.3 0.093 - - - - - - 
VE/VCO2 33 ± 6 30 ± 7 27 ± 2 29 ± 3 0.042      0.999 0.999  0.032 0.999   0.437     0.700 
 
Table 2. 2 Baseline ventilation, respiratory timing variability and metabolism in behaving rats during quiet rest  
fR, respiratory frequency (brpm, breaths per min); VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, 
expiratory time; SD1, short-term respiratory timing variability; SD2, long-term respiratory timing variability VO2, oxygen consumption; VCO2, carbon 
dioxide production; VE/VCO2, ventilatory equivalent; VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal 
microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as mean ± SD and were statistically 
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compared using one-way ANOVA with Bonferroni post hoc where appropriate, or non-parametric Kruskal-Wallis test, where appropriate. Each p-




2.3.4 Ventilatory and metabolic responsiveness to chemostimulation in behaving rats during 
quiet rest 
Ventilatory and metabolic responsiveness to hypoxia : No significant differences were 
observed between respective groups in ventilatory and metabolic responsiveness to hypoxia 
determined under steady-state conditions during the last 5 minutes of exposure (two-way 
ANOVA, Fig. 2.3b, c, f, g, j, k, repeated measures two-way ANOVA; Appendix Fig.  A.2a, b, e, 
f, i, j; and Table 2.3). However, analysis during the first 120 seconds of hypoxia, when the 
peak hypoxic ventilatory response was observed, revealed that manipulation of the gut 
microbiota had a significant effect on minute ventilation due to a decrease in the respiratory 
frequency response in ABX rats compared with VEH rats (VE, time, p=0.0001; ABX, p=0.045; 
time x ABX, p=0.459, two-way ANOVA; fR, time, p=0.0001; ABX, p=0.022; time x ABX, 
p=0.486, two-way ANOVA, Appendix Fig.  A.3a) and in VEH-FMT rats compared with VEH rats 
(VE, time, p=0.0001; FMT, p=0.001; time x FMT, p=0.0009, two-way ANOVA; fR, time, 
p=0.0001; FMT, p=0.002; time x FMT, p=0.039, two-way ANOVA, Appendix Fig. A.3c). 
Ventilatory responses to the AIH protocol were equivalent between respective groups 
(p>0.05; Appendix Fig. A.4, Appendix Table A.1). 
Ventilatory and metabolic responsiveness to hypercapnia: One of the major findings of this 
study is that manipulation of the gut microbiota has a significant effect on the  ventilatory 
response to hypercapnia (p=0.02, Kruskal-Wallis, Table 2.5). VE was significantly blunted in 
ABX rats compared with VEH rats (p=0.038, two-way ANOVA, Fig. 2.3h; and p=0.045; Kruskal-
Wallis with Dunn’s post hoc, Table 2.5), a consequence of reduced fR response to CO2 
challenge (p=0.044, two-way ANOVA, Fig. 2.3d; and p=0.043, one-way ANOVA with 
Bonferroni post hoc, Table 2.5). Further analysis of the fR response during each minute of the 
hypercapnic exposure revealed a significant difference in the fR response to CO2 challenge in 
ABX rats compared with VEH rats (time, p<0.0001; ABX, p=0.047; time x ABX, p=0.638, 
Appendix Fig. A.5a). The hypoventilation was evident as a blunted VE/VCO2 response  in ABX 
rats compared with VEH rats, however this was not statistically significant (p=0.093, two-way 
ANOVA, Fig. 2.3l), with values for VCO2 during hypercapnia equivalent between groups (data 
not shown). Manipulation of the gut microbiota had a significant depressant effect on 
ventilatory drive to breathe (VT/Ti) in response to hypercapnic challenge (Table 2.5). No other 
ventilatory differences were noted between groups (Appendix Fig. A.5b-d and Table 2.5). 
Repeated measures two-way ANOVA was performed for ventilatory and metabolic 
responsiveness to hypercapnia revealing that FMT significantly decreased VE (gas, p<0.0001; 
FMT, p=0.014; gas x FMT, p=0.043; repeated measures two-way ANOVA, Appendix Fig. A.2g),  
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fR (gas, p<0.0001; FMT, p=0.046; gas x FMT, p=0.103; repeated measures two-way ANOVA, 
Appendix Fig. A.2c)  and VE/VCO2 (gas, p<0.0001; FMT, p=0.003; gas x FMT, p=0.048; repeated 
measures two-way ANOVA, Appendix Fig. A.2k) in VEH-FMT rats compared with VEH rats. 
Repeated measures two-way ANOVA revealed no difference for VE, fR, and VE/VCO2 in ABX 
rats compared with ABX-FMT (Appendix Fig. A.2d, h, i). Similarly, no differences were 
observed for values in ABX-FMT rats compared with VEH-FMT rats (Fig 2.3e, I, m; p>0.05; 
two-way ANOVA). 
2.3.5 Respiratory timing variability, apnoeas and sighs during hypoxia and hypercapnia in 
behaving rats during quiet rest 
Assessments of short-term (SD1) and long-term (SD2) respiratory timing variability for Ti, Te 
and Ttot in response to hypoxia (Table 2.4) and for Te and Ttot in response to hypercapnia 
(Table 2.6) were equivalent between groups. Ti SD2 in hypercapnia was altered by microbiota 
manipulation (Table 2.6). There was no difference in apnoea index or sigh frequency (Table 
2.4 and 2.6) between groups. Furthermore, the average duration of apnoeas during 















Figure 2. 3 Chronic antibiotic administration and faecal microbial transfer blunts 
hypercapnic ventilation in behaving rats during quiet rest 
a) Representative traces of typical respiratory flow during normoxic, hypoxic and 
hypercapnic ventilation in VEH, ABX, VEH-FMT and ABX-FMT rats; downward deflections 
represent inspiration. Group data for respiratory frequency (b, c, d, e), minute ventilation (f, 
g, h, i) and ventilatory equivalent (j, k, l, m) during normoxia and in response to hypoxia (b, 
c, f, g, j, k) and hypercapnia (d, e, h, i, l, m) for VEH and ABX (b, f, j, d, h, l) and VEH-FMT and 
ABX-FMT (c, g, k, e, i, m). VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-
FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by 
faecal microbiota transfer. Data (b-m) are expressed as mean ± SD during baseline, hypoxia 
and hypercapnia; n=10 for all groups. Groups were statistically compared by two-way ANOVA 
with Bonferroni post hoc where appropriate. p-values are shown. ** p<0.01, ABX versus VEH, 
Bonferroni post hoc test.  
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Δ fR (brpm) 68 ± 20 63 ± 20 57 ± 21 65 ± 17 0.585 
Δ VE (ml/min/ 100g) 43 ± 8 36 ± 14 36 ± 9 43 ± 13 0.244 
Δ VT (ml/100g) 0.07 ± 0.08 0.06 ± 0.08 0.08 ± 0.06 0.02 ± 0.08 0.35 
Δ VT/Ti (ml/s/100g) 4.4 ± 0.7 4.1 ± 1.1 3.6 ± 0.7 4.1 ± 0.6 0.168 
Δ Ti (ms) -87 ± 28 -95 ± 41 -87 ± 32 -92 ± 34 0.933 
Δ Te (ms) -236 ± 62 -239 ± 78 -208 ± 72 -263 ± 106 0.153 
Δ VO2 (ml/min/ 100g) -1.0 ± 0.7 -1.4 ± 1.1 -0.9 ± 0.8 -0.86 ± 0.9 0.522 
Δ VCO2 (ml/min/ 
100g) 
0.2 ± 0.5 -0.005 ± 0.3 0.09 ± 0.2 0.02 ± 0.2 0.444 
Δ VE/VCO2 22 ± 10 20 ± 9 18 ± 6 24 ± 5 0.335 
 
Table 2. 3 Ventilatory and metabolic responsiveness during hypoxia in behaving rats during 
quiet rest 
fR, respiratory frequency (brpm, breaths per min); V E, minute ventilation; VT, tidal volume; 
VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory time; SD1, short-term 
respiratory timing variability; SD2, long-term respiratory timing variability VO2, oxygen 
consumption; VCO2, carbon dioxide production; VE/VCO2, ventilatory equivalent; VEH, 
autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal 
microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. 
Data are shown as mean ± SD and were statistically compared using one-way ANOVA with 
Bonferroni post hoc where appropriate. Each p-value is adjusted to account for multiple 
comparisons. Data are expressed as absolute change from baseline (Δ parameter). 
 
Table 2. 4 Respiratory timing variability, apnoeas and sighs during hypoxia in behaving rats 
during quiet rest 
Ti, inspiratory time; Te, expiratory time; Ttot, total breath duration; SD1, short-term respiratory 
timing variability; SD2, long-term respiratory timing variability; VEH, autoclaved deionised 
water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-
FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as mean ± SD 
and were statistically compared using one-way ANOVA or non-parametric Kruskal-Wallis test 
where appropriate.  
 






Ti SD1 (ms) 28 ± 5 30 ± 6 30 ± 6 29 ± 7 0.744 
Ti SD2 (ms) 57 ± 10 67 ± 19 59 ± 9 57 ± 16 0.272 
Te SD1 (ms) 79 ± 28 89 ± 35 77 ± 15  80 ± 31 0.804 
Te SD2 (ms) 140 ± 27 147 ± 32 132  ± 37 130 ± 42 0.699 
Ttot SD1 (ms) 102 ± 31 112  ± 38 99  ± 15 102  ± 33 0.803 
Ttot SD2 (ms) 217 ± 30 237 ± 35 217 ± 32 203 ± 64 0.405 
Apnoea index 
(events/hr) 
0.6 ± 1.9 3.0 ± 4.2 1.2 ± 2.5 1.2 ± 2.5 0.398 
Sigh frequency 
(events/hr) 









































   0.33 - - - - - - 
Δ VT/Ti 
(ml/s/100g) 
4.7 ± 1.6 3.1 ±  1.3 2.9 ± 1.0 3.0 ± 0.8 0.028 0.131 0.999 0.059 0.999 0.082 0.999 
Δ Ti (ms) -75 ± 42 - 46 ± 33 -58 ± 35 -49 ± 30 0.253 - - - - - - 








- 0.2 ± 0.4 - 0.3 ± 0.5 - 0.2 ± 0.6 - 0.2 ± 0.5 0.886 - - - - - - 
Δ VE/VCO2 59  ± 30 35 ± 31 36 ±  18 38 ± 18 0.115 - - - - - - 
 
Table 2. 5 Ventilatory and metabolic responsiveness during hypercapnia in behaving rats during quiet rest 
fR, respiratory frequency (brpm, breaths per min); VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, 
expiratory time; SD1, short-term respiratory timing variability; SD2, long-term respiratory timing variability VO2, oxygen consumption; VCO2, carbon 
dioxide production; VE/VCO2, ventilatory equivalent; VEH, autoclaved deionised water; ABX, antibiotic-administration; VEH-FMT, VEH followed by 
faecal microbiota transfer; ABX-FMT, antibiotic administration followed by faecal microbiota transfer. Data are shown as mean ± SD and were 
statistically compared using one-way ANOVA with Bonferroni post hoc where appropriate, or non-parametric Kruskal-Wallis test with Dunn’s post 
hoc, where appropriate.  Each p-value is adjusted to account for multiple comparisons. p-values shown in bold highlight significant differences. 


























Ti SD1 (ms) 24 ± 6 18 ± 8 17 ± 5 17 ± 4 0.042 0.232 0.999 0.091 0.999 0.083 0.999 
Ti SD2 (ms) 55 ± 27 29 ± 14 30 ± 11 36 ± 10 0.004 0.006 0.999 0.019 0.701 0.511 0.999 
Te SD1 (ms) 28 ± 46 54 ± 27 53 ± 29 51 ± 22 0.697 - - - - - - 
Te SD2 (ms) 109 ± 55 73 ± 32 78  ± 34 76 ± 28 0.329 - - - - - - 
Ttot SD1 (ms) 80 ± 29 64  ± 31 62  ± 26 61  ± 24 0.375 - - - - - - 




5.5 ± 5.5 9.5 ± 5.5 11.0 ± 6.1 12.0 ± 8.6 0.159 - - - - - - 
Apnoea 
duration (s) 




14 ± 6 14 ± 5 15 ± 7 19 ± 11 0.87 - - - - - - 
 
Table 2. 6 Respiratory timing variability, apnoeas and sighs during hypercapnia in behaving rats during quiet rest 
Ti, inspiratory time; Te, expiratory time; Ttot, total breath duration; SD1, short-term respiratory timing variability; SD2, long-term respiratory timing 
variability; VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-
treated followed by faecal microbiota transfer. Data are shown as mean ± SD and were statistically compared using one-way ANOVA with Bonferroni 
post hoc where appropriate, or non-parametric Kruskal-Wallis test with Dunn’s post hoc, where appropriate.  Each p-value is adjusted to account for 
multiple comparisons. p-values shown in bold highlight significant differences.
98 
 
2.3.6 Cardiorespiratory recordings in anaesthetised rats 
Baseline cardiorespiratory and blood gas parameters: Baseline cardiorespiratory and blood 
gas measurements in anaesthetised rats are shown in Table 2.7. There were no significant 
differences for baseline respiratory parameters between groups. Arterial blood oxygenation, 
pH and carbon dioxide and bicarbonate concentration were equivalent across groups. 
Haematocrit and haemoglobin concentrations were significantly lower in ABX rats compared 
with VEH rats. Manipulation of the gut microbiota lowered systolic blood pressure (Table 
2.7). Post hoc analysis revealed that systolic blood pressure was significantly lower in ABX 
rats compared with VEH, VEH-FMT and ABX-FMT rats but no difference in mean arterial 










































fR (brpm) 99 ± 13 103 ± 9 92 ± 14 88 ± 12 0.066 - - - - - - 
VE (ml/ min/ 
100g) 
35.9 ± 3.7 36.3 ± 4.6 31.6 ± 6.7 30.2 ± 12 0.071 - - - - - - 
VT (ml/ 100g) 0.36 ± 0.03 0.35 ± 0.04 0.34 ± 0.05 0.38 ± 0.06 0.312 - - - - - - 
ETCO2 5.9 ± 0.6 5.9 ± 0.9 5.6 ± 0.6 5.6 ± 0.6 0.536 - - - - - - 
pH 7.34 ± 0.02 7.36 ± 0.06 7.36 ± 0.03 7.37 ± 0.03 0.272 - - - - - - 
PaCO2 (mmHg) 48.2 ± 3.9 47.2 ± 7.9 48.6 ± 5.2 45.2 ± 4.3 0.272 - - - - - - 
PaO2 (mmHg) 107 ± 16 100 ± 8 106 ± 10 104 ± 6 0.712 - - - - - - 
[HCO3- ] 
(mmol/ l) 
26.3 ± 1.2 26.4 ± 2.0 27.1 ± 1.4 26.1 ± 0.9 0.106 - - - - - - 
TCO2 (mmol/l) 27.7 ± 1.3 27.8 ± 2.4 28.3 ± 1.5 27.5 ± 1.0 0.303 - - - - - - 
SaO2 (%) 97.5 ± 1.1 97.3 ± 0.9 97.7 ± 0.7 97.6 ± 0.7 0.987 - - - - - - 
[Na+] (mmol /l) 136.6 ± 2.6 137.0 ± 1.8 135.4 ± 1.4 135.1 ±1.4 0.078 - - - - - - 
[K+ ] (mmol/l) 4.2 ± 0.1 4.0 ± 0.2 4.2 ± 0.1 4.2 ± 0.2 0.149 - - - - - - 
Haematocrit 
(%) 
51.7 ± 2.9 47.9 ± 2.0 48.3 ± 2.9 49.7 ± 2.3 0.016 0.024 0.999 0.062 0.665 0.792 0.999 
[Hb] (g/dl) 17.5 ± 0.9 16.3 ± 0.7 16.1 ± 1.4 16.1 ± 2.9 0.021 0.028 0.999 0.082 0.999 0.596 0.999 
MAP (mmHg) 96 ± 9 93 ± 12 90 ± 10 94 ± 13 0.712 - - - - - - 
DBP (mmHg) 73 ± 9 74 ± 13 66 ± 7 70 ± 12 0.463 - - - - - - 
SBP (mmHg) 148 ± 15 119 ± 12 140 ± 15 147 ± 15 0.0005 0.0007 0.999 0.999 0.001 0.999 0.024 
HR (bpm) 410 ± 29 407 ± 40 389 ± 27 410 ± 28 0.438 - - - - - - 
 
Table 2. 7 Baseline ventilation, blood gases and cardiovascular measurements in anaesthetised rats 
fR, respiratory frequency (brpm, breaths per min); VE, minute ventilation; VT, tidal volume; ETCO2, end-tidal carbon dioxide production; Pco2, partial 
pressure of arterial carbon dioxide; Pao2, partial pressure of arterial oxygen; [HCO3-], bicarbonate concentration; TCO2, total carbon dioxide; SaO2, 
arterial oxygen saturation; [Na+], sodium concentration; [K+], potassium concentration; [Hb], haemoglobin concentration; MAP, mean arterial blood 
pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate (bpm, beat per min); VEH, autoclaved de ionised water; ABX, 
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antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data 
are shown as mean ± SD and were statistically compared using one-way ANOVA with Bonferroni post hoc where appropriate, or non-parametric 
Kruskal-Wallis test with Dunn’s post hoc, where appropriate.  Each p-value is adjusted to account for multiple comparisons. p-values shown in bold 
highlight significant differences. 
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Cardiorespiratory responses to 5-HT3 receptor agonism evoking the cardiopulmonary reflex: 
Stimulation, using PBG, of 5-HT3 receptors found on pulmonary vagal afferent nerves evoked 
the integrated cardiopulmonary reflex with no significant difference in apnoea duration in 
ABX rats compared with VEH rats (p>0.05, two-way ANOVA, Fig. 2.4b), or in ABX-FMT rats 
compared with VEH-FMT rats (p>0.05, two-way ANOVA, Fig. 2.4f). A similar outcome was 
determined for post-apnoea induced tachypnoeic episodes in ABX rats compared with VEH 
rats (p>0.05, two-way ANOVA, Fig. 2.4c), and ABX-FMT rats compared with VEH-FMT rats 
(p>0.05, two-way ANOVA, Fig. 2.4g). The depressor response to PBG administration 
(hypotension) and bradycardia were also equivalent between ABX rats and VEH rats ( p>0.05, 
two-way ANOVA, Fig. 2.4d, e) and in ABX-FMT rats compared with VEH-FMT rats (p>0.05, 
two-way ANOVA, Fig. 2.4h, i). The cardiorespiratory responses to high-dose PBG were 






Figure 2. 4 Chronic antibiotic administration and faecal microbial transfer do not alter 
cardiorespiratory responses to phenylbiguanide administration in anaesthetised rats  
a) Representative traces of blood pressure (red indicates mean value), heart rate, tracheal 
airflow, raw and integrated diaphragm (Dia) electromyogram (EMG) activity and arterial 
oxygen saturation (SaO2) during intravenous administration of 5-HT3 agonist 
phenylbiguanide (PBG; 8µg/kg) indicated by the upwards arrow. Group data for maximum 
apnoea duration (b, f) and tachypnoea (c, g) normalised to baseline respiratory period in 
response to 2 ,4, 8, 16 and 32µg/kg of PBG for VEH and ABX (b, c) and for VEH-FMT and ABX-
FMT rats (f, g). Absolute change in mean arterial blood pressure (MAP; d, h) and heart rate 
(e, i) in response to 2 ,4, 8, 16 and 32µg/kg of PBG for VEH and ABX (d, e) and for VEH-FMT 
and ABX-FMT rats (h, i). VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, 
VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal 
microbiota transfer. Data (b-i) are expressed mean ± SD; VEH (n=8), ABX (n=8), VEH-FMT 
(n=9) and ABX-FMT (n=10). Groups were statistically compared by two-way ANOVA for VEH 
and ABX and separately for VEH-FMT and ABX-FMT.   
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2.3.7 Brainstem neurochemistry 
L-DOPA, DA, HVA, HVA/DA ratio, 5-HT and 5-HIAA concentrations in the brainstem were 
significantly affected by manipulation of the gut microbiota (p<0.05; one -way ANOVA or 
Kruskal-Wallis, Fig. 2.5). Additionally, post hoc analysis revealed that compared with VEH, 
ABX brainstem homogenates contained elevated concentrations of L-DOPA (p=0.009; 
Kruskal-Wallis with Dunn’s post hoc, Fig. 2.5a) and an increased HVA/DA ratio (p=0.0001; 
one-way ANOVA with Bonferroni post hoc, Fig. 2.5d), a consequence of augmented HVA 
concentrations (p<0.0001, one-way ANOVA with Bonferroni post hoc, Fig. 2.5c) and 
decreased DA concentrations (p=0.025; one-way ANOVA with Bonferroni post hoc, Fig. 2.5b). 
ABX-FMT samples compared with VEH, ABX and VEH-FMT brainstem homogenates had 
significant increases in HVA/DA ratio (p<0.0001; p=0.001; p=0.0001, respectively; one-way 
ANOVA with Bonferroni post hoc, Fig. 2.5d) due to elevated HVA concentrations (p<0.0001; 
p=0.003; p=0.0002, respectively; one-way ANOVA with Bonferroni post hoc, Fig. 2.5c). L-
DOPA was elevated in ABX-FMT rats compared with VEH and VEH-FMT brainstem 
homogenates (p=0.001; p=0.038, respectively, Kruskal-Wallis with Dunn’s post hoc, Fig. 
2.5a). Furthermore, ABX-FMT contained increased concentrations compared with VEH of 5-
HT (p=0.021; one-way ANOVA with Bonferroni post hoc, Fig. 2.5f) and 5-HIAA (p=0.01; one-
way ANOVA with Bonferroni post hoc, Fig. 2.5g) along with a decrease in DA concentration 
(p=0.0009; one-way ANOVA with Bonferroni post hoc, Fig. 2.5b). VEH-FMT brainstem 
homogenates compared with VEH had elevated HVA/DA ratio (p=0.0005; one-way ANOVA 
with Bonferroni post hoc, Fig. 2.5d) due to an increase in HVA (p=0.0004; one-way ANOVA 






Figure 2. 5 Chronic antibiotic administration and faecal microbial transfer alter rat 
brainstem neurochemistry 
Group data for L-3,4-dihydroxyphenylalanine (a), dopamine (b), homovanillic acid (c), 
homovanillic acid/dopamine ratio (d), noradrenaline (e), serotonin (f), 5-hydroxyindole 
acetic acid (g) and 5-hydroxyindole acetic acid/serotonin ratio (h) in VEH, ABX, VEH-FMT and 
ABX-FMT rats. VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH 
followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal 
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microbiota transfer. Data (a-h) are expressed as box and whisker plots (median, IQR and 
minimum to maximum values). VEH (n=10), ABX (n=8), VEH-FMT (n=9) and ABX-FMT (n=10). 
Groups were statistically compared by one-way ANOVA with Bonferroni post hoc or non-
parametric Kruskal-Wallis with Dunn’s post hoc, where appropriate. * p<0.05, ** p<0.01, 
**** p<0.0001, ABX versus VEH; $ p<0.05, $$$ p<0.001, VEH versus VEH-FMT; &p<0.01, &&& 
p<0.001, &&&& p<0.0001, VEH versus ABX-FMT; # p<0.05, ### p<0.001, VEH-FMT versus 




2.3.8 Ex vivo intestinal macromolecular permeability 
The distal ileum from ABX rats was significantly more permeable compared with VEH rats: 
FITC flux was enhanced in ABX tissue compared with VEH at the 120-minute time point 
(p=0.025, two-way ANOVA with Bonferroni post-hoc, Fig. 2.6a). However, no statistically 
significant difference was detected in the permeability of the proximal colon of ABX rats 
compared with VEH rats (p>0.05; Fig. 2.6c). Permeability was equivalent in both the distal 
ileum and proximal colon of ABX-FMT rats compared with VEH-FMT rats (p>0.05; Fig. 2.6b, 
d). Permeability of the distal ileum, but not proximal colon, was increased in VEH-FMT 






Figure 2. 6 Chronic antibiotic administration increases the macromolecular permeability of 
rat distal ileum 
Group data for FITC flux in distal ileum (a, b) and proximal colon (c, d) in VEH and ABX (a, c) 
and in VEH-FMT and ABX-FMT rats (b, d). VEH, autoclaved deionised water; ABX, antibiotic-
treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated 
followed by faecal microbiota transfer. Groups (a-d) showing baseline (0 minutes), 60 
minutes and 120 minutes FITC flux for VEH (n=4-5), ABX (n=6), VEH-FMT (n=5) and ABX-FMT 
(n=4). Groups were statistically compared by two-way ANOVA with Bonferroni post hoc, 




2.3.9 Alterations in the caecal microbiota 
As expected, ABX rats had a significantly heavier caecum compared with VEH rats ( p=0.002; 
Kruskal-Wallis with Dunn’s post hoc, Fig. 2.7d). Faecal microbiota transfer attenuated the 
effects of antibiotics on caecum weight; ABX-FMT and VEH-FMT rat caecum weights were 
lighter compared with ABX (p=0.0001 and p=0.03, respectively; Kruskal-Wallis with Dunn’s 
post hoc, Fig. 2.7d). DNA concentrations in caecal samples from ABX rats were critically low, 
likely a result of depletion of bacteria by the broad-spectrum antibiotic cocktail and thus 
below the level of detection. This prevented a comparative analysis of microbiota 
composition and diversity as 16S rRNA sequencing was not possible in this group. In the 
remaining groups, 16S rRNA sequencing identified around 130 bacterial genera from 46 
families of 9 different phyla (Appendix Tables A.14-22). The majority of the bacterial genera 
belonged to two major phyla (Bacteroidetes and Firmicutes), which together comprise 95% 
(VEH), 90% (VEH-FMT) and 85 % (ABX-FMT) of intestinal microbiota. The analysis of alpha 
and beta diversities revealed that FMT procedure significantly altered the microbiota 
composition in both VEH-FMT and ABX-FMT rats as compared with VEH rats. There was a 
clear trend towards enhanced species richness of caecal microbiota in VEH-FMT and ABX-
FMT samples: number of observed species, Chao1 (an estimate of total richness in a sample 
(Chao, 1984)) and phylogenetic whole tree diversity (PD whole tree, an estimate of diversity 
based on structure and branch length of the phylogenetic tree in each sample (Faith, 1992)) 
indices were all increased in these groups (Fig. 2.7a,  p=0.035, p=0.043 and p=0.004 between 
VEH-FMT versus VEH; p=0.052 for parameters in ABX-FMT versus VEH). However, only an 
increase in PD whole tree diversity in VEH-FMT vs. VEH rats remained significant after 
adjustment for multiple comparisons. Shannon and Simpson metrics of alpha diversity, 
which take into account the evenness of species abundance, were less affected by FMT. 
Further, PCoA analysis identified structural differences across all three groups, with VEH-FMT 
and ABX-FMT rats clearly separating from VEH rats (Fig. 2.7b, p=0.001, PERMANOVA).  
At the phyla level, VEH-FMT and ABX-FMT rat caecal contents displayed a distinct shift 
towards an increase in Proteobacteria and Cyanobacteria with a decrease in Bacteroidetes 
and Deferribacteres compared with VEH rats (Appendix Tables A.14 and 15). Five minor phyla 
remained unchanged between VEH-FMT and ABX-FMT rats compared with VEH rats 
(Appendix Tables A.14 and 15). The minor phyla Verrucomicrobia and Saccharibacteria were 
significantly altered in ABX-FMT rats compared with VEH-FMT rats (Appendix Tables A.16).  
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An increase in the relative abundance of Proteobacteria in VEH-FMT and ABX-FMT rats was 
primarily caused by a shift in Helicobacter bacteria, a genus of Helicobacteraceae family (Fig. 
2.7c). Increased abundance of Helicobacter in VEH-FMT rats compared with VEH rats 
appeared to be at the expense of Parasutterella (Alcaligenaceae) and Enterobacter 
(Enterobacteriaceae), which both displayed a reduced relative abundance. The 
Cyanobacteria shifts evident in VEH-FMT and ABX-FMT rats were attributed to an increase in 
Gastranaerophilales uncultured species. Bacteroidales S24-7 uncultured bacteria, a 
dominant genus of S24-7 family, was the main source of Bacteroidetes reduction in VEH-FMT 
rat caecal samples compared with VEH rats; nonetheless, an increase in minor Bacteroidetes 
V2.1 Bac22 uncultured species was noted (Fig. 2.7c). The decrease in Bacteroidetes in the 
ABX-FMT rats was not related to a compelling decrease in any one genus but rather small 
shifts in the relative abundance of multiple genera. Similar to the VEH-FMT group, a minor 
increase in Bacteroidetes V2.1 Bac22 uncultured bacterium was detected in ABX-FMT rats. 
The decrease in Deferribacteres in VEH-FMT and ABX-FMT rats compared with VEH rats was 
a consequence of a decrease in Mucispirillum (Deferribacteraceae family). Although there 
was no significant difference at the Firmicutes phylum level, VEH-FMT rats showed an 
increase in uncultured bacterium and unidentified  genera from Clostridiales vadin BB60 
family, Lachnoclostridium-10, Lachnospiraceae uncultured, Flavonifractor, Ruminococcaceae 
UCG-013 compared with VEH. A decrease occurred in Bacillus, Lachnospiraceae UCG-008, 
Tyzzerella and Ruminoclostridium-9 (Fig. 2.7c). In ABX-FMT rats there was an increase in 
Lachnoclostridium-10 and Ruminococcaceae UCG-011 and a decrease in Bacillus, 
Streptococcus and Lachnospiraceae UCG-008 compared with VEH rats. Furthermore, 
uncultured Coriobacteriaceae bacteria from the Actinobacteria phylum was reduced in the 
VEH-FMT and ABX-FMT rats compared with VEH rats. The alterations evident at phyla level 
in ABX-FMT rats compared with VEH-FMT rats were not related to changes in highly 
abundant genera. Nonetheless, there was a decrease in Streptococcus (Streptococcaceae), 
Peptoclostridium (Peptococcaceae), Ruminococcaceae UCG-005 (Ruminococcaceae) 
compared with VEH-FMT rats. ABX-FMT rats displayed an increase in Allobaculum 
(Erysipelotrichaceae) and Parasutterella (Alcaligenaceae) from the phyla Firmicutes and 





Figure 2. 7 Faecal microbiota transfer alters rat caecal microbiota composition 
Group data for alpha diversity (a) and principal coordinate analysis (PCoA; b) in 2-dimensinal 
representations for VEH, VEH-FMT and ABX-FMT. Heatmap of Log2 fold change ratios on 
genus level (c) showing increases (red) and decreases (purple) in the relative abundance of 
bacterial genera in VEH-FMT (left column) and ABX-FMT (middle column) compared with 
VEH, as well as differences between ABX-FMT and VEH-FMT (right column). Group (d) data 
for caecum weight in VEH, ABX, VEH-FMT and ABX-FMT. VEH, autoclaved deionised water; 
VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed 
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by faecal microbiota transfer. Data (a and d) are expressed as box and whisker plots (median, 
IQR and minimum to maximum values). Data (a) were statistically compared by non-
parametric Mann-Whitney U test. Group (d) were statistically compared by Kruskal-Wallis 
with Dunn’s post hoc. **p<0.01, ABX versus VEH; ££££ p<0.0001, VEH-FMT vs ABX; ^ p<0.05, 
ABX-FMT vs. ABX. c)  p<0.05,  p<0.01,  p<0.001 compared with VEH or VEH-FMT values. 
Benjamini-Hochberg adjustment with Q = 0.1 was used to correct p values for multiple 




2.3.10 Correlation analysis between microbiota composition and brainstem neurochemistry 
and heart rate 
Associations between genera and brainstem neurochemistry as well as basal heart rate in 
VEH, VEH-FMT and ABX-FMT rats were identified utilising Hierarchical All-against-All (HAllA) 
correlation analysis. Identified associations are presented as a correlogram in Figure 2.8. 
Individual data points for the most significant correlations for homovanillic, 
homovanillic/dopamine and dopamine are presented as scatter plots in Appendix Figure A.7. 
Anaerovorax, a member of Firmicutes phylum positively associated with basal heart rate. 
Further to this, several genera from different phyla correlated with brainstem 
neurochemistry. Peptoclostridium and Ruminococcaceae UCG-005 of Firmicutes phylum 
negatively associated with L-DOPA. Lachnspiraceae (Eubacterium) ventriosum group and 
Erysipelotrichaceae UCG-004 of Firmicutes positively associated with NA, while 
Coriobacteriaceae uncultured, a genus of Actinobacteria negatively associated with NA. 
Helicobacter, a member of Proteobacteria phylum as well as Bacteroidetes VC2.1 Bac22 
uncultured, a member of Bacteroidetes phylum negatively correlated with DA. Bacillus, of 
Firmicutes phylum and Coriobacteriaceae uncultured positively correlated with DA. 
Bacteroidetes VC2.1 Bac22 uncultured Gastranaerophilales uncultured organism as well as 3 
genera from Firmicutes phylum, Ruminococcaceae UCG-011, Lachnoclostridium 10 and 
Clostridiales vadin BB60 group uncultured bacterium positively associated with HVA, 
whereas Bacillus and Mucispirillum, a member of Deferribacteres phylum negatively 
associated with HVA. Ruminococcaceae UCG-009, Lachnoclostrdium 10, Bacteroidetes VC2.1 
Bac22 uncultured and Burkholderia, a member of phylum Proteobacteria positively 
associated with HVA/DA turnover. Bacillus, Mucispirillum and Coriobacteriaceae uncultured 
negatively associated with this ratio. Lachnoclostridium 10 positively correlated with 5-HT. 
Ruminococcaceae V9D2013 group, Clostridiales vadinBB60 group uncultured bacterium, 
Gastranaerophilales uncultured bacterium and Bacteroidetes VC2.1 Bac22 uncultured, 
positively correlated with 5-HIAA. Natranaerovirga negatively associated with 5-HIAA. 






Figure 2. 8 Brainstem neurochemistry and heart rate are associated with the abundance of 
specific genera 
Hallagram depicting spearman correlations between the relative abundance of bacterial 
genera and brainstem neurochemistry as well as basal heart rate (VEH, VEH-FMT and ABX-
FMT). Genera are ordered taxonomically. HR, heart rate; L-DOPA, L-3,4-
dihydroxyphenylalanine; NA, noradrenaline; DA, dopamine; HVA, homovanillic acid; 
HVA/DA, homovanillic acid/dopamine; 5-HT, serotonin; 5-HIAA, 5-hydroindole acetic acid; 5-
HIAA/5-HT, 5-hydroindole acetic acid/serotonin. Significant correlations are represented by 
black dots (  ). Benjamini-Hochberg adjustment p-value with Q = 0.2 was used to correct p 











There is considerable interest in the role of the gut microbiota in health and disease. This 
interest stems from established associations between the gut microbiota and brain 
behaviours (Bercik et al., 2011a; Bravo et al., 2011; Collins et al., 2012; Cryan & Dinan, 2012; 
Kelly et al., 2016b; Burokas et al., 2017). Our interests relate to the potential influence of the 
microbiota on the cardiorespiratory system. We sought to assess the effects of manipulation 
of the gut microbiota by chronic antibiotic administration on cardiorespiratory physiology in 
adult male rats, and to investigate if faecal microbiota transfer of pooled control faeces could 
reverse or ameliorate putative deleterious effects induced by chronic antibiotic 
administration (microbiota disruption). The principal findings of this study are: 1) ABX and 
FMT blunt the ventilatory response to hypercapnia due to decreased respiratory frequency; 
2) ABX and FMT blunt respiratory frequency during the peak hypoxic ventilatory response; 
3) neither ABX nor FMT interventions alter respiratory timing variability; 4) ABX decre ases 
systolic blood pressure; 5) cardiorespiratory responsiveness to vagal afferent nerve 
stimulation is unaffected by ABX or FMT; 6) ABX and FMT alter brainstem monoamine and 
monoamine metabolite concentrations; 7) ABX and FMT increase distal ileum permeability; 
8) FMT significantly altered gut microbiota composition and diversity; 9) Genera from 6 
phyla, predominantly Firmicutes, correlate with brainstem neurochemistry.  
2.4.1 Animal model  
Microbiota manipulation by chronic antibiotic administration : Two different approaches 
were used in this study to manipulate the microbiota. First, we used an antibiotic cocktail, 
informed by previous studies where microbiota depletion was successful (Hoban et al., 2016; 
Kelly et al., 2016b). Failure to determine the caecal microbiota composition of ABX rats in 
the current study was likely the result of severe microbiota depletion and substantially 
diminished available bacterial DNA for detection. This was further supported by the dramatic 
enlargement of the caecum in ABX rats; an increase in caecum mass results from the loss of 
bacterial fermentation, consistent with previous observations both in germ-free and 
antibiotic-treated animals (Grasa et al., 2015; Luczynski et al., 2016). Faecal output in ABX 
rats was qualitatively determined as having an increased water composition, a frequent 
complication of antibiotic administration (Grasa et al., 2015). We postulate that altered 
defaecation may have resulted from antibiotic-induced microbiota depletion and potential 
expansion of opportunistic bacteria (Wurm et al., 2017).  
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Faecal microbiota transfer significantly altered gut microbiota composition and diversity : In 
addition to ABX, we utilised a FMT strategy to manipulate microbiota. It has been shown that 
behavioural phenotypes can be transferred via FMT in rodents (Le Roy et al., 2013; Li et al., 
2015; Kelly et al., 2016a; Kelly et al., 2016b). The FMT strategy used in our study did not 
recover or normalise the microbiota composition. VEH-FMT and ABX-FMT groups both 
displayed profound changes in microbiota structure and species diversity compared with the 
VEH group. Caecal samples from VEH-FMT and ABX-FMT animals had the relative abundance 
of 18 and 10 genera altered, respectively, compared with VEH animals. Only 5 genera were 
significantly different between VEH-FMT and ABX-FMT. Our findings are consistent with 
recent clinical data where FMT to persons with irritable bowel syndrome led to the 
establishment of unique taxonomy as well as increased diversity with no improvement in 
symptoms (Halkjaer et al., 2018). Pooled exogenous bacteria has been shown to increase 
microbiota diversity in recipient rats, resembling that of the donor (Manichanh et al., 2010). 
However, pre-treatment with antibiotics does not facilitate establishment of the donor 
microbiota (Manichanh et al., 2010). Interestingly, autologous FMT had no effect on insulin 
sensitivity in obese metabolic syndrome, however allogenic FMT had transient benefits on 
insulin sensitivity which was driven by baseline faecal microbiota composition (Kootte et al., 
2017). 
Caecum weights of ABX-FMT rats were lighter than that of ABX rats, but did not recover 
completely to VEH values. After discontinuing antibiotic exposure, gastrointestinal responses 
of ABX-FMT rats, assessed qualitatively by faecal output, returned to levels equivalent to VEH 
rats. Similar results were observed both in rodent and clinical studies where FMT was used 
to treat Clostridium difficile infection and sepsis (Li et al., 2015; Jiang et al., 2017). Thus, ABX-
induced alterations to the microbiota were not reversed by FMT intervention in our study. 
Indeed, FMT itself led to significant modification of the microbiota, establishing a separate 
model of microbiota disruption in our study (VEH-FMT and ABX-FMT groups), with distinct 
microbiota signatures compared with that of VEH animals. 
2.4.2 Chronic antibiotic administration and faecal microbiota transfer blunt ventilatory 
responses to hypoxia and hypercapnia 
To date few studies have examined the consequences of manipulation of the gut microbiota 
on the control of breathing. We previously revealed enhanced variability of breathing 
frequency during normoxic breathing, and altered ventilation during hypoxic and 
hypercapnic chemostimulation in adult rats exposed to antecedent pre -natal stress 
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(Golubeva et al., 2015). Significant correlations were found between respiratory frequency 
during hypercapnia and bacterial genera of the Firmicutes phylum (Golubeva et al., 2015), 
suggesting a potential influence of alterations in the gut microbiota on the control of 
respiratory rhythm during CO2 exposure.  
We reasoned that perturbation of the gut microbiota by ABX would elicit a distinctive 
respiratory control signature. In conscious behaving rats during quiet rest, no apparent 
aberrant respiratory control phenotype was evident in ABX rats during normoxia such that 
we observed normal values for ventilation and metabolism equivalent to VEH. Moreover, 
VEH-FMT and ABX-FMT rats were similar to VEH revealing the remarkable capacity of the 
neural network to maintain homeostasis in the light of major disruption to brainstem 
monoamine concentrations (discussed below). VE/VCO2 was decreased in VEH-FMT rats 
compared with VEH during normoxia, revealing a relatively depressed level of ventilation per 
se in VEH-FMT rats. 
Compared with VEH, ABX depressed the peak hypoxic ventilatory response and respiratory 
frequency component of the response during the first 2 minutes of exposure to hypoxia. A 
similar blunted minute ventilation and frequency response was observed in VEH-FMT rats 
compared with VEH revealing a consistent outcome in response to manipulation of the gut 
microbiota. Interestingly, respiratory timing variability was unaffected by ABX or FMT. 
Moreover, analysis of steady-state responses during the last 5 minutes of hypoxic exposure 
revealed that there was no aberrant respiratory phenotype evident in ABX or FMT rats. Our 
findings in ABX and FMT rats of a blunted minute ventilation and respiratory frequency 
response in phase 1 of the hypoxic ventilatory response is similar to the depressed hypoxic 
ventilatory response evident in adult rats exposed to pre-natal stress, where a significantly 
depressed respiratory frequency response to hypoxia was also observed (Golubeva et al., 
2015). It is plausible that manipulation of the gut microbiota resulted in altered integration 
of chemosensory inputs from the carotid bodies (the primary peripheral oxygen sensors) at 
the level of the nucleus tractus solitarius, leading to the development of a blunted frequency 
response to hypoxia. It is intriguing to consider that microbiota disruption may have resulted 
in re-programming of the carotid bodies, resulting in modified chemosensory afferent 
discharge to the brain, but this remains to be tested in future work. Although the peak 
hypoxic ventilatory response was blunted, the steady-state response (phase 2) was intact, 
again highlighting the robust capacity of the chemoreflex pathway in maintaining respiratory 
homeostasis in our models. 
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Chemoactivation of ventilation in response to hypercapnic stress (elevated inspired CO2) 
revealed a robust blunted VE response to CO2 challenge in ABX rats compared with VEH, a 
ventilatory depression manifest as a reduced fR response to hypercapnia (bradypnoea), 
which was maintained throughout the hypercapnic chal lenge. Manipulation of the gut 
microbiota had no effect on metabolic responses (VCO2) to hypercapnia. Thus, the 
ventilatory equivalent for carbon dioxide (VE/VCO2), which relates ventilation to the 
prevailing metabolism, was depressed in ABX rats compared with VEH rats, highlighting 
inadequate ventilation to meet metabolic demand (hypoventilation). Microbiota disruption 
by FMT resulted in decreased ventilation in hypercapnia in FMT groups to levels similar to 
that seen in ABX animals, and significantly below that of VEH rats. Therefore, two modes of 
disrupted microbiota in our study were associated with depressed ventilatory response to 
hypercapnia. Respiratory timing variability and associated respiratory behaviours such as 
apnoeas and sighs were essentially unaffected by microbiota manipulation. 
The disruptions to ventilation in response to hypoxic or hypercapnic stress observed in 
behaving animals using whole-body plethysmography, were not evident in urethane-
anaesthetised animals, suggesting that the changes in respiratory control may be state-
dependent (Doi & Ramirez, 2010). Indeed anaesthesia depresses respiratory drive and 
chemoresponsiveness (Teppema & Baby, 2011), and this may have masked the otherwise 
blunted ventilatory responsiveness to hypercapnic stress and the blunted peak ventilatory 
response to hypoxia in animals with manipulations to the microbiota. Alternatively, it may 
be that chemoreflex-driven homeostatic control of breathing is unaffected in ABX and FMT 
rats, but that the composite behavioural response to hypoxic and hypercapnic stress---
manifest in the integrated respiratory behavioural response to challenges---is blunted.  
The hypercapnic stimulus used in our study was modest, sufficient to evoke a ventilatory 
response through the activation of central nervous system CO2 chemoreceptors, but not 
intended as an overt behavioural stressor. Nevertheless, hypercapnia can provoke fear-
associated responses and there are strong links between emotion and respiratory behaviour. 
Indeed, ventilatory hypersensitivity to CO2 is a hallmark of panic disorder in susceptible 
individuals. Thus, it is possible in our study that manipulation of the microbiota altered 
neurochemistry in brain regions such as the amygdala (Hoban et al., 2016), which is known 
to modulate ventilatory responsiveness to CO2 (Tenorio-Lopes et al., 2017). Dopamine is a 
candidate neurotransmitter in emotion-associated respiratory control, with evidence that 
breathing is modulated by dopaminergic signalling in the basolateral amygdala (Sugita et al., 
2015). The data from behaving rats demonstrate a capacity for aberrant respiratory plasticity 
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in animals with altered gut microbiota, supporting the concept that the microbiota-gut-
brainstem axis may function as an important modulator of the respiratory control network, 
either directly or indirectly. Blunted CO2 chemoreflex ventilatory responses are 
physiologically significant as they increase the risk of the development of systemic acidosis 
in circumstances of elevated CO2 (e.g. sleep, pulmonary and respiratory control diseases, 
respiratory depression by drugs) (Brinkman & Sharma, 2018; Patel & Majmundar, 2018). 
Hypercapnic acidosis can compromise the function of neural networks and systemic tissues 
due to pH imbalance. As such, disruptions to the microbiota could via aberrant respiratory 
control, exert deleterious effects on whole body homeostasis.   
2.4.3 Chronic antibiotic administration decreases systolic blood pressure  
Cardiovascular control is complex and multifaceted with recent studies in animal models and 
humans demonstrating the contribution of the gut microbiome to the regulation of blood 
pressure (Yang et al., 2015; Adnan et al., 2017; Li et al., 2017). In spontaneously hypertensive 
rat and angiotensin-II hypertensive rat models, shifts in microbiota richness and increases in 
the Firmicutes:Bacteroidetes ratio are evident (Yang et al., 2015). Of note, FMT from 
hypertensive human donors to germ-free mice elevates blood pressure in the recipient mice, 
which was observed to be transferrable through the microbiota (Li et al., 2017). Similarly, it 
has been demonstrated that antibiotic-treated normotensive rats that received a FMT of 
donor faeces from hypertensive rats subsequently developed hypertension (Adnan et al., 
2017). Bacterial metabolites are associated with the development of high blood pressure; 
specifically, a decrease in butyrate-producing and acetate-producing bacteria, which 
promote intestinal barrier integrity, and an increase in lactate-producing bacteria are each 
associated with hypertension (Yang et al., 2015; Durgan et al., 2016; Adnan et al., 2017). Oral 
administration of a probiotic (Clostridium butyricum) or a prebiotic (Hylon VII) prevented 
microbiota disruption, increased acetate levels and prevented the development of 
hypertension in a rat model of obstructive sleep apnoea (Ganesh et al., 2018). Additionally, 
caecal acetate administration prevented obstructive sleep apnoea induced hypertension 
(Ganesh et al., 2018). The anti-inflammatory antibiotic minocycline was shown to ameliorate 
hypertension and reduce the Firmicutes:Bacteroidetes ratio in an angiotensin II hypertensive 
rat model (Yang et al., 2015). The absence of gut microbiota in germ free mice appears to be 
protective against angiotensin II induced hypertension and vascular dysfunction (Karbach et 
al., 2016). Our study revealed that chronic broad-spectrum ABX intervention results in lower 
systolic blood pressure and pulse pressure, although no difference was evident in mean 
arterial blood pressure.  
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Evidence is accruing in support of a microbial influence over cardiovascular control although 
a defined microbiota signature essential to the maintenance of normal blood pressure has  
yet to be determined. An enrichment in Lactobacillus, Bifidobacterium and Allobaculum 
along with a reduction in Lachnospiraceae, Lactococcus, Blautia, Coprobacillus and 
Erysipelotrichaceae species occurred in a rat model of obstructive sleep apnoea compared 
with sham. In sham animals, prebiotic (Hylon VII) treatment increased the abundance of 
acetate-producing genera, including Blautia, Collinsella, Bifidobacterium and Ruminococcus, 
preventing the development of hypertension (Ganesh et al., 2018). Intriguingly, a dramatic 
proliferation of certain genera such as Prevotella and Klebsiella has been shown both in pre-
hypertensive and hypertensive individuals compared with normotensive controls. In this 
clinical population, Firmicutes including Oscillibacter, Roseburia and Blautia, Bifidobacterium 
from Actinobacteria phylum and Akkermansia from Verrucomicrobiaceae phylum were 5 out 
of 11 genera enriched in healthy normotensive controls compared with pre -hypertensive 
and hypertensive individuals (Li et al., 2017). Indeed, these genera were in the top 45% of 
highly abundant genera in VEH, VEH-FMT and ABX-FMT groups. Genera which were highly 
abundant in pre-hypertensive and hypertensive humans were not abundant in this study, 
but comparisons between species may not be appropriate. Of interest, Blautia and 
Bifidobacterium were highly abundant in prebiotic-treated normotensive rodents and 
healthy normotensive controls. These acetate-producing bacterial taxa may have a role in 
the regulation of normal blood pressure (Li et al., 2017; Ganesh et al., 2018). Correlation 
analysis in our study revealed no associations between genera and blood pressure 
parameters. However, Anaerovorax, of Firmicutes phylum positively correlated with basal 
heart rate.  
2.4.4 Cardiorespiratory responsiveness to vagal afferent nerve stimulation is unaffected by 
chronic antibiotic administration and faecal microbiota transfer 
The afferent vagal pathway provides crucial signalling between the gut microbiota and the 
central nervous system (Forsythe et al., 2014). Alterations in gut microbiota composition or 
diversity, resulting in differential production of bacterial metabolites, have been shown to 
influence afferent vagal traffic (Lal et al., 2001; Bonaz et al., 2018). Vagal afferents innervate 
the nucleus tractus solitarius, a critical relay hub in the integration of cardiorespiratory 
control (Foster et al., 2017). The 5-HT3 receptor agonist, PBG, stimulates pulmonary vagal 
afferent C-fibres manifesting the classical chemoreflex characterised by apnoea and post-
apnoea tachypnoea, bradycardia and a fall in blood pressure (Dutta & Deshpande, 2010; 
Lucking et al., 2018a). Manipulation of the gut microbiota could conceivably mani fest 
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abnormal vagal afferent signalling and aberrant central processing of sensory inputs. 
However, in our study, there was no difference in the cardiorespiratory efferent responses 
to PBG challenge. We conclude that manipulation of the microbiota by ABX and FMT 
interventions does not alter the cardiorespiratory response to the vagal afferent pulmonary 
C-fibre stimulation, notwithstanding evidence of significant disruptions in brainstem 
monoamine concentrations. Whereas PBG can also induce neurotransmitter release 
centrally in the nucleus accumbens (Chen et al., 1991) and the nucleus tractus solitarius 
(Hosford et al., 2014), we confirmed in our study that cardiorespiratory effects were 
mediated exclusively by vagal afferent feedback since responses were abolished following 
bilateral cervical vagotomy. Examination of vagal afferent activation from other peripheral 
sites, notably the gut, was not performed in this study, but would be interesting to determine 
in future work.  
2.4.5 Chronic antibiotic administration and faecal microbiota transfer alter brainstem 
monoamine and monoamine metabolite concentrations  
We examined the concentrations of brainstem monoamines important in the 
neuromodulation of cardiorespiratory control with a particular interest in monoamines and 
metabolites that play a role in central chemoreception. Significant disruptions to 
monoamine, monoamine precursor and metabolite concentrations were determined in the 
brainstem of ABX and FMT rats, an outcome that coincides with depressed hypercapnic 
ventilation.  
Noradrenaline is a potent modulator of breathing (Doi & Ramirez, 2008). We found no 
change in brainstem noradrenaline concentration between groups. 5-HT is a pivotal 
neuromodulator of the respiratory motor network and primarily has an excitatory effect on 
breathing (Richerson, 2004). It is well established that pharmacological manipulation of 
serotonergic signalling affects respiratory motor output (Fenik & Veasey, 2003; de Souza 
Moreno et al., 2010). Transgenic mice lacking central 5-HT neurons show a significant 
reduction in the hypercapnic ventilatory response (Hodges & Richerson, 2008; Hodges et al., 
2008; Li & Nattie, 2008) and lesions of raphé serotonergic neurons decrease the respiratory 
response to hypercapnia (Dias et al., 2007). Pharmacological manipulation of 5-HT affects 
ventilation and arousal during hypercapnia (Messier et al., 2004; Buchanan et al., 2015). Our 
data revealed a blunted ventilatory response to hypercapnia in ABX rats. However, 5-HT 
concentrations were not changed in ABX rats, thus, it is not likely that 5-HT is implicated in 
the depressed ventilatory responsiveness observed in ABX rats. 5-HT concentrations were 
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significantly increased in ABX-FMT compared with VEH with no change evident in VEH-FMT 
rats. This suggests that changes in brainstem 5-HT were not pivotal to hypercapnic 
ventilatory depression. Interestingly, an increase in 5-HT turnover was observed in the 
hippocampus and pre-frontal cortex following ABX treatment in rats (Hoban et al., 2016), 
germ free mice (Clarke et al., 2013) and acutely stressed mice (Desbonnet et al., 2015).  
Dopamine significantly contributes to the central control of breathing (Lalley, 2009). 
Transgenic mice lacking dopaminergic neurons or dopamine transport proteins exhibit 
severe breathing disturbances such as hypoventilation, apnoea and altered hypoxic 
ventilatory response (Nsegbe et al., 2004; Vincent et al., 2007). Similarly, blunted respiratory 
frequency during hypercapnic breathing was observed in rat models of Parkinson’s disease 
with confirmed degeneration of tyrosine hydroxylase expressing neurons in the substantia 
nigra and a reduction in chemosensitive neurons (Phox2b-expressing and fos-activated) in 
the retrotrapezoid nucleus (Tuppy et al., 2015; Oliveira et al., 2017), a key brainstem site for 
CO2 chemosensitivity (Guyenet & Bayliss, 2015). The modulatory influence of dopamine on 
respiratory physiology is complex and depends on target receptor sub-families (Kline et al., 
2002). There are 2 classes of dopamine receptors, D1-like (D1 and D5) and D2-like (D2, D3 and 
D4) receptors (Beaulieu & Gainetdinov, 2011), with D1, D2 and D4 receptors having a 
significant neuromodulatory role in respiration (Fujii et al., 2004; Lalley, 2004, 2009). 
Dopaminergic neurons within the brainstem reinforce CO2-dependent respiratory drive and 
increase minute ventilation, predominantly through the D1 receptor (Lalley, 2004, 2008). 
Thus, it appears that D1 receptor activation increases respiratory neuron excitability, 
whereas D2 and D4 receptor stimulation depresses respiratory rhythm (Fujii et al., 2004; 
Lalley, 2004; Fujii et al., 2006). Our data reveal an increase in brainstem dopamine turnover 
in ABX rats and depressed ventilation during hypercapnia compared with VEH rats. Similar 
findings are reported in Parkinson’s disease models (Tuppy et al., 2015; Blesa et al., 2017; 
Oliveira et al., 2017). An increase in the dopamine metabolite HVA was also evident in the 
cerebellum of ABX rats compared with VEH rats in our study (Appendix Table A.10). Increased 
concentrations of HVA were observed in the prefrontal cortex and amygdala of ABX-treated 
rodents (Desbonnet et al., 2015; Hoban et al., 2016). We observed depressed respiratory 
frequency responses to hypercapnic stress in ABX and FMT groups, which may have related 
to increased dopaminergic signalling via D2 and D4 receptors (Fujii et al., 2004; Lalley, 2004; 
Fujii et al., 2006). 
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Our findings demonstrate that disruption to the gut microbiota results in altered 
neurochemistry at the level of the brainstem and cerebellum, with striking effects on 
dopamine concentrations and dopamine turnover. Correlation analysis revealed significant 
associations between brainstem neurochemistry and genera from 6 phyla, suggesting a 
potential link. Of particular interest correlations were found between L-DOPA, DA, HVA and 
HVA/DA and genera predominantly of Firmicutes phylum; Ruminococcaceae UCG-005, 
Peptoclostridium, Bacillus, Erysipelotrichaceae UCG-004, Ruminococcaceae UCG-011, 
Lachnoclostridium 10, Clostridiales vadinBB60 group uncultured bacterium and 
Ruminococcaceae UCG-009. Brainstem monoamines and metabolites also correlate with  
Coriobacteriaceae uncultured (Actinobacteria) Bacteroidetes VC2.1 Bac22 uncultured 
(Bacteroidetes), Gastranaerophilales uncultured organism (Cyanobacteria), Helicobacter 
(Proteobacteria) and Mucispirillum (Deferribacteres). We acknowledge that correlations 
were often weak and in any event do not provide evidence of a mechanistic link. Disrupted 
brainstem neurochemistry is also evident in other models of microbiota perturbation. Germ 
free mice have increased 5-HT in hippocampal regions and acutely stressed and non-stressed 
ABX-treated animals have an increase in HVA in prefrontal cortex and amygdala (Clarke et 
al., 2013; Desbonnet et al., 2015; Hoban et al., 2016). To assess if altered afferent vagal nerve 
communication (gut-brain axis) contributed to the altered brainstem neurochemistry and 
respiratory behaviour, future studies exploring manipulation of the gut microbiota in 
vagotomised animals are required. However, vagal axotomy may itself evoke plasticity within 
the brainstem neural circuits controlling cardiorespiratory control, which may be a 
confounding factor in such studies. 
2.4.6 Chronic antibiotic administration and faecal microbiota transfer increase distal ileum 
permeability 
Altered intestinal permeability has been described in various models of disrupted microbiota 
including a mouse model of autism (Golubeva et al., 2017), spontaneously hypertensive rat 
(Santisteban et al., 2017), and rat models of maternal separation stress (Gareau et al., 2007) 
and pre-natal stress (Golubeva et al., 2015). The dysfunctional barrier of the distal ileum in 
ABX rats in our study is consistent with reports of disrupted intestinal permeability in 
response to specific antibiotics, which also perturb the microbiota (Wlodarska et al., 2011; 
Tulstrup et al., 2015). An impaired epithelial barrier can induce low-grade inflammation and 
facilitate the passage of bacterial constituents, such as lipopolysaccharide across the 
epithelium into systemic tissues (Araujo et al., 2017). It is conceivable that the ‘leaky’ distal 
ileum could have, at least partially, contributed to modulation of brainstem neurochemistry 
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and depressed ventilatory responsiveness to CO2. However, ABX rats may have limited 
maladies associated with intestinal barrier breach due to reduced bacterial components 
and/or the direct effects of antibiotics on other inflammatory mediators.  
The shifts evident in Helicobacter and Mucispirillum genera are of particular interest with 
respect to gastrointestinal health. Of critical importance, the highest log-fold change 
occurred in Helicobacter, which was significantly increased both in VEH-FMT and ABX-FMT 
rats compared with VEH rats. Guo et al. 2009 found that Helicobacter pylori was increased in 
the stomach of Balb/c mice in response to stress. A similar stress could have been evoked by 
the use of oral gavage, resulting in increased abundance of  Helicobacter. The dominance of 
various species from Helicobacter genera in the gut microbiota coincides with 
gastrointestinal disorders in humans and rodents, often triggering intestinal inflammatory 
pathogenesis (Flahou et al., 2013). A mucin degrading bacterium Mucispirillum was 
decreased in VEH-FMT and ABX-FMT rats compared with VEH. Increased abundance of 
Mucispirillum coincides with inflammatory response in germ-free mice (El Aidy et al., 2014a), 
in a model of colitis (Rooks et al., 2014), and in age-related inflammation in rodents (Conley 
et al., 2016). It is plausible that Helicobacter proliferated at the expense of Mucispirillum. 
Intestinal pathogenesis could have occurred as a result of insults to the microbiota associated 
with our interventions.  
2.4.7 Limitations 
Our FMT strategy was designed to replenish the microbiota of ABX rats. To control for the 
FMT intervention, VEH rats also received FMT and were studied in parallel. However, FMT 
per se caused major disruption to the microbiota composition and diversity compared with 
VEH rats. As such, our study did not allow us to determine if restoration of normal (control) 
gut microbiota was associated with restoration of normal (control) brainstem 
neurochemistry and ventilatory responsiveness to hypercapnia. Whereas this is a limitation 
of the study, it nevertheless provided unexpected additional test groups (FMT groups), 
wherein gut microbiota disruptions were shown to be related to altered brainstem 
neurochemistry and blunted ventilatory responsiveness to CO2, in essence confirming the 
observations made in ABX rats compared with VEH rats. Future studies could explore the 
capacity to transfer the phenotypes described in the present study from ABX donor to naïve 
recipient animals. Moreover, it would be interesting to explore FMT strategies designed to 




DNA concentrations in caecal samples from ABX rats were critically low, likely a result of the 
broad-spectrum antibiotic cocktail depleting bacteria and thus detectable bacterial DNA. 
This prevented the analysis of microbiota composition and diversity analysis as 16S rRNA 
sequencing was not possible in this group. Thus, correlation analysis was performed with 
metadata and microbiota composition from three groups (VEH, VEH-FMT and ABX-FMT).  
Our study design was such that we were unable to perform correlations between breathing 
parameters and microbiota in ABX-treated rats, since ABX rats studied in the plethysmograph 
proceeded to FMT intervention.  
2.4.8 Summary and conclusions 
Using two modes to manipulate the gut microbiota (ABX and FMT), our study suggests that 
perturbation to the gut microbiota has consequences for brainstem neurochemistry and 
respiratory control. Our study reveals the capacity for chronic antibiotic administration and 
faecal microbiota transfer to affect respiratory behaviour, blunting a critical homeostatic 
reflex defence or integrated behavioural response to acute hypercapnic stress, with resultant 
consequences for acid-base status. Our results may have relevance to human respiratory 
disorders of the lungs or neural control networks, such as chronic obstructive pulmonary 
diseases and sleep disordered breathing, where there is evidence of altered gut microbiota 
composition. Blunted chemoreflex control of breathing, wherein arterial blood CO2 levels can 
rise due to inadequate ventilatory drive, is a risk for the development of significant 
respiratory acidosis, with whole-body consequences. Our study adds to emerging evidence 
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Background: Carotid body (peripheral oxygen sensor) sensitisation is pivotal in the 
development of chronic intermittent hypoxia (CIH)-induced hypertension. We sought to 
determine if exposure to CIH, modelling human sleep apnoea, adversely affects 
cardiorespiratory control in guinea-pigs, a species with hypoxia-insensitive carotid bodies. 
We reasoned that CIH-induced disruption of gut microbiota would evoke cardiorespiratory 
morbidity.  
Methods: Adult male guinea-pigs were exposed to CIH (6.5% O2 at nadir, 6 cycles.hour-1) for 
8h.day-1 for 12 consecutive days.  
Findings: CIH-exposed animals established reduced faecal microbiota species richness, with 
increased relative abundance of Bacteroidetes and reduced relative abundance of  Firmicutes 
bacteria. Urinary corticosterone and noradrenaline levels were unchanged in CIH-exposed 
animals, but brainstem noradrenaline concentrations were lower compared with sham. 
Baseline ventilation was equivalent in CIH-exposed and sham animals; however, respiratory 
timing variability, sigh frequency and ventilation during hypoxic breathing were all lower in 
CIH-exposed animals. Baseline arterial pressure was unaffected by exposure to CIH, but β-
adrenoceptor-dependent tachycardia and blunted bradycardia during phenylephrine-
induced pressor responses was evident compared with sham controls.  
Interpretation: Increased carotid body chemo-afferent signalling appears obligatory for the 
development of CIH-induced hypertension and elevated chemoreflex control of breathing 
commonly reported in mammals, with hypoxia-sensitive carotid bodies. However, we reveal 
that exposure to modest CIH alters gut microbiota richness and composition, brainstem 
neurochemistry, and autonomic control of heart rate, independent of carotid body 
sensitisation, suggesting modulation of breathing and autonomic homeostasis via the 
microbiota-gut-brainstem axis. The findings have relevance to human sleep-disordered 
breathing. 
Funding: The Department of Physiology, and APC Microbiome Ireland, UCC. 





Research in Context 
 
Evidence before this study: Chronic intermittent hypoxia (CIH) is the primary pathogenic 
factor associated with obstructive sleep apnoea. Carotid body (CB) sensi tisation is widely 
implicated in the development of CIH-induced cardiorespiratory morbidity, including 
hypertension.  
Added value of this study: We provide evidence of residual cardiorespiratory dysfunction in 
CIH-exposed guinea-pigs, a mammalian species with hypoxia-insensitive CBs, with a potential 
interplay via the microbiota-gut-brainstem axis. CIH alters microbiota richness and 
composition, brainstem neurochemistry and cardiorespiratory control, independent of CB 
sensitisation, suggesting modulation of brainstem control via the microbiota-gut-brainstem 
axis.  
Implications of all the available evidence: Our findings have implications for human sleep-
disordered breathing and contribute to an emerging interest in manipulation of the 










Exposure to chronic intermittent hypoxia (CIH) mimicking the recurring episodic oxygen 
fluctuations that are characteristic of human sleep apnoea causes sympathetic nervous 
system hyperactivity and systemic hypertension (Lesske et al., 1997; Dick et al., 2007; 
Moraes et al., 2012; Prabhakar et al., 2015; Del Rio et al., 2016). There is considerable 
evidence that exposure to CIH sensitises the carotid bodies---the dominant peripheral 
oxygen sensors---increasing chemo-afferent traffic to the brainstem, with consequential 
changes in autonomic outflow that serve to increase blood pressure (Peng et al., 2014a; 
Moya et al., 2016; Nanduri et al., 2017). Fletcher and colleagues were the first to describe 
CIH-induced hypertension, highlighting the pivotal roles of carotid body chemoreceptors and 
sympatho-excitation in driving the hypertensive phenotype (Fletcher et al., 1992b; Lesske et 
al., 1997). The hypoxic sensitivity of the carotid body is elevated after exposure to CIH, which 
manifests increased hypoxic ventilatory and sympathetic responsiveness to chemo-
stimulation (Peng et al., 2003; Huang et al., 2009). Hypertension is a consistent feature of 
various models of CIH in several mammalian species (Brooks et al., 1997; Iturriaga & 
Alcayaga, 2007; Lucking et al., 2014; Moreno-Indias et al., 2015), including human subjects 
(Tamisier et al., 2009). The significance of these findings is that enhanced peripheral sensory 
facilitation may serve to destabilise cardiorespiratory control, with resultant sympathetic 
nervous over-activity, leading to diurnal hypertension. Moreover, respiratory stability 
decreases in rats exposed to CIH, with evidence of increased propensity for central apnoea 
(Edge et al., 2012; Donovan et al., 2014; Souza et al., 2015b), which disrupts respiratory-
sympathetic coupling (Machado et al., 2017) potentially establishing a vicious cycle of 
disrupted breathing and blood pressure in people with sleep apnoea.  
Carotid body denervation or ablation blocks CIH-induced persistent elevations in blood 
pressure, with studies revealing that an intact peripheral chemosensory network appears 
essential for the development of respiratory plasticity, sympathetic nervous system 
hyperactivity and systemic hypertension after exposure to CIH (Fletcher et al., 1992b; Lesske 
et al., 1997; Edge et al., 2012; Moraes & Machado, 2015; Del Rio et al., 2016; Prabhakar, 
2016). However, interruption of peripheral sensory input can give rise to central respiratory 
network reconfiguration and can establish a persistent hypoventilation (Mouradian et al., 
2012). Thus, whereas carotid bodies are implicated in the development and maintenance of 
CIH-induced cardiorespiratory morbidity, it is not clear if they are obligatory. There is clear 
evidence of CIH-induced plasticity in other key sites of the cardiorespiratory control network, 
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including cells of the nucleus tractus solitarius (Costa-Silva et al., 2012), respiratory-related 
cells of the medullary network (Moraes et al., 2012) and rhythmogenic cells of the pre-
Bötzinger complex (Garcia et al., 2017). Prabhakar and colleagues have revealed that 
epigenetic changes in the medulla oblongata dependent on increased chemoafferent input 
arising from exposure to CIH result in redox-dependent persistently elevated sympathetic 
outflow to target tissues implicated in the control of blood pressure (Nanduri et al., 2017). 
However, neurons of the rostral ventrolateral medulla that govern spinal vasomotor neurons 
are excited by systemic hypoxia in carotid body denervated rats demonstrating that the 
carotid body is not obligatory to the hypoxic recruitment of sympathetic neurons per se (Sun 
& Reis, 1994). There is also evidence of direct effects of CIH on respiratory-related neurons 
within the medulla, and altered respiratory-autonomic coupling with implications for 
cardiovascular control (Garcia et al., 2017; Machado et al., 2017). Indeed, it is well recognised 
that exposure to CIH evokes adverse effects in various tissues, including end-effector organs 
of the cardio-respiratory system i.e. respiratory muscles (Skelly et al., 2012; McDonald et al., 
2014) and cardiomyocytes (Chen et al., 2008), which predisposes to cardiorespiratory 
morbidity. Moreover, there is the possibility that exposure to CIH indirectly affects host 
physiology. Intriguingly, exposure to CIH alters the gut microbiome (Moreno-Indias et al., 
2015; Tripathi et al., 2018) and metabolome (Tripathi et al., 2018) and CIH-induced 
alterations in microbiota composition remains perturbed even during extended normoxic 
recovery periods (Moreno-Indias et al., 2016).  
The microbiota are increasingly recognised as orchestrators of host physiology, brain and 
behaviour extending to cardiovascular homeostasis (Bravo et al., 2011; Golubeva et al., 2015; 
Durgan, 2017). Transplant of gut microbiota from spontaneously hypertensive rats into 
normotensive, microbiome-compromised control rats triggers the development of a 
hypertensive phenotype with evidence of a positive correlation between systolic blood 
pressure and Lactobacillus bacteria (Adnan et al., 2017). Similarly, gut microbiota samples 
transferred from hypertensive donors (animal model of sleep apnoea fed a high-fat diet) to 
normotensive recipient rats caused gut microbiome disruption and hypertension (Durgan et 
al., 2016). Reduced microbiota diversity and richness is established in hypertensive patients 
compared with normotensive controls (Li et al., 2017). Furthermore, faecal transplant from 
hypertensive human donors into germ-free mice establishes higher blood pressures than 
faecal transplants from normotensive human donors (Li et al., 2017). Collectively, these 
findings provided the rationale for our hypothesis that CIH-induced alterations in gut 
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microbiota modulate cardiorespiratory control via altered microbe-gut-brainstem signalling, 
independent of carotid body plasticity. 
For a large number of problems there will be some animal of choice or a few such animals on 
which it can be most conveniently studied.  
               August Krogh ---The Progress of Physiology, 1929. 
Examination of the putative effects of CIH-induced alterations to the microbiome and 
resultant influences on cardiorespiratory control in mammals are complicated by the 
dominant effect of exposure to CIH on carotid body function. Ablation of the carotid bodies 
to remove their contribution to CIH-induced cardiorespiratory morbidity (Del Rio et al., 2016) 
is confounded by the potential for redundancy in hypoxia-sensing and central 
reconfiguration of the respiratory network in the absence of a major afferent drive to 
breathe. However, the carotid bodies of the guinea-pig are structurally and biochemically 
‘normal’ (Kummer et al., 1989) and yet the guinea-pig carotid body is generally insensitive to 
hypoxia (Schwenke et al., 2007). Of interest, the carotid body of the guinea-pig is responsive 
to cyanide, severe hypoxia and to hypercapnia  and as such is ‘functional’ but lacks the 
inherent capacity to respond to moderate hypoxaemia; moreover, it appears that the 
contribution of the carotid body to eupnoeic drive to breathe in the guinea-pig is negligible 
(Schwenke et al., 2007). Because of these unique characteristics, we reasoned that guinea-
pigs serve as a useful experimental model to explore the effects of exposure to CIH on 
cardiorespiratory control, as all afferent and efferent pathways maintain their physiological 
connections, therefore putative CIH-induced effects on cardiorespiratory control can be 
explored without a dominant influence of the carotid bodies.  
Our major aim was to explore the effects of exposure to CIH on blood pressure in guinea-
pigs, mammals with hypoxia-insensitive carotid bodies. We reasoned that exposure to CIH, 
utilising a paradigm that causes hypertension in rats (Ray et al., 2015), would not evoke 
hypertension supporting suggestions of an obligatory role for carotid body sensitisation in 
the manifestation of CIH-induced hypertension. We also explored the potential for residual 
cardiorespiratory effects of exposure to CIH with a focus on the gut microbiota as a potential 





3.2. Materials and Methods 
 
3.2.1 Ethical approval 
All procedures on live animals were performed under licence from the Government of 
Ireland Department of Health (B100/4498) in accordance with National and European Union 
legislation, with prior ethical approval by University College Cork (AEEC #2013/035). 
Experiments were carried out in accordance with guidelines laid down by University College 
Cork Animal Welfare Body, and conform to the principles and regulations described by 
Grundy (2015). 
3.2.2 Chronic intermittent hypoxia animal model 
Adult male Duncan Hartley guinea pigs (n=16; purchased from Envigo, UK) were randomly 
assigned to one of two groups: sham (810 ± 66g; mean ± SD; n=8) and CIH exposed (816 ± 
60g; n=8). Animals were housed in standard cages in a temperature (20.4±0.6°C) and 
humidity-controlled (46.8±6.6%) environment on a 12h light:12h dark cycle, with ad libitum 
access to standard guinea-pig chow and water. The CIH group was placed in environmental 
chambers wherein ambient oxygen concentration was tightly-controlled using a dynamic 
oxygen/nitrogen controller (Oxycycler™; Biospherix, New York, NY, USA). Animals assigned 
to the CIH group were exposed to repeated 10-minute cycles consisting of 5 minutes of 
exposure to hypoxia (nadir, FiO2 = 0.065, balance N2) and 5 minutes of normoxia (FiO2 =0.21; 
balance N2) for eight hours.day-1 for twelve consecutive days during the light phase. 
Contemporaneously, sham animals were exposed to room air in the same room with similar 
environmental cues for the duration of the study. Cardiorespiratory parameters were 
assessed on day 13, the day subsequent to the final episodes of CIH or sham exposure.  
3.2.3 Assessment of respiratory flow in awake guinea-pigs 
Whole-body plethysmography: Respiratory flow recordings were recorded in unrestrained, 
unanaesthetised awake guinea-pigs during quiet rest using the technique of whole-body 
plethysmography (Buxco Ltd., St. Paul, Minneapolis, USA). CIH-exposed and sham guinea-
pigs were introduced into custom plethysmograph chambers with room air flushed through 
each chamber (4L/min) ensuring the maintenance of O2 and CO2 environmental conditions. 
Animals were allowed to settle during an acclimation period of 40 minutes to ensure the 
animals were habituated to the new environment.  
Following the acclimation period, baseline respiratory parameters were assessed during a 10 
to 15 minute steady-state normoxia period (FiO2 = 0.21; balance N2). This was followed by a 
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10 minute poikilocapnic hypoxia challenge (FiO2=0.10; balance N2). Following hypoxia, each 
animal was re-exposed to normoxia and after an adequate recovery period of at least 10 
minutes a second baseline period was established. Animals were subsequently exposed to a 
10 minute hypercapnia challenge (FiCO2 = 0.05; balance O2). Respiratory variables including 
respiratory frequency (fR), minute ventilation (VE), tidal volume (VT), inspiratory time (Ti), 
expiratory time (Te) and mean inspiratory flow (VT/Ti) were recorded on a breath-by-breath 
basis for offline analysis. Concentrations of O2 and CO2 in gas entering and exiting the 
plethysmograph chambers were constantly measured (O2 and CO2 analyser; ADInstruments, 
Colorado Springs, CO, USA). O2 consumption (VO2) and CO2 production (VCO2) in sham and 
CIH-exposed animals were determined. 
Data analysis for whole-body plethysmography: FinePointe software (Buxco Research 
Systems, Wilmington, NC, USA) generated breath-by-breath analysis of respiratory flow 
signals. Artefacts related to movement, exploratory behaviour and sniffing were excluded 
from analysis by software algorithm and by visual inspection of the recording sessions 
designated for analyses. Baseline breathing and metabolic analyses were averaged from the 
10-15 minute period of stable normoxia. Data are reported for the final 5 minutes of each of 
the hypoxic and hypercapnic challenges allowing for steady-state assessment of respiratory 
and metabolic parameters. VT, VE, VT/Ti, VO2 and VCO2 were normalised for body mass (per 
100g). Additionally, respiratory flow signals were analysed for the occurrence of apnoeas and 
augmented breaths (sighs) during normoxic breathing. The criterion for apnoea was a pause 
in breathing greater than two missed breaths, expressed as either a spontaneous or post-
sigh apnoea as previously described (Edge et al., 2012). Sighs were defined as an augmented 
breath twice the amplitude of the average VT. Poincaré plots expressing breath-to-breath 
(BBn) versus next breath-to-breath interval (BBn+1) for 200 consecutive breaths were 
extrapolated for sham and CIH-exposed guinea-pigs. Respiratory timing variability in total 
breath duration and expiratory time were analysed for short-term (SD1) and long-term (SD2) 
variability.  
3.2.4 Assessment of cardiorespiratory parameters under urethane anaesthesia 
Surgical protocol: Subsequent to plethysmography challenges, animals were anaesthetised 
via an intraperitoneal injection of 20% w/v urethane (1.5 g.kg-1), placed in the supine body 
position and core body temperature was maintained at 38.5°C using a rectal temperature 
probe and homeothermic blanket system (Harvard Apparatus, Holliston, MA, USA). Depth of 
anaesthesia was regularly monitored by absence of the pedal withdrawal to noxious pinch; 
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supplemental doses of anaesthetic were administered as required. A mid-cervical 
tracheotomy was performed and the right jugular vein was cannulated for intravenous (i.v.) 
infusion of supplemental anaesthetic and drugs. The left femoral artery was cannulated for 
the recording of arterial blood pressure as well as withdrawal of arterial blood gas samples. 
Arterial blood gas, pH and electrolyte assessment was performed using specialised cartridges 
(EG6+; Abbott Laboratories Ltd, Dublin Ireland) and a portable blood gas analyser (I-STAT; 
Abbot Laboratories Ltd). All animals were maintained with a bias flow of supplemental O2 to 
maintain an arterial oxygen saturation (SaO2; Starr Life Sciences, PA, USA) above 95% during 
basal conditions. A pneumotachometer was connected to a tracheal cannula to determine 
tracheal flow (Hans Rudolph Inc., KS, USA). A side arm of the tracheal cannula was connected 
to a CO2 analyser (microCapStar End-Tidal CO2 analyser; CWE Inc., USA), which provided 
measurement of tracheal end-tidal CO2. All data were digitised and displayed using LabChart 
v7 (ADInstruments).  
Experimental protocol: Following a 30-minute period of stabilisation following surgical 
procedures, an arterial blood gas sample was acquired and baseline parameters were 
assessed. The bias flow was manipulated using an electronic gas mixer (GSM-3 Gas Mixer; 
CWE Inc.) to administer chemostimulation challenges to the animals. A graded hypercapnic 
challenge was performed in which animals were exposed to increasing levels of inspired 
carbon dioxide: FiCO2=0.05 and 0.10 (supplemental O2; balance N2) consecutively for 5 
minutes each with no recovery period between hypercapnic stimuli. A minimum of 10 
minutes was allowed for the recovery of stable parameter recordings between all challenges. 
Animals were subsequently challenged with a 5 minute hypoxia challenge (FiO2=0.1; balance 
N2), followed by a 5 minute asphyxic challenge (FiO2=0.1, FiCO2=0.05, balance N2). 
Subsequent to the inspired gas challenges and after recovery, sodium cyanide (NaCN; 
200µg/kg) was administered i.v. to stimulate the type 1 glomus cell of the carotid body. Some 
guinea-pigs presented with an apnoea upon NaCN infusion and were excluded from data 
analysis as no hypoxic ventilatory response was elicited. Successively, intravenous 
administrations of phenylephrine (PE; 50µg.kg-1), propranolol (PROP; 1mg.kg-1) and 
hexamethonium (25mg.kg-1) were used to assess cardiovascular responses to 
pharmacological manipulation. Due to the intrinsic hypotensive phenotype of guinea-pigs 
(Table 3.3), some animals failed to recover from the otherwise transient hypotensive state 
induced pharmacologically by propranolol (sham, n=2; CIH, n=3) and hexamethonium (sham, 
n=1; CIH, n=1). Animals were euthanised by i.v. anaesthetic overdose and various organs 
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were collected, weighed and frozen at -80°C for subsequent analysis. Lungs were weighed 
wet, dried at 37°C for a minimum of 48 hours and reweighed.  
Data analysis of cardiorespiratory parameters in anaesthetised guinea-pigs: Baseline 
parameters were averaged over 10 minutes of stable recording and data are presented as 
absolute units. Cardiorespiratory responses during graded hypercapnic, hypoxic and 
asphyxic challenges were averaged in 10 second time bins and were compared with the 
respective 1-minute pre-challenge baseline. To assess dynamic responses to drug 
administration (NaCN, PE, PROP and hexamethonium), cardiorespiratory responses were 
averaged into 1-second time bins and were compared with the respective 1-minute pre-
challenge baseline. Cardiorespiratory responses to chemostimulation and drug 
administration are expressed as a percent change from the preceding baseline value.  
3.2.5 Analysis of brainstem homogenates and urine 
Brainstem monoamine concentrations determined by high-performance liquid 
chromatography (HPLC) coupled to electrochemical detection : Brainstems were removed 
from the guinea-pigs immediately after euthanasia, snap frozen in isopentane cooled in 
liquid nitrogen and transferred to -80˚C for long-term storage. Each brainstem was separated 
into two distinct regions, pons and medulla oblongata at -20˚C. The dissected pons and 
medulla oblongata tissues were sonicated in 1 ml of chilled mobile phase, spiked with 
2ng/20µl of a N-methyl 5-HT (internal standard) (Bandelin Sonolus HD 2070) for six by six 
second bursts. The mobile phase contained 0.1 M citric acid (Alkem/Reagecon), 0.01 mM 
ethylenediaminetetraacetic acid (EDTA), 0.1 M sodium dihydrogen phosphate 
(Alkem/Reagecon), 5.6 mM octane-1-sulphonic acid (Alkem/Reagecon) and 9% (v/v) 
methanol, adjusted to pH 2.8 using 4N sodium hydroxide. Samples were centrifuged at 
14,000 g for 20 min at 4˚C (MIKRO 22R refrigerated centrifuge). Cell pellets were stored at -
80 ˚C. The supernatant (20µl) was injected onto the HPLC system coupled to electrochemical 
detection. The HPLC system consisted of a SCL 10-Avp system controller, LC-10AS pump, SIL-
10A autoinjector (with sample cooler maintained at 4˚C), CTO-10A oven, LECD 6A 
electrochemical detector and an online Gastorr Degasser. A reverse-phase column (kinetex 
2.6u C18 100Amm X 4.6mm), maintained at 30˚C, was employed in the separation (flow rate 
0.9 ml/min). The monoamines, dopamine, noradrenaline (NA), serotonin (5-HT), and 
monoamine metabolite 5-hydroxyindoleacetic acid (5-HIAA), L-3,4-dihydroxyphenylalanine 
(L-DOPA) and homovanillic acid (HVA) were assessed. The monoamines were identified by 
their characteristic retention times, which were determined by standard injections run at 
regular intervals during the sample analysis. Chromatographs were processed using Class-
148 
 
VP5 software and allowed the identification of the desired monoamines. Concentrations 
were calculated using analyte:internal standard peak response ratios.  
Urine immunoassays: Urine samples collected from anaesthetised animals were stored at -
80 ˚C until use. After storage, samples were thawed and concentrations of corticosterone 
(ENZO Life Sciences, UK), noradrenaline (Abnova) and creatinine (Sigma-Aldrich, Ireland.) 
were determined (sham n=6; CIH n=6) using commercially available enzyme -linked 
immunosorbent assay kits according to the manufacturers’ instructions. A 
spectrophotometer (SpectraMax M3, Molecular devices) was used in reading absorbance for 
each assay. Urine samples were diluted 50-fold to determine corticosterone concentrations 
and 100-fold to determine creatinine and catecholamine concentrations. Urinary 
catecholamine and corticosterone concentrations were normalised to creatinine 
concentration of the urine, which provided a biomarker of urine production.  
3.2.6 Microbiota composition analysis of faecal content 
Faecal content DNA extraction: Faecal content was removed from the guinea-pig rectum and 
snap frozen in liquid nitrogen for long-term storage. DNA was extracted from the faecal 
material using the QIAamp DNA Stool Mini Kit (Qiagen, Venlo, Netherlands) according to the 
manufacturer’s instructions, but including an additional bead-beating step at the beginning 
of the procedure for mechanical lysis. 200mg of each faecal sample was homogenised in the 
extraction buffer and transferred to 2ml screw cap tubes containing 2 x 2.3mm, 0.2g of 
1.0mm and 0.2g of 0.1mm zirconia/silica beads before being subjected to a 3-minute bead-
beating step using a Mini-Beadbeater-16 (Bispec, Bartlesville, USA). The following steps were 
in accordance with the manufacturer’s instructions. The obtained faecal genomic DNA was 
quantified using the Qubit broad range DNA kit (Qubit, London, UK), measured on a Qubit 
3.0 fluorometer (Qubit, London, UK), normalised to 5ng/µl before following the Illumina 16S 
rRNA Metagenomic Sequencing Library protocol. 
16S rRNA Gene sequence-based microbiota analysis: The V3-V4 hypervariable region of the 
16S rRNA gene was amplified and prepared for sequencing, the amplicon products were 
purified with Agencourt AMPure XP kit (Backman Coulter, Pasadena, USA). Amplicon PCR 
negative controls were utilised and verified through a 1.5% agarose gel made up with a tris 
base, acetic acid and EDTA buffer with Midori green stain (100V for 30 mins; Nippon genetics,  
52351 Dueren, Germany). In the next step the purified product underwent an index PCR step 
using the Nextere XT index primer kit (Illumina, San Diego, USA). Following this a second 
purification step occurred with Agencourt AMPure XP. The index PCR products were 
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quantified using the Qubit high sensitivity DNA kit (Qubit, London, UK) and measured on 
Qubit 3.0. The PCR products were normalised and pooled before being sequenced on the 
MiSeq sequencing platform (Illumina, San Diego, USA) using a 2 x 250bp cycle kit, according 
to standard Illumina sequencing protocols at the Teagasc sequencing facility, Teagasc Food 
Research Centre, Fermoy, County Cork, Ireland.   
Bioinformatic sequence analysis: Briefly, 250 base paired-end sequences were assembled 
using FLASH (FLASH: fast length adjustment of short reads to improve genome assemblies).  
Further processing of paired-end reads including quality filtering based on a quality score > 
25 and removal of mismatched barcodes and sequences below length thresholds was 
completed using QIIME version 1.9.0 (Quantitative Insights Into Microbial Ecology). 
Sequences were quality checked (denoising, chimera detection) and the remaining 
sequences were clustered into operational taxonomic units (OTUs) using USEARCH v7 (64-
bit). OTUs were aligned using PyNAST (PyNAST; a flexible tool for aligning sequence to a 
template alignment) and taxonomy was assigned using BLAST against the SILVA SSURef 
database release 123. Data was rarefied to 60,000 reads. Alpha diversity indices were 
generated in QIIME and the beta diversity Bray Curtis index was calculated in R software 
package. Relative abundance of bacterial taxa was expressed as % of identified sequences.  
3.2.7 Statistical analysis 
Statistical analysis on microbiota data was carried out in SPSS version 24 and R statistical 
environment (R version 3.4.4). GraphPad Prism Software (GraphPad Software, San Diego, CA, 
USA) was used for all other statistical analysis and for the generation of graphs. Data are 
presented as mean ± SD, median (IQR) or box and whisker plots (median, IQR,  minimum and 
maximum values). Data were checked for a normal distribution with a Shapiro-Wilk test and 
for homogeneity of variances with Levene’s test. Two-tailed Student’s unpaired t test and 
non-parametric Mann-Whitney U test were used, where appropriate, unless otherwise 
stated. Brainstem monoamine concentrations were assessed using two-way ANOVA 
(treatment and brainstem region as two independent factors) with Bonferroni post-hoc 
tests. Pearson correlation coefficients were used to assess associations be tween brainstem 
monoamines and physiological parameters. 
Bacterial taxa that were detected in fewer than three samples in each group were omitted 
from the subsequent analysis. Principal coordinate analysis (PCoA) plots were generated 
from Bray-Curtis dissimilarity matrices using the Vegan and Car packages in R. Differences in 
Bray-Curtis dissimilarity on the PCoA were assessed by PERMANOVA with the vegan package 
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in R. The most substantially changed bacterial genera (p<0.053) were chosen for the 
construction of the Z-score heatmap with the ggplot2 package in R. LEfSe analysis (43) was 
carried out using Calypso (v8.72) (44) with Chloroplast and Cyanobacteria counts removed.  
Hierarchical All Against All (HAllA) was used to detect correlations between microbiota data 
and the physiological measurements. Statistical significance was accepted at p<0.05. The 
Benjamini-Hochberg adjustment procedure was applied with the false discovery rate (FDR) 








3.3.1 Baseline ventilation and ventilatory responses to chemostimulation in sham and CIH-
exposed awake guinea-pigs. 
Baseline ventilation and metabolism in sham and CIH-exposed awake guinea-pigs: Baseline 
minute ventilation (Fig. 3.1e; p=0.545) and the ventilatory equivalent (VE/VCO2) during 
normoxia (Fig. 3.1h; p=0.201) were equivalent in sham and CIH-exposed guinea-pigs. Basal 
O2 consumption and CO2 production (Table 3.1) were similar in sham and CIH-exposed 
guinea-pigs. Exposure to acute hypoxia (FiO2=0.10) failed to evoke an excitatory ventilatory 
response (Fig. 3.1f; p=0.798); CO2 production during exposure to hypoxia was higher in CIH-
exposed guinea-pigs (1.00 ± 0.09 vs 1.15 ± 0.19 ml.min-1.100g-1; p= 0.067), such that 
(VE/VCO2) during hypoxia was lower in CIH-exposed guinea-pigs compared with sham guinea-
pigs (Fig. 3.1i; p<0.001). Minute ventilation during hypercapnia (Fig. 3.1g; p=0.180) and 
VE/VCO2 during exposure to CO2 (Fig. 3.1j; p=0.613) were equivalent in sham and CIH-







Figure 3. 1 CIH does not significantly affect baseline, hypoxic or hypercapnic ventilation in 
guinea-pigs. 
(a) Representative respiratory airflow traces during normoxic, hypoxic and hypercapnic 
ventilation in Sham (black) and CIH-exposed (grey) guinea-pigs; inspiration represented by 
downward deflections. b-j) Group data for respiratory frequency (b-d) minute ventilation (e-
g) and the ventilatory coefficient (h-j) in sham and CIH-exposed guinea-pigs during normoxic 
(b, e, h), hypoxic (c, f, i) and hypercapnic (d, g, j) ventilation. Values are expressed as box and 
whisker plots (median, 25–75 percentiles and minimum and maximum values). Groups were 











0.462  ± 0.502 0.454 ± 0.066 0.781 
Ti  
(ms) 
227 ± 23 239 ± 25 0.351 
Te  
(ms) 
341 ± 57 363 ± 38 0.384 
VT/Ti  
(ml/s/100g) 
2.03 ± 0.23 1.91 ± 0.28 0.341 
VO2  
(ml/min/100g) 
1.33 ± 0.61 1.75 ± 0.31 0.103 
VCO2  
(ml/min/100g) 
1.25 ± 0.27 1.32 ± 0.20 0. 603 
VCO2/VO2 1.15 ± 0.57  0.76 ± 0.11 0.038 
 
Table 3. 1 Baseline ventilation and metabolic parameters in sham and CIH-exposed awake 
guinea-pigs. 
VT, tidal volume; Ti, Inspiratory time; Te, expiratory time; VT/Ti, inspiratory flow; VO2, oxygen 
consumption; VCO2, carbon dioxide production. Data are shown as mean ± SD and were 





Respiratory timing indices in sham and CIH-exposed awake guinea-pigs: Fig. 3.2 displays 
Poincaré plots of breath-to-breath period (BBn) and subsequent interval (BBn+1) during 
baseline breathing both for expiratory duration (Te; Fig. 3.2a) and total breath duration (Ttot; 
Fig. 3.2b). Assessment of the short-term (SD1) and long-term (SD2) variability of respiratory 
timing revealed lower values in CIH-exposed guinea-pigs compared with sham guinea-pigs. 
Long-term variability for Te (Fig. 3.2d; p=0.026), and both short-term (Fig. 3.2e; p=0.007) and 








Figure 3. 2 Normoxic breathing variability is reduced in CIH-exposed awake guinea-pigs. 
Poincaré plots of breath-to-breath (BBn) and next breath-to-breath interval (BBn+1) of time 
to expire (a) and total breath duration (b) during normoxic breathing in Sham (n = 8) and CIH-
exposed (n = 8) guinea-pigs. Group data for average expiratory time short-term (c) and long-
term (d) variability of breathing in sham and CIH-exposed guinea-pigs. Average total breath 
duration short-term (e) and long-term (f) variability of breathing in sham and CIH-exposed 
guinea-pigs. Values (c-f) are expressed as box and whisker plots (median, 25–75 percentiles 
and minimum and maximum values). Groups were statistically compared by unpaired 




Expression of sighs and apnoeas in sham and CIH-exposed awake guinea-pigs: Sigh frequency 
was lower in CIH-exposed animals compared with sham animals (Fig. 3.3b; p=0.015). Lower 
sigh frequency was also observed during hypoxic (Fig. 3.3c; p=0.016) and hypercapnic 
ventilation (Fig. 3.3d; p=0.026) in CIH-exposed guinea-pigs compared with sham guinea-pigs. 
Sigh amplitude was equivalent in both groups during normoxia, hypoxia and hypercapnia 
(p>0.05). Spontaneous apnoeas were absent in sham and CIH-exposed guinea pigs. Post-sigh 
apnoeas were infrequent, however they were more prevalent in sham guinea-pigs (n=5) 
compared with CIH-exposed (n=2) guinea-pigs. Owing to the low apnoea count, statistical 







Figure 3. 3 Sigh frequency is reduced in CIH-exposed awake guinea-pigs. 
(a) Representative trace of respiratory airflow demonstrating an augmented breath (sigh); 
inspiration represented by downward deflections. Group data for sigh frequency during 
normoxic (b), hypoxic (c) and hypercapnic ventilation (d) in Sham (n=8) and CIH-exposed 
(n=8) guinea pigs. Values (b-d) are expressed as box and whisker plots (median, 25–75 
percentiles and minimum and maximum values). Groups were statistically compared by 
unpaired Student’s t tests or non-parametric Mann-Whitney U test where appropriate. 




3.3.2 Cardiorespiratory parameters in sham and CIH-exposed anaesthetised guinea-pigs.  
Baseline respiratory parameters in sham and CIH-exposed anaesthetised guinea-pigs: 
Baseline arterial blood gases were similar in both groups (Table 3.2). Arterial blood 
bicarbonate concentration was lower (p=0.023) in CIH-exposed guinea-pigs compared with 
sham animals, consistent with a trend towards lower values for PaCO2 (Table 3.2). Higher fR 
and VE was evident in CIH-exposed guinea-pigs compared with sham guinea-pigs (Table 3.3), 
but ETCO2 values were similar in CIH-exposed and sham animals (Table 3.3).  
Cardiovascular responsiveness in sham and CIH-exposed anaesthetised guinea-pigs: Guinea 
pigs exposed to 12 consecutive days of CIH did not develop systemic hypertension (Table 
3.3); however, a significant tachycardia was evident in CIH-exposed guinea-pigs compared 
with sham animals. Left ventricular weights tended to be heavier in CIH-exposed guinea-pigs 
compared with sham guinea-pigs suggesting the onset of development of left ventricular 
hypertrophy (Table 3.4) in the absence of hypertension (no increase in afterload). There was 
a trend towards an increased haemoglobin concentration in CIH-exposed animals compared 
with sham animals (Table 3.2). Urinary concentrations of noradrenaline and corticosterone 









pH 7.36 ± 0.04 7.36 ± 0.06 0.820 
PaCO2 (mmHg) 46.1 ± 5.4 42.3 ± 3.7 0.137 
PaO2 (mmHg) 110 ± 15 111 ± 14 0.896 
[HCO3-] (mmol/L) 26.2 ± 2.3 24.1 ± 2.4 0.041 
[TCO2] (mmol/L) 27.1 ± 2.9 25.3 ± 2.2 0.293 
SaO2 (%) 97.8 ± 0.9 98 ± 1 0.681 
[Na+] (mmol/L) 143 ± 3 143 ± 4 0.745 
[K+] (mmol/L) 3.43 ± 0.47 3.53 ± 0.34 0.338 
Hct (%) 42.9 ± 4.8 45.4 ± 2.5 0.104 
[Hb] (g/dl) 14.6 ± 1.6 15.5 ± 0.9 0.088 
 
Table 3. 2 Baseline arterial blood gas and electrolyte concentrations in sham and CIH-
exposed guinea-pigs 
PaCO2, arterial blood partial pressure of CO2; PaO2, arterial blood partial pressure of O2; 
[HCO3-], bicarbonate concentration; [TCO2], total CO2 concentration; SaO2, arterial oxygen 
saturation; [Na+], sodium concentration; [K+], potassium concentration; Hct, haematocrit; 
[Hb], haemoglobin concentration. Data are shown as mean ± SD. Haematocrit and 
haemoglobin parameters were statistically compared using one-tailed unpaired Student’s t 
tests. All other parameters were statistically compared using two-tailed unpaired Student’s 
t tests. 
 







37.3 ± 9.4 35.6 ± 6.9 0.346 
SBP  
(mmHg) 
51.0 ± 18.3 48.3 ± 11.1 0.362 
DBP  
(mmHg) 
 27.9 ± 5.2 27.8 ± 4.7 0.483 
HR 
(bpm) 
279 ± 27 307 ± 36 0.048 
fR  
(brpm) 
50.4 ± 12.1 62.4 ± 12.4 0.071 
VT  
(ml/100g) 
0.184 ± 0.024 0.177 ± 0.014 0.515 
VE   
(ml/min/100g) 
 9.1 ± 1.4 11.0 ± 1.9  0.036 
ETCO2 
(%) 
6.26 ± 0.78 6.16 ± 0.92 0.818 
 
Table 3. 3 CIH induces tachycardia and hyperventilation in anaesthetised guinea-pigs 
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MAP, mean arterial blood pressure; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HR, heart rate (bpm, beats.min-1); fR, respiratory frequency (brpm, breaths.min-1); 
VT, tidal volume; VE, minute ventilation; ETCO2, end-tidal carbon dioxide; CIH, chronic 
intermittent hypoxia. Data are shown as mean ± SD. Blood pressure and heart rate 
parameters were statistically compared using one-tailed unpaired Student’s t tests. All other 
parameters were statistically compared using two-tailed unpaired Student’s t tests. 
 







170 ± 12 179 ± 13 0.075 
RV  
(mg/100g) 
54.9 ± 4.0 57.5 ± 5.4 0.144 
RV+LV  
(mg/100g) 
225 ± 15 237 ± 17 0.074 
RV:LV 0.324 ± 0.018 0.322 ± 0.027 0.409 
Lung wet weight 
(mg/100g) 
427 ± 26 487 ± 67 0.032 
Lung dry weight 
(mg/100g) 
95 ± 5 111 ± 13 0.006 
Lung fluid content  
(%) 
77.8 ± 1.4 77.2 ± 0.9 0.353 
Spleen  
(mg/100g) 
0.804 ± 0.163 0.678 ± 0.124 0.102 
 (n=6) (n=6)  
Urinary noradrenaline  
(ng/mg creatinine) 
215 ± 156 190 ± 196 0.404 
Urinary corticosterone 
(ng/mg creatinine) 
2.56 ± 2.40 1.38 ± 0.34 0.410 
 
Table 3. 4 Body organ weights and urinary stress profile of sham and CIH-exposed guinea-
pigs 
LV, left ventricle; RV right ventricle; CIH, chronic intermittent hypoxia. Data are shown as 
mean ± SD. Ventricular, noradrenaline and corticosterone parameters were statistically 
compared using one-tailed unpaired Student’s t tests. All other parameters were statistically 







IV injection of phenylephrine produced a pressor response equivalent in CIH-exposed and 
sham guinea-pigs (Fig. 3.4a; p=0.327), however the associated reflex bradycardia was 
significantly blunted in CIH-exposed guinea-pigs compared with sham guinea-pigs (Fig. 3.4b 
p=0.032). β-adrenoceptor blockade with iv propranolol evoked a greater bradycardia in CIH-
exposed guinea-pigs compared with sham guinea pigs (Fig. 3.4d; p=0.023). Interestingly, the 
propranolol-induced hypotensive response was blunted in CIH-exposed animals compared 
with sham controls (Fig. 3.4c; p=0.047). IV administration of hexamethonium produced 
similar hypotensive responses in CIH-exposed and sham guinea-pigs (-38 ± 7% vs. -35 ± 9%, 






Figure 3. 4 Autonomic control of heart rate is altered in CIH-exposed anaesthetised 
guinea-pigs 
Group data for systolic blood pressure (a, c), heart rate (b, d) in response to intravenous 
infusion of the β-adrenoceptor blocker propranolol (a-b) and α-adrenoceptor agonist 
phenylephrine (c-d). Values (a-d) are expressed as box and whisker plots (median, 25–75 
percentiles and minimum and maximum values). Groups were statistically compared by 





Cardiorespiratory responses to chemostimulation in sham and CIH-exposed anaesthetised 
guinea-pigs: Blood pressure and heart rate reflex responses to chemostimulation challenges 
were equivalent in CIH-exposed and sham animals in all instances (p>0.05). The hypercapnic 
ventilatory response in anaesthetised CIH-exposed guinea-pigs was significantly blunted 
compared with sham guinea-pigs (Table 3.5), particularly during the 10% inspired CO2 
challenge. Respiratory parameters were unaffected by exposure to acute hypoxia, however 
there was a trend for a blunted ventilatory response to asphyxia in CIH-exposed guinea-pigs 
(Table 3.5). There was a trend towards a blunted ventilatory response to iv NaCN 
administration in CIH-exposed guinea-pigs, arising predominantly due to a significantly 









% change from baseline Hypercapnia (FiCO2 = 0.05) 
fR  20 ± 13 3 ± 14 0.027 
VT  70 ± 14 74 ± 20 0.643 
VE   104 ± 30 79 ± 29 0.124 
 Hypercapnia (FiCO2 = 0.10) 
fR  13 ± 26  -14 ± 18 0.034 
VT  171 ± 40 113 ± 71 0.064 
VE   206 ± 92 82 ± 69 0.009 
 Hypoxia (FiO2 = 0.10) 
(n=8) (n=7)  
fR  1 ± 12 5 ± 18 0.286 
VT  5 ± 6 2 ± 13 0.298 
VE   6 ± 17 7 ± 20 0.451 
 Asphyxia (FiCO2 = 0.05 & FiO2 = 0.10) 
 (n=8) (n=8)  
fR  25 ± 21 9 ± 19 0.064 
VT  71 ± 17 69 ± 17 0.413 
VE   114 ± 34 85 ± 42 0.086 
 Sodium cyanide (200µg/kg i.v.) 
 (n=7) (n=5)  
fR  41 ± 19 22 ± 6 0.043 
VT  63 ± 25 63  ± 47 0.9922 
VE   101 ± 46 89 ± 36 0.086 
 
Table 3. 5 Respiratory responsiveness to chemostimulation in sham and CIH-exposed 
anaesthetised guinea-pigs 
fR, respiratory frequency; VT, tidal volume; VE, minute ventilation; CIH, chronic intermittent 
hypoxia. Data are shown as mean ± SD and were statistically compared using unpaired 




3.3.3 Brainstem monoamine analysis.   
Pontine and medulla oblongata noradrenaline concentrations were significantly lower in 
CIH-exposed guinea-pigs compared with sham guinea-pigs (Fig. 3.5a). Brainstem dopamine, 
5-HIAA and 5-HT concentrations were equivalent in CIH-exposed and sham samples (Fig. 3.5c 
d). Correlation analysis was performed for pontine and medullary noradrenaline 
concentrations and breathing variability, sigh frequency, heart rate and heart rate 
responsiveness to drug administration. No significant correlations were evident between 
medullary noradrenaline concentrations and all physiological parameters ( p>0.05; see 
supplementary data; Appendix Fig. B.1). However, there were positive correlations between 
pontine noradrenaline concentrations and Te SD2 (p=0.032; Fig. 3.6b), Ttotal SD1 (p=0.047; Fig. 
3.6d), Ttotal SD2 (p=0.049; Fig. 3.6d e) and respiratory frequency under urethane anaesthesia 






Figure 3. 5 Pontine and medulla oblongata noradrenaline concentrations are reduced in 
CIH-exposed guinea-pigs  
Group data for noradrenaline (a), dopamine (b), 5-HIAA (c) and 5-HT (d) in pontine and 
medulla oblongata tissue homogenates from sham (n=7) and CIH-exposed (n=6) guinea-pigs. 
Values (a-d) are expressed as box and whisker plots (median, 25–75 percentiles and 
minimum and maximum values). 5-HIAA, 5-Hydroxyindole acetic acid; 5-HT, serotonin. 
Groups were statistically compared by two-way ANOVA with Bonferroni post hoc test. *sham 





Figure 3. 6 Significant correlations are evident between pontine noradrenaline 
concentrations and various cardiorespiratory parameters.  
Individual data points for correlations between pontine noradrenaline (NA) concentrations 
and time to expire (Te) short-term variability (SD1; a), Te long-term variability (SD2; b), sigh 
frequency (c), total breath duration (Ttotal) SD1 (d), Ttotal SD2 (e) in sham and CIH-exposed 
awake guinea-pigs, and respiratory frequency (fR; f), heart rate (HR; g), change in HR in 
response to propranolol administration (h) and change in HR in response to phenylephrine 
(PE) administration (i) in sham and CIH-exposed anaesthetised guinea-pigs. Solid black lines 




3.3.4 Microbiota richness and composition  
The species richness of faecal microbiota was reduced in CIH-exposed guinea-pigs (Chao1 
index, p=0.011; total number of species observed, p=0.053; Fig. 3.7a-b). However, the 
difference in other metrics of alpha-diversity, which take into account the evenness of 
species abundance (Simpson and Shannon), was modest between groups (Fig. 3.7c-e). 
Principal coordinate analysis revealed a strong trend towards separation of microbiota 
communities between sham and CIH-exposed animals (p=0.059; Fig. 3.7f). To address in 
more detail the structural changes of faecal microbiota, we compared the relative 
abundance of individual bacterial taxa at the phylum, family and genus level. Significant 
differences between CIH-exposed and sham guinea-pigs were uncommon at the family and 
genus level (see supplementary data; Appendix Fig. B.2). However, at the phylum level, the 
relative abundance of Firmicutes bacteria was significantly lower (p=0.007), whereas 
Bacteroidetes phylum was significantly more abundant in CIH-exposed animals compared 
with sham animals (p=0.038; Fig. 3.8a and Appendix Table B.1). As a result, there was a trend 
for the Firmicutes:Bacteroidetes ratio to be lower in CIH-exposed guinea-pigs compared with 
sham guinea-pigs (p=0.068). The increase in Bacteroidetes in CIH-exposed samples was 
mainly driven by dominant Bacteroidales S24-7 family (Fig. 3.8b and Appendix Table B.2). 
These increases occurred at the expense of some Firmicutes taxa, such that bacterial genera 
from the Lachnospiraceae and Ruminococcaceae families were decreased in CIH-exposed 
faecal samples compared with sham faecal samples (Fig. 3.8b and Appendix Table B.2), 
although the changes in the relative abundance of bacterial genera were no longer significant 
after the Benjamini-Hochberg adjustment ((i/m)*Q<p; Appendix Table B.3).  
The linear discriminant analysis (LDA) effect size method (LEfSe) was employed to identify 
bacterial genera associated with exposure to CIH, which might explain the underlying 
differences in the microbiota between sham and CIH-exposed animals (Appendix Fig. B.3). 
At the genus level, LEfSe analysis identified 7 genera associated with exposure to CIH and 
thus over-represented in the CIH-exposed group were: an uncultured bacterium belonging 
to the Bacteroidales S24-7 family and Butyricimonas (both from the Bacteroidetes phylum), 
Bifidobacterium and Coriobacteriaceae UCG002 (Actinobacteria), Coprococcus 2 and 
Flavonifractor (Firmicutes), Methanobrevibacter (Eurvarchaeota). In contrast, 6 genera were 
associated with sham guinea-pigs and were therefore under-represented in CIH-exposed 
guinea-pigs. These genera were: Blautia, Anaerotruncus, Lachnospiraceae UCG005,  
Intestinimonas, Ruminiclostridium 5 and Lachnoclostridium 10 (all from the Firmicutes 
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phylum). Fig. 3.8c represents significant correlations identified between various 





Figure 3. 7 Faecal microbiota richness is reduced CIH-exposed guinea-pigs 
Group data for alpha-diversity indices (a-e) and principal coordinate analysis (PCoA) plot 
based on Bray-Curtis dissimilarity matrices (f) for Sham and CIH-exposed animals. Values (a-
e) are expressed as box and whisker plots (median, 25-75 percentiles and minimum to 
maximum values) and were statistically compared by non-parametric Mann-Whitney U test. 
Benjamini-Hochberg adjustment with Q=0.2 was used to correct p-values for multiple testing 






Figure 3. 8 CIH reduces Firmicutes and increases Bacteroidetes relative abundance in 
guinea-pig faecal samples 
Stacked barplot (a1) at the phylum level of faecal samples taken from each guinea-pig with 
group data (a2) showing significant changes in the relative abundance of Bacteroidetes and 
Firmicutes phyla in CIH-exposed microbiota. Heatmap of Z-scores at the genus level (b) 
showing increases (red) and decreases (purple) in the relative abundance of bacterial genera 
in each guinea-pig; sham (left-side columns) and CIH (right-side columns). (c) Hallagram 
depicting Spearman correlations between the relative abundance of bacterial genera and 
physiological readouts. Genera are ordered taxonomically. Significant correlations are 
ranked 1-5 (strongest-weakest): positive associations are shown in red, negative – in blue. 
Benjamini-Hochberg adjustment p-value with Q=0.2 was used to correct p-values for 
multiple testing. 5-HIAA, 5-hydroindole acetic acid; fR. respiratory frequency; NaCN, sodium 
cyanide; VE/VCO2, ventilatory equivalent; VO2, oxygen consumption; WBP, whole-body 






There is considerable interest in the mechanisms driving CIH-induced respiratory plasticity 
and hypertension. This interest stems from the potential clinical relevance of the findings to 
an understanding of cardiorespiratory and autonomic function in persons with sleep-
disordered breathing, a disorder characterised by recurrent apnoeic episodes during sleep 
manifesting in exposure to CIH. We sought to explore the putative obligatory role of carotid 
body sensitisation in the expression of aberrant cardiorespiratory control following exposure 
to CIH by use of a unique rodent model---the guinea-pig. If carotid body sensitisation is 
essential for aberrant respiratory plasticity and the development of hypertension following 
exposure to CIH, then little change should be expected in cardiorespiratory control in guinea-
pigs exposed to CIH, based on the premise that the guinea-pig carotid body is essentially 
insensitive to hypoxia (Schwenke et al., 2007; Gonzalez-Obeso et al., 2017; Docio et al., 
2018). Conversely, if exposure to CIH disrupts cardiorespiratory control in guinea-pigs, this 
would provide evidence of sites beyond the carotid body that are sufficient to drive aberrant 
cardiorespiratory control in rodents, and perhaps humans. Our findings are generally 
supportive of the hypothesis that the carotid body is essential for the expression of CIH-
induced aberrant control of breathing. In rodents with hypoxia-sensitive carotid bodies, CIH 
has been shown to cause hyperventilation and augmented responsiveness to hypoxic 
chemostimulation (Morgan et al., 2016). Whereas elevated ventilatory responses to hypoxia 
have not been universally observed in studies of rodents exposed to CIH (Edge et al., 2009), 
Morgan et al. 2016 provided the definitive study by measurement of breathing and 
metabolism (which are both affected by hypoxia in rodents), and careful consideration of the 
stimulus-response relationship by way of concurrent assessment of oxygen saturation during 
hypoxic challenge. Assessing the relationship of all three parameters reveals that exposure 
to CIH increases the ventilatory response to hypoxia in rats (Morgan et al., 2016). 
Additionally, several groups have reported increased ventilatory drive in rats exposed to CIH 
(Skelly et al., 2012; Morgan et al., 2016).  
Exposure to CIH in guinea-pigs did not affect baseline ventilation or metabolism or 
ventilatory responses to hypoxia and hypercapnia in awake animals. Indeed, the ventilatory 
equivalent (VE/VCO2) during hypoxic ventilation was depressed, not augmented, in CIH-
exposed guinea-pigs. Unaltered ventilation and ventilatory responsiveness to chemo-
stimulation in CIH-exposed guinea-pigs supports the contention that carotid body sensory 
facilitation is wholly necessary for CIH-mediated enhancement of hypoxic ventilatory 
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responses. Likewise, in CIH-exposed anaesthetised guinea-pigs, there was no evidence of 
potentiated chemoreceptor responsiveness. Indeed, responses were generally less in CIH-
exposed animals, with a significant blunting of the ventilatory response to 10% inspired CO2. 
Of interest, in a recent study in guinea-pigs, utilising a more severe CIH protocol, consisting 
of 30 cycles.hour-1 (5% O2 at nadir), 8h.day-1, for 30 days, VE/VO2 during severe hypoxia (FiO2 
= 0.07) and hypercapnia (FiCO2 = 0.05) was blunted compared with sham, principally owing 
to CIH-induced increases in oxygen consumption (Docio et al., 2018). Whereas a modest 
hyperventilation can be evoked by severe hypoxia in sham guinea-pigs, these effects are not 
potentiated, but instead are diminished, following exposure to CIH (Docio et al., 2018). 
Moreover, exposure to CIH failed to potentiate intracellular calcium or catecholamine 
release from carotid body type 1 cells during acute activation by hypoxia or high K +, revealing 
convincingly that exposure to CIH fails to sensitise carotid bodies of the guinea-pig (Docio et 
al., 2018). Carotid bodies of the guinea-pig lack O2-sensitive K+ channels (Gonzalez-Obeso et 
al., 2017) and exposure to CIH does not evoke a capacity for hypoxia-dependent type 1 cell 
depolarisation and neurosecretory response (Docio et al., 2018), which is essential to chemo-
afferent signalling from the carotid body. However, the type 1 cells retain the ability to excite 
sensory nerve endings as evidenced by cyanide mitochondrial poisoning. These elegant data 
provide evidence that exposure to CIH does not potentiate carotid body activity in guinea-
pigs (unlike rats), and confirm the characteristic quiescent nature of the guinea-pig carotid 
body in normoxia and hypoxia. In our study, exposure to CIH did not evoke alterations to 
breathing in normoxia or hypoxia, whereas similar paradigms disrupt respiratory control in 
rats (Edge et al., 2012; Skelly et al., 2012; Morgan et al., 2016).  
In rodents with hypoxia-sensitive carotid bodies, CIH increases the propensity for central 
apnoeas and respiratory instability (Edge et al., 2012; Donovan et al., 2014; Souza et al., 
2015b). Interestingly, CIH-exposed guinea-pigs exhibited reduced respiratory variability 
concurrent with decreased sigh frequency and qualitative observations of fewer central 
apnoeas. We observed altered brainstem neurochemistry evidenced by lower noradrenaline 
concentrations in CIH-exposed pons and medulla. Noradrenaline drives breathing 
irregularities in IH-exposed anaesthetised mice (Zanella et al., 2014). Thus, lower 
sigh/apnoea frequency and lower brainstem noradrenaline concentrations in CIH-exposed 
guinea-pigs are congruent observations, especially when one considers that CIH-exposed 
rats show evidence of increased central noradrenergic terminals (Mody et al., 2011) and 
elevated apnoea index (Edge et al., 2012). Whereas, we observed no evidence of a significant 
correlation between sigh frequency and medullary or pontine noradrenaline concentrations, 
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significant correlations between respiratory timing variability and pontine noradrenaline 
concentrations were evident.  
CIH impairs baroreflex control (Yan et al., 2008) and drives the development of hypertension  
in rodents with hypoxia-sensitive carotid bodies (Marcus et al., 2009; Ray et al., 2015). 
Hypertension did not manifest in our guinea-pig model of CIH, which seemingly supports the 
hypothesis that carotid body sensitisation is essential for cardiovascular maladaptation, as 
previously suggested by carotid body denervation studies (Lesske et al., 1997; Prabhakar, 
2016). Exposure to CIH, using a profile similar to the present study evokes hypertension in 
rats (Ray et al., 2015). Indeed, hypertension can manifest after as few as two days of 
exposure to CIH (Marcus et al., 2009). Thus, we are confident that the CIH protocol utilised 
in this study would be sufficient to induce hypertension in a rodent model with hypoxia-
sensitive carotid bodies. Remarkably, exposure to CIH (30 cycles.hour -1 for 8h.day-1 for 30 
days) caused hypertension in guinea-pigs (Docio et al., 2018), with tachycardia and increased 
concentrations of circulating noradrenaline, indicative of sympathetic nervous hyperactivity, 
the hallmark of carotid body-dependent sympatho-excitation in rat models of CIH. It is 
therefore apparent that exposure to CIH has the capacity to evoke cardiovascular morbidity 
in guinea-pigs, through a carotid body-independent mechanism. We posit that our modest 
paradigm (6 cycles.hour-1 for 8.hours day-1 for 12 days), sufficient to evoke hypertension in 
rats (Ray et al., 2015), was most likely insufficient to provoke sensory facilitation of carotid 
chemoafferent input to the brainstem, but was also insufficient to evoke sympathetic 
overactivity, by whatever means, and hence hypertension. This is supported by urinary 
measures of noradrenaline and corticosterone in our study, which were unchanged in CIH-
exposed guinea-pigs.  
Of interest, we observed a CIH-induced tachycardia, which is also reported in some studies 
in CIH-exposed rats (Zoccal et al., 2007b; Lucking et al., 2014), and consistent with 
observations in the rat that CIH-induced tachycardia was amenable to β-adrenoceptor 
blockade with propranolol (Lucking et al., 2014). Of note, enhanced heart rate responses to 
sympathetic nervous stimulation was observed in an isolated atria/right stellate ganglion 
preparation in CIH-exposed guinea-pigs (Mohan et al., 2001). Tachycardia was also evident 
in guinea-pigs exposed to CIH for 30 days (Docio et al., 2018), accompanied by evidence of 
sympathetic over-activity and hypertension. Our finding of a β-adrenoceptor-mediated 
tachycardia suggests activation of the cardiac sympathetic branch with resultant 
chronotropic effects without elevation in blood pressure. Blunted bradycardia responses to 
phenylephrine-induced elevations in blood pressure (which were equivalent in magnitude 
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between groups), suggests impaired baroreflex responsiveness in CIH-exposed guinea-pigs, 
perhaps secondary to CIH-induced central remodelling at the level of the nucleus tractus 
solitarius and paraventricular nucleus (Mifflin et al., 2015) or related to increased inhibitory 
neurotransmission to cardiac vagal neurons of the nucleus ambiguous and dorsal motor 
nucleus of the vagus resulting in blunted heart rate responsiveness, which has been reported 
following exposure to CIH (Dyavanapalli et al., 2014). We conclude that these effects are 
independent of carotid body sensitisation, or at least are not dependent upon it, revealing a 
capacity for CIH to alter autonomic control of the heart through actions at one or more extra-
carotid sites. Whereas our modest paradigm of CIH was insufficient to evoke hypertension 
in guinea-pigs, at least over the timeframe of our study, Docio et al. 2018 have clearly 
demonstrated a capacity for more severe exposures to CIH to elicit sympathetic over-activity 
and hypertension in guinea-pigs, without carotid body sensitisation.  
Regulation of blood pressure is complex with multiple contributory mechanisms over varying 
time domains. Increasing evidence supports the symbiotic gut microbiota as a major 
contributor to long-term blood pressure regulation (Durgan et al., 2016; Adnan et al., 2017). 
New evidence implicates sympathetic neuronal communication between the hypothalamic 
paraventricular nucleus and the gut in the regulation of blood pressure (Marques et al., 
2018). In recent years, it has become apparent that various hypertensive animal models 
develop gut dysbiosis, including spontaneously hypertensive rats (Adnan et al., 2017; 
Santisteban et al., 2017) and animal models of sleep apnoea (Everard & Cani, 2013; Moreno-
Indias et al., 2015; Durgan et al., 2016). A variety of systemic stressors are capable of inducing 
alterations in the gut microbiota, including prenatal stress (Golubeva et al., 2015), maternal 
separation (O'Mahony et al., 2011), social disruption (Bailey et al., 2011; van de Wouw et al., 
2018a) and sleep fragmentation (Bailey et al., 2011). Hyper-activation of the sympathetic 
nervous system appears to be fundamental to this process. As such, exposure to CIH could 
conceivably disrupt gut microbiota through autonomic dysregulation.  In addition, CIH is a 
systemic insult that may directly influence microbiota function and microbiota/host 
interaction. Repeated bouts of hypoxia may favour the proliferation of obligate anaerobes. 
Moreover, exposure to CIH induces oxidative stress and inflammation and decreases the 
expression of tight junction proteins (Wu et al., 2016), all of which contribute to altered 
microbiota composition and diversity. Spontaneously hypertensive rats have decreased 
expression of several tight junction proteins in the gut, which increases intestinal 
permeability (Santisteban et al., 2017). We did not examine the effects of exposure to CIH 
on intestinal permeability in this study, but others have reported that exposure to CIH results 
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in a late-onset persistent low-grade endotoxaemia in mice, with positive correlations 
between plasma LPS and the abundance of Mucispirillum and Desulfovibrio (Moreno-Indias 
et al., 2016). Also, bacteria-derived metabolites such as short-chain fatty acids are influenced 
by CIH exposure (Adnan et al., 2017; Marques et al., 2018) and these bacterial metabolites, 
in addition to others such as hydrogen sulphide (Tomasova et al., 2016) and indole (Huc et 
al., 2018), are associated with blood pressure control.  
A pivotal role for microbiota in blood pressure regulation is revealed by demonstration that 
faecal transplant from spontaneously hypertensive rats into normotensive, microbiome-
compromised control rats induces hypertension and gut dysbiosis (Adnan et al., 2017). 
Alterations in the composition of the gut microbiota coincide with increases in blood 
pressure, since changes in the microbiota are not evident in pre-hypertensive rats, whereas 
expansion of  Bacteroidetes and a reduction in Firmicutes, as well as increased gut barrier 
permeability are evident once hypertension is established (Santisteban et al., 2017). Changes 
in the relative proportions of Firmicutes and Bacteroidetes bacteria have been reported in 
animal models of hypertension and sleep apnoea, although the results are inconsistent 
across the studies (Everard & Cani, 2013; Moreno-Indias et al., 2015; Durgan et al., 2016). 
Indeed, six weeks of recovery in normoxia following exposure to CIH is insufficient for 
recovery of the microbiota (Moreno-Indias et al., 2016), a potential mechanism underlying 
failed interventional therapy for hypertension despite prevention of CIH in persons with 
sleep apnoea, in addition to suggestions of persistent epigenetic redox changes driving 
sympathetic over-activity (Nanduri et al., 2017).  
In the present study, the relative abundance of Firmicutes was significantly reduced and the 
relative abundance of Bacteroidetes was significantly increased. As a consequence, the  
Firmicutes:Bacteroidetes ratio tended to decrease, as did the alpha diversity indices 
following exposure to CIH. Post-hoc analysis revealed that this comparison was 
underpowered to detect a significant difference, based upon the effect size determined in 
our study and sample size, which we acknowledge is a limitation of our study. LEfSe analysis 
detected statistically significant over-representation of Actinobacteria (Bifidobacterium and 
Coriobacteriaceae UCG-002) and Bacteroidetes species (Butyricimonas and Bacteroidales 
S24-7 group) in the CIH-exposed group, while Firmicutes bacteria (Blautia, Anaerotruncus, 
Ruminoclostridium, Lachnoclostridium) were largely under-represented in CIH-exposed 
guinea pigs. The LEfSe results largely overlap with the differential abundance data presented 
on the heatmap (Fig. 3.8b), thus supporting the observed shift towards an increase in the 
relative abundance of Bacteroidetes and a reduction in Firmicutes bacteria in CIH-exposed 
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microbiota. Similar to our findings, an increase in the abundance of Bacteroidetes bacterial 
species was observed in deoxycorticosterone acetate (DOCA)-salt mice fed with a high fibre 
diet. This shift in the microbiota was accompanied by reduced systolic and diastolic blood 
pressures, as well as reduced cardiac weight index, cardiac fibrosis and improved cardiac 
function (Marques et al., 2017), suggesting beneficial effects of increased abundance of 
Bacteroidetes on cardiovascular function in the DOCA model. An additional common feature 
of disrupted microbiota is reduced microbial diversity. Hypertensive animals have reduced 
Shannon diversity and Chao1 richness (Yang et al., 2015; Durgan, 2017; Li et al., 2017). We 
observed a decrease in Chao1 richness in CIH-exposed animals in our study, with trends 
towards decreases in other measures of microbiota diversity.  
We posit that CIH-induced reduction in microbiota richness, in tandem with changes in 
microbiota composition demonstrate the physiologically significant influence of exposure to 
CIH on microbiota populations. These likely direct effects of exposure to CIH,  independent 
of sympathetic nervous activation, notwithstanding that putative links between CIH-induced 
hypertension and alterations to the gut microbiome are dependent upon hyper-activation of 
the sympathetic nervous system, which in turn serves to perpetuate cardiorespiratory 
dysregulation. CIH in rodents with hypoxia-sensitive carotid bodies is associated with 
increased catecholamine secretions from the adrenal glands (Kumar et al., 2006), hormones 
which act to promote epithelial barrier dysfunction (Lyte et al., 2011; Santisteban et al., 
2017) as well as the proliferation of specific bacteria (Lyte, 2014b). It is plausible to suggest 
that exposure to CIH characterised by more frequent and/or severe and/or longer durations 
than those used in the present study, which have been shown to cause hypertension in 
guinea-pigs (Docio et al., 2018), could cause severe disruption to gut microbiota, and indeed 
may be the basis for the observations of CIH-induced hypertension and sympathetic hyper-
activity in guinea-pigs (Docio et al., 2018). 
Our study reveals the capacity for CIH to alter microbiota composition, richness and beta-
diversity which may have contributed to altered autonomic control of the heart, effects 
independent both of carotid body sensitisation and sympathetic over-activity, therefore 
purportedly a result of direct actions of CIH on the microbiota. It is also possible that direct 
actions of CIH on the microbiota, in the absence of sympathetic over-activity, may have 




The afferent vagal nerve pathway is proposed as an essential link between the gut microbiota 
and the central nervous system (Bravo et al., 2011; Foster et al., 2017; Bonaz et al., 2018). 
Alterations in microbiota diversity/populations and their production of metabolites could 
influence vagal afferent traffic directed towards the cardiorespiratory centres of the 
brainstem. Positive correlations between disruption of the microbiota and respiratory timing 
variability have been described in adult rats exposed to pre-natal stress (Golubeva et al., 
2015). Exposure to CIH in adult guinea-pigs caused a reduction in the frequency of sighs, a 
critical component of the normal respiratory control repertoire, important in the control of 
respiratory timing variability. Moreover, as a result of the mechanical consequences of 
augmented breaths, sighs defend the respiratory gas exchange units against collapse 
(atelectasis). CIH-associated alterations to the microbiota and/or direct effects on the central 
neural circuitry within the brainstem demonstrably interfered with the protective sigh reflex, 
revealing a CIH-induced respiratory-related morbidity unrelated to carotid body 
sensitisation.  
In conclusion, hallmark features of cardiorespiratory morbidity evoked by exposure to CIH in 
rats, principally apnoea and high blood pressure, were not evident in guinea-pigs. There were 
nevertheless residual aberrant phenotypes including decreased respiratory timing variability 
and frequency of sighs as well as tachycardia and decreased heart rate responsiveness. 
Exposure to CIH altered brainstem neurochemistry, revealed as a significant reduction in the 
concentration of noradrenaline in the pons and medulla oblongata. In the absence of 
sympathetic over-activity, exposure to CIH decreased gut microbiota species richness, and 
altered microbiota composition, decreasing the relative abundance of Firmicutes and 
increasing the relative abundance of Bacteroidetes. 
Our study reveals obligatory roles for the carotid body in CIH-induced cardiorespiratory 
morbidity. Moreover, the gut microbiota are potential players contributing to central 
remodelling during exposure to CIH through potential alterations in microbiota-gut-brain 
axis signalling. Our findings have implications for human sleep-disordered breathing and 
contribute to an emerging interest in the potential of manipulation of the microbiota as an 
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Abbreviations: AUC, area under the curve; BH, Benjamini-Hochberg; CIH, chronic 
intermittent hypoxia; DA, dopamine; DOPAC, 3,4-Dihydroxyphenylacetic acid; Dia, 
diaphragm; EMG, electromyogram; ETCO2, end-tidal carbon dioxide; FDR, false discovery 
rate; fR, respiratory frequency; FiCO2, fractional inspired carbon dioxide concentration; F iO2, 
fractional inspired oxygen concentration; GABA, gamma-Aminobutyric acid; HFD, high-fat 
diet; HSD, high-salt diet; HVA, homovanillic acid; IFN, interferon; IL, interleukin; KC/GRO,  
keratinocytechemoattractant/growth-related oncogene; LSD, least significant difference; L-
DOPA, L-3,4-dihydroxyphenylalanine; NA, noradrenaline; NaCN, sodium cyanide; NTS, 
nucleus tractus solitarius; OSA, Obstructive sleep apnoea; PBG, phenylbiguanide; PCA, 
principal component analysis; PCoA, Principal coordinates analysis; PaCO2, partial pressure 
of arterial carbon dioxide; PaO2,  partial pressure of arterial oxygen; PREB, prebiotic; SaO2, 
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timing variability; SD2, long-term respiratory timing variability; Te, expiratory time; Ti, 
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equivalent for CO2; Vo2, oxygen consumption; VT, tidal volume; VT/Ti, mean inspiratory flow; 
5-HIAA, 5-hydroindoleacetic acid; 5-HT, 5-hydroxytryptamine (serotonin); 5-HT3, 5-

















Background: Evidence is accruing to suggest that microbiota-gut-brain signalling plays a 
regulatory role in cardiorespiratory physiology. Chronic intermittent hypoxia (CIH), 
modelling human sleep apnoea, affects gut microbiota composition and elicits 
cardiorespiratory morbidity. We determined if treatment with prebiotic fibres, promoting 
the expansion of beneficial microbes, ameliorates cardiorespiratory dysfunction in CIH-
exposed rats.  
Methods: Adult male rats were exposed to CIH (96 cycles/day, 6.0% O2 at nadir) for 14 
consecutive days with and without prebiotic supplementation (fructo- and galacto-
oligosaccharides) beginning two weeks prior to gas exposures.  
Findings: CIH increased apnoea index, and caused cardiac autonomic imbalance and 
hypertension. CIH exposure altered the gut microbiota, predominantly decreasing the 
relative abundance of Lactobacillus rhamnosus and increasing the relative abundance of 
pathogenic species. Faecal short-chain fatty acid (SCFA) concentrations, plasma and 
brainstem pro-inflammatory cytokine concentrations as well as brainstem neurochemistry 
were unaffected by exposure to CIH. Prebiotic administration modulated gut microbiota 
composition and diversity, increasing faecal acetic and propionic acid concentrations, but did 
not recover CIH-induced reductions in Lactobacillus rhamnosus or prevent adverse CIH-
induced cardiorespiratory phenotypes. 
Interpretation: CIH-induced cardiorespiratory dysfunction is not critically dependent upon 
decreased gut SCFA concentrations. Prebiotic-related boosting of SCFAs was not sufficient to 
prevent CIH-induced apnoea and hypertension in our model. We identified associations 
between multiple gut bacterial species and blood pressure. CIH-induced cardiorespiratory 
and autonomic dysfunction may relate to an aberrant gut microbiota signature contributing 
to maladaptive plasticity in the neural circuitry controlling respiratory and autonomic 
homeostasis. Our findings have relevance for human sleep-disordered breathing and 
contribute to an emerging interest in the manipulation of the gut microbiota as an adjunctive 
therapy for human cardiorespiratory disease. 
Funding: Department of Physiology and APC Microbiome Ireland, University College Cork, 
Ireland. 
Keywords: Chronic intermittent hypoxia; prebiotics; apnoea; hypertension; autonomic 





Obstructive sleep apnoea (OSA), the most common form of sleep-disordered breathing 
(SDB), is recognised as a major worldwide health crisis with devastating consequences for 
integrative body systems (Garvey et al., 2015). OSA is characterised by repetitive collapse of 
the pharyngeal airway during sleep, with episodic oxygen fluctuations culminating in 
recurrent exposure to chronic intermittent hypoxia (CIH). It is now apparent that exposure 
to CIH has adverse effects on the cardiorespiratory control network and is recognised as a 
major driver of OSA-related morbidities (Prabhakar et al., 2007; Julien et al., 2008; Edge & 
O'Halloran, 2015; O'Halloran, 2016; Iturriaga et al., 2017; Laouafa et al., 2017; Elliot-Portal 
et al., 2018).  
Studies have recurrently implicated the carotid bodies, the dominant peripheral oxygen 
sensors, in the manifestation of CIH-induced cardiorespiratory dysfunction (Prabhakar et al., 
2007; Peng et al., 2011; Iturriaga et al., 2015; Del Rio et al., 2016; Iturriaga et al., 2017). 
However, exposure to CIH elicits cardiorespiratory and autonomic disturbances in guinea-
pigs with hypoxia-insensitive carotid bodies (Docio et al., 2018; Lucking et al., 2018b), 
revealing that sites beyond the carotid bodies can contribute to the manifestation of CIH-
induced cardiorespiratory and autonomic disturbances. It is  known that CIH-induced 
plasticity also occurs at other key sites of the cardiorespiratory control circuit, including the 
nucleus tractus solitarius (NTS), pre-Bötzinger complex, ponto-medullary network and 
paraventricular nucleus of the hypothalamus  (Veasey et al., 2004; Almado et al., 2012; 
Moraes et al., 2013; Garcia et al., 2016; Garcia et al., 2017; Li et al., 2018). More recently, 
studies have described effects of CIH on other peripheral sites including the gut microbiota 
(Moreno-Indias et al., 2015; Moreno-Indias et al., 2016; Lucking et al., 2018b; AlMarabeh et 
al., 2019; O'Neill et al., 2019).  
The microbiota-gut-brain axis plays a critical regulatory role in physiological systems. 
Dysregulated microbiota-gut-brain axis signalling affects homeostatic neurocontrol 
networks manifesting in pathophysiological behaviours and brain functions (Golubeva et al., 
2015; Kelly et al., 2016b; Dinan & Cryan, 2017). Recent studies extend this concept to 
cardiorespiratory control (Lucking et al., 2018b; O'Connor et al., 2019a). There is 
considerable interest in the modulatory role of the gut microbiota and the gut microbiota 
metabolites, short-chain fatty acids (SCFAs), in cardiovascular and autonomic function 
(Durgan et al., 2016; Ganesh et al., 2018; Kim et al., 2018; Meng et al., 2019). Proliferation 
of lactate-producing, as well as diminished butyrate- and acetate-producing taxa is evident 
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in hypertensive models (Yang et al., 2015; Durgan et al., 2016; Adnan et al., 2017; Kim et al., 
2018). Hypertensive donor faeces transferred to normotensive animals leads  to the 
development of hypertension in recipient animals (Durgan et al., 2016; Adnan et al., 2017; 
Toral et al., 2019). Moreover, in a rat model of SDB, prebiotic administration (Hylon VII) 
stimulates the expansion of beneficial commensal microbiota, augmenting several SCFA-
producing taxa including Bifidobacterium, Ruminococcus, Blautia and Collinsella, restoring 
caecal acetate concentrations and preventing the establishment of hypertension (Ganesh et 
al., 2018).  Chronic acetate administration into the caecum of OSA + high-fat diet (OSA+ HFD) 
rats prevents the development of high blood pressure (Ganesh et al., 2018). Additionally, 
butyrate treatment in angiotensin-II-induced hypertensive mice prevented establishment of 
hypertension, decreased baroreceptor reflex gain, cardiac autonomic dysfunction and 
cardiac hypertrophy (Kim et al., 2018).   
In rat models, disruption of the gut microbiota using antibiotic administration, faecal 
microbiota transfer or pre-natal stress results in altered ventilatory responses to hypoxic and 
hypercapnic chemostimulation (Golubeva et al., 2015; O'Connor et al., 2019a). Respiratory 
frequency response to hypercapnic chemostimulation correlated with altered bacterial 
genera in adult rats with antecedent pre-natal stress (Golubeva et al., 2015). Several genera, 
predominantly of Firmicutes phylum correlated with brainstem neuromodulators crucial in 
the control of breathing (O'Connor et al., 2019a). Exposure to CIH dysregulates 
cardiorespiratory control in guinea pigs resulting in aberrant phenotypes including altered 
autonomic control of heart rate, decreased respiratory variability and prevalence of 
protective sighs and brainstem noradrenaline concentrations, as well as disturbed gut 
microbiota indicating that aberrant gut microbiota may at least partly contribute to 
cardiorespiratory and autonomic malaise in CIH-exposed guinea pigs (Lucking et al., 2018b).  
Collectively, these studies highlight a contributory role of perturbations to microbiota-gut-
brain axis signalling in the manifestation of CIH-induced cardiorespiratory dysfunction, of 
relevance to OSA.  There is a growing interest in developing strategies to manipulate the 
microbiota as a potential therapeutic intervention in the treatment of cardiorespiratory 
disease. Rodent and human studies have revealed that prebiotic administration has positive 
impacts on brain neurochemistry and functions (Savignac et al., 2013; Burokas et al., 2017; 
Dinan & Cryan, 2017; Mika et al., 2017). Moreover, prebiotic feeding prevented the 
development of hypertension in a rat model of OSA (Ganesh et al., 2018). Therefore, we 
assessed cardiorespiratory physiology and gut microbiota composition and diversity in adult 
rats following exposure to normoxia (Sham) or CIH. We hypothesised that there would be 
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evidence of cardiorespiratory and autonomic dysfunction and altered gut microbiota in CIH-
exposed rats.  We examined the effects of prebiotic fibre supplementation to test the 
hypothesis that manipulation of the gut microbiota ameliorates or prevents the deleterious 
effects of exposure to CIH on cardiorespiratory physiology. We performed whole -genome 
shotgun sequencing with a view to identifying microbial signatures that underscore 




4.2. Materials and Methods 
 
4.2.1 Ethical approval 
Procedures on live animals were performed in accordance with European directive 
2010/63/EU under authorisation from the Government of Ireland Department of Health 
(B100/4498) and Health Products Regulatory Authority (AE19130/P070). Ethical approval 
was obtained from University College Cork (AEEC #2013/035; #2017/023) and procedures 
were carried out in accordance with guidelines laid down by University College Cork’s Animal 
Welfare Body. 
4.2.2 Experimental animals 
Eight- to ten-week old adult male Sprague Dawley rats (n=72; purchased from Envigo, UK) 
were housed as age-matched pairs in standard rat cages. Rodents had ad libitum access to 
standard rat chow and were housed under a 12-hr light: 12-hr dark cycle. 
4.2.3 Prebiotic administration 
Eight-week old rats (n=24) were randomly allocated to receive prebiotic fibres in water 
(PREB; galactooligossaccharides and fructooligosaccharides) with ad libitum access for 4-
weeks to promote the growth of beneficial host microbiota (Savignac et al., 2013; Alves et 
al., 2017). After 2 weeks of PREB treatment, a subset of rats was exposed to CIH (see section 
4.2.4) for the final 2 weeks creating two groups: Sham+PREB (n=12) and CIH+PREB (n=12).  
4.2.4 Chronic intermittent hypoxia rat model 
Ten-week old rats (n=48) were randomly assigned to one of two groups, each receiving 
vehicle (VEH): Sham+VEH (n=24) and CIH+VEH (n=24). CIH exposed rats were placed in 
chambers wherein ambient oxygen concentration was tightly regulated using a dynamic 
oxygen/nitrogen controller (Oxycycler™; Biospherix, New York, NY, USA). CIH exposure was 
comprised of 96 cycles of 90 secs of exposure to hypoxia (nadir, FiO2 = 0.06, balance N2) and 
180 secs of exposure to normoxia (FiO2 =0.21; balance N2), over 8 hours during the light 
phase for 14 consecutive days. Animals were studied on the day subsequent to the last day 
of CIH exposure. Concurrently, rats assigned to the Sham group were exposed to room air 
(normoxia) in the same room with similar environmental cues for the duration of the study.  
4.2.5 Assessment of respiratory flow in rats during quiet rest 
Whole-body plethysmography: During quiet rest, whole-body plethysmography (DSI, St. Paul, 
Minnesota, USA) was used to record respiratory flow signals during quiet rest. Animals were 
placed into custom plethysmograph chambers (601-1427-001 PN, DSI) with a room air flow 
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rate maintained at 3l/min. Animals were allowed to acclimate for 30-90 minutes to 
encourage habituation to the new surroundings. Paired contemporaneous observations 
were performed during light hours in Sham+VEH (n=12) versus CIH+VEH (n=12) and 
subsequently Sham+PREB (n=12) versus CIH+PREB (n=12) using a pair of plethysmograph 
chambers. 
Metabolic measurements: O2 consumption (VO2) and CO2 production (VCO2) were measured 
in rodents throughout the experimental protocol (O2 and CO2 analyser; AD Instruments, 
Colorado Springs, CO, USA) as previously described (Haouzi et al., 2009; Bavis et al., 2014; 
Lucking et al., 2018b; O'Connor et al., 2019a). 
Experimental protocol: Once the acclimation period was complete and animals were 
confirmed to be at quiet rest, baseline parameters were recorded during a 10-15 minute 
steady-state normoxia period (FiO2 = 0.21; balance N2). This was followed by a 10 minute 
poikilocapnic hypoxia challenge (FiO2=0.10; balance N2). Normoxia was subsequently 
restored in each chamber to re-establish stable baseline breathing. Thereafter, a second 
baseline period was recorded followed by a 10 minute hypercapnia challenge (FiCO 2 = 0.05; 
balance O2). Subsequently, a third normoxic baseline period was recorded. Rats were then 
exposed to a 10 minute hypoxic hypercapnic challenge (FiO2 = 0.10; FiCO2 =0.05, balance N2). 
Data analysis for whole-body plethysmography: Respiratory parameters including tidal 
volume (VT), respiratory frequency (fR), minute ventilation (VE), expiratory time (Te) and 
inspiratory time (Ti) were recorded on a breath-by-breath basis for analysis (FinePointe 
software Buxco Research Systems, Wilmington, NC, USA). Artefacts relating to animal 
movement and sniffing in respiratory flow recordings were omitted from analysis.  A single 
baseline period during normoxia was determined by averaging the three baseline recording 
epochs to determine resting steady-state respiratory and metabolic parameters. Ventilatory 
and metabolic data were averaged and reported for the final 5 minutes of acute poikilocapnic 
hypoxia, hypercapnia and hypoxic hypercapnia allowing sufficient time for gas mixing in the 
custom plethysmograph chambers as well as steady-state assessment of metabolic and 
ventilatory parameters during gas challenges. Data are expressed as absolute change from 
baseline values. Respiratory flow recordings were assessed for the occurrence of augmented 
breaths (sighs) during normoxia, poikilocapnic hypoxia and hypercapnia, as well as the 
frequency of apnoea events (post-sigh and spontaneous apnoeas) during normoxia as 
previously described (Edge et al., 2012). The criterion for an apnoea was a pause in breathing 
greater than two consecutive missed breaths. Apnoea data are expressed as apnoea index 
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(apnoea events per hour), combining post-sigh and spontaneous apnoeas. A sigh was defined 
as an augmented breath double the amplitude of the average VT. The frequency and 
amplitude of sighs were determined. Poincaré plots expressing breath-to-breath (BBn) 
versus subsequent breath-to-breath interval (BBn+1) were extrapolated allowing for 
determination of short- (SD1) and long-term (SD2) respiratory timing variability during 
steady-state baseline breathing. VT, VE, VT/Ti, VO2 and VCO2 were normalised per 100g body 
mass. 
4.2.6 Assessment of cardiorespiratory parameters under urethane anaesthesia 
Surgical protocol and cardiorespiratory measures: Following whole-body plethysmography, 
cardiorespiratory parameters were assessed in Sham+VEH, CIH+VEH, Sham+PREB and 
CIH+PREB rats (n=11-12 per group) under urethane anaesthesia (1.5 g/kg i.p.; 20% w/v) 
following isoflurane induction (5% by inhalation in room air). Throughout the surgical and 
experimental protocol, the depth of anaesthesia was carefully assessed by monitoring reflex 
responses to tail/paw pinch and the corneal reflex. Supplemental doses of anaesthetic were 
given as required. Rodents were placed in a supine position on a homeothermic blanket 
system (Harvard Apparatus, Holliston, MA, USA) to maintain core temperature at 37 °C, 
which was measured by a rectal temperature probe. A mid-cervical tracheotomy was 
performed, followed by intravenous (i.v.) cannulation of the right jugular vein for infusion of 
supplemental anaesthetic and drugs. The carotid (n=22)/femoral artery (n=1) was 
cannulated for the recording of arterial blood pressure and the withdrawal of blood samples 
for arterial blood gas, pH and electrolyte analysis (i -STAT; Abbott Laboratories Ltd). Using a 
foot clip, arterial oxygen saturation (SaO2; Starr Life Sciences, PA, USA) was determined and 
maintained above 95% via a bias flow of supplemental O2 passing the tracheal cannula 
sourced from a gas mixing system (GSM-3 Gas Mixer; CWE Inc.). A pneumotachometer (Hans 
Rudolf) and a CO2 analyser (microCapStar End-Tidal CO2 analyser; CWE Inc., USA) were 
connected to the tracheal cannula to measure tracheal flow and end-tidal CO2 (ETCO2), 
respectively. Diaphragm electromyogram (EMG) activity was continuously measured using a 
concentric needle electrode (26G; Natus Manufacturing Ltd., Ireland). Signals were amplified 
(x5,000), filtered (band pass; 500–5000 Hz) and integrated (50 ms time constant; Neurolog 
system, Digitimer Ltd., UK).  Data were digitised via a PowerLab-LabChart v7 (ADInstruments) 
data acquisition system.  
Experimental protocol: An arterial blood sample was obtained from each animal following a 
30 minute stabilisation period, after which, a minimum 10 minute baseline recording period 
was observed for assessment of baseline parameters (FiO2 = 0.25-0.40; balance N2). The rats 
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were exposed to a poikilocapnic hypoxia challenge (FiO2 = 0.12, balance N2) for 5 minutes, 
followed by a recovery period. Animals were then exposed to a 5 minute hypoxic hypercapnic 
challenge (FiO2 = 0.12, FiCO2 = 0.05, balance N2). Following a recovery period, sodium cyanide 
(NaCN; 200 μg/kg i.v.) was administered to evoke carotid body-dependent increases in 
ventilation. After an adequate recovery period and removal of the pneumotachometer, a 
second arterial blood sample was taken. Next, the serotonin type 3 (5-HT3) receptor agonist 
phenylbiguanide (PBG; 25 μg/kg i.v.) was administered to stimulate pulmonary vagal afferent 
C-fibres (Dutta & Deshpande, 2010; Lucking et al., 2018a) eliciting the classic pulmonary 
chemoreflex. Successively, phenylephrine (50 μg/kg i.v.), sodium nitroprusside (50 μg/kg 
i.v.), atenolol (2 mg/kg i.v.), propranolol (1 mg/kg i.v.) and hexamethonium (25mg/kg i.v.) 
were administered to assess cardiovascular responses to pharmacological manipulation with 
sufficient recovery periods allowed between each pharmacological challenge. Animals were 
euthanised by urethane (i.v) overdose. One animal (Sham+PREB, n=1) presented with 
uncharacteristically poor ventilatory and cardiovascular responses throughout the 
experimental protocol; this animal was excluded from data analysis. In all animals, blood was 
collected, prepared in 3% Na2EDTA (disodium salt dehydrate) and centrifuged. Plasma was 
snap frozen in liquid nitrogen for subsequent analysis of corticosterone and inflammatory 
cytokine concentrations. Whole brains were removed, separated into pons and medulla 
oblongata, frozen in isopentane at −80 °C and stored at −80 °C until subsequent analysis by 
high-performance liquid chromatography. The lungs were removed and weighed and were 
allowed to air dry at 37°C for at least 48 hrs before being re-weighed to provide an index of 
pulmonary oedema. The caecum was removed, weighed and caecal contents were removed 
and snap frozen in liquid nitrogen for whole-genome shotgun sequencing. Faeces was 
removed from the colon for the assessment of SCFA concentrations by gas chromatography. 
The heart was removed, and the right ventricle was separated from the left ventricle + 
septum and each were weighed separately. 
Data analysis of cardiorespiratory parameters in anaesthetised rats : Baseline parameters 
were averaged over 10 minutes of stable recording and data are presented as absolute 
values. For cardiorespiratory and EMG responses to poikilocapnic hypoxia and hypoxic 
hypercapnia the average of the last minute of recordings was determined and data were 
compared with the 1 minute pre-challenge baseline. Data for drug challenges were averaged 
into 3 or 5 second bins and the peak cardiorespiratory responses to NaCN, PBG, 
phenylephrine, sodium nitroprusside, atenolol, propranolol and hexamethonium 
administration were determined and compared to the respective 1 minute pre -challenge 
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baseline. Maximum apnoea and post-apnoea tachypnoea in response to PBG are expressed 
as the duration of the apnoea or tachypnoea period normalised in each trial to the average 
cycle duration determined during the 30 sec pre-challenge baseline period. All 
cardiorespiratory responses to chemostimulation and drug administration are expressed as 
percent change from the preceding baseline values. 
4.2.7 Brainstem monoamine concentrations 
High-performance liquid chromatography (HPLC) coupled to electrochemical detection for 
the measurement of brainstem monoamine concentrations: Pons (n=11-12/group) and 
medulla oblongata (n=11-12/group) tissues were sonicated in 1 ml of chilled mobile phase, 
spiked with 2ng/20μl of a N-methyl 5-HT (internal standard; Bandelin Sonolus HD 2070). 
Brainstem monoamine, precursor and metabolite concentrations were measured as 
previously described (Lucking et al., 2018b; O'Connor et al., 2019a). Noradrenaline (NA), 
dopamine (DA), serotonin (5-HT), and monoamine metabolites and precursor, 5-
hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), 3,4-Dihydroxyphenylacetic acid 
(DOPAC) and L-3,4 dihydroxyphenylalanine (L-DOPA) were identified by their characteristic 
retention times. This was determined by standard injections run at regular intervals during 
sample analysis. 
Data analysis: Class-VP5 software was used to process chromatographs. Concentrations 
(ng/g) of monoamines, precursors and metabolites in each sample were determined using 
analyte:internal standard peak response ratios. 
4.2.8 Plasma and brainstem cytokine concentrations 
Brainstem tissue homogenisation and protein quantification : A separate cohort of rats 
(Sham, n=12; CIH, n=12) were euthanised by pentobarbitone (i.v.) overdose and whole brains 
were removed. The pons and medulla oblongata were separated from the brain, frozen in 
isopentane at -80oC and stored at -80oC until subsequent determination of brainstem 
cytokine concentrations. Pons and medulla oblongata tissue (Sham, n=12; CIH, n=12) were 
weighed and sonicated (1 ml per 100 mg of tissue) in radioimmunoprecipitation assay (RIPA 
buffer) (10X RIPA, deionised H20, 200Mm sodium fluoride, 100Mm, 
phenylmethylsulfonylfluoride (PMSF), 1X protease inhibitor cocktail and 1X phosphate 
inhibitor cocktail). Samples were centrifuged at 10,000 x g for 15 minutes at 4 °C, to pellet 
membranes and nuclei. The protein concentration of each sample was determined using a 
bicinchonic acid (BCA) protein quantification assay (Thermo Fisher Scientific) as per the 
manufacturer’s instructions, at a dilution of 1:10. 
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Multiplex assay for measurement of plasma and brainstem cytokines: Concentrations of 
interleukin(IL)-1β, IL-4, IL-5, IL-10, IL-13, interferon (IFN)-γ, 
keratinocytechemoattractant/growth-related oncogene (KC/GRO) and tumor necrosis 
factor (TNF)-α were measured in plasma (all groups; n=11-12/group) as well as pons  and 
medulla oblongata (Sham and CIH only; n=12) supernatants by sandwich immunoassay 
methods using commercially available detection kits (V-Plex Pro-inflammatory Panel 2 (rat) 
kit; Meso Scale Discovery, Gaithersburg, USA) as per manufacturer’s instructions. For pons 
and medulla oblongata tissues 100 μg of protein sample was loaded per well as previously 
described (Lucking et al., 2018a). Plates were read using QuickPlex SQ 120 imager and 
computer (Meso Scale Discovery). 
4.2.9 Plasma corticosterone 
Plasma samples were thawed and concentrations of corticosterone were determined using 
commercially available enzyme-linked immunosorbent assay kit according to the 
manufacturer’s instructions (ENZO Life Sciences, UK) using a spectrophotometer 
(SpectraMax M3, Molecular devices). 
4.2.10 Microbiota composition and diversity  
DNA extraction from caecal material: DNA was extracted from caecal material as previously 
described (Gough et al., 2018).  
Whole-metagenome shotgun sequencing: Whole-metagenome shotgun libraries were 
prepared in accordance with the Nextera XT DNA Library Preparation Guide from Illumina 
with the exception that the tagmentation time was increased to 7 minutes.   After indexing 
and clean-up of the PCR products as described in the protocol, each sample was run on an 
Agilent bioanalyser high sensitivity chip (Agilent) to determine the size range of the 
fragments obtained.  The concentration of the samples was also determined at this point 
using a Qubit High Sensitivity Assay (Life-Sciences). Samples were then pooled equimolarly 
and the final concentration of the pooled library was determined by quantitative PCR using 
the Kapa Library Quantification kit for Illumina (Roche).  The pooled library was then 
sequenced on the Illumina NextSeq using the 2 x150 High Output kit according to standard 
Illumina sequencing protocols. 
Metagenomic bioinformatic analysis: Shotgun metagenomic sequence files (BCL, base calls) 
were converted to fastq format using bcl2fastq version 2.19. Forward and reverse fastq files 
were processed using KneadData version 0.7.2 from the Huttenhower bioBakery suite 
(McIver et al., 2018).  A reference library was created to remove host DNA in Bowtie2 version 
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2.3.4 from the NCBI rat genome (Rattus norgegicus, GCF 000001895.5). Quality filtering was 
performed using the default setting (ex., phred=33) and trimming with Trimmomatic version 
0.38-1. Resulting high quality paired-end reads for each sample were then concatenated in 
KneadData.  Kraken2 version 2.0.7-beta was used for taxonomic classification with the 
standard database. Report files of taxonomic counts for each sample were merged into a 
single count file using a custom R script and ran in R version 3.5.2.  
4.2.11 Faecal short-chain fatty acid concentrations 
SCFA analysis and extraction were carried out by MS-Omics (Vedbaek, Denmark) as follows. 
Faecal water was prepared by homogenising the faecal samples (approximately 100 mg) in 
ultrapure water (3µl/µg). Samples were then vortexed for 2 minutes followed by 
centrifugation (5 minutes, 30000g, 5°C). The supernatant was transferred to a centrifuge 
filter and the filtered samples were used for analysis. The filtrate was acidified using 
hydrochloride acid, and deuterium labelled internal standards where added. All samples 
were analysed in a randomized order. Analysis was performed using a high polarity  column 
(Zebron™ ZB-FFAP, GC Cap. Column 30 m x 0.25 mm x 0.25 µm) installed in a gas 
chromatography (GC; 7890B, Agilent) coupled with a quadropole detector (59977B, Agilent). 
The system was controlled by ChemStation (Agilent).  Raw data was converted to netCDF 
format using Chemstation (Agilent), before the data was imported and processed in Matlab 
R2014b (Mathworks, Inc.) using the PARADISe software (Johnsen et al., 2017). Data are 
expressed as absolute concentration in mM. 
4.2.12 Statistical analysis 
Data was assessed for outliers, normal distribution and equality of variances using box-plots, 
Shapiro-Wilk test and Levene’s test, respectively.  In situations of normal distribution, data 
were statistically compared using independent samples t-test and two-way ANOVA followed 
by Fisher’s least significant test for pairwise comparisons, where appropriate. In some 
instances, the assumptions of no significant outliers and homogeneity of variances were 
violated for the two-way ANOVA. When the assumption of normal distribution was violated, 
data were statistically compared using non-parametric Mann-Whitney U test and non-
parametric Kruskal-Wallis test followed by Mann-Whitney U test for pairwise comparisons, 
where appropriate. Statistical significance was assumed at p<0.05. Bonferroni correction was 
applied to adjust for multiple comparisons with the exception of microbiota composition 
data. Statistical significance for multiple comparisons (except microbiota composition data) 
was accepted at p<0.05 divided by the number of comparisons made. Benjamini-Hochberg 
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(BH) adjustment procedure was applied with the false discovery rate (FDR) set at 10% to 
correct for multiple testing in the relative abundance microbiota data. Microbiota data are 
expressed as median (IQR). All other data are expressed as mean ± SD or displayed 
graphically as box and whisker plots (median, IQR and minimum to maximum values). The 
2D principal component analysis (PCA) was constructed using the center-log ratio 
transformed values (aitchison distance) computed using the ALDEx2 (Fernandes et al., 
2013) library in R (version 3.6.0) with Rstudio (version 1.1.453), as is appropriate for 
compositional data (Gloor et al., 2017) using recommended parameters and 1000 
permutations. For correlation analysis between bacterial species, including Lactobacillus 
rhamnosus and physiological parameters of interest, Hierarchical All-against-All association 
testing (HAllA) was used (version 0.8.7) with Spearman correlation as correlation  
metric, medoid as clustering method and q < 0.1 as threshold for significance. Microbiota 
analysis was performed in SPSS v25 and R software environment. SPSS v25 was used for all 
other statistical analysis. GraphPad Software v6 (GraphPad Software, San Diego, CA, USA) 
and R software environment were used to generate graphs. Adobe illustrator CS5 (v15) was 







4.3.1 Body and tissue weight 
CIH exposure and prebiotic administration had a significant effect on body weight (Diet*CIH, 
F (1, 43) = 5.426, p=0.025, ƞ2=0.112, Table 4.1). The combination of CIH+PREB, decreased 
body weight gain compared with CIH+VEH or Sham+PREB rats; Sham+PREB rats were also 
lighter than Sham+VEH rats. CIH exposure had no effect on caecum weight but as expected, 
prebiotic supplementation increased caecum weight. Differences between groups in cardiac 



















368 ± 16 346 ±  21 308 ± 27 263 ± 16 N/A Diet, p<0.0005; 
CIH, p<0.0005; 
Diet*CIH, p=0.025 
0.057 0.0005 <0.0005 <0.0005 
RV 
(mg/100g) 
46 ± 7.8 50  ± 6 58 ± 9.1 61  ± 9.1 <0.0005 N/A 0.325 0.004 0.908 0.001 
LV 
(mg/100g) 
235 ± 24 232  ± 19 238 ±  22 236  ± 22 N/A Diet, p=0.280; 
CIH, p=0.810; 
Diet*CIH, p=0.603 
- - - - 
LV+RV 
(mg/100g) 
278 ± 18 282 ± 15 299 ± 25 297 ± 29  Diet, p=0.009; 
CIH, p=0.821; 
Diet*CIH, p=0.569 
0.578 0.139 0.806 0.023 
Caecum 
(g/100g) 
0.97 ± 0.27 0.87 ±  
0.1 
2.1 ± 0.46 2.3  ± 0.7 N/A Diet, p<0.0005; 
CIH, p=0.716; 
Diet*CIH, p=0.345 





78 ± 1 77 ± 3 79 ± 1 76 ± 5 0.110 N/A - - - - 
 
Table 4. 1 Body and tissue weights 
BW, body weight; RV, right ventricle; LV, left ventricle; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean ± SD and 
were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric 
Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by 




4.3.2 Baseline ventilation and metabolism in rats during quiet rest 
CIH exposure did not affect the majority of respiratory parameters during normoxia. 
Prebiotic fibre supplementation increased baseline VE, VT and VT/Ti in Sham+PREB and 
CIH+PREB compared with Sham+VEH and CIH+VEH rats, respectively (Table 4.2), but the 
differences related to body weight (Appendix Table C.1). CIH exposure had no effect on VCO2 
production; CIH+PREB rats had significantly increased VCO2 production compared with 
CIH+VEH rats, but VCO2 production in Sham+PREB rats was not different compared with 
Sham+VEH (Table 4.2). CIH exposure had no effect on VE/VCO2 (breathing as a function of 
metabolism), but prebiotic administration increased VE/VCO2, however post hoc analysis 
revealed no difference between groups (Table 4.2). In summary, CIH exposure and prebiotic 
administration had modest effects on ventilation and metabolism during normoxia.  
4.3.3 Respiratory timing variability, apnoeas and sighs during normoxia in rats during quiet 
rest 
Assessments of short-term (SD1) and long-term (SD2) respiratory timing variability during 
normoxia did not reveal differences between groups (p>0.05; Fig. 4.1a-f). Apnoea index was 
significantly increased by CIH exposure (X2(3) = 9.284, p=0.026, Fig. 4.1j), a consequence of 
alterations in spontaneous apnoea events; no statistically significant differences were 
evident in post-sigh apnoea events (Table 4.2). Post hoc analysis revealed that apnoea index 
was increased in CIH+PREB compared with Sham+PREB rats (p=0.008; Fig. 4.1j). The 
frequency of sighs was not affected by CIH exposure or prebiotic administration (p>0.05; Fig. 
4.1k). Sham+PREB had elevated sigh amplitude compared with Sham+VEH rats (Table 4.2). 
The major finding was that CIH exposure increased apnoea index during quiet breathing at 






Figure 4. 1 CIH increase apnoea index 
Poincaré plots of breath-to-breath (BBn) and subsequent breath-to-breath (BBn + 1) interval 
of expiratory duration (Te; a) and total breath duration (Ttot; b) for Sham+VEH, CIH+VEH, 
Sham+PREB and CIH+PREB. Group data for Te short-term variability (SD1; c) and long-term 
variability (SD2; d) and Ttot SD1 (e) and SD2 (f) in Sham+VEH, CIH+VEH, Sham+PREB and 
CIH+PREB rats during normoxia. Representative respiratory flow traces (downward 
deflections represent inspiration) illustrating a spontaneous sigh followed by an apnoea (g), 
a spontaneous apnoea (h) and a spontaneous sigh (i). Group data of apnoea index (j) and 
sigh frequency (k). CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Groups 
(c-f, j, k) are expressed as box and whisker plots (median, IQR and minimum to maximum 
values); n = 11-12. Groups were statistically compared using two-way ANOVA, followed by 
Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric 
Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Apnoea index was 
significantly affected by CIH exposure (p=0.026; Fig. 4.1j). Assessments of respiratory timing 
variability and frequency of sighs were not different between groups ( p>0.05; Fig. 4.1a-f, 





















- - - - 
VE (ml/min/ 
100g) 
53 ± 9 54 ± 6 63 ± 9 71 ± 6 <0.0005 N/A 0.498 <0.0005 0.038 0.009 
VT (ml/100g) 0.7 ± 0.1 0.7 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 <0.0005 N/A 0.356 0.001 0.028 0.009 
VT/Ti (ml/s/ 
100g) 




0.331 <0.0005 0.198 0.093 




0.028 0.370 0.402 0.584 




- - - - 
VO2 (ml/min/ 
100g) 




0.467 0.028 0.681 0.251 
VCO2 (ml/ 
min/100g) 
1.9 ± 0.3 1.9 ± 0.2 2.0 ± 0.3 2.1 ± 0.3 0.046 N/A 0.758 0.012 0.525 0.166 




















0.8 ± 0.2 1.2 ± 0.4 1.2 ± 0.2 1.4 ± 0.2 <0.0005 N/A 0.023 0.176 0.05 <0.0005 
 
Table 4. 2 Baseline ventilation, apnoea, sigh and metabolism in rats during quiet rest  
fR, respiratory frequency (brpm, breaths per minute); VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory 
time; VO2, oxygen consumption; VCO2, carbon dioxide production; VE/VCO2, ventilatory equivalent; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, 
vehicle. Data are shown as mean ± SD and were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc 
where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple 





4.3.4 Ventilatory and metabolic responsiveness to chemostimulation in rats during quiet 
rest 
Ventilatory and metabolic responsiveness to hypoxic chemostimulation : No significant 
differences were evident in CIH+VEH compared with Sham+VEH rats. CIH+PREB rats had 
decreased fR, VE, VT/Ti and increased Ti and Te compared with Sham+PREB rats (Table 4.3). Ti 
was decreased in Sham+PREB compared with Sham+VEH rats (Table 4.3). Sigh frequency and 
amplitude were not different in CIH+VEH compared with Sham+VEH rats, but CIH+PREB rats 
had less frequent but larger sighs compared with CIH+VEH rats. Sigh frequency was reduced 
in CIH+PREB compared with Sham+PREB rats (Table 4.3). The major observation was that 
prebiotic administration reduced the frequency of sighs during hypoxia in CIH-exposed rats.  
Ventilatory and metabolic responsiveness to hypercapnic chemostimulation: CIH exposure 
elevated sigh frequency during hypercapnia, as such CIH+VEH rats had increased generation 
of sigh compared with Sham+VEH rats. Other respiratory and metabolic parameters were 
not different in CIH+VEH compared with Sham+VEH rats in response to hypercapnia (Table 
4.3). Prebiotic administration in CIH-exposed rats elevated VT/Ti compared with CIH+VEH 
rats. Interestingly, Sham+PREB rats had elevated ventilation (V E) and increased drive to 
breathe (VT/Ti) in response to hypercapnia compared with Sham+VEH rats, with no change 
in VE/VCO2 (Table 4.3). Furthermore, Sham+PREB rats had augmented sigh frequency and 
amplitude compared with Sham+VEH rats. There was no difference between CIH+PREB and 
Sham+PREB rats (Table 4.3). The major finding was that prebiotic fibre supplementation 
increased sigh frequency and the ventilatory response to hypercapnia. 
Ventilatory and metabolic responsiveness to hypoxic hypercapnia chemostimulation :  No 
significant differences were evident in CIH+VEH compared with Sham+VEH rats. CIH+PREB 
rats had elevated VE compared with CIH+VEH rats. Sham+PREB rats had an elevated 
ventilatory response to hypoxic hypercapnia compared with Sham+VEH rats, evident by 
increased VE, VT and VT/TI; VE/VCO2 was not different between groups (Table 4.3). 
Furthermore, there was no apparent difference between Sham+PREB and CIH+PREB rats. 
The major observation was that prebiotic administration elevated the ventilatory response 


















Hypoxia           




0.082 0.221 <0.0005 0.338 
Δ VE (ml/min/ 
100g) 




0.140 0.544 0.006 0.462 
Δ VT 
(ml/100g) 
0.09 ± 0.10 0.10 ± 
0.08 




- - - - 
Δ VT/Ti 
(ml/s/100g) 




0.993 0.406 0.001 0.015 
Δ Ti (ms) -79 ± 36 -81 ± 27 -108 ± 27 -65 ± 24 0.005 N/A 0.786 0.295 0.001 0.008 
Δ Te (ms) -228 ± 90 -170 ±  
106 
















0.3 ± 0.2 0.3 ± 0.3 0.3 ±  0.4 0.2 ± 0.2 0.412 N/A - - - - 
209 
 













1.0 ± 0.14 1.1 ± 0.2 1.2 ± 0.23 1.4 ± 0.3 0.001 N/A 0.538 0.001 0.083 0.033 
Hypercapnia           





- - - - 
Δ VE (ml/min/ 
100g) 





0.994 0.064 0.214 0.002 
Δ VT 
(ml/100g) 
0.18 ± 0.18 0.2 ± 0.1 0.23 ± 0.1 0.3 ± 0.1 0.019 N/A 0.268 0.056 0.729 0.021 
Δ VT/Ti 
(ml/s/100g) 





0.480 0.01 0.494 <0.0005 
Δ Ti (ms) -53 ± 28 -59 ± 19 -72 ± 27 67 ±24 0.307 N/A - - - - 
Δ Te (ms) -304 ± 109 -232 ± 89 -223 ±  67 -190 ± 112 0.081 N/A - - - - 
Δ VCO2 
(ml/min/ 













1.1 + 0.3 1.5 +  0.3 1.6 + 0.3 1.4 + 0.2 0.017 N/A 0.031 0.389 0.389 0.006 
Hypoxic hypercapnia          





- - - - 
Δ VE (ml/min/ 
100g) 





0.446 0.006 0.088 <0.0005 
Δ VT 
(ml/100g) 
0.3  ±  0.2 0.3  ± 0.1 0.4  ± 0.2 0.4  ± 0.2 0.030 N/A 0.683 0.286 0.094 0.010 
Δ VT/Ti 
(ml/s/100g) 





0.713 0.070 0.135 0.001 





- - - - 
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Δ Te (ms) -291  ± 194 -234 ±  
112 









0.980 0.435 0.132 0.030 





- - - - 
 
Table 4. 3 Ventilatory and metabolic responsiveness to chemostimulation in rats during quiet rest  
fR, respiratory frequency (brpm, breaths per minute); VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory 
time; VO2, oxygen consumption; VCO2, carbon dioxide production; VE/VCO2, ventilatory equivalent; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, 
vehicle. Data are shown as mean ± SD and were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc 
where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple 






4.3.5 Baseline cardiorespiratory and blood gas parameters in anaesthetised rats  
CIH exposure had no effect on respiration in the anaesthetised rat during baseline conditions 
(Table 4.4). VE and VT were increased in CIH+PREB rats compared with CIH-exposed rats 
(Table 4.4). CIH exposure significantly increased diastolic blood pressure (DBP) (CIH; F (1,41) 
= 16.321, p<0.0005, ƞ2=0.285, Fig. 4.2b). As a consequence, mean arterial blood pressure 
(MAP) was elevated (CIH; F (1, 41) = 17.485, p<0.005, ƞ2=0.299). Post hoc analysis revealed 
CIH+VEH had elevated blood pressure compared with Sham+VEH rats (DBP, p=0.006, Fig. 
4.2b; MAP, p=0.004, Fig. 4.2a). DBP was not restored by prebiotic administration as 
CIH+PREB had elevated DBP compared with CIH+VEH rats (p=0.007, Fig. 4.2b). There was no 
statistical difference evident in MAP between CIH+PREB compared with CIH+VEH (p>0.05, 
Fig. 4.2a), and MAP was elevated in CIH+PREB compared with Sham+PREB rats (p=0.006; Fig. 
4.2a). CIH exposure or prebiotic administration had no effect on systolic blood pressure or 
heart rate (p>0.05, Fig. 4.2c, 4.2d). CIH exposure had no effect on haematocrit and 
haemoglobin concentrations; Sham+PREB had reduced concentrations compared with 
Sham+VEH (Table 4.4).  
CIH exposure increased the low-frequency band (LF) (CIH; nu, F (1, 40) = 6.170, p=0.017, 
ƞ2=0.134, Fig. 4.2 f; %, F (1, 40) = 6.723, p=0.013, ƞ2=0.144, Table 4.5) and decreased the 
high-frequency band (HF; nµ) (CIH, F (1, 40) = 1.159, p=0.014, ƞ2=0.142, Table 4.5) elevating 
the LF: HF ratio (CIH, F (1, 40) = 7.748, p=0.008, ƞ2=0.162, Fig. 4.2e) during steady-state 
baseline recordings, indicating sympathetic dominance. LF:HF was increased in CIH+VEH 
compared with Sham+VEH rats (p=0.059, Fig. 4.2 e). There was no difference in CIH+PREB 
compared with CIH+VEH rats (p>0.05), however CIH+PREB rats had elevated LF:HF ratio 
compared with Sham+PREB rats (p=0.053, Fig. 4.2e). After adjusting for multiple 
comparisons these changes were not statistically significant (Table 4.5). Other heart rate 
variability parameters were not different between groups (Table 4.5). The major finding was 
that CIH exposure caused hypertension and cardiac autonomic imbalance, which were not 






Figure 4. 2 CIH causes hypertension and cardiac autonomic imbalance 
Group data for MAP (a), DBP (b), SBP (C), heart rate (D), LF: HF (e) and HF (f) for Sham+VEH, 
CIH+VEH, Sham+PREB and CIH+PREB. MAP, mean arterial blood pressure; DBP, diastolic 
blood pressure; SBP, systolic blood pressure; LF, low-frequency band; HF, high frequency 
band; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle.  Groups (a-f) are 
expressed as box and whisker plots (median, IQR and minimum to maximum values); n = 10-
12 for all groups. Groups were statistically compared using two-way ANOVA, followed by 
Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric 
Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. CIH significantly 
affected MAP, DBP, LF: HF and LF (p<0.005, p<0.0005, p=0.008 and p=0.017, respectively; 
Fig. 4.2a, 4.2b, 4.2e, 4.2f). There was no change in SBP or HR (p>0.05, Fig. 4.2c, 4.2d).* 






















- - - - 
VE (ml/ min/ 
100g) 




0.111 0.001 0.387 0.339 
VT (ml/ 100g) 0.25 ± 0.05 0.22 ±  
0.03 





0.081 <0.0005 0.103 0.306 




- - - - 
pH 7.37  ± 0.04 7.33 ± 
0.02 




0.023 0.738 0.598 0.155 
PaCO2 
(mmHg) 




0.03 0.406 0.518 0.050 














0.918 0.017 0.470 0.002 
[Hb] (g/dl) 16.8  ± 0.7 16.8  ± 
1.0 





0.907 0.013 0.510 0.002 
 
Table 4. 4 Baseline ventilation, blood gases and cardiovascular parameters in anaesthetised rats  
fR, respiratory frequency (brpm, breaths per minute); VE, minute ventilation; VT, tidal volume; ETCO2, end-tidal carbon dioxide production; Pco2, partial pressure 
of arterial carbon dioxide ; Pao2, partial pressure of arterial oxygen; [Hb], haemoglobin concentration; CIH, chronic intermittent hypoxia; PREB, prebiotic; V EH, 
vehicle. Data are shown as mean ± SD and were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc 
where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple 























16 ± 28 10 ± 11 4 ± 3 13 ± 15 0.653 N/A - - - - 






0.138 0.648 0.039 0.301 
VLF (ms2) 0.4 ± 0.3 1.0 ± 1.7 0.4 ± 0.2 0.3 ± 0.5 0.163 N/A - - - - 
LF (ms2) 0.3 ± 0.5 0.4 ± 0.5 0.1 ± 0.1 0.5 ± 0.7 0.214 N/A - - - - 
HF (ms2) 12 ± 20 6 ± 7 3 ± 2 9 ± 12 0.590 N/A - - - - 
VFL (%) 15 ± 14 24 ± 26 16 ± 11 9 ± 11 0.251 N/A - - - - 






0.146 0.497 0.035 0.970 
HF (%) 66 ± 15 53 ± 15 70  ± 11 67 ± 11 0.109 N/A - - - - 
Average 
RRI (ms) 






- - - - 
Median 
RRI (ms) 
153 ± 19 152 ± 10 155 ± 14 144 ± 14 N/A Diet, 
p=0.460; 
CIH, 








3.3 ± 2.5 3 ± 2 2 ± 0.5 3.6 ± 2.3 0.626 N/A - - - - 
CVRR 0.02 ± 0.02 0.02 ± 0.01 0.01 ± 0.003 0.03 ± 0.02 0.373 N/A - - - - 
SD Rate 
(bpm) 
8.2 ± 5.8 7.8 ± 5.2 5.2 ± 1.5 11 ± 8.4 0.380 N/A - - - - 
SDSD 
(ms) 
4.5 4.7 4.1 ± 3.8 2.6 ±1.2 5.5 ± 4.2 0.586 N/A - - - - 
RMSSD 
(ms) 
4.5 ± 4.8 4.1 ± 3.8 2.6 ± 1.2 5.5 ± 4.2 0.586 N/A - - - - 
SD1 (ms) 3.2 ± 3.3 2.9 ± 2.7 1.8 ± 0.8 3.9 ± 2.9 0.586 N/A - - - - 






- - - - 
 
Table 4. 5 Heart rate variability in the urethane anaesthetised rats 
VLF, very low frequency; LF, low frequency; HF, high frequency; RRI, R-R interval; SDRR, standard deviation of R-R interval; CVRR, coefficient of variance of R-
R intervals; SD rate, standard deviation of heart rate; SDSD, standard deviation of successive R-R intervals; RMSSD, root mean square of successive R-R interval 
differences; SD1, short term variability; SD2, long-term variability; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean 
± SD and were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-
parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 




4.3.6 Cardiorespiratory responses to 5-HT3 receptor agonism evoking the cardiopulmonary 
reflex 
Stimulation of 5-HT3 receptors expressed on pulmonary vagal afferent nerve fibres, using 
PBG, evoked the integrated cardiopulmonary reflex. CIH exposure had no effect on 
hypotension, bradycardia, apnoea or post-apnoea induced tachypnoea associated with the 
pulmonary chemoreflex (Fig. 4.3b-e). Prebiotic supplementation altered apnoea duration 
(Diet, F (1, 41) = 4.950, p=0.032, ƞ2=0.108, Fig. 4.3b), however, post hoc analysis revealed no 
differences between groups. There was no significant difference between groups in all other 
parameters (Fig. 4.3c-e). The major finding was that pulmonary chemoreflex responses to 






Figure 4. 3 CIH did not alter cardiorespiratory responses to pulmonary vagal afferent C-
fibre stimulation 
a) Representative traces of blood pressure, heart rate, arterial oxygen saturation (SpO 2) and 
raw and integrated diaphragm (Dia) electromyogram (EMG) activity during intravenous 
administration of the 5-HT3 agonist, phenylbiguanide (25 μg.kg-1 i.v.). Group data for 
maximum apnoea duration (b) and tachypnoea (c) normalised to respective baseline 
respiratory period in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB rats. Absolute change 
in MAP (d) and heart rate (e) in response to PBG in Sham, CIH, Sham+PREB and CIH+PREB 
rats. MAP, mean arterial blood pressure; CIH, chronic intermittent hypoxia; PREB, prebiotic; 
VEH, vehicle. Data (b-e) are expressed as box and whisker plots (median, IQR and minimum 
to maximum values); n= 11-12. Groups (b-e) were statistically compared using two-way 
ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, 
or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. 
CIH exposure had no effect on hypotension, bradycardia, apnoea or post-apnoea induced 
tachypnoea (p>0.05; Fig. 4.3b-e). Prebiotic supplementation had a significant effect on 




4.3.7 Cardiovascular responses to pharmacological blockade of sympathetic activity in 
anaesthetised rats 
The blood pressure response to β1 receptor antagonist administration (atenolol) was 
significantly increased by CIH exposure (X2(3) = 9.347, p=0.025). CIH+VEH was not different 
compared with Sham+VEH rats. There was a greater depressor response in CIH+PREB 
compared with Sham+PREB rats; the associated bradycardia was similar between all groups 
(Table 4.6). Intravenous infusion of the non-selective β-adrenoceptor blocker (propranolol), 
and sympathetic ganglion blocker (hexamethonium) evoked similar bradycardia and 



















Propranolol (% change from baseline)        
SBP -24  ± 9 -22  ± 6 -21 ± 6 -23 ± 5 0.906 N/A - - - - 
HR -12  ± 5 -18  ± 13 -16 ± 6 -19 ± 11 0.092 N/A - - - - 
Atenolol (% change from baseline)       
SBP 8 ± 10 9 ± 5 3 ± 5 7 ± 3 0.025 N/A 0.268 0.538 0.006 0.235 
HR -27 ± 17 -28 ± 11 -28 ± 10 -30 ± 5 0.276 N/A - - - - 
Hexamethonium (% change from baseline)       






- - - - 
HR -14  ± 17 -15  ± 18 -13  ± 14 -12  ± 11 0.743 N/A - - - - 
 
Table 4. 6 Cardiovascular responses to pharmacological blockade of sympathetic activity in urethane anaesthetised rats  
SBP, systolic blood pressure; HR, heart rate; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are show n as mean ± SD and were 
statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-
Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by the 




4.3.8 Pons and medulla oblongata neurochemistry 
Comparison of L-DOPA and DOPAC concentrations in the pons, as well as DOPAC/DA, HVA, 
HVA/DA, 5-HT and 5-HIAA concentrations in the medulla oblongata revealed group 
differences (p<0.05; Fig. 4.4a, 4.4c-f, 4.4h, 4.4i). However, post hoc analysis revealed that 
monoamine, monoamine metabolites and precursors were not different in CIH+VEH 
compared with Sham+VEH rats in the pons or medulla oblongata (Fig. 4.4a-j). Pontine L-DOPA 
(p=0.020) and medulla oblongata 5-HIAA (p=0.008) concentrations were significantly 
increased, with medulla oblongata HVA (p=0.041) levels decreased in CIH+PREB compared 
with CIH+VEH rats. CIH+PREB rats had increased pontine L-DOPA (p=0.038) concentrations 
compared with Sham+PREB rats.  Sham+PREB rats had reduced pontine DOPAC (p=0.021) as 
well as medulla oblongata HVA (p=0.006) and HVA/DA (p=0.016) concentrations compared 
with Sham+VEH rats.  Additionally, Sham+PREB rats had elevated pontine L-DOPA (p=0.012) 
concentrations compared with Sham+VEH rats. After adjusting for multiple comparisons, 
differences in pontine L-DOPA and medulla oblongata HVA concentrations in Sham+PREB 
compared with Sham+VEH and medulla oblongata 5-HIAA concentrations in CIH+PREB 
compared with Sham+PREB remained significantly different. In summary, prebiotic 






Figure 4. 4 Prebiotic administration alters brainstem neurochemistry 
Group data for L-DOPA (a), dopamine (b), DOPAC (c) DOPAC/Dopamine (d), homovanillic acid (e), homovanillic acid/dopamine ratio (f), noradrenaline (g), 
serotonin (h), 5-HIAA (i) and 5-HIAA/Serotonin ratio (j) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. L-DOPA, L-3,4-dihydroxyphenylalanine; DOPAC, 
3,4-dihydroxyphenylacetic acid; 5-HIAA, 5-hydroindoleacetic acid; CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (a-j) are expressed 
as box and whisker plots (median, IQR and minimum to maximum values); n= 10-12. Groups were statistically compared using two-way ANOVA, followed by 
Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where 
224 
 
appropriate. L-DOPA (p=0.003; Fig. 4.4a) and DOPAC (p=0.006; Fig. 4.4c) concentrations in the pontine region as well as DOPAC/DA (Diet*CIH, p=0.042; Fig. 
4.4d), HVA (p=0.001; Fig. 4.4e), HVA/DA (p=0.020; Fig. 4.4f), 5-HT (Diet, p=0.043; Fig. 4.4h) and 5-HIAA (p=0.043; Fig. 4.4i) concentrations in the medulla 
oblongata are different. Other monoamine, metabolites and precursors were not statistically different between groups ( p>0.05; Fig. 4.4b, 4.4g, 4.4h, 4.4j). ~ 




4.3.9 Plasma cytokine and corticosterone concentrations 
IL-4 (X2(3) = 8.042, p=0.045, Fig.  4.5c) and TNF-α (X2(3) = 10.784, p=0.013, Fig. 4.5h) were 
different between groups. Post hoc analysis adjusted for multiple comparisons revealed that 
CIH exposure had no significant effect on IL-4 or TNF-α levels. However, TNF-α and IL-4 were 
decreased in Sham+PREB compared with Sham+VEH rats. All other cytokines and 
corticosterone concentrations were not different between groups (Fig. 4.5a-b, 4.5d-g). In 
summary, CIH exposure had no effect on plasma cytokine or corticosterone concentrations. 






Figure 4. 5 Corticosterone and inflammatory mediators were equivalent between groups 




REB. IFN-γ, interferon-γ; IL-4, interleukin-4; IL-6, interleukin-6; IL-10, interleukin-10;  IL-13, interleukin-13;   TNF-α, tumor necrosis factor-α; 
KC/GRO, keratinocyte chemoattractant/growth-related oncogene; CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle.  Data (a-h) are expressed 
as box and whisker plots (median, IQR and minimum to maximum values); n= 11-12. Groups (a-h) were statistically compared using two-way ANOVA, followed 
by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where 




4.3.10 Caecal microbiota 
CIH exposure had no effect on indices of alpha diversity (Fig. 4.6b-d). Prebiotic treatment 
significantly reduced bacteria species evenness in all statistical compari sons, indicated by 
decreases in Shannon and Simpson indices of alpha diversity (Fig. 4.6c-d). However, bacterial 
species richness, indicated by Chao1 index was not affected by prebiotic administration (Fig. 
4.6b). These findings suggest proliferation of a select number of bacterial species with no 
overall difference in bacterial richness. Principal component analysis revealed that CIH 
exposure did not affect β-diversity.  Prebiotic administration shifted β-diversity in Sham+VEH 
and CIH+VEH compared with Sham+PREB and CIH+PREB rats, respectively (Fig. 4.6a, p<0.001, 
PERMANOVA).  
Whole-metagenome shotgun sequencing identified around 3200 bacteria species of 34 
phyla. The majority of bacterial species in each group are of Bacteroidetes and Firmicutes 
phyla (Sham+VEH, 18% and 60%; CIH+VEH, 21% and 56%; Sham+PREB, 28% and 40%; 
CIH+PREB, 30% and 41%, Bacteroidetes and Firmicutes, respectively). Bacteria phyla were 
not affected by CIH exposure; there was no statistically significant difference observed in 
Sham+VEH and Sham+PREB rats compared with CIH+VEH and CIH+PREB rats, respectively. 
Prebiotic administration significantly increased the relative abundance of the major phyla 
Bacteroidetes and Actinobacteria and decreased the relative abundance of Firmicutes and 
Proteobacteria. Minor phyla were also affected by prebiotics. 
BH adjustment for multiple comparisons at bacterial species level did not reveal statistically 
significant differences between CIH+VEH and Sham+VEH rats given the exhaustive multiple 
comparisons performed. However, 222 moderate (>0.5) and 9 large effect sizes (>0.8) were 
evident between CIH+VEH and Sham+VEH rats; 3 species had an effect size >1. Pathogenic 
species, namely, Streptomyces sp. 452 and Raoultella planticola were increased and 
Lactobacillus rhamnosus (>1 effect size; Fig. 4.6e), a beneficial commensal bacterial species, 
was decreased in CIH+VEH compared with Sham+VEH rats. Similarly, no statistically 
significant difference was evident between Sham+PREB and CIH+PREB rats, but moderate 
(>0.5) and large effect sizes (>0.8) were evident in 130 and 4 species, respectively. The 
pathogenic species Helicobacter bilis was increased whereas Candidatus Gullanella endobia, 
Pectobacterium wasabiae and Corynebacterium striatum were decreased in CIH+PREB 
compared with Sham+PREB rats (>0.8 effect size). A total of 420 bacterial species were 
statistically different in CIH+VEH rats compared with CIH+PREB rats, with 549 species 
different in Sham+VEH rats compared with Sham+PREB rats. The largest difference between 
these comparisons was due to a significant increase in the beneficial bacterial species 
229 
 
Bifidobacterium animalis in the prebiotic groups. Of note, some beneficial and pathogenic 
bacterial species, decreased and increased, respectively, in prebiotic groups but an overall 
augmented abundance of beneficial bacterial species and reduced abundance of pathogenic 




Figure 4. 6 Prebiotic 
administration alters rat 
caecal microbiota structure 
Group data for principal 
coordinate analysis (a) in 2-
dimensional representations, 
Chao1 (b), Shannon (c), 
Simpson (d) and abundance 
of Lactobacillus rhamnosus, 
Streptomyces sp. 452 and 
Raoultella planticola (e) in 
Sham+VEH, CIH+VEH, 
Sham+PREB and CIH+PREB. 
CIH, chronic intermittent 
hypoxia; PREB; prebiotic; 
VEH, vehicle.  Data (a-c, e) are 
expressed as box and whisker 
plots (median, IQR and 
minimum to maximum 
values); n=11-12. Data (a-c, e) 
were statistically compared 
by non-parametric Mann-
Whitney U test. ~ p<0.01, 
CIH+PREB versus CIH+VEH; $ 






Figure 4. 7 Caecal microbiota composition. 
Stacked barplot showing the abundance of dominant bacteria species ( rare 
taxa cutoff of 1%) in the caecal microbiota of Sham+VEH, CIH+VEH, Sham+PREB and 
CIH+PREB rats. CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle.  Species are 
ordered taxonomically.  
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4.3.11 Correlation analysis 
Administration of Lactobacillus rhamnosus in rodents alters brain behaviours and function, 
reducing anxiety and depressive-like behaviour as well as neuromodulator receptor 
abundance, in particular GABA receptor expression; effects abolished in vagotomised 
animals (Bravo et al., 2011). Considering that Lactobacillus rhamnosus was diminished in 
CIH+VEH compared with Sham+VEH rats we investigated if an association exists between 
Lactobacillus rhamnosus and physiological parameters assessed in our study. Using 
Hierarchical All-against-all correlation analysis the relative abundance of Lactobacillus 
rhamnosus negatively correlated with sigh frequency and amplitude during hypercapnia 
(Appendix Fig. C.1a-b). No significant correlations were evident between major physiological 
parameters, including apnoea, heart rate variability and blood pressure and Lactobacillus 
rhamnosus relative abundance. Given that hypertension is a well-established cardiovascular 
pathology in CIH-exposed rodents and a primary outcome measure in our study, we 
investigated if blood pressure parameters only (removing multiple comparison assessment 
of all physiological parameters) correlated with Lactobacillus rhamnosus. No significant 
correlations were evident. We assessed if other bacterial species correlated with 
physiological parameters. Francisella sp. FSC1006 strongly negatively correlated with sigh 
frequency during hypercapnia in rats that did not receive prebiotics. No other significant 
correlations were evident. A total of 269, 16 and 110 bacterial species correlated with mean, 
diastolic and systolic blood pressure respectively, when we independently investigated if 
blood pressure parameters correlated with bacterial species (Appendix Tables C.9-11).  
4.3.12 Faecal short-chain fatty acid concentrations  
PCA analysis did not identify distinct clustering of CIH+VEH compared with Sham+VEH rats. 
However, separation of vehicle from prebiotic groups was evident (Fig. 4.8a). The loading 
plot (Fig. 4.8b) demonstrates this separation is due to higher concentrations of acetic, 
propanoic and hexanoic acid in prebiotic groups. Further analysis revealed that prebiotic 
supplementation significantly influenced faecal acetic (X2(3) = 22.420, p<0.0005, Fig. 4.8c) 
and propanoic (X2(3) = 11.211, p=0.011, Fig. 4.8d) concentrations. Prebiotic treatment 
significantly increased faecal acetic acid in all statistical comparisons (CIH+PREB versus 
CIH+VEH, p=0.002; Sham+PREB versus Sham+VEH, p=0.001; Fig. 4.8c), propanoic acid 
concentrations were increased in CIH+PREB compared with Sham+PREB rats (p=0.009; Fig. 
4.8d). There was no significant difference in other SCFA concentrations (Fig.  4.8e -h). CIH 
exposure had no effect on SCFA, whereas prebiotic administration increased SCFA 





Figure 4. 8  Prebiotic administration increases faecal acetic and propanoic acid 
Score plot (a) from principal component analysis (PCA) model calculated on the relative 
concentrations of detected SCFA and loading plot (b) from PCA model calculated on the 
relative concentrations showing which variables are responsible for the pattern observed in 
(a). Group data for acetic acid (c), propanoic acid (d), hexanoic acid (e), butanoic acid (f), 
pentanoic acid (g) and 3-methylbutanoic acid (h) in Sham+VEH, CIH+VEH, Sham+PREB and 
CIH+PREB. CIH, chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle.  Data (c-h) are 
expressed as box and whisker plots (median, IQR and minimum to maximum values); n= 11-
12. Groups (c-h) were statistically compared using two-way ANOVA, followed by Fisher’s 
least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-
Wallis test, followed by Mann-Whitney U test, where appropriate. Acetic (p<0.0005; Fig. 
4.8c) and propanoic acid (p=0.011; Fig. 4.8d) were increased as a result of prebiotic 
supplementation. All other SCFAs were not different (p>0.05 Fig. 4.8e-h). ~ p=0.002, CIH+VEH 





There is a growing evidence-based consensus that the gut microbiota plays a modulatory 
role in physiological homeostasis. Recent studies posit that cardiorespiratory morbidity is 
linked to aberrant microbiota-gut-brain axis signalling (Ganesh et al., 2018; Meng et al., 2019; 
O'Connor et al., 2019a; Toral et al., 2019). Investigations in rodents reveal that exposure to 
CIH disturbs the gut microbiota (Moreno-Indias et al., 2015; Moreno-Indias et al., 2016; 
Lucking et al., 2018b). Exposure to CIH elicits cardiorespiratory dysfunction (O'Halloran, 
2016; Laouafa et al., 2017; Elliot-Portal et al., 2018; Laouafa et al., 2019), predominantly 
considered to be mediated via CIH-induced carotid body sensitisation (Prabhakar et al., 2007; 
Iturriaga et al., 2009; Iturriaga et al., 2017), but also suggested to relate to aberrant signalling 
from other sites (Docio et al., 2018; Lucking et al., 2018b). When viewed together, these 
observations encourage a new line of enquiry. Dysregulated microbiota-gut-brain axis 
signalling in CIH-exposed rodent models may play a modulatory role in cardiorespiratory 
disturbances evident in animal models of SDB.  Manipulation of the gut microbiota via 
antibiotic administration/faecal microbiota transfer perturbs the gut microbiota and alters 
cardiorespiratory control (O'Connor et al., 2019a). As such, prebiotic administration, 
promoting the expansion of beneficial microbes, could prove effective in the prevention of 
CIH-induced cardiorespiratory dysfunctions.  
We sought to explore the interplay between cardiorespiratory physiology and the gut 
microbiota in a rat model of SDB, investigating if  manipulation of the gut microbiota by 
prebiotic fibre administration could prevent or ameliorate cardiorespiratory dysfunctions 
evident in a CIH animal model. The principal findings of this study are: 1) CIH-exposed rats 
have reduced relative abundance of Lactobacillus species, predominantly Lactobacillus 
rhamnosus; prebiotic administration shifted the bacteria microbiota composition and 
diversity but did not restore Lactobacillus rhamnosus relative abundance; 2) CIH-exposed 
rats develop hypertension, which prebiotics failed to prevent; 3) CIH exposure evoked 
cardiac autonomic imbalance, which was not prevented by prebiotic administration; 4) CIH 
exposure had no effect on faecal SCFA concentrations; acetic and propanoic acid are 
increased in prebiotic groups; 5) CIH exposure did not affect inflammatory mediators in the 
periphery; prebiotic administration reduced TNF-α and IL-4 levels in Sham rats; 6) CIH 
exposure and prebiotic administration did not alter respiratory timing variability during 
normoxia; 7) CIH exposure increases the apnoea index during normoxia, which was 
unaffected by prebiotic administration; 8) Monoamine, monoamine precursor and 
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metabolite concentrations were unaffected by exposure to CIH; prebiotic administration had 
modest effects on brainstem neurochemistry; 9) Cardiorespiratory responsiveness to vagal 
afferent nerve stimulation was unaffected by CIH exposure; prebiotic administration had 
modest effects on apnoea duration.  
In our study, both exposure to CIH and prebiotic administration had significant effects on rat 
body weight. Consistent with observations in previous studies, CIH exposure reduced weight 
gain (Zoccal et al., 2008; McDonald et al., 2015), likely due to a CIH-induced stress response 
(Hwang et al., 2017).  Plasma corticosterone concentrations were not different between 
groups determined on the day following exposure to CIH, however, corticosterone levels 
were not determined at early time-points during the CIH protocol, where stress-induced 
elevations in corticosterone may well have been evident. Remarkably, prebiotic 
administration prevented rodent body weight gain. In rodent and human subjects, prebiotic 
supplementation stimulated satiety hormone secretion (glucagon-like-peptide-1 and 
peptide YY) and decreased ghrelin concentrations (Parnell & Reimer, 2009, 2012). The 
inability of prebiotic rodent groups to gain weight may stem from modifications in hunger 
and satiety hormones. Differences in normalised tissue weights between groups related to 
differences in body weight (Appendix Table C.1). As expected, prebiotic supplemented 
animals had increased caecum weight, consistent with previous studies (Burokas et al., 2017; 
Boehme et al., 2019), related to augmented dietary fibre consumption.  
Exposure to CIH elicited hypertension and a shift in autonomic balance towards sympathetic 
dominance, as evident by alterations in heart rate variability and spectral analysis 
parameters. However, there was no evidence of tachycardia, similar to previous findings 
(Zoccal et al., 2007a; Yamamoto et al., 2013).  CIH-induced hypertension was characterised 
by augmented diastolic blood pressure, suggestive of elevated peripheral vascular resistance 
or reduced arterial compliance (Philippi et al., 2010). There is considerable evidence 
supporting CIH-induced sensitisation of the carotid bodies, the principal peripheral oxygen 
sensors, with persistent elevation in chemo-afferent traffic to the NTS of the brainstem and 
resultant potentiation of sympathetic nervous outflow giving rise to hypertension (Fletcher 
et al., 1992a; Kumar & Prabhakar, 2012; Iturriaga et al., 2015; Del Rio et al., 2016; Lucking et 
al., 2018b). Carotid body ablation prevents CIH-induced hypertension and elevations in heart 
rate variability indicative of cardiac autonomic dysfunction (Iturriaga et al., 2015; Del Rio et 
al., 2016). Nevertheless, CIH-exposed guinea-pigs, with hypoxia-insensitive carotid bodies, 
have altered autonomic control of heart rate associated with modification in gut microbiota 
composition and diversity (Lucking et al., 2018b). Moreover, exposure to severe CIH elicits 
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sympathetic over-activity and hypertension in guinea-pigs in the absence of carotid body 
sensitisation (Docio et al., 2018), revealing sites beyond the carotid bodies that can 
contribute to the manifestation of CIH-induced hypertension. Numerous studies have 
recently linked the development of hypertension to perturbed gut microbiota and altered 
SCFA production, portraying that the microbiota-gut-brain axis has a regulatory role in blood 
pressure control (Yang et al., 2015; Adnan et al., 2017; Li et al., 2017; Santisteban et al., 2017; 
Yan et al., 2017; Toral et al., 2019).  
In our study, whole-metagenome shotgun sequencing revealed novel data showing that 
CIH+VEH hypertensive rats have altered bacterial species compared with Sham+VEH 
normotensive rats. The greatest difference evident was in the relative abundance of the 
beneficial commensal bacterial species, Lactobacillus rhamnosus (>1 effect size), which was 
diminished in CIH+VEH compared with Sham+VEH rats. Of particular interest, Lactobacillus 
rhamnosus supplementation ameliorated CIH+HSD-induced hypertension, decreasing serum 
pro-inflammatory mediators and trimethylamine N-oxide (TMAO) levels in rats (Liu et al., 
2019). Furthermore, administration of Lactobacillus rhamnosus in rodents altered central 
GABA receptor expression; effects abolished in vagotomised animals (Bravo et al., 2011). 
GABAergic mechanisms modulate sympathetic vasomotor outflow, arterial baroreflex 
activity and blood pressure (Potts et al., 2003; Teixeira et al., 2019). This suggests that CIH-
induced reductions in the relative abundance of Lactobacillus rhamnosus may have 
contributed to the development of cardiovascular and autonomic dysfunction in our study, 
at least the development of hypertension. Considering that the relative abundance of 
Lactobacillus rhamnosus was reduced in CIH+VEH rats, we assessed if other species of the 
Lactobacillus genera were altered in CIH+VEH rats. Interestingly, the relative abundance of 
an additional 24 Lactobacillus species were decreased (>0.5 effect size) in CIH+VEH 
compared with Sham+VEH rats. These included beneficial  commensal bacterial species 
including, Lactobacillus johnsonii, Lactobacillus fermentum, Lactobacillus lindneri and 
Lactobacillus jensenii, extending previous observations of reduced Lactobacillus abundance 
in CIH + high salt diet fed (CIH+HSD) and IH-exposed animal models (Moreno-Indias et al., 
2016; Liu et al., 2019). Furthermore, the pathogenic species, Streptomyces sp. 452 and 
Raoultella planticola were increased in CIH+VEH rats compared with Sham+VEH rats (>1 
effect size).  
Prebiotic treated groups had an overall increase in the abundance of beneficial species and 
a decrease in the abundance of pathogenic species, with reduced species evenness 
compared with Sham+VEH and CIH+VEH rats. The relative abundance of Bifidobacterium was 
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significantly increased by prebiotic administration consistent with previous studies (Gibson 
et al., 1995; Boehme et al., 2019). Elevated Bifidobacterium was predominantly related to 
augmented relative abundance of a recognised probiotic species, Bifidobacterium animalis, 
which has typically been associated with improvements in intestinal function (Marteau et al., 
2002; Guyonnet et al., 2007). Increases in other Bifidobacterium species such as 
Bifidobacterium choerinum and Bifidobacterium pseudolongum were also evident in 
prebiotic groups. 
Of interest, there were reductions in relative abundance of Lactobacillus gasseri, 
Lactobacillus casei and Lactobacillus ruminis (>0.5 effect size) in hypertensive CIH+PREB 
compared with hypertensive CIH+VEH rats, with a number of other Lactobacillus species 
increased. The relative abundance of Lactobacillus rhamnosus remained decreased in 
CIH+PREB, again drawing focus to a potential contributory role in the development of 
hypertension. Correlation analysis between Lactobacillus rhamnosus relative abundance and 
blood pressure revealed a correlation. However, this was an artefact of compositionality 
(Gloor et al., 2017) as correlation analysis between Lactobacillus rhamnosus center-log ratio 
transformed values and heart rate variability and blood pressure parameters, namely mean, 
systolic and diastolic blood pressure did not reveal any significant correlations.    
Other species of Lactobacillus including Lactobacillus casei and Lactobacillus fermentum 
(>0.8 effect size) were also decreased in Sham+PREB rats (normotensive) compared with 
Sham+VEH (normotensive) rats, likely as some Lactobacillus species cannot consume fructo- 
or galacto-oligossaccharides (Sims et al., 2014). Of interest, there was decreased abundance 
of Lactobacillus ruminis and Lactobacillus lindneri and increased relative abundance of 
Lactobacillus fermentum (>0.5 effect size) in CIH+PREB compared with Sham+PREB rats. The 
largest difference between CIH+PREB and Sham+PREB rats was due to an increase in the 
relative abundance of the pathogenic species Helicobacter bilis in CIH+PREB rats (>0.8 effect 
size).  
When the pattern of Lactobacillus species abundance between groups is considered, it is not 
apparent that changes in one specific species protects against or contribute to the 
development of hypertension. Mean arterial blood pressure significantly correlated with 269 
bacterial species; 3 of these bacterial species where of Lactobacillus, including Lactobacillus 
parabuchneri, Lactobacillus murinus and Lactobacillus casei (Appendix Table C.9). Diastolic 
blood pressure correlated with 16 bacterial species, the majority of these species were 
pathogenic, including Corynebacterium jeikeium (Appendix Table C.10). It is plausible that a 
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complex interplay between commensal and pathogenic species creates distinct microbiota 
signatures that contribute to blood pressure regulation per se and the development of 
hypertension in CIH-exposed rats.  
SCFAs, produced by bacterial fermentation of digestible and indigestible polysaccharides, 
have been associated with cardiovascular function (Pluznick, 2014). Acetate-producing 
bacteria taxa, such as Holdemania were shown to be decreased in hypertensive rodents 
(Yang et al., 2015; Ganesh et al., 2018).  Intriguingly, probiotic or prebiotic administration 
prevented the progression of hypertension in an OSA+HFD rat model, increasing caecal 
acetate and various SCFA producing bacteria that are diminished in the hypertensive rats 
(Ganesh et al., 2018).  In our study, SCFA concentrations were unaffected by CIH exposure, 
yet, CIH-exposure caused hypertension, revealing that depletion of gut SCFAs is not 
obligatory for the development of CIH-induced hypertension. Prebiotic administration 
increased faecal acetic and propionic acid concentrations but had no beneficial effects on 
cardiovascular control, such that hypertension and enhanced heart rate variability were 
evident in CIH+PREB rats. In our study, elevations in SCFAs in prebiotic treated rodents may 
have had divergent effects on blood pressure regulation that offset one another given that 
SCFAs act via olfactory receptor 78 (Olfr78) and G-protein-coupled receptor (Gpr41) to 
increase and decrease blood pressure, respectively (Pluznick, 2013).  Of note, elevated acetic 
acid has been suggested to be a crucial signalling molecule in the ability of Bifidobacterium 
to inhibit expansion of enteropathogens (Fukuda et al., 2011), suggesting that in our study 
augmented acetic acid concentrations may have diminished the overall relative abundance 
of pathogenic species, such as Helicobacter cinaedi. Despite these beneficial changes 
however, prebiotic feeding did not ameliorate CIH-induced hypertension revealing that 
elevations in SCFA concentrations (or at least increases in acetic acid and propionic acid) do 
not protect against CIH-induced hypertension. 
We did not examine the effects of CIH exposure on intestinal function, but of interest CIH 
exposure did not increase plasma (or brainstem) inflammatory cytokines in this study, 
although prebiotic administration decreased plasma TNF-α and IL-4 levels in Sham rats. 
Others have reported that CIH exposure in rodents increases plasma lipopolysaccharides 
(LPS), induces oxidative stress, reduces tight junction protein expression and elevates gut 
inflammation, contributing to intestinal barrier dysfunction (Moreno-Indias et al., 2015; Wu 
et al., 2016), a phenotype also evident in other hypertensive models (Santisteban et al., 
2017; Kim et al., 2018). Faecal microbiota transfer from donor normotensive to hypertensive 
recipient rats, and prebiotic and probiotic administration each independently decrease blood 
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pressure, and prevent intestinal dysfunction and neuroinflammation in hypertensive models, 
including OSA animal models (Ganesh et al., 2018; Liu et al., 2019; Toral et al., 2019). 
Furthermore, butyrate administration prevented elevated blood pressure and increased 
cardiac sympathetic tone in angiotensin-II-induced hypertensive mice; in tandem, butyrate 
treatment, increased tight junction receptor expression, reduced intestinal permeability and 
peripheral inflammatory markers and restored physiological oxygen status in the gut 
epithelia in the hypertensive mouse (Kim et al., 2018).  
Several research groups have identified adverse respiratory phenotypes in animal models of 
CIH and in persons with OSA (Edge et al., 2009, 2010; Souza et al., 2015a; McNicholas, 2017). 
Augmented normoxic ventilatory drive, increased respiratory instabilities and elevated 
responsiveness to hypoxic chemostimulation are common consequences of CIH exposure 
(Prabhakar & Peng, 2004; Edge et al., 2009; Del Rio et al., 2010; Souza et al., 2015a); however 
these findings were not evident in our CIH model and are not always observed, likely due to 
variations in CIH paradigms (Reeves & Gozal, 2006; Zoccal et al., 2008; Edge et al., 2009; Edge 
et al., 2012).  There was an elevated propensity for central apnoea apparent in CIH-exposed 
rats, an observation commonly observed in CIH animal models (Julien et al., 2008; Edge et 
al., 2012; Donovan et al., 2014; Souza et al., 2015a). Prebiotic administration did not reverse 
CIH-induced increase in apnoea index. Increased apnoea index is proposed to manifest due 
to disturbances in the respiratory control network (Nsegbe et al., 2004; McKay & Feldman, 
2008; Ramirez, 2014; Mateika et al., 2019). The pre-Bötzinger complex is the primary rhythm-
generating site located within the respiratory network of the medulla oblongata of the 
brainstem and is implicated in apnoea generation (Lieske et al., 2000; McKay & Feldman, 
2008; Tan et al., 2008). Carotid body plasticity and altered chemoreflex responsiveness is 
also suggested to be a driver of respiratory instability and apnoea (Prabhakar et al., 2007; 
Marcus et al., 2010; Julien et al., 2011) and may have been a driver of apnoea in our model, 
although the lack of change in basal breathing and ventilatory responses to hypoxia in our 
study suggest a central origin.  
Prebiotic administration increased chemoreflex control of breathing in response to 
hypercapnia and hypoxic hypercapnia. Hypercapnia is primarily sensed by central 
chemoreceptors residing in the brainstem. Increased ventilatory responsiveness to 
hypercapnia is particularly interesting given that rats exposed to pre-natal stress exhibit 
altered ventilatory responsiveness to hypoxic and hypercapnic chemostimulation in 
adulthood with evidence of altered gut microbiota (Golubeva et al., 2015). Moreover, 
antibiotic administration and faecal microbiota transfer perturbed the gut microbiota 
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composition in adult rats and blunted chemoreflex control of breathing (O'Connor et al., 
2019a). The latter observation combined with findings from the present study suggests that 
microbial signatures shape central nervous system responsiveness to carbon dioxide 
(acidosis) with implications for a range of respiratory control disorders.  
We assessed monoamines and monoamine metabolites and precursors in the pons and 
medulla oblongata of the brainstem that are crucial in the neuromodulation of respiratory 
control. No significant modifications in monoamine, metabolite and precursor 
concentrations were evident in the brainstem of CIH-exposed rats. Previous studies present 
evidence of elevated central noradrenergic terminals in brainstem sensory and motor nuclei 
of CIH-exposed rats (Mody et al., 2011). Of note, noradrenaline has been associated with 
breathing irregularities in IH-exposed animals (Zanella et al., 2014) and rodents with lesions 
of noradrenergic locus coeruleus neurones display blunted hypercapnic ventilatory 
responses (Gargaglioni et al., 2010; de Carvalho et al., 2017). Our data revealed that CIH 
exposure did not affect noradrenaline brainstem neurochemistry. Similarly, prebiotic 
administration had no effect on brainstem noradrenaline, in accordance with previous 
studies reporting that prebiotic supplementation did not alter noradrenaline levels in rodent 
brainstem, prefrontal cortex, cerebellum or frontal cortex (Kannampalli et al., 2014; Burokas 
et al., 2017). These observations indicate that noradrenaline is not likely implicated in 
apnoea generation in CIH-exposed rats or elevated chemoreflex control of breathing in 
response to hypercapnia and hypoxic hypercapnia in prebiotic treated rodents.  
Transgenic mice that fail to develop dopaminergic neurones exhibit several respiratory 
disturbances; indeed, these mice tend to hypoventilate and have increased propensity for 
apnoea generation during normoxia (Nsegbe et al., 2004). Furthermore, a Parkinson disease 
mouse model, with confirmed reduction in tyrosine hydroxylase and chemosensitive 
(Phox2b) neurones in the substantia nigra and retrotrapezoid nucleus respectively, displays 
blunted ventilatory responses to hypercapnia (Oliveira et al., 2019). Notably, the modulatory 
role of dopamine is complex and depends on the target receptor sub-type (Beaulieu & 
Gainetdinov, 2011). In our study, the monoamine, metabolites and precursors of the 
dopaminergic pathway were not different in CIH+VEH compared with Sham+VEH rats. There 
was a trend for reduced dopamine turnover in the medulla oblongata of Sham+PREB rats, 
with elevated ventilatory responses to hypercapnia and hypoxic hypercapnia compared with 
Sham+VEH rats. This finding is particularly interesting given that antibiotic treated and faecal 
microbiota transfer rodents with perturbed gut microbiota each display blunted ventilatory 
responses to hypercapnia and exhibit increased brainstem dopamine turnover (O'Connor et 
241 
 
al., 2019a). Perhaps, D1 receptor activation (Lalley, 2004) underpins elevated ventilatory 
responses to chemostimulation in Sham+PREB rats.  Previous studies demonstrate that 
prebiotic administration affected DOPAC concentrations in the brainstem and frontal cortex 
of mice (Burokas et al., 2017). Yet, prebiotic administration did not alter other monoamine, 
metabolites and precursors of the dopaminergic pathway in animal models (Kannampalli et 
al., 2014; Burokas et al., 2017).  
Infant and adult rats lacking 5-HT display unstable breathing and increased propensity for 
apnoea (Hodges et al., 2009; Young et al., 2017; Davis et al., 2019; Mateika et al., 2019). 
Furthermore, in a gestational stress model, reduced 5-HT and noradrenaline concentrations 
were evident in newborn rats with augmented apnoea index (Fournier et al., 2013a). CIH 
exposure has been shown to decrease the number of serotonergic cells in the brainstem 
(Baum et al., 2018). CIH+PREB rats revealed significantly increased 5-HIAA concentrations in 
the medulla oblongata compared with CIH+VEH rats. Noteworthy, lesions of raphé 
serotonergic neurons and transgenic rodents without 5-HT neurones display reduced 
respiratory response to hypercapnic chemostimulation (Dias et al., 2007; Hodges et al., 2008; 
Li & Nattie, 2008; Hodges & Richerson, 2010). However, serotonin turnover was not different 
in CIH+PREB rats compared with CIH+VEH. It is not likely that serotonin mediated the 
elevated ventilatory drive to breathe in response to hypercapnia associated with prebiotic 
supplementation. Altered 5-HT receptor levels and 5-HT concentrations have been observed 
in the rodent pre-frontal cortex after prebiotic administration (Savignac et al., 2016; Burokas 
et al., 2017). Our data suggest however that neither the serotonergic nor dopaminergic 
pathway are likely responsible for alterations in apnoea index. However, elevated dopamine 
turnover in Sham+PREB rats may be associated with increased ventilatory responses to 
hypercapnic chemostimulation. Based on the assessment of neuromodulators and apnoea 
generation in our study it may be that other neuromodulators that were not measured, such 
as GABA, which is altered in models of manipulated gut microbiota (Bravo et al., 2011; 
Strandwitz et al., 2019), may have influenced apnoea generation. Indeed, other mechanisms 
such as oxidative stress, which can be altered by the gut microbiota (Toral et al., 2019), may 
influence central respiratory circuit function (Garcia et al., 2016). No significant correlations 
were evident between the gut microbiota and respiratory parameters (apnoea and breathing 
in response to hypercapnia) in our study. 
The afferent vagal pathway is a pivotal signalling pathway of the microbiota-gut-brain axis, 
which responds to various stimuli including cytokines, bacterial metabolites including SCFAs, 
gut hormones and neurotransmitters (Goehler et al., 2000; Raybould et al., 2003; Johnston 
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& Webster, 2009; Nohr et al., 2015).  Central integration of vagal afferent signals occurs 
within the NTS of the brainstem. PBG, which is a 5-HT3 receptor agonist, activates pulmonary 
vagal afferent C-fibres manifesting the pulmonary chemoreflex characterised by decreased 
blood pressure, bradycardia, apnoea and post apnoea-induced tachypnoea. Exposure to CIH 
did not affect the pulmonary chemoreflex but prebiotic administration increased apnoea 
duration. Post hoc analysis determined that there were no statistical ly significant differences 
between groups suggesting that vagal influence over these critical control centres was 
unaltered by any potential changes in microbiota-gut-brain signalling. Of interest, 
cardiorespiratory responses to PBG was also unaffected in other models of disrupted gut 
microbiota (O'Connor et al., 2019a). Thus, notwithstanding alterations to the gut microbiota 
in CIH+VEH rats, as well as the notable changes in the gut microbiota, SCFA concentrations 
and brainstem neurochemistry in prebiotic groups, no major differences in cardiorespiratory 
efferent responses to vagal afferent stimulation were observed revealing intact pulmonary 
chemoreflex circuit function in CIH-exposed and prebiotic supplemented animals. This does 
not preclude however, the possibility of altered vagal signalling from the gut in our models, 
which warrants attention in future studies.  
4.4.1 Summary and conclusion 
Our novel findings add to the growing body of evidence pointing to aberrant microbiota-gut-
brain axis signalling in the manifestation of cardiorespiratory dysfunction in OSA animal 
models  (Ganesh et al., 2018; Liu et al., 2019). Herein we confirmed that CIH exposure leads 
to the development of adverse cardiorespiratory and autonomic control, resulting in 
hypertension, cardiac autonomic imbalance and elevated propensity for apnoea. We reveal 
for the first time that CIH exposure decreases the relative abundance of a beneficial 
commensal species, Lactobacillus rhamnosus, and increased the abundance of several 
pathogenic bacterial species, with no resultant effects on SCFA concentrations, indicating 
that diminished SCFA concentrations are not obligatory for the manifestation of CIH-induced 
hypertension. Prebiotic fibre supplementation did not ameliorate cardiorespiratory malaise 
in CIH-exposed rats but had considerable effects on the gut microbiota, increasing the overall 
abundance of beneficial species including Bifidobacterium animalis, and decreasing the 
abundance of pathogenic species. However, the relative abundance of Lactobacillus 
rhamnosus remained decreased in CIH+PREB rats, suggesting a potential contributory role of 
Lactobacillus rhamnosus in the pathogenesis of hypertension. Arguing against this, however, 
the relative abundance of Lactobacillus rhamnosus was also low in Sham+PREB 
(normotensive rats), and there was no correlation between Lactobacillus rhamnosus 
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abundance and blood pressure measures. Correlation analysis revealed that blood pressure 
significantly correlated with numerous bacterial species, suggesting that a complex interplay 
between pathogenic and commensal species may create a distinct microbiota signature that 
culminates in the establishment of hypertension in CIH-exposed rats by shaping maladaptive 
plasticity in neural control circuitry. Of note, it is also plausible that aberrant plasticity, at 
least in our CIH model, occurs independently of the gut microbiota. Prebiotic administration 
increased acetic and propionic acid concentrations but had no beneficial effects on 
cardiovascular control, indicating that SCFAs (at least acetic and propionic acid) do not 
protect against CIH-induced hypertension in our model.  
Considering our observations in tandem with the extensive literature portraying the carotid 
body as the dominant driver of cardiorespiratory morbidity in CIH-exposed rodents (Peng et 
al., 2014b; Del Rio et al., 2016; Iturriaga et al., 2017) and the evidence that SCFA 
supplementation is sufficient to prevent hypertension in a rat model of OSA (Ganesh et al., 
2018), it is interesting to speculate that a microbiota-gut-carotid body axis may exist. G-
protein coupled receptors, predominantly Olfr 78 is enriched in carotid body glomus cells 
playing an important role in carotid body function. Several short-chain fatty acids, including 
lactic, propionic and acetic acid act as potent Olfr 78 agonists (Chang et al., 2015; Zhou et al., 
2016). Indeed, carotid body glomus cell activity is altered by metabolites of the gut 
microbiota (Chang et al., 2015; Zhou et al., 2016). However, SCFA activation of the carotid 
body should serve to increase sympathetic nervous outflow and raise blood pressure. This 
suggests that elevated plasma SCFA concentrations act at other sites to promote blood 
pressure homeostasis (Kimura et al., 2011; Pluznick, 2013; Pluznick et al., 2013; Kimura et 
al., 2014).  Remarkably, Ganesh et al. (2018), demonstrated that prebiotic, probiotic or 
acetate administration diminished hypertension in OSA+HFD fed rodents, with presumed 
carotid body sensitisation and sympathetic overactivity. It is al so established that gut 
microbiota derived metabolites can exert effects on peripheral sympathetic circuits (Kimura 
et al., 2011; Meng et al., 2019). Considering these studies together, it is likely that gut 
microbiota metabolites have a capacity to modulate not only central integrative sites within 
the brainstem, but also peripheral afferent and efferent pathways contributing to blood 
pressure regulation and the development of CIH-induced cardiorespiratory and autonomic 
malaise, at least in some models. Our findings have relevance for human SDB and contribute 
to an emerging interest in the putative role of the gut microbiota in cardiorespiratory 
homeostasis and the potential application of manipulation of the gut microbiota as an 
adjunctive therapy for human cardiorespiratory disease.  
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Chapter 5. Discussion - The microbiota-gut-brain axis in the control of 






Microbes that inhabit the gut form a diverse and complex ecosystem. Microbiota-gut-brain 
axis signalling has recently been linked with whole body function in both health and disease. 
Dysregulated microbiota-gut-brain axis communication affects an array of homeostatic 
functions of neurocontrol networks; consequently, myriad maladies of brain behaviours and 
integrative body systems manifest. Our group and others have extended this line of enquiry 
to investigate how microbiota-gut-brain axis signalling influences cardiorespiratory and 
autonomic control. We have previously described altered respiratory control and perturbed 
gut microbiota in rat offspring of a prenatal stress model. Furthermore, multiple studies have 
demonstrated that the gut microbiota impacts blood pressure control. Herein, we review 
recent work by our group exploring the potential for the gut microbiota to shape 
cardiorespiratory homeostasis. We performed a comprehensive assessment of 
cardiorespiratory physiology in animal models of modified gut microbiota, and sleep-
disordered breathing with altered gut microbiota. We describe findings from our studies 
revealing that the gut microbiota contributes to the control of breathing and cardiovascular 
function. Our work highlights the potential relevance of the gut microbiota in human 
cardiorespiratory diseases such as obstructive sleep apnoea. We explore possible 
mechanisms of microbiota-gut-brain axis signalling that appear to play a modulatory role in 
cardiorespiratory control. Manipulation of the gut microbiota may be a promising approach 
as an adjunctive therapy in the treatment of cardiorespiratory disorders. 
Keywords: Cardiorespiratory control; chronic intermittent hypoxia; microbiota manipulation; 
microbiota-gut-brain axis; neurochemistry; cardiorespiratory disease 
Abbreviations: ABX, antibiotic administration; CIH, chronic intermittent hypoxia; FMT, faecal 
microbiota transfer; HFD, high-fat diet; HSD, high-salt diet; LPS, lipopolysaccharides; OSA, 




5.1. Gut microbiota 
 
Bacteria, fungi, viruses, archaea and parasites residing within the gut, form a dynamic and 
extensive microbial ecosystem termed the gut microbiota. Interestingly, the bacteria within 
the gut combine to occupy a ratio of 1:1 with host cells (Sender et al., 2016). Early life factors, 
including delivery mode, gestational age at birth, method of feeding and early life stress have 
profound impact on the formation of the gut microbiome; each individual inherits a distinct 
gut microbiota profile (Penders et al., 2006; O'Mahony et al., 2009; Dunphy-Doherty et al., 
2018; Fouhy et al., 2019). Furthermore, factors including diet, lifestyle and medication, 
amongst others orchestrate the continuous evolution of the gut microbiome throughout life. 
Broad inter-individual differences occur (Del Chierico et al., 2014; Panda et al., 2014; Murphy 
et al., 2015; De Filippis et al., 2016). Over the last number of years, several studies have 
revealed that the gut microbiota is associated with brain behaviours and whole -body 
homeostasis in both health and disease. The gut microbiota communicates with the brain 
via a bidirectional signalling pathway termed the microbiota-gut-brain axis. Dysregulated 
signalling of this multifaceted axis affects major homoeostatic neurocontrol systems 
promoting pathophysiological phenotypes (O'Mahony et al., 2014; Desbonnet et al., 2015; 
Hoban et al., 2016; Kelly et al., 2016b; Adnan et al., 2017; Burokas et al., 2017; Golubeva et 
al., 2017; Li et al., 2017). Studies in our laboratory and others have recently extended this 
research to other critically important homeostatic systems including the cardiorespiratory 
control network (Golubeva et al., 2015; Durgan et al., 2016; Santisteban et al., 2017; Ganesh 





5.2. Cardiorespiratory control 
 
The cardiorespiratory control system is composed of sensors (peripheral and central), central 
control regions determining rhythm and pattern and effector motor nerves and autonomic 
pathways. This network is an intricate homeostatic system providing regulatory mechanisms 
to maintain adequate blood oxygenation to meet whole-body metabolic requirements. The 
regulatory web of neuronal networks predominantly located in the brainstem is critical in 
the integration of sensory cues from the periphery as well as modulation of appropriate 
cardiorespiratory reflex responses. The brainstem (pons and medulla oblongata) also 
receives sensory traffic from the vagus nerve, a key signalling pathway of the microbiota-gut-
brain axis. Notwithstanding the homeostatic capacity of the control network, adaptive and 
maladaptive plasticity may develop within the cardiorespiratory control circuitry, both at the 
central and peripheral level (Bavis, 2005; Peng et al., 2009; Edge et al., 2010; Joseph et al., 
2013; Fuller & Mitchell, 2017; Lucking et al., 2018b). Maladaptive plasticity results in 
unfavourable outcomes for cardiorespiratory control and has adverse consequences for 
whole-body function, for example, breathing instability and the establishment of 
hypertension (Julien et al., 2008; Fournier et al., 2013a; Joseph et al., 2013; Kinkead et al., 





5.3. The gut microbiota, cardiorespiratory and autonomic control  
 
Elaborate mechanisms of respiratory and blood pressure regulation are slowly being 
unravelled. Recently, investigations conducted by our group and others have proposed that 
the gut microbiota appears to play an important modulatory role in cardiorespiratory and 
autonomic control (Santisteban et al., 2017; Kim et al., 2018; Lucking et al., 2018b; Marques 
et al., 2018; O'Connor et al., 2019a). Several studies using models that manipulate the gut 
microbiota, including faecal microbiota transplant strategies, antibiotic administration and 
probiotics, demonstrate substantial interplay between the gut microbiota and blood 
pressure homeostasis (Ganesh et al., 2018; Lucking et al., 2018b; Marques et al., 2018; Toral 
et al., 2019). Moreover, perturbed gut microbiota composition and diversity, specifically 
elevated Firmicutes: Bacteroidetes ratio, and decreased microbial richness and evenness has 
been associated with hypertension in multiple animal models (Durgan et al., 2016; Adnan et 
al., 2017; Santisteban et al., 2017; Toral et al., 2019). Recently, it was reported that the gut 
microbiota and/or gut microbiota metabolites function in autonomic control of the heart 
(Kim et al., 2018).  Additionally, our laboratory has previously described that pre-natal stress 
disturbs the gut microbiota composition in rat offspring with associated effects on 
respiratory control, resulting in elevated variability of breathing frequency during normoxia 
and altered ventilatory responsiveness to hypoxic and hypercapnic chemostimulation. 
Intriguingly, breathing frequency responsiveness to hypercapnia positively correlated with 
Anaerotruncus and Oscillibacter genera and enhanced variability of breathing frequency 
during normoxia correlated with Mucispirillum and Papillibacter (Golubeva et al., 2015). 
Moreno-Indias et al., (2015, 2016) demonstrated that respiratory dysregulation and 
alterations to the gut microbiota structure develop in an animal model of intermittent 
hypoxia. Beyond these studies, to our knowledge there are no other reports investigating 
the potential regulatory role of the gut microbiota on the control of breathing. We 
performed the first comprehensive assessment of respiratory control and cardiovascular 
function in animal models of manipulated gut microbiota, and sleep-disordered breathing 
with altered gut microbiota. 
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5.4. Respiratory control in animal models of manipulated gut microbiota 
 
In O’Connor et al. (2019a), two methods were utilised to manipulate the gut microbiota.  
Adult male rats were treated with broad spectrum antibiotics (ABX) designed to deplete the 
gut microbiota. Additionally, rats received a faecal microbiota transfer (FMT) of pooled sham 
faeces in an attempt to reverse gut microbiota disruptions after antibiotic administration. 
However, this FMT strategy did not normalise the gut microbiota profile; instead, a second 
model of perturbed gut microbiota was created with a unique gut microbiota composition 
and increased gut microbiota diversity. Similarly, unfavourable disturbances to the gut 
microbiota from a FMT intervention were also evident in a clinical study wherein FMT to 
irritable bowel syndrome patients led to the proliferation of a distinct gut microbiota 
assembly with no amelioration of symptoms (Halkjaer et al., 2018).  
Considering that deleterious respiratory behaviours are evident in adult rats with disrupted 
gut microbiota following antecedent pre-natal stress (Golubeva et al., 2015), and that 
dysregulated microbiota-gut-brain axis signalling promotes the development of aberrant 
brain behaviours, such as anxiety, depression and altered learning and memory (Hoban et 
al., 2016; Burokas et al., 2017; Foster et al., 2017), we aimed to investigate if the gut 
microbiota has a modulatory role in respiratory homeostasis. Using the technique of whole-
body plethysmography, allowing the assessment of respiratory control and whole -body 
metabolism in unrestrained unanaesthetised animals, we observed aberrant respiratory 
phenotypes in response to chemostimulation in ABX and FMT rats during quiet rest, with no 
change evident during baseline normoxic breathing. Normal ventilation during normoxia 
indicates a remarkably capacity for the maintenance of respiratory homeostasis within the 
control network. Furthermore, we presented evidence that ABX and FMT rats had depressed 
respiratory frequency and minute ventilation during the initial (peak) hypoxic ventilatory 
response (O'Connor et al., 2019a), similar to the blunted hypoxic ventilatory response 
evident in adult rats exposed to pre-natal stress (Golubeva et al., 2015). These studies 
suggest that refined integration of chemosensory cues from the dominant peripheral oxygen 
sensors, the carotid bodies, develop due to a disrupted gut microbiota signature. Although 
the initial hypoxic ventilatory responses were depressed in ABX and FMT rats (O'Connor et 
al., 2019a), the phase 2 steady-state response to hypoxia remained unchanged, further 
displaying the ability of the network to preserve respiratory homeostasis.  
The major and most intriguing finding of chapter 2 was that ABX and FMT rats have 
depressed ventilatory responsiveness to hypercapnia, revealing that modifications to the gut 
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microbiota are associated with blunted chemoreflex control of breathing in response to 
hypercapnia. This striking observation is physiologically significant as systemic acidosis may 
present during periods of elevated carbon dioxide concentrations. Hypercapnia is sensed by 
central chemoreceptors residing in the brainstem. Therefore, we assessed brainstem 
monoamine and monoamine metabolite concentrations in brainstem homogenates from 
ABX and FMT rats, as altered brain neurochemistry is evident in various models of disrupted 
gut microbiota (Clarke et al., 2013; Desbonnet et al., 2015; Hoban et al., 2016). High-
performance liquid chromatography revealed that brainstem neuromodulators specifically 
relating to the dopaminergic pathway were modified in ABX and FMT groups. Notably, a 
number of bacterial genera, predominantly from the Firmicutes phylum correlated with 
brainstem neurochemistry, which in turn may be responsible for the perturbed chemoreflex 
control of breathing evident in ABX and FMT rats. Using two different models of perturbed 
gut microbiota (O'Connor et al., 2019a) our study suggests that dysregulated microbiota-gut-
brain axis signalling culminates in deleterious outcomes for respiratory control and 
brainstem neurochemistry, extending previous work by our group linking the gut microbiota 
to respiratory control (Golubeva et al, 2015).  
Dysregulated intestinal permeability has been associated with systemic inflammation and 
the transfer of bacterial metabolites such as lipopolysaccharides (LPS) into the periphery 
(Araujo et al., 2017). Intestinal barrier dysfunction frequently occurs in models of perturbed 
gut microbiota, such as rodent models of maternal separation stress, hypertension and 
antibiotic administration (Gareau et al., 2007; Tulstrup et al., 2015; Ganesh et al., 2018; Kim 
et al., 2018). Consistent with these observations, ABX and FMT rats had a ‘leaky’ distal ileum, 
but not colon. It is conceivable to suggest that disrupted intestinal integrity contributed to 
altered brain neurochemistry and in turn the aberrant respiratory control in ABX and FMT 
rats. Considering the dominant role of the vagus nerve in the gut-brain axis, it presents as a 
potential player in the establishment and progression of cardiorespiratory disturbances 
evident in the ABX and FMT rats. Interestingly, no notable differences in cardiorespiratory 
responses to pulmonary vagal C-fibre stimulation were evident between groups, however, 
vagal afferent stimulation from other peripheral sites such as the gut were not examined in 
our study (O'Connor et al., 2019a). In summary, perturbation to the gut microbiota is 
associated with altered respiratory control evident in response to chemosensory stimulation. 
Mismatches in ventilation and metabolism have consequences for acid-base balance with 
potential consequences for whole-body systems. Our novel findings have revealed a link 
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between gut microbiota and neural control of breathing with potential implications for a 
variety of respiratory control disorders across the lifespan.  
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5.5. Cardiorespiratory and autonomic control in animal models sleep-disordered breathing 
 
In an endeavour to determine if beneficial manipulation of the gut microbiota has viable 
application as adjunctive therapy for human cardiorespiratory disease, studies investigating 
microbiota-gut-brain axis signalling in animal models are required. In CIH-exposed rodents, 
modelling human sleep apnoea, the influence of CIH exposure on the gut microbiota and 
resultant effects on cardiorespiratory physiology are complicated by CIH-induced carotid 
body sensitisation and resultant alterations in autonomic control. Carotid body 
chemoreceptors are proposed to be critical in the development of numerous CIH-induced 
cardiorespiratory morbidities, including hypertension and elevated hypoxic ventilatory 
responses (Huang et al., 2009; Peng et al., 2009; Del Rio et al., 2016; Iturriaga et al., 2017). 
Moreover, autonomic imbalance disrupts the gut microbiota (Kelly et al., 2015; Santisteban 
et al., 2017; Toral et al., 2019), which could establish a feed-forward cycle of disability. In 
chapter 3, Lucking et al. (2018), we explored the effects of CIH exposure on gut microbiota 
and cardiorespiratory control in guinea-pigs, a rodent with hypoxia-insensitive carotid 
bodies. Using a CIH paradigm that evokes hypertension in rats, we reasoned that if 
cardiorespiratory impairments presented in CIH-exposed guinea-pigs in the absence of 
carotid body sensitisation, then peripheral structures other than the carotid bodies are 
potential contributors to development of CIH-induced morbidities. 
CIH-exposed guinea-pigs displayed lower respiratory variability in concert with reduced 
frequency of sighs and central apnoeas assessed by whole body plethysmography. In the 
light of these adverse respiratory behaviours, we measured brainstem neuromodulators 
involved in the control of breathing.  High-performance liquid chromatography revealed 
decreased concentrations of noradrenaline in the pons and medulla oblongata. Lower 
brainstem noradrenaline concentrations and reduced apnoea/sigh frequency are congruent 
observations, considering that noradrenaline promotes respiratory instabilities in mice 
exposed to IH (Zanella et al., 2014) and elevated central noradrenergic terminals are noted 
in CIH-exposed rats (Mody et al., 2011), that have increased propensity for generation of 
apnoea (Edge et al., 2012). CIH exposure in guinea-pigs did not induce hypertension, but 
tachycardia was evident together with impaired baroreflex responsiveness. Work by another 
group convincingly demonstrated that exposure to an extended duration of CIH in guinea-
pigs manifested in the establishment of hypertension and tachycardia, without carotid body 
sensitisation (Docio et al., 2018).  These observations illustrate that peripheral sites other 
than the carotid bodies contribute to cardiorespiratory and autonomic impairments 
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following exposure to CIH (Docio et al., 2018; Lucking et al., 2018b; AlMarabeh et al., 2019; 
O'Connor et al., 2019b). 
16S rRNA sequencing revealed for the first time that CIH-exposed guinea-pigs exhibit altered 
gut microbiota composition and diversity, in the likely absence of carotid body sensitisation 
and elevated sympathetic nervous system activity (Lucking et al. 2018), consistent with 
observations in other CIH-exposed animal models (Moreno-Indias et al., 2015; Moreno-
Indias et al., 2016; O’Connor et al., chapter 4). It is conceivable that dysregulated microbiota-
gut-brain axis signalling may have culminated in aberrant autonomic control of the heart, 
undesirable respiratory phenotypes and reduced noradrenaline concentrations. This is 
particularly intriguing in light of the evidence that ABX and FMT rats exhibit respiratory 
control deficits and altered brainstem neurochemistry  (O'Connor et al., 2019a). Butyrate, 
which is a metabolite of the gut microbiota, modified the gut microbiota, reduced blood 
pressure and normalised baroreflex activity and cardiac autonomic control in a hypertensive 
mouse model with perturbed gut microbiota (Kim et al., 2018). Considering that 
dysregulated autonomic control occurs in CIH-exposed guinea-pig with altered gut 
microbiota (Docio et al., 2018; Lucking et al., 2018b) our study further supports these 
findings, which implicate disruption to the gut microbiota as a causal factor in the 
development of cardiovascular and autonomic dysfunction. 
Given that manipulation of the gut microbiota via ABX and FMT perturbed the gut microbiota 
and altered respiratory behaviours and brainstem neurochemistry (O'Connor et al., 2019a) 
and that CIH-exposed guinea-pigs, modelling human sleep apnoea, have a disturbed gut 
microbiota as well as perturbed respiratory and autonomic control (Lucking et al., 2018b), it 
is reasonable to postulate that beneficial manipulation of the gut microbiota may have 
potential application as an adjunctive treatment in human cardiorespiratory disease. In 
chapter 4, we explored cardiorespiratory control and gut microbiota structure in rats 
exposed to CIH. We investigated if prebiotic supplementation, designed to promote the 
expansion of beneficial microbes, is effective in the prevention of CIH-induced 
cardiorespiratory dysfunctions.  
Plethysmography studies revealed that CIH exposure in rats triggered an increased 
propensity for the generation of apnoeas during normoxia. Prebiotic administration did not 
prevent CIH-induced increases in apnoea index but increased chemoreflex control of 
breathing in response to hypercapnia and hypoxic hypercapnia. We assessed 
neuromodulator concentrations key in respiratory control in pontine and medulla oblongata 
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homogenates. High-performance liquid chromatography revealed that CIH exposure did not 
affect brainstem neurochemistry, whereas prebiotic administration altered monoamine 
precursor and metabolite concentrations in sham animals, notably  L-3,4-
dihydroxyphenylalanine, homovanillic acid and 5-hydroindoleacetic acid. We confirmed also 
that CIH exposure did not increase pro-inflammatory brainstem cytokine concentrations, 
with the concentrations of IL-10 and IL-5 decreased in CIH-exposed rats. Oxidative stress 
and/or other brainstem neuromodulators not examined in our study (Tryba et al., 2008; 
Garcia et al., 2016), or effects at the level of the carotid body (Donovan et al., 2014), could 
underpin aberrant CIH-related respiratory behaviours.  
CIH exposure led to the development of hypertension and increased cardiac sympathetic 
tone in the anesthetised rat, which have previously been described (Zoccal et al., 2007b; 
Lucking et al., 2014; Peng et al., 2014b; Del Rio et al., 2016; Laouafa et al., 2017; Laouafa et 
al., 2019). Prebiotic administration did not prevent adverse cardiovascular and autonomic 
control in CIH-exposed rats (O’Connor et al. chapter 4). Our findings are interesting in the 
context of previous observations wherein prebiotic (Hylon VII) administration normalised 
caecal acetate concentrations, increased levels of short-chain fatty acid (SCFA) producing 
bacteria and prevented the development of hypertension in an obstructive sleep apnoea + 
high-fat diet fed (OSA+HFD) rat model. Additionally, chronic acetate administration in rat 
caecum during exposure to OSA+HFD restored caecal acetate concentrations and prevented 
hypertension (Ganesh et al., 2018). Furthermore, propionate and acetate mitigated the 
development of hypertension in chronic angiotensin II -induced and mineralocorticoid 
excess-induced hypertensive rodent models (Marques et al., 2017; Kim et al., 2018; 
Bartolomaeus et al., 2019). Prebiotic administration increased faecal acetic and propanoic 
acid concentrations in sham and CIH-exposed rats (O’Connor et al. chapter 4), but CIH 
exposure had no effect on SCFA concentrations, which clearly demonstrates that diminished 
SCFA concentrations are not essential to the development of cardiovascular pathologies, 
including hypertension in our model. 
We observed for the first time, using whole-metagenome shotgun sequencing, that CIH 
exposure affects gut bacterial species. Specifically, the abundance of  Lactobacillus 
rhamnosus, a commensal bacterial species, was diminished in CIH-exposed rats compared 
with sham rats. Interestingly, prebiotic administration did not restore Lactobacillus 
rhamnosus abundance in CIH-exposed rats. Lactobacillus rhamnosus administration 
prevented CIH+HSD-induced hypertension in rats (Liu et al., 2019), suggesting that decreased 
abundance of Lactobacillus rhamnosus evident in CIH-exposed rats may underpin the 
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establishment of hypertension. We advance this hypothesis with caution as Lactobacillus 
rhamnosus abundance was also decreased in sham animals treated with prebiotics, most 
likely because this bacterial species cannot consume galactooligossacharides and 
fructooligosaccharides, the prebiotic combination used in our study (Chapter 4); yet these 
animals were normotensive, which argues against a pivotal role for Lactobacillus rhamnosus 
in the control of blood pressure. Furthermore, there was increased abundance of a number 
of pathogenic species and a trend towards reduced abundance of several other Lactobacillus 
species in CIH-exposed rats. Multiple bacterial species correlated with blood pressure,  
suggesting that a complex interplay of changes in commensal and pathogenic species 
abundance may create a distinct microbiota signature that contributes to blood pressure 
regulation per se and/or drives a hypertensive phenotype following CIH exposure.   
CIH exposure affects gut barrier function, resulting in gut inflammation, increased plasma 
oxidative stress and LPS concentrations as well as decreased tight junction receptor 
expression (Moreno-Indias et al., 2015; Wu et al., 2016), maladies which are often evident 
in hypertensive animal models (Santisteban et al., 2017; Kim et al., 2018). Although we did 
not examine intestinal function in our study, plasma inflammatory mediators were not 
affected by CIH exposure implying that gut barrier integrity was maintained. Hence, we 
conclude that intestinal dysfunction did not contribute to the development of CIH-induced 
cardiorespiratory dysfunction in our study. Notably, prebiotic administration reduced 
hypertension and prevented epithelial goblet cell loss and mucus barrier thinning, which 
were evident in OSA+HFD rats (Ganesh et al., 2018). Considering the pivotal role of the vagus 
nerve in cardiorespiratory control and microbiota-gut-brain axis signalling we assessed 
cardiorespiratory responsiveness to pulmonary vagal C-fibre activation. No significant 
differences were evident between groups. It would be interesting to explore vagal afferent 
signalling from other peripheral sites, especially the gut. In summary, prebiotic fibre 
administration did not normalise Lactobacillus rhamnosus relative abundance or prevent 
major cardiorespiratory maladies in CIH-exposed rats. Correlation analysis revealed 
significant associations between blood pressure and several commensal and pathogenic 
bacterial species suggesting that a specific microbiota signature may at least partly 
contribute to the establishment of hypertension shaping maladaptive plasticity within neural 
control networks that underpin cardiorespiratory pathologies in CIH-exposed rats. It is 
interesting to speculate that a microbiota-gut-carotid body axis exists, but this warrants 
further investigation. Our findings add to emerging studies investigating the regulatory role 
of the gut microbiota in animal models of OSA. 
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5.6. Potential mechanisms linking cardiorespiratory and autonomic dysfunction to the gut 
microbiota 
 
A number of intricate mechanisms are proposed as communication pathways of the 
microbiota-gut-brain axis.  The vagus nerve is argued to be the primary signalling pathway. 
Studies in animals report that vagal afferent fibres respond to multiple stimuli within the gut, 
such as cytokines and gut bacterial metabolites including SCFAs (Johnston & Webster, 2009; 
Nohr et al., 2015). Administration of probiotic species, Lactobacillus rhamnosus and 
Bifidobacterium longum, which reverse and ameliorate intestinal epithelial barrier 
dysfunction, respectively (West et al., 2017; Chen et al., 2019; Liu et al., 2019), alter 
neuromodulators and neuronal activity in multiple brain regions and modify anxiety-related 
brain behaviours; these effects are abolished in vagotomised rodents (Bercik et al., 2011b; 
Bravo et al., 2011). Considering the governing role of the vagus nerve, it presents as a 
potential mechanism linking adverse cardiorespiratory and autonomic dysfunction to a 
disturbed gut microbiota. Vagotomy studies are required to investigate if microbiota-gut 
brain axis signalling via the vagus nerve has a modulatory role in the control of breathing and 
cardiovascular function.  
ABX and FMT rats had disrupted gut microbiota, elevated intestinal permeability and altered 
respiratory control (O'Connor et al., 2019a). CIH-exposed rats developed cardiorespiratory 
and autonomic impairments and altered gut microbiota, but did not present with systemic 
inflammation. Prebiotic administration did not prevent CIH-induced cardiorespiratory and 
autonomic dysfunction (chapter 4). The latter observation is in contrast to previous studies 
wherein prebiotic (Hylon VII), probiotic (Clostridium butyricum) and SCFA administration 
independently ameliorate gut barrier function and prevent/restore cardiovascular and 
autonomic maladies in OSA and hypertensive animal models (Ganesh et al., 2018; Kim et al., 
2018; Liu et al., 2019). Gut microbiota and metabolites are associated with gut intestinal 
homeostasis (Macfarlane & Macfarlane, 2012; Ganesh et al., 2018; Kim et al., 2018). Elevated 
levels of pathogenic species encourage gut barrier inflammation and intestinal damage 
(Riegler et al., 1995; Bucker et al., 2018). Beneficial bacterial species and SCFAs protect 
against gut dysfunction (Ganesh et al., 2018; Kim et al., 2018). It is plausible to suggest that 
increased intestinal barrier permeability by whatever means, including perturbed gut 
microbiota and autonomic dysfunction may compromise cardiorespiratory homoeostasis 
and accommodate the development of pathologies. A complex interplay of microbiota-gut-
brain axis signalling mechanisms may play a regulatory role in cardiorespiratory and 





Figure 5. 1 Potential mechanisms linking aberrant cardiorespiratory and autonomic 
control to the gut microbiota. 
Vagal signalling and intestinal epithelial barrier dysfunction are proposed communication 
pathways associated with develop of adverse cardiorespiratory and autonomic control. 
ACTH, adrenocorticotrophic hormone; CRF, corticotropin-releasing factor; HPA axis; 
hypothalamic pituitary adrenal axis; LPS; lipopolysaccharides; NTS, nucleus tractus solitarius; 
SCFA, short-chain fatty acid. Cortisol and corticosterone are released from the adrenal 
medulla in humans and rodents, respectively.   
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5.7. Future studies 
 
Whilst we performed a comprehensive assessment of cardiorespiratory control in models of 
altered gut microbiota (ABX, FMT, CIH and prebiotic supplementation), many unresolved 
questions remain. The FMT strategy utilised in chapter 2 perturbed the gut microbiota, 
blunted chemoreflex control of breathing, disrupted brainstem neurochemistry and elevated 
intestinal permeability in vehicle- and antibiotic-treated rats. We are currently examining 
alternative intervention strategies (prebiotic administration, faecal microbiota transfer and 
natural recolonization) to establish an optimum approach that restores a control -like 
microbiota. We aim to determine if re-establishment of the gut microbiota reverses aberrant 
respiratory phenotypes in antibiotic-treated animals.  
Studies should be performed in rodents exposed to more severe CIH paradigms with 
variations in the frequency of cycles, intensity of hypoxia and/or duration of exposure with 
and without the influence of a dietary intervention. These investigations would  add to 
emerging observations in animal models of obstructive sleep apnoea using a CIH stimulus in 
concert with high-fat diet/high-salt diet. Considering that hypertensive CIH-exposed rats 
have reduced Lactobacillus rhamnosus abundance, which is not restored by prebiotic 
supplementation, studies should be performed investigating the effects of Lactobacillus 
rhamnosus administration on cardiorespiratory control in CIH-exposed rodents.  
Metagenomics and metabolomics approaches to explore the gut microbiome in  animal 
models with aberrant cardiorespiratory phenotypes would be advantageous in an attempt 
to determine if a distinct gut microbiota-dependent metabolic signature drives adverse 
cardiorespiratory control. In the event that specific microbial taxa contri bute to 
cardiorespiratory malaise or favour homeostasis, then targeting these particular species via 
probiotic or narrow-spectrum antibiotic administration could function as a corrective 
remedy in the treatment of human disease.  
Studies assessing signalling mechanisms contributing to cardiorespiratory dysregulation in 
animal models of altered gut microbiota including models of SDB are required. Vagal-
mediated communication between the gut microbes and the brain should be examined in 
our models. Manipulation of the gut microbiota in vagotomised animals would enhance our 
understanding of the role of microbiota-gut-brain axis signalling via the vagus nerve in 
cardiorespiratory control. SCFAs prevented hypertension and autonomic dysfunction in 
animal models of SDB and hypertension, respectively (Ganesh et al., 2018), but contrastingly 
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elevated SCFA concentration did not attenuate hypertension in our study (chapter 4). It is 
important to further investigate the contributory roles of SCFAs in various animal models of 
perturbed cardiorespiratory control. Considering that antibiotic administration and faecal 
microbiota transfer elevated intestinal permeability (chapter 2) and CIH-exposed animals 
exhibit perturbed intestinal barrier function (Wu et al., 2016), investigations establishing if 
altered intestinal permeability contributes to modified brain neurochemistry and  
cardiorespiratory morbidity are necessary. 
The composition of the lung and airway microbiota in animal models of cardiorespiratory 
disorders as well as of targeted microbiota manipulations (ABX, FMT, probiotics, prebiotics 
or germ free rodents) should be characterised. At present there i s a dearth of studies 
investigating gut, lung and airway microbiota composition and diversity in patients with 
cardiorespiratory diseases such as obstructive sleep apnoea and chronic obstructive 
pulmonary disease. These studies are necessary to advance therapeutic strategies for the 
treatment of human cardiorespiratory disorders. It is worthy to note that beneficial 
modulation of the gut microbiota via prebiotics, probiotic, FMT or targeted narrow-spectrum 
antibiotic administration may function as adjunctive therapy for human cardiorespiratory 





The gut microbiota signals via an intricate bidirectional communication pathway termed the 
‘microbiota-gut-brain axis’. Perturbed microbiota-gut-brain axis signalling has detrimental 
consequences for homeostatic regulation of neurocontrol systems; an ever-expanding array 
of deleterious brain behaviours and disease states manifest. To date, dysregulated 
communication between the gut microbes and the brain has been associated with multiple 
maladies including but not exclusive to stress-related pathologies such as anxiety, depression 
and irritable bowel syndrome and neurodevelopmental disorders such as autism. 
Remarkably, our findings add to the emerging field exploring microbiota-gut-brain axis 
signalling in homeostatic systems, extending investigations to behaviours predominantly 
regulated by the brainstem (pons and medulla oblongata), specifically cardiorespiratory 
control. Manipulation of the gut microbiota, via ABX, FMT and prebiotic supplementation, 
indicates that modification of the gut microbiota has implications for chemoreflex control of 
breathing especially during hypercapnia, as well as brainstem neurochemistry and intestinal 
permeability. These findings have relevance for whole-body health as a blunted ventilatory 
response to hypercapnia has detrimental consequences for acid-base balance, increasing the 
possibility of developing respiratory acidosis.  CIH exposure, modelling human sleep apnoea, 
in guinea-pigs leads to the development of respiratory and autonomic dysfunction and 
reduced brainstem noradrenaline, suggesting that sites beyond the carotid bodies have a 
contributory role in the development of adverse CIH-induced cardiorespiratory phenotypes. 
CIH-exposed guinea-pigs have an altered gut microbiota, emerging as a potential protagonist 
in the manifestation of CIH-induced cardiorespiratory dysfunctions. Moreover, CIH-exposed 
rats have diminished relative abundance of Lactobacillus species, increased relative 
abundance of several pathogenic species, elevated apnoea index, hypertension and cardiac 
autonomic imbalance. Prebiotic supplementation elevated SCFA concentrations, but did not 
restore Lactobacillus rhamnosus relative abundance or cardiorespiratory pathologies in CIH-
exposed rats. Our findings suggest that a complex interplay of changes in commensal and 
pathogenic species abundance may at least partly contribute to the development of 
hypertension in CIH-exposed rodents shaping aberrant plasticity in neural control networks, 
but it is also plausible that cardiorespiratory dysfunction in CIH-exposed rats, at least in our 
model, is driven independently by maladaptive plasticity with the neural circuitry controlling 
breathing and blood pressure. Considering that aberrant microbiota-gut-brain axis signalling 
extends to homeostatic neural control systems which maintain adequate oxygen and acid-
base balance, vital for whole-body health, findings from our studies suggest that 
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dysregulated microbiota-gut-brain axis signalling has the capacity to culminate in a flood of 
new maladies. Given that a disturbed gut microbiota is implicated in an ever-expanding 
portfolio of pathologies associated with neurocontrol networks, one can conclude that there 
is no safe harbour from aberrant microbiota-gut-brain axis signalling. At present, there are 
many unresolved questions pertaining to the interplay between the gut microbiota and 
cardiorespiratory and autonomic control. Additional research is required to unde rstand the 
elaborate signalling mechanisms of the gut-brain axis. If this can be achieved, it may shape 
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Appendix A. Manipulation of gut microbiota blunts the ventilatory 




















Appendix Figure A.1 Body weight, fluid intake and faecal output 
Group data for (a) animal body weights and (b) fluid intake in ml per cage (two animals per 
cage) over the experimental timeline. Group data (c) for excreted faecal pellets per hour; 
n=10 all groups. VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH 
followed by faecal microbial transfer; ABX-FMT, antibiotic-treated followed by faecal 
microbial transfer. Data (a-b) are expressed as mean ± SD or (c) as box and whisker plots 
(median, IQR and minimum to maximum values). Data (a-b) were statistically compared by 
two-way ANOVA with Bonferroni post hoc test. Data (c) were statistically compared by non-
parametric Kruskal-Wallis with Dunn’s post hoc. *** p<0.01, ABX vs. VEH; £ p<0.005, VEH-






Appendix Figure A.2 Chronic antibiotic administration and faecal microbial transfer blunts 
hypercapnic ventilation in behaving rats during quiet rest 
Group data for respiratory frequency (a, b, c, d), minute ventilation (e, f, g, h) and ventilatory 
equivalent (i, j, k, l) during normoxia and in response to hypoxia (a, b, e, f, i, j) and hypercapnia 
(c, d, g, h, k, l) for VEH and VEH-FMT (a, c, e, g, i, k) and ABX and ABX-FMT (b, d, f, h, j, l). VEH, 
autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal 
microbial transfer; ABX-FMT, antibiotic-treated followed by faecal microbial transfer. Data 
(a-l) are expressed as mean ± SD during baseline, hypoxia and hypercapnia; n=10 for all 




Bonferroni post hoc where appropriate. p-values are shown. $$ p<0.01, VEH versus VEH-

























Appendix Figure A.3 Chronic antibiotic administration and faecal microbial transfer blunt 
the peak respiratory frequency response to hypoxia in behaving rats during quiet rest 
Respiratory frequency for VEH and ABX (a), VEH-FMT and ABX-FMT (b), VEH and VEH-FMT 
(c), ABX and ABX-FMT (d) rats immediately before and during 120 seconds of exposure to 
hypoxia. VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed 
by faecal microbial transfer; ABX-FMT, antibiotic-treated followed by faecal microbial 
transfer. Data (a-d) are expressed mean ±SD; n=10 for all groups. Data were statistically 
compared by repeated measures two-way ANOVA (time x ABX or time x FMT) with 
Bonferroni post hoc test, where appropriate. p-values are shown. ** p<0.01 compared with 











Appendix Figure A.4 Ventilatory response to acute intermittent hypoxia in behaving rats 
during quiet rest 
Group data for minute ventilation during normoxia (6-minute baseline), acute intermittent 
hypoxia (AIH) and 5 minutes normoxia baseline 60 minutes following exposure to AIH for 
VEH and ABX (a) and VEH -FMT and ABX-FMT (b) groups. Data (a-b) are expressed as mean ± 




















Appendix Figure A.5 Chronic antibiotic administration blunts the respiratory frequency 
response to hypercapnia in behaving rats during quiet rest 
Respiratory frequency for VEH and ABX (a), VEH-FMT and ABX-FMT (b), VEH and VEH-FMT 
(c), ABX and ABX-FMT (d) rats immediately before and during10 minutes of exposure to 
hypercapnia. VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH 
followed by faecal microbial transfer; ABX-FMT, antibiotic-treated followed by faecal 
microbial transfer. Data (a-d) are expressed mean ±SD; n=10 for all groups. Data were 
statistically compared by repeated measures two-way ANOVA (time x ABX or time x FMT). p-










Appendix Figure A.6 Group data for FITC flux in distal ileum and proximal colon 
Group data for FITC flux in distal ileum (a, b) and proximal colon (c, d) in VEH and VEH-FMT 
(a, c) and in ABX and ABX-FMT rats (b, d). VEH, autoclaved deionised water; ABX, antibiotic-
treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated 
followed by faecal microbiota transfer. Groups (a-d) showing baseline (0 min), 60 min and 
120 min FITC flux for VEH (n = 4–5), ABX (n = 6), VEH-FMT (n = 5) and ABX-FMT (n = 4). 
Groups were statistically compared by two-way ANOVA with Bonferroni post hoc, where 






Appendix Figure A.7 Scatter plots for the most significant correlations between 
homovanillic acid, homovanillic acid/dopamine and dopamine concentrations and genus 
Individual data points for correlation analysis between homovanillic acid and Bacillus (a), 
homovanillic acid and Bacteroidetes VC2.1 Bac22 uncult. (b) homovanillic acid/dopamine 
and Bacillus (c), homovanillic acid/dopamine and Bacteroidetes VC2.1 Bac22 uncult. (d), 
dopamine and Bacteroidetes VC2.1 Bac22 uncult. (e) and dopamine 
and Coriobacteriaceae uncult. (f) in VEH, VEH-FMT and ABX-FMT rats. Solid black lines 
represent linear regression analysis for each parameter. Spearman correlation coefficients 




% change from 
baseline 
 






fR 75 ± 28 61 ± 18 51 ± 34 67 ± 24 0.337 
VT 24 ± 8 25 ± 8 25 ± 13 23 ± 10 0.931 
VE 110 ± 22 98 ± 19 89 ± 39 82 ± 33 0.202 
 
Appendix Table A.1. Ventilatory response to the tenth (final) intermittent hypoxia 
challenge in behaving rats during quiet rest 
fR, respiratory frequency; VT, tidal volume; VE, minute ventilation; VEH, autoclaved deionised 
water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbial transfer; ABX-
FMT, antibiotic administration followed by faecal microbial transfer.  Data are shown as 
mean ± SD and were statistically compared using one-way ANOVA or non-parametric 






























fR 0 ± 27 6 ± 13 - 6 ± 33 4 ± 14 0.692 - - - - - - 
VT -4 ± 13 8 ± 16 -2 ± 12 -11 ± 8 0.029 0.364 0.804 0.999 0.02 0.999 0.64 
VE 4 ± 20 16 ± 18 -6 ± 27 -7 ± 16 0.075 - - - - - - 
 
Appendix Table A.2 Ventilation following exposure to acute intermittent hypoxia in behaving rats during quiet rest  
fR, respiratory frequency; VT, tidal volume; VE, minute ventilation; VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed 
by faecal microbial transfer; ABX-FMT, antibiotic treated followed by faecal microbial transfer. Data are shown as mean ± SD and were statistically 
compared using one-way ANOVA with Bonferroni post hoc where appropriate. Each p-value is adjusted to account for multiple comparisons. p-




























Hypoxia            
Δ fR (brpm) 30 ± 15 34 ± 11 29 ± 21 30 ± 24 0.824 - - - - - - 




0.08 ± 0.05 0.06 ± 
0.07 
0.431 - - - - - - 
Δ VE (ml min-1 
100g-1) 
20 ± 10 19 ± 7 27 ± 12 20 ± 16 0.443 - - - - - - 
Δ MAP 
(mmHg) 
-31 ± 10 -30 ± 16 -20 ± 12 -22 ± 17 0.228 - - - - - - 
Δ DBP (mmHg) -24 ± 7 -27 ± 12 -19 ± 10 -19 ± 11 0.221 - - - - - - 
Δ SBP (mmHg) -44 ± 17 -41 ± 16 -29 ± 18 -32 ± 24 0.299 - - - - - - 
Δ HR (bpm) 19 ± 24 21 ± 19 34 ± 16 28 ± 25 0.451 - - - - - - 
Hypoxic Hypercapnia           
Δ fR (brpm) 31 ± 7 36 ± 12 29 ± 11 33 ± 12 0.581 - - - - - - 




0.18 ± 0.07 0.17 ± 
0.05 
0.84 - - - - - - 
Δ VE (ml min-1 
100g-1) 
31 ± 5 31 ± 7 38 ± 8 33 ± 8 0.14 - - - - - - 
Δ MAP 
(mmHg) 
-20 ± 10 -18 ± 11 -2 ± 10 -10 ± 16 0.013 0.999 0.999 0.017 0.999 0.424 0.066 
Δ DBP (mmHg) -16 ± 8 -16 ± 10 -6 ± 6 -10 ± 11 0.062 - - - - - - 
Δ SBP (mmHg) -30 ± 18 -19 ± 18 -12 ± 12 -17 ± 21 0.155 - - - - - - 
Δ HR (bpm) 15 ± 14 12 ± 15 29 ± 12 21 ± 12 0.052 - - - - - - 
 
Appendix Table A.3 Cardiorespiratory responsiveness to hypoxic and hypoxic hypercapnic chemostimulation in urethane anaesthetised rats  
fR, respiratory frequency (brpm, breaths per min); VT, tidal volume; VE, minute ventilation; MAP, mean arterial pressure; DBP, diastolic blood pressure; 
SBP, systolic blood pressure; HR, heart rate (bpm, beats per min); VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed 




statistically compared using one-way ANOVA with Bonferroni post hoc where appropriate, or non-parametric Kruskal-Wallis test where appropriate. 











5% Carbon Dioxide     
Δ fR (brpm) 14 ± 14 21 ± 19 7 ± 6 10 ± 8 0.131 
Δ VT (ml 100g-
1) 
0.08 ± 0.12 0.09 ± 0.07 0.1 ± 0.05 0.11 ± 0.02 0.988 
Δ VE (ml min-1 
100g-1) 
15 ± 3.9 18 ± 5.3 16 ± 6.8 15 ± 6 0.557 
Δ MAP 
(mmHg) 
10 ± 8 5 ± 5 8 ± 6 5 ± 7 0.634 
Δ DBP 
(mmHg) 
4 ± 2 4 ± 4 5 ± 3 4 ± 5 0.989 
Δ SBP 
(mmHg) 
7 ± 6 6 ± 6 7 ± 5 6 ± 9 0.98 
Δ HR (bpm) -2 ± 9 -8 ± 18 -2 ± 13 -4 ± 9 0.699 
10% Carbon Dioxide    
Δ fR (brpm) 15 ± 20 27 ± 20 6 ± 11 16 ± 12 0.079 
Δ VT (ml 100g-
1) 
0.25 ± 0.12 0.24 ± 0.08 0.26 ± 0.09 0.28 ± 0.05 0.823 
Δ VE (ml min-1 
100g-1) 
32 ± 7.5 38 ± 7.2 32 ± 10.6 36 ± 10.8 0.491 
Δ MAP (mmHg) 19 ± 9 14 ± 7 13 ± 7 12 ± 8 0.166 
Δ DBP (mmHg) 12 ± 5 14 ± 7 10 ± 4 9 ± 6 0.163 
Δ SBP (mmHg) 22 ± 10 16 ± 8 17 ± 8 14 ± 11 0.342 
Δ HR (bpm) 8 ± 13 3 ± 27 6 ± 26 2 ± 11 0.917 
 
Appendix Table A.4 Cardiorespiratory responsiveness to hypercapnic chemostimulation in 
urethane anaesthetised rats  
fR, respiratory frequency (brpm, breaths per min); VT, tidal volume; VE, minute ventilation; 
MAP, mean arterial pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; HR, 
heart rate (bpm, beats per min); VEH, autoclaved deionised water; ABX, antibiotic-treated; 
VEH-FMT, VEH followed by faecal microbial transfer; ABX-FMT, antibiotic administration 
followed by faecal microbial transfer. Data are shown as mean ± SD and were statistically 
compared using one-way ANOVA or non-parametric Kruskal-Wallis test, where appropriate. 











Baseline      
Area under the 
curve (mV.s) 
32 ± 15 28 ± 10 32 ± 18 33 ± 14 0.904 
Hypoxia      
Area under the 
curve (% change  
from baseline) 
-12 ± 12 -12 ± 32 1 ± 16 -5 ± 16 0.162 
5% Carbon Dioxide     
Area under the 
curve (% change  
from baseline) 
6 ± 7 16 ± 14 9 ± 10 15 ± 10 0.138 
10% Carbon Dioxide     
Area under the 
curve (% change  
from baseline) 
29 ± 12 21 ± 12 24 ± 18 20 ± 21 0.623 
Hypoxic Hypercapnia     
Area under the 
curve (% change  
from baseline) 
6 ± 13 -6 ± 14 13 ± 20 9 ± 17 0.119 
 
Appendix Table A.5 Diaphragm EMG activity during baseline and chemostimulation in 
urethane anaesthetised rats  
VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal 
microbial transfer; ABX-FMT, antibiotic administration followed by faecal microbial transfer. 
Data are shown as mean ± SD and were statistically compared using one-way ANOVA or non-













Baseline      
Δ fR (brpm) -42 ± 14 -46 ± 11 -37 ± 19 -40 ± 16 0.668 
Δ VT (ml 100g-1) 0.17 ± 0.06 0.19 ± 0.06 0.17 ± 0.1 0.18 ± 0.09 0.917 
Δ VE (ml min-1 
100g-1) 
-7 ± 4 -6 ± 3 -3 ± 7 -5 ± 9 0.730 
Δ MAP (mmHg) -1 ± 7 -6 ± 12 -1 ± 15 2 ± 9 0.561 
Δ DBP (mmHg) 2 ± 7 -3 ± 11 1 ± 13 3 ± 8 0.613 
Δ SBP (mmHg) -0 ± 13 -8 ± 13 -2 ± 25 1 ± 16 0.781 
Δ HR (bpm) 63 ± 26 71 ± 31 
 
66 ± 35 57 ± 32 0.707 
 
Appendix Table A.6 Cardiorespiratory responses to vagotomy in urethane anaesthetised 
rats  
fR, respiratory frequency (brpm, breaths per min); VT, tidal volume; VE, minute ventilation; 
MAP, mean arterial pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; HR, 
heart rate (bpm, beats per min); VEH, autoclaved deionised water; ABX, antibiotic-treated; 
VEH-FMT, VEH followed by faecal microbial transfer; ABX-FMT, antibiotic administration 
followed by faecal microbial transfer. Data are shown as mean ± SD and were statistically 
compared using one-way ANOVA or non-parametric Kruskal-Wallis test, where appropriate. 






























Hypoxia            
Δ fR (bpm) 20 ± 18 9 ± 4 19 ± 6 19 ± 11 0.041 0.244 0.999 0.999 0.039 0.999 0.129 




0.14 ± 0.08 0.04 ± 
0.08 
0.015 0.999 0.013 0.849 0.139 0.417 0.999 
Δ VE (ml min-1 
100g-1) 
16.0 ± 5.3 12.7 ± 3.8 23.0 ± 4.7 13.2 ± 
10.7 
0.014 0.999 0.027 0.201 0.999 0.999 0.034 
Δ MAP 
(mmHg) 
-23 ± 17 -18 ± 7 -27 ± 13 -29 ± 10 0.185 - - - - - - 
Δ DBP (mmHg) -19 ± 12 -17 ± 7 -25 ± 11 -26 ± 8 0.241 - - - - - - 
Δ SBP (mmHg) -30 ± 27 -23 ± 9 -33 ± 18 -34 ± 14 0.388 - - - - - - 
Δ HR (bpm) 21 ± 6 12 ± 14 26 ± 7 17 ± 12 0.037 0.391 0.243 0.999 0.999 0.999 0.042 
Hypoxic Hypercapnia          
Δ fR (brpm) 14 ± 12 9 ± 17 15 ± 7 20 ± 4 0.294 - - - - - - 




0.23 ± 0.07 0.18 ± 
0.04 
0.271 - - - - - - 
Δ VE (ml min-1 
100g-1) 
20 ± 15 14 ± 18 25 ± 5 24 ± 4 0.255 - - - - - - 
Δ MAP 
(mmHg) 
-11 ± 20 -9 ± 22 -17 ± 15 -16 ± 11 0.729 - - - - - - 
Δ DBP (mmHg) -9 ± 16 -8 ± 18 -19 ± 6 -15 ± 8 0.296 - - - - - - 
Δ SBP (mmHg) -12 ± 29 -9 ± 22 -23 ± 16 -18 ± 12 0.338 - - - - - - 
Δ HR (bpm) 13 ± 8 4 ± 10 19 ± 7 14 ± 7 0.007 0.204 0.999 0.54 0.093 0.999 0.004 
 
Appendix Table A.7 Cardiorespiratory responsiveness to hypoxic and hypoxic hypercapnic chemostimulation in urethane anaesthetised 
vagotomised rats  
fR respiratory frequency (bpm, breaths per min); VT, tidal volume; VE, minute ventilation; MAP, mean arterial pressure; DBP, diastolic blood pressure; 
SBP, systolic blood pressure; HR, heart rate (bpm, beats per min); VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed 
by faecal microbial transfer; ABX-FMT, antibiotic administration followed by faecal microbial transfer. Data are shown as mean ± SD and were 




multiple comparisons test, where appropriate. Data are shown as absolute change from baseline. Each p-value is adjusted to account for multiple 


































5% Carbon Dioxide           
Δ fR (brpm) 2.5 ± 5.4 3.3 ± 3.8 1.3 ± 5.5 4.5 ± 5.4 0.593 - - - - - - 






0.11 ± 0.04 0.12 ± 
0.04 
0.505 - - - - - - 
Δ VE (ml min-1 
100g-1) 
8.3 ± 4.6 9.6 ± 3.1 8.1 ± 6.1 8.4 ± 5.8 0.939 - - - - - - 
Δ MAP 
(mmHg) 
6.8 ± 5.4 5 ± 6.1 13.9 ± 6 5.3 ± 9 0.059 - - - - - - 
Δ DBP 
(mmHg) 
5.8 ± 2.5 5.1 ± 5.3 9 ± 3.5 5 ± 7.2 0.389 - - - - - - 
Δ SBP (mmHg) 9.1 ± 5.1 5.7 ± 8.4 15.4 ± 7.4 7.8 ± 12.5 0.147 - - - - - - 
Δ HR (bpm) -8.6 ± 6.1 -10.2 ± 
4.6 
-5.2 ± 7.6 -10.1 ± 
6.5 
0.201 - - - - - - 
10% Carbon Dioxide          
Δ fR (brpm) 2.1 ± 7.4 4.6 ± 3.2 2.3 ± 5.7 5.8 ± 6.6 0.502 - - - - - - 






0.26 ± 0.07 0.28 ± 
0.07 
0.832 - - - - - - 
Δ VE (ml min-1 
100g-1) 
16.7 ± 6.4 20.4 ± 2.8 18.0 ± 6.6 17.6 ± 9.3 0.762 - - - - - - 
Δ MAP 
(mmHg) 
14.4 ± 8.1 11 ± 10.9 29.4 ± 10.5 18.8 ± 
11.8 
0.006 0.999 0.205 0.798 0.022 0.999 0.008 
Δ DBP 
(mmHg) 
11.4 ± 4.8 10.7 ± 
10.2 
21.8 ± 6.3 16.6 ± 
10.1 
0.025 0.999 0.999 0.878 0.0502 0.921 0.063 
Δ SBP (mmHg) 19.6 ± 9.3 12.6 ± 
14.4 
37.7 ± 14.2 26.4 ± 
17.5 
0.007 0.999 0.546 0.328 0.051 0.999 0.008 
Δ HR (bpm) -9.7 ± 7.9 -10.2 ± 
6.2 
-1.7 ± 9.9 -11 ± 7.9 0.072 - - - - - - 
 
Appendix Table A.8 Cardiorespiratory parameter responsiveness to hypercapnic chemostimulation in urethane anaesthetised vagotomised rats  
fR, respiratory frequency (brpm, breaths per min); VT, tidal volume; VE, minute ventilation; MAP, mean arterial pressure; DBP, diastolic blood pressure; 




by faecal microbial transfer; ABX-FMT, antibiotic administration followed by faecal microbial transfer. Data are shown as mean ± SD and were 
statistically compared using one-way ANOVA with Bonferroni post hoc or non-parametric Kruskal-Wallis test where appropriate. Data are shown as 













% change from baseline   
Normoxia      
Area under the 
curve  
32 ± 12 31 ± 15 28 ± 13 27 ± 10   0.788 
Hypoxia      
Area under the 
curve  
-7 ± 12 -5 ± 9 5 ± 15 -4 ± 13 0.308 
5% Carbon Dioxide 
Area under the 
curve  
1 ± 9 0 ± 7 -1 ± 5 6 ± 11 0.542 
10% Carbon Dioxide 
Area under the 
curve  
-3 ± 13 -7 ± 14 -12 ± 8 - 2 ± 8 0.176 
Hypoxic Hypercapnia      
Area under the 
curve  
-1 ± 21 -9 ± 10 0 ± 8 -8 ± 15 0.428 
 
Appendix Table A.9 Diaphragm EMG activity and responsiveness to chemostimulation in 
urethane anaesthetised vagotomised rats  
VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal 
microbial transfer; ABX-FMT, antibiotic treated followed by faecal microbial transfer. Data 
are shown as mean ± SD and were statistically compared using one-way ANOVA or non-
parametric Kruskal-Wallis test where appropriate. Responses are expressed as % change 


























L-DOPA (ng/g) 213 ± 245 2394 ± 
1258 
914 ± 885 1479 ± 
392 
0.0001 0.0004 0.618 0.366 0.999 0.002 0.138 
DA (ng/g) 111 ± 29 103 ± 74 112 ± 29 71 ± 32 0.114 - - - - - - 
HVA (ng/g) 62 ± 48 155 ± 69 107 ± 56 143 ± 34 0.002 0.007 0.796 0.358 0.999 0.007 0.507 
HVA/DA 0.59 ± 0.5 1.3 ± 0.4 1.0 ± 0.7 2.3 ± 1.0 0.0001 0.592 
 
0.002 0.999 0.066 0.0001 0.999 
NA (ng/g) 89 ± 58 222 ± 199 343 ± 124 128 ± 149 0.002 0.54 0.012 0.004 0.992 0.999 0.685 
5-HT (ng/g) 110 ± 31 134 ± 94 121 ± 50 113 ± 60 0.857 - - - - - - 
5-HIAA (ng/g) 171 ± 30 193 ± 155 166 ± 33 146 ± 59 0.257 - - - - - - 
5-HIAA/5-HT 1.6 ± 0.3 1.7 ± 0.6 1.5 ± 0.5 1.4 ± 0.2 0.355 - - - - - - 
 
Appendix Table A.10 Cerebellar monoamine neurochemistry 
 L-DOPA, L-3,4-dihydroxyphenylalaine; DA, dopamine; HVA, homovanillic acid; NA, noradrenaline 5-HT, serotonin; 5-HIAA, 5-hydroxyindole acetic 
acid; VEH, autoclaved deionised water; ABX, antibiotic administration; VEH-FMT, VEH followed by faecal microbial transfer; ABX-FMT, antibiotic 
administration followed by faecal microbial transfer. Data are shown as mean ± SD and were statistically compared using one-way ANOVA with 
Bonferroni post hoc where appropriate, or non-parametric Kruskal-Wallis test with Dunn’s multiple comparison test, where appropriate. Each p-




Alpha diversity VEH VEH-FMT p-value (1/m)*Q 
Observed species 836.5 (90.5) 891.0 (101.3) 0.035 0.013 
Chao1 864.9 (84.2) 918.7 (93.3) 0.043 0.027 
Shannon 6.9 (0.45) 7.1 (0.27) 0.063 0.053 
Simpson 0.978 (0.01) 0.982 (0.01) 0.218 0.067 
PD whole tree 43.6 (2.6) 47.0 (4.3) 0.004 0.007 $ 
 
Appendix Table A.11 Alpha diversity indices in caecal samples from VEH and VEH-FMT rats  
VEH, autoclaved deionised water; VEH-FMT, VEH followed by faecal microbial transfer. Data 
are shown as median (IQR) and were statistically compared using unpaired non-parametric 
Mann-Whitney U test and Benjamini-Hochberg adjustment procedure with Q = 0.1 used to 
correct p values for multiple testing.   $ indicates an increase in VEH-FMT.  
 
 
Appendix Table A.12 Alpha diversity indices in caecal samples from VEH and ABX-FMT rats  
VEH, autoclaved deionised water; ABX-FMT, antibiotic administration followed by faecal 
microbial transfer. Data are shown as median (IQR) and were statistically compared using 
unpaired non-parametric Mann-Whitney U test and Benjamini-Hochberg adjustment 
procedure with Q = 0.1 used to correct p values for multiple testing.   
 
Alpha diversity VEH-FMT ABX-FMT p-value (i/m)*Q 
Observed species 891.0 (101.3) 893.0 (116.0) 0.684 0.087 
Chao1 918.7 (93.3) 927.3 (114.5) 0.971 0.1 
Shannon  7.1 (0.27) 7.15 (0.18) 0.684 0.08 
Simpson  0.982 (0.01) 0.934 (0.01) 0.739 0.093 
PD whole tree 47.0 (4.3) 45.8 (4.65) 0.529 0.073 
 
Appendix Table A.13 Alpha diversity indices in caecal samples from VEH-FMT and ABX-FMT 
rats  
VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic administration 
followed by faecal microbial transfer. Data are shown as median (IQR) and were statistically 
compared using unpaired non-parametric Mann-Whitney U test and Benjamini-Hochberg 
adjustment procedure with Q = 0.1 used to correct p values for multiple testing.  
Alpha diversity VEH ABX-FMT p-value (1/m)*Q 
Observed species 836.5 (90.5) 893.0 (116.0) 0.052 0.047 
Chao1 864.9 (84.2) 927.3 (114.5) 0.052 0.027 
Shannon  6.9 (0.45) 7.15 (0.18) 0.043 0.02 
Simpson  0.978 (0.01) 0.934 (0.01) 0.123 0.06 





Appendix Table A.14 Relative abundance (%) of bacterial phyla in caecal samples from VEH 
and VEH-FMT rats  
VEH, autoclaved deionised water; VEH-FMT, VEH followed by faecal microbial transfer. Data 
are shown as median (IQR) and were statistically compared using unpaired non-parametric 
Mann-Whitney U test and Benjamini-Hochberg adjustment procedure with Q = 0.1 used to 
correct p values for multiple testing.  $ indicates an increase or decrease in the relative 
abundance of bacterial taxa in VEH-FMT. 
 
Phylum VEH ABX-FMT p-value (i/m)*Q 
Proteobacteria 2.55 (2.426) 7.392 (1.628) 0.000 0.019 & 
Bacteroidetes 29.739 (1.847) 27.723 (7.062) 0.023 0.03 & 
Cyanobacteria 0.628 (0.726) 1.428 (1.335) 0.015 0.026 & 
Deferribacteres 0.139 (0.301) 0 (0.0002) 0.000 0.015 & 
Verrucomicrobia 0.041 (0.149) 0.064 (0.156) 0.71 0.17 
Firmicutes 65.518 (2.475) 61.676 (8.674) 0.143 0.052 
Actinobacteria 0.131 (0.177) 0.098 (0.140) 0.28 0.063 
Saccharibacteria 0.419 (0.49) 0.582 (0.360) 0.315 0.067 
Tenericutes 0.360 (0.482) 0.569 (1.325) 0.089 0.041 
No blast hit 0.085 (0.076) 0.081 (0.066) 0.971 0.1 
 
Appendix Table A.15 Relative abundance (%) of bacterial phyla in caecal samples from VEH 
and ABX-FMT rats  
VEH, autoclaved deionised water; ABX-FMT, antibiotics followed by faecal microbial transfer. 
Data are shown as median (IQR) and were statistically compared using unpaired non-
parametric Mann-Whitney U test and Benjamini-Hochberg adjustment procedure with Q = 
0.1 used to correct p values for multiple testing.  
Phylum             VEH VEH-FMT p-value (i/m)*Q 
Proteobacteria 2.55 (2.426) 7.087 (1.607) 0.000  0.011 $ 
Bacteroidetes 29.739 (1.847) 25.166 (3.665) 0.000  0.004 $ 
Cyanobacteria 0.628 (0.726) 1.396 (0.731) 0.015  0.022 $ 
Deferribacteres 0.139 (0.301) 0.0 (0.002) 0.000  0.007 $ 
Verrucomicrobia 0.041 (0.149) 0.313 (1.67) 0.105 0.044 
Firmicutes 65.518 (2.475) 64.799 (3.288) 0.143 0.048 
Actinobacteria 0.131 (0.177) 0.136 (0.139) 0.481 0.074 
Saccharibacteria 0.419 (0.49) 0.354 (0.207) 0.529 0.529 
Tenericutes 0.360 (0.482) 0.363 (0.26) 0.631 0.631 





Phylum VEH-FMT ABX-FMT p-value (i/m)*Q 
Proteobacteria 7.087 (1.607) 7.392 (1.628) 0.912 0.1 
Bacteroidetes 25.166 (3.665) 27.723 (7.062) 0.393 0.07 
Cyanobacteria 1.396 (0.731) 1.428 (1.335) 0.853 0.096 
Deferribacteres 0 (0.002) 0 (0.0002) 0.684 0.089 
Verrucomicrobia 0.313 (1.67) 0.064 (0.156) 0.029 0.037 ¥ 
Firmicutes 64.799 (3.288) 61.676 (8.674) 0.218 0.056 
Actinobacteria 0.136 (0.139) 0.098 (0.140) 0.684 0.085 
Saccharibacteria 0.354 (0.207) 0.582 (0.360) 0.023 0.033 ¥ 
Tenericutes 0.363 (0.26) 0.569 (1.325) 0.218 0.059 
No blast 0.050 (0.072) 0.081 (0.066) 0.634 0.1 
Appendix Table A.16 Relative abundance (%) of bacterial phyla in caecal samples from VEH-
FMT and ABX-FMT rats  
VEH-FMT, VEH followed by faecal microbial transfer; ABX-FMT, antibiotics followed by faecal 
microbial transfer. Data are shown as median (IQR) and were statistically compared using 
unpaired non-parametric Mann-Whitney U test and Benjamini-Hochberg adjustment 
procedure with Q = 0.1 used to correct p values for multiple testing.  ¥ indicates an increase 

















0.024 (0.137) 0.044 (0.584) 0.631 0.073 
Nocardiaceae (Corynebacteriales) 0.003 (0.004) 0.0008 (0.002) 0.123 0.03 
Micrococcaceae (Micrococcales) 0.002 (0.009) 0.007 (0.011) 0.315 0.046 
Coriobacteriaceae (Coriobacteriales) 0.091 (0.092) 0.042 (0.099) 0.247 0.041 
Bacteroidetes  
Bacteroidetes VC2.1 Bac22 
(Uncultured bacterium) 
0.0 (0.0) 0.116 (0.081) 0.000 0.001 $ 
Bacteroidaceae (Bacteroidales) 1.656 (1.139) 1.820 (0.885) 0.971 0.093 
Porphyromonadaceae 
(Bacteroidales) 
0.387 (0.235) 0.388 (0.327) 0.529 0.066 
Prevotellaceae (Bacteroidales) 5.504 (3.486) 6.082 (3.709) 0.631 0.074 
Rikenellaceae (Bacteroidales) 3.555 (3.251) 1.961 (1.097) 0.089 0.025 
S24-7 
(Bacteroidales) 
17.898 (3.667) 14.416 (2.940) 0.004 0.01 $ 




0.627 (0.724) 0.837 (0.685) 0.19 0.035 
Uncultured organism 
(Gastranaerophilales) 








0.13 (0.279) 0 (0.0) 0.000 0.003 $ 
Streptococcaceae (Lactobacillales) 0.004 (0.004) 0.003 (0.005) 0.912 0.091 
Aerococcaceae (Lactobacillales) 0.006 (0.002) 0.001 (0.003) 0.529 0.067 
Lactobacillaceae (Lactobacillales) 2.318 (3.128) 2.949 (2.691) 0.481 0.063 
Caldicoprobacteraceae 
(Clostridiales) 
0.015 (0.019) 0.03 (006) 0.105 0.027 
Christensenellaceae (Clostridiales) 0.039 (0.089) 0.058 (0.039) 0.143 0.086 
Clostridiaceae 1 (Clostridiales) 0.117 (0.371) 0.24 (0.635) 0.143 0.031 
Clostridiales vadinBB60 group 
(Clostridiales) 
1.746 (1.299) 3.016 (1.631) 0.001 0.008 $ 
Defluviitaleaceae (Clostridiales) 0.004 (0.008) 0.004 (0.011) 0.631 0.075 
Eubacteriaceae (Clostridiales) 0 (0) 0 (0.001) 0.315 0.047 
Family XIII (Clostridiales) 0.121 (0.066) 0.097 (0.028) 0.190 0.036 
Lachnospiraceae (Clostridiales) 34.595 (7.196) 35.788 (5.362) 0.684 0.079 






0.676 (1.24) 0.950 (0.731) 0.436 0.059 
Ruminococcaceae (Clostridiales) 21.85 (6.573) 19.23 (4.245) 0.075 0.022 
Erysipelotrichaceae 
(Erysipelotrichales) 
0.31 (0.23) 0.391 (0.357) 0.393 0.057 
Proteobacteria  
Rhodospirillaceae (Rhodospirillales) 0.236 (0.38) 0.446 (0.198) 0.123 0.03 
Mitochondria (Rickettsiales) 0 (0.001) 0 (0.0002) 0.481 0.064 
Alcaligenaceae (Burkholderiales) 0.039 (0.094) 0.01 (0.011) 0.005 0.011 $ 
Burkholderiaceae (Burkholderiales) 0 (0) 0 (0.001) 0.393 0.058 
Desulfovibrionaceae 
(Desulfovibrionales) 
1.84 (2.289) 2.432 (1.405) 0.247 0.041 
Helicobacteraceae 
(Camplylobacterales) 
0.002 (0.003) 4.226 (1.378) 0.000 0.004 $ 
Enterobacteriaceae 
(Enterobacteriales) 
0.004 (0.002) 0.001 (0.003) 0.007 0.012 $ 
Pasteurellaceae (Pasteurellales) 0.0008 (0.013) 0.003 (0.006) 0.971 0.093 
Saccharibacteria  




0.083 (0.277) 0.217 (0.185) 0.247 0.042 
Uncultured Mollicutes bacterium 
(Mollicutes) 
0 (0.001) 0 (0.002) 0.631 0.075 
Uncultured bacterium (Mollicut es 
RF9) 
0.062 (0.033) 0.078 (0.064) 0.529 0.068 
Uncultured rumen bacteria 
(Mollicutes RF9) 
0.112 (0.242) 0.073 (0.079) 0.971 0.094 
Unidentified Mollicutes (Mollicut es 
RF9) 
0.001 (0.003) 0.002 (0.003) 0.353 0.051 
Uncultured Bacillales bacterium 
(Mollicutes) 
0.012 (0.042) 0.034 (0.100) 0.218 0.04 
Verrucomicrobia     
Verrucomicrobiaceae 
(Verrucomicrobiales) 
0.041 (0.149) 0.313 (1.167) 0.105 0.028 
 
Appendix Table A.17 Relative abundance (%) of bacterial families in caecal samples from 
VEH and VEH-FMT rats  
VEH, autoclaved deionised water; VEH-FMT, VEH followed by faecal microbial transfer. Data 
are shown as median (IQR) and were statistically compared using unpaired non-parametric 
Mann-Whitney U test and Benjamini-Hochberg adjustment procedure with Q = 0.1 used to 
correct p values for multiple testing.   $ indicates an increase or decrease in the relative 





Family VEH ABX-FMT p-value (i/m) *Q 
Actinobacteria  
Bifidobacteriaceae (Bifidobacteriales) 0.024 (0.137) 0.053 (0.119) 0.28 0.044 
Nocardiaceae (Corynebacteriales) 0.003 (0.004) 0.003 (0.004) 0.739 0.082 
Micrococcaceae (Micrococcales) 0.002 (0.009) 0.001 (0.004) 0.436 0.06 
Coriobacteriaceae (Coriobacteriales) 0.091 (0.092) 0.036 (0.024) 0.003 0.009 & 
Bacteroidetes  
Bacteroidaceae (Bacteroidales) 1.656 (1.139) 2.166 (1.539) 0.315 0.048 
Bacteroidetes VC2.1 Bac22 
(Uncultured bacterium) 
0.0 (0.0) 0.1 (0.062) 0.000 0.004 & 
Porphyromonadaceae (Bacteroidales) 0.387 (0.235) 0.462 (0.128) 0.436 0.061 
Prevotellaceae (Bacteroidales) 5.504 (3.486) 3.306 (3.762) 0.075 0.022 
Rikenellaceae (Bacteroidales) 3.555 (3.251) 2.535 (0.804) 0.315 0.08 
S24-7 
(Bacteroidales) 
17.898 (3.667) 17.381 (3.995) 0.353 0.052 




0.627 (0.724) 1.396 (1.062) 0.035 0.029 
Uncultured organism 
(Gastranaerophilales) 
0 (0.0006) 0.111 (0.442) 0.000 0.005 & 
Deferribacteres  




0.13 (0.279) 0.0 (0.0) 0.000 0.007 & 
Streptococcaceae 
(Lactobacillales) 
0.004 (0.004) 0.001 (0.002) 0.007 0.013 & 
Aerococcaceae (Lactobacillales) 0.006 (0.002) 0.0 (0.002) 0.631 0.076 
Lactobacillaceae (Lactobacillales) 2.318 (3.128) 1.399 (1.76) 0.19 0.036 
Caldicoprobacteraceae (Clostridiales) 0.015 (0.019) 0.023 (0.023) 0.105 0.028 
Christensenellaceae (Clostridiales) 0.039 (0.892) 0.088 (0.086) 0.353 0.052 
Clostridiaceae 1 (Clostridiales) 0.117 (0.371) 0.14 (0.469 0.436 0.062 
Clostridiales vadinBB60 group 
(Clostridiales) 
1.746 (1.299) 3.857 (3.605) 0.0009 0.014 & 
Defluviitaleaceae (Clostridiales) 0.004 (0.008) 0.008 (0.012) 0.579 0.07 
Eubacteriaceae (Clostridiales) 0 (0) 0 (0) 0.739 0.083 
Family XIII (Clostridiales) 0.121 (0.066) 0.115 (0.052) 0.481 0.064 
Lachnospiraceae (Clostridiales) 34.595 (7.196) 28.987 
(10.732) 
0.143 0.032 
Peptococcaceae (Clostridiales) 0.431 (0.328) 0.425 (0.142) 0.796 0.086 
Peptostreptococcaceae (Clostridiales) 0.676 (1.244) 0.351 (0.784) 0.481 0.065 
Ruminococcaceae (Clostridiales) 21.849 (6.573) 22.66 (4.94) 0.912 0.092 
Erysipelotrichaceae (Erysipelotrichales) 0.31 (0.23) 0.208 (0.238) 0.796 0.087 
Proteobacteria  






Mitochondria (Rickettsiales) 0 (0.001) 0 (0.0004) 0.579 0.071 
Alcaligenaceae (Burkholderiales) 0.039 (0.094) 0.048 (0.094) 0.971 0.095 
Burkholderiaceae (Burkholderiales) 0 (0) 0.0008 (0.003) 0.052 0.021 
Desulfovibrionaceae 
(Desulfovibrionales) 
1.84 (2.289) 3.273 (1.256) 0.023  0.014 
Helicobacteraceae (Camplylobacterales)  0.002 (0.003) 3.514 (1.354) 0.000 0.007 & 
Enterobacteriaceae (Enterobacteriales) 0.004 (0.002) 0.002 (0.005) 0.19 0.037 
Pasteurellaceae (Pasteurellales) 0.0008 (0.013) 0.002 (0.007) 1.000 0.099 
Saccharibacteria  




0.083 (0.277) 0.181 (1.059) 0.19 0.038 
Uncultured Moliicutes bacterium 
(Mollicutes) 
0 (0.001) 0 (0.0005) 0.85 0.089 
Uncultured bacterium (Mollicutes RF9) 0.062 (0.033) 0.095 (0.093) 0.315 0.08 
Uncultured rumen bacteria (Mollicut es 
RF9) 
0.112 (0.242) 0.128 (0.321) 0.579 0.072 
Unidentified Mollicutes (Mollicutes RF9)  0.001 (0.003) 0.002 (0.002) 0.28 0.045 
Uncultured Bacillales bacterium 
(Mollicutes) 
0.012 (0.042) 0.029 (0.071) 0.19 0.05 
Verrucomicrobia     
Verrucomicrobiaceae 
(Verrucomicrobiales) 
0.041 (0.149) 0.064 (0.156) 0.739 0.083 
 
Appendix Table A.18 Relative abundance (%) of bacterial families in caecal samples from 
VEH and ABX-FMT rats 
VEH, autoclaved deionised water; ABX-FMT, antibiotics followed by faecal microbial transfer. 
Data are shown as median (IQR) and were statistically compared using unpaired non -
parametric Mann-Whitney U test and Benjamini-Hochberg adjustment procedure with Q = 
0.1 used to correct p values for multiple testing.  & indicates an increase or decrease in the 









Family VEH-FMT ABX-FMT p-value (i/m)*Q 
Actinobacteria     
Bifidobacteriaceae (Bifidobacteriales) 0.044 (0.584) 0.053 (0.119) 0.796 0.088 
Nocardiaceae (Corynebacteriales) 0.0008 (0.002) 0.003 (0.004) 0.075 0.023 
Micrococcaceae (Micrococcales) 0.007 (0.011) 0.001(0.004) 0.035 0.019 
Coriobacteriaceae (Coriobacteriales) 0.042 (0.099) 0.036 (0.024) 0.315 0.051 
Bacteroidetes  
Bacteroidetes VC2.1 Bac22 (Uncultured 
bacterium) 
0.116 (0.081) 0.1 (0.062) 0.853 0.09 
Bacteroidaceae (Bacteroidales) 1.820 (0.885) 2.166 (1.539) 0.353 0.052 
Porphyromonadaceae (Bacteroidales) 0.388 (0.327) 0.462 (0.128) 0.971 0.096 
Prevotellaceae (Bacteroidales) 6.082 (3.709) 3.306 (3.762) 0.247 0.043 
Rikenellaceae (Bacteroidales) 1.961 (1.097) 2.535 (0.804) 0.353 0.054 
S24-7 
(Bacteroidales) 
14.416 (2.940) 17.381 (3.995) 0.043 0.02 




0.837 (0.685) 1.396 (1.062) 0.19 0.039 
Uncultured organism 
(Gastranaerophilales) 
0.491 (0.893) 0.111 (0.442) 0.089 0.026 
Deferribacteres     
Deferribacteraceae (Deferribacterales) 0 (0.002) 0.0 (0.0002) 0.684 0.08 
Firmicutes     
Bacillaceae (Bacillales) 0 (0.0) 0.0 (0.0) 1.00 0.099 
Streptococcaceae (Lactobacillales) 0.003 (0.005) 0.001 (0.002) 0.003 0.009 ¥ 
Aerococcaceae (Lactobacillales) 0.001 (0.003) 0.0 (0.002) 0.393 0.059 
Lactobacillaceae (Lactobacillales) 2.949 (2.691) 1.399 (1.76) 0.075 0.024 
Caldicoprobacteraceae (Clostridiales) 0.03 (006) 0.023 (0.023) 0.796 0.088 
Christensenellaceae (Clostridiales) 0.058 (0.039) 0.088 (0.086) 0.143 0.033 
Clostridiaceae 1 (Clostridiales) 0.240 (0.635) 0.14 (0.469) 0.353 0.055 
Clostridiales vadinBB60 group 
(Clostridiales) 
3.016 (1.631) 3.857 (3.605) 0.971 0.096 
Defluviitaleaceae (Clostridiales) 0.00 (0.011) 0.008 (0.012) 0.971 0.097 
Eubacteriaceae (Clostridiales) 0 (0.001) 0 (0) 0.143 0.034 
Family XIII (Clostridiales) 0.097 (0.028) 0.115 (0.052) 0.28 0.046 
Lachnospiraceae (Clostridiales) 35.788 (5.362) 28.987 
(10.732) 
0.029 0.017 
Peptococcaceae (Clostridiales) 0.387 (0.187) 0.425 (0.142) 0.684 0.08 
Peptostreptococcaceae (Clostridiales) 0.95 (0.731) 0.351 (0.784) 0.023 0.015 
Ruminococcaceae (Clostridiales) 19.23 (4.245) 22.66 (4.94) 0.035 0.02 
Erysipelotrichaceae (Erysipelotrichales) 0.391 (0.357) 0.208 (0.238) 0.436 0.062 
Proteobacteria  
Rhodospirillaceae (Rhodospirillales) 0.446 (0.198) 0.36 (0.243) 0.631 0.077 




Alcaligenaceae (Burkholderiales) 0.01 (0.011) 0.048 (0.094) 0.005 0.012 ¥ 
Burkholderiaceae (Burkholderiales) 0 (0.001) 0.0008 (0.003) 0.353 0.056 
Desulfovibrionaceae 
(Desulfovibrionales) 
2.432 (1.405) 3.273 (1.256) 0.075 0.025 
Helicobacteraceae (Camplylobacterales)  4.226 (1.378) 3.514 (1.354) 0.105 0.029 
Enterobacteriaceae (Enterobacteriales) 0.001 (0.003) 0.002 (0.005) 0.631 0.078 
Pasteurellaceae (Pasteurellales) 0.003 (0.006) 0.002 (0.007) 0.6484 0.08 
Saccharibacteria     
Unknown family (Unknown order) 0.354 (0.207) 0.582 (0.360) 0.023 0.016 
Tenericutes     
Anaeroplasmataceae 
(Anaeroplasmatales) 
0.217 (0.195) 0.181 (1.059) 0.739 0.084 
Uncultured Mollicutes bacterium 
(Mollicutes) 
0 (0.002) 0 (0.0005) 0.529 0.069 
Uncultured bacterium (Mollicutes RF9) 0.078 (0.064) 0.095 (0.093) 0.579 0.072 
Uncultured rumen bacteria (Mollicut es 
RF9) 
0.073 (0.079) 0.128 (0.321) 0.631 0.078 
Unidentified Mollicutes (Mollicutes RF9)  0.002 (0.003) 0.002 (0.002) 0.971 0.098 
Uncultured Bacillales bacterium 
(Mollicutes) 
0.002 (0.003) 0.029 (0.071) 0.739 0.085 
Verrucomicrobia     
Verrucomicrobiaceae 
(Verrucomicrobiales) 
0.313 (1.167) 0.064 (0.156) 0.029 0.017 
 
Appendix Table A.19 Relative abundance (%) of bacterial families in caecal samples from 
VEH-FMT and ABX-FMT rats  
VEH-FMT, VEH followed by faecal microbial transfer; ABX-FMT, antibiotics followed by faecal 
microbial transfer. Data are shown as median (IQR) and were statistically compared using 
unpaired non-parametric Mann-Whitney U test and Benjamini-Hochberg adjustment 
procedure with Q = 0.1 used to correct p values for multiple testing.   ¥ indicates an increase 




Genus    VEH VEH-FMT p-value (i/m)*
Q 
Bifidobacteriaceae (Bifidobacteriales, Actinobacteria) 
Bifidobacterium 0.024 (0.137) 0.044 (0.058) 0.631 0.07 
Coriobacteriaceae (Coriobacteriales, Actinobacteria) 
Uncultured 
Coriobacteriaceae 
0.035 (0.036) 0.007 (0.015) 0.003 0.005 $ 
Uncultured bacterium (Unknown order, Bacteroidetes) 
Bacteroidetes VC21 Bac22 
uncultured bacterium 
0 (0) 0.116 (0.081) 0.000 0.000 $ 
Bacteroidaceae (Bacteroidales, Bacteroidetes) 
Bacteroides 1.656 (1.138) 1.182 (0.885) 0.971 0.094 
Bacteroidales S24-7 group (Bacteroidales, Bacteroidetes) 
Uncultured bacterium 17.13 (2.798) 14.372 (2.949) 0.004 0.006 $ 
unidentified 0.161 (0.933) 0.067 (0.059) 0.063 0.018 
Porphyromonadaceae (Bacteroidales, Bacteroidetes) 
Odoribacter 0.360 (0.212) 0.296 (0.289) 0.796 0.084 
Parabacteroides 0.046 (0.042) 0.099 (0.07) 0.011 0.009 
Prevotellaceae (Bacteroidales, Bacteroidetes) 
Alloprevotella 1.594 (2.192) 0.748 (1.639) 0.123 0.026 
Prevotellaceae NK3B31 
group 
1.715 (2.18) 2.017 (2.704) 0.631 0.07 
Prevotellaceae UCG-001 1.743 (2.486) 2.134 (2.167) 0.393 0.051 
Rikenellaceae (Bacteroidales, Bacteroidetes) 
Alistipes 3.555 (3.252) 1.961 (1.097) 0.089 0.022 
Uncultured bacterium (Gastranaerophilales, Cyanobacteria) 
Uncultured bacterium 0.627 (0.725) 0.837 (0.685) 0.19 0.032 
Uncultured organism 0 (0.006) 0.491 (0.893) 0.000 0.000 $ 
Deferribacteraceae (Deferribacterales, Deferribacteres) 
Mucispirillum 0.139 (0.301) 0 (0.002) 0.000 0.001 $ 
Bacillaeae (Bacillales, Firmicutes) 
Bacillus 0.13 (0.279) 0 (0) 0.000 0.001 $ 
Lactobacillaceae (Lactobacillales, Firmicutes) 
Lactobacillus 2.318 (3.128) 1.441 (2.691) 0.481 0.059 
Caldicoprobacteraceae (Clostridiales, Firmicutes) 
Caldicoprobacter 0.015 (0.019) 0.0297 (0.056) 0.105 0.023 
Christensenellaceae (Clostridiales, Firmicutes) 
Christensenellaceae R-7 
group 
0.031 (0.074) 0.046 (0.045) 0.912 0.091 
Clostridiaceae 1 (Clostridiales, Firmicutes) 
Clostridium sensu stricto 1 0.116 (0.371) 0.238 (0.065) 0.143 0.028 
Clostridiales vadin BB60 group (Clostridiales, Firmicutes) 
Uncultured clostridiales 
bacterium 
0.004 (0.036) 0.045 (0.022) 0.029 0.012 
Uncultured bacterium 1.317 (1.181) 2.147 (0.811) 0.002 0.004 $ 
Uncultured rumen 
bacterium 




Unidentified 0.126 (0.341) 0.756 (1.352) 0.003 0.005 $ 
Family XIII (Clostridiales, Firmicutes) 
Anaerovorax 0.055 (0.046) 0.038 (0.013) 0.123 0.027 
Lachnospiraceae (Clostridiales, Firmicutes) 
Blautia 0.07 (0.252) 0.566 (1.207) 0.052  0.016 
Coprococcus 1 0.125 (0.063) 0.127 (0.06) 0.631 0.071 
Coprococcus 2 0.178 (0.462) 0.011 (0.207) 0.075 0.02 
Incertae Sedis 1.398 (1.351) 0.913 (0.926) 0.165 0.03 
Lachnoclostridium 0.121 (0.07) 0.124 (0.040) 0.971 0.095 
Lachnoclostridium 10 0.0 (0) 0.133 (0.362) 0.000 0.001 $ 
Lachnospiraceae NC2004 
group 
0.586 (1.377) 0.4 (0.391) 0.481 0.06 
Lachnospiraceae NK4A136 
group 
22.823 (5.829) 19.789 (5.348) 0.089 0.022 
Lachnospiraceae NK4B4 
group 
0.01 (0.116) 0.003 (0.016) 0.529 0.062 
Lachnospiraceae UCG-
0001 














Lachnospiraceae UCG-008 0.081 (0.113) 0.009 (0.014) 0.000 0.001 $ 
Roseburia 0.913 (0.649) 1.798 (1.915) 0.105 0.024 
 
Shuttleworthia 0.024 (0.036) 0.015 (0.027) 0.912 0.091 
 








0.185 (0.276) 0.035 (0.363) 0.739 0.08 
Lachnospiraceae 
uncultured 
5.073 (4.202) 9.821 (5.779) 0.005 0.006 $ 
Peptococcaceae (Clostridiales, Firmicutes) 
Peptococcaceae 
(uncultured) 
0.352 (0.312) 0.325 (0.1) 0.436 0.055 
Peptococcus 0.079 (0.029) 0.085 (0.083) 0.631 0.071 
Peptostreptococcaceae (Clostridiales, Firmicutes) 
Intestinibacter 0.092 (0.499) 0.046 (0.093) 0.853 0.088 
Peptoclostridium 0.46 (0.906) 0.626 (0.767) 0.28 0.04 
Ruminococcaceae (Clostridiales, Firmicutes) 
Anaerotruncus 0.929 (0.248) 0.764 (0.17) 0.029 0.012 
Flavonifractor 0.003 (0.01) 0.065 (0.169) 0.005 0.007 $ 
Intestinimonas 0.064 (0.04) 0.026 (0.015) 0.011 0.009 
Oscillibacter 0.908 (0.281) 0.586 (0.175) 0.019 0.01 




Ruminoclostridium 0.084 (0.836) 0.152 (0.094) 0.043 0.015 
Ruminoclostridium 5 0.343 (0.175) 0.407 (0.27) 0.218 0.035 
Ruminoclostridium 6 0.723 (0.781) 1.0 (0.9) 0.853 0.088 
Ruminoclostridium 9 3.962 (1.396) 2.305 (0.576) 0.002 0.005 $ 
Ruminococcaceae 
NK4A214 group 
0.239 (0.146) 0.234 (0.094) 0.971 0.095 
Ruminococcaceae UCG-
003 
1.392 (1.069) 1.429 (0.472) 0.853 0.089 
Ruminococcaceae UCG-
005 
0.324 (0.247) 0.417 (0.313) 0.393 0.052 
Ruminococcaceae UCG-
009 
0.081 (0.043) 0.083 (0.029) 0.796 0.085 
Ruminococcaceae UCG-
010 
0.282 (0.208) 0.418 (0.26) 0.143 0.029 
Ruminococcaceae UCG-
011 
0 (0) 0.002 (0.003) 0.015 0.01 
Ruminococcaceae UCG-
013 
0.067 (0.059) 0.204 (0.15) 0.001 0.004 $ 
Ruminococcaceae UCG-
014 
1.134 (0.706) 0.945 (0.78) 0.739 0.08 
Ruminococcus 1 2.6 (1.577) 2.412 (3.09) 0.912 0.092 
Ruminococcus 2 0.093 (0.114) 0.082 (0.045) 0.912 0.092 
[Eubacterium] 
coprostanoligenes group 
1.339 (1.0) 0.963 (1.529) 0.436 0.056 
Ruminococcaceae 
uncultured 
7.016 (3.051) 5.734 (2.825) 0.043 0.015 
Erysipelotrichaceae (Erysipelotrichales, Firmicutes) 
Turicibacter 0.206 (0.216) 0.297 (0.295) 0.393 0.052 
Erysipelotrichaceae 
uncultured 
0.019 (0.088) 0.011 (0.017) 0.481 0.061 
Rhodospirillaceae (Rhodospirillales, Proteobacteria) 
Thalassospira 0.236 (0.415) 0.361 (0.186) 0.19 0.033 
Alcaligenaceae (Burkholderiales, Proteobacteria) 
Parasutterella 0.039 (0.094) 0.01 (0.011) 0.0005 0.007 $ 
Desulfovibrionaceae (Deltaproteobacteria, Proteobacteria) 
Bilophila 0.089 (0.327) 0.171 (0.128) 0.579 0.066 
Desulfovibrio 1.753 (2.685) 2.262 (1.294) 0.353 0.048 
Helicobacteraceae (Campylobacterales, Proteobacteria) 
Helicobacter 0.002 (0.003) 4.226 (1.378) 0.000 0.002 $ 
Enterobacteriaceae (Enterobacteriales, Proteobacteria) 
Enterobacter 0.004 (0.003) 0 (0.002) 0.004 0.006 $ 
Unknown Family (Unknown order, Saccharibacteria) 
Candidatus 
Saccharimonas 
0.419 (0.49) 0.354 (0.207) 0.529 0.063 
Anaeroplasmataceae (Anaeroplasmatales, Tenericutes) 
Anaeroplasma 0.083 (0.277) 0.217 (0.195) 0.247 0.037 
Uncultured bacterium, (Mollicutes RF9, Tenericutes) 
Uncultured bacterium 0.062 (0.033) 0.078 (0.064) 0.529 0.064 






0.112 (0.242) 0.073 (0.079) 0.971 0.096 
Uncultured Bacillales bacterium (NB1-n, Tenericutes) 
Uncultured Bacillales 
bacterium 
0.012 (0.042) 0.034 (0.1) 0.218 0.035 
Verrucomicrobiaceae (Verrucomicrobiales, Verrucomicrobia) 
Akkermansia 0.041 (0.149) 0.313 (1.167) 0.105 0.024 
 
Appendix Table A.20 Relative abundance (%) of bacterial genera in the caecal samples from 
VEH and VEH-FMT rats  
VEH, autoclaved deionised water; VEH-FMT, VEH followed by faecal microbial transfer. Data 
in these tables are the top 45% of genera plus genera with raw p<0.05 and present in > two 
animals in each group. Data are shown as median (IQR) and were statistically compared using 
unpaired non-parametric Mann-Whitney U test and Benjamini-Hochberg adjustment 
procedure with Q = 0.1 used to correct p values for multiple testing. $ indicates an increase 





Genus VEH ABX-FMT p-value (i/m)*Q 
Bifidobacteriaceae (Bifidobacteriales, Actinobacteria) 
Bifidobacterium 0.024 (0.137) 0.052 (0.119) 0.28  0.04 
Coriobacteriaceae (Coriobacteriales, Actinobacteria) 
Uncultured coriobacteriaceae 0.035 (0.036) 0.008 (0.011) 0.000 0.002 
& 
Enterorhabdus 0.023 (0.021) 0.011 (0.01) 0.011 0.009 
Uncultured bacterium (Unknown order, Bacteroidetes) 
Bacteroidetes VC21 Bac22 uncultured 
bacterium 
0 (0) 0.1 (0.062) 0.000 0.002 
& 
Bacteroidaceae (Bacteroidales, Bacteroidetes) 
Bacteroides 1.656 (1.138) 2.17 (1.539) 0.315 0.045 
Bacteroidales S24-7 group (Bacteroidales, Bacteroidetes) 
Uncultured bacterium 17.13 (2.798) 17.353 (3.996) 0.631 0.072 
Unidentified 0.161 (0.933) 0.0429 (0.177) 0.043 0.015 
Porphyromonadaceae (Bacteroidales, Bacteroidetes) 
Odoribacter 0.36 (0.212) 0.296 (0.100) 0.353 0.048 
Parabacteroides 0.046 (0.042) 0.147 (0.129) 0.023 0.01 
Prevotellaceae (Bacteroidales, Bacteroidetes) 
Alloprevotella 1.594 (2.192) 2.173 (2.118) 1.000 0.099 
Prevotellaceae NK3B31 group 1.715 (2.18) 0.63 (2.525) 0.143 0.029 
Prevotellaceae UCG-001 1.743 (2.486) 1.379 (2.066) 0.684 0.076 
Rikenellaceae (Bacteroidales, Bacteroidetes) 
Alistipes 3.555 (3.252) 2.535 (0.804) 0.315 0.045 
 Uncultured bacterium (Gastranaerophilales, Cyanobacteria) 
Uncultured bacterium 0.627 (0.725) 1.396 (1.062) 0.035 0.012 
Uncultured organism 0 (0.0006) 0.111 (0.442) 0.000 0.002 $ 
Deferribacteraceae (Deferribacterales, Deferribacteres) 
Mucispirillum 0.139 (0.301) 0 (0.0002) 0.000 0.003 $ 
Bacillaeae (Bacillales, Firmicutes) 
Bacillus 0.13 (0.279) 0 (0) 0.000 0.003 $ 
Lactobacillaceae (Lactobacillales, Firmicutes) 
Lactobacillus 2.318 (3.128) 1.399 (1.761) 0.190 0.033 
Streptococcaceae (Lactobacillales, Firmicutes) 
Streptococcus 0.004 (0.004) 0.003 (0.005) 0.007 0.008 $ 
Christensenellaceae (Clostridiales, Firmicutes) 
Christensenellaceae R-7 group 0.031 (0.074) 0.081 (0.082) 0.393 0.053 
Clostridiaceae 1 (Clostridiales, Firmicutes) 
Clostridium sensu stricto 1 0.116 (0.371) 0.139 (0.469) 0.436 0.056 
Clostridiales vadin BB60 group (Clostridiales, Firmicutes) 
Uncultured clostridiales bacterium 0.004 (0.036) 0.031 (0.051) 0.035 0.013 
Uncultured bacterium 1.317 (1.181) 2.927 (2.541) 0.011 0.01 
Uncultured rumen bacterium 0.058 (0.096) 0.077 (0.099) 0.631 0.072 
Unidentified 0.126 (0.341) 0.702 (0.868) 0.052 0.017  




Anaerovorax  0.055 (0.046) 0.053 (0.033) 0.971 0.096 
Lachnospiraceae (Clostridiales, Firmicutes) 
Blautia 0.07 (0.252) 0.084 (0.233) 0.796 0.085 
Coprococcus 1 0.125 (0.063) 0.147 (0.138) 0.481 0.061 
Coprococcus 2 0.178 (0.462) 0.155 (0.279) 0.912 0.092 
Incertae Sedis 1.398 (1.351) 0.566 (0.680) 0.143 0.029 
Lachnoclostridium 0.121 (0.07) 0.071 (0.164) 0.353 0.049 
Lachnoclostridium 10 0 (0) 0.128 (0.16) 0.000 0.003 
Lachnospiraceae NC2004 group 0.586 (1.377) 0.07 (0.223) 0.035 0.013 
Lachnospiraceae NK4A136 group 22.823 (5.829) 19.099 (7.826) 0.052  0.017 
Lachnospiraceae NK4B4 group 0.01 (0.116) 0.0008 (0.006) 0.247 0.037 
Lachnospiraceae UCG-0001 0.168 (0.195) 0.193 (0.246) 0.739 0.081 
Lachnospiraceae UCG-0005 0.067 (0.088) 0.063 (0.052) 0.436 0.056 
Lachnospiraceae UCG-0006 0.281 (0.218) 0.346 (0.606) 0.684 0.076 
Lachnospiraceae UCG-008 0.081 (0.113) 0.011 (0.019) 0.001 0.004 
& 
Roseburia 0.913 (0.649) 0.851 (1.281) 0.853 0.089 
Tyzzerella 0.207 (0.19) 0.177 (0.109) 0.089 0.022 
Lachnospiraceae [Eubacterium] 
oxidoreducens group 
0.262 (0.278) 0.269 (0.465) 0.631 0.24 
Lachnospiraceae [Eubacterium] 
ruminantium group 
0.185 (0.276) 0.043 (0.155) 0.218 0.1 
Lachnospiraceae uncultured 5.073 (4.202) 6.788 (4.27) 0.28 0.19 
Natranaerovirga 0.005 (0.007) 0 (0.0006) 0.009 0.008 
Peptococcaceae (Clostridiales, Firmicutes) 
Peptococcaceae (uncultured) 0.352 (0.312) 0.301 (0.104) 0.631 0.073 
Peptococcus 0.079 (0.029) 0.09 (0.04) 0.165 0.03 
Peptostreptococcaceae (Clostridiales, Firmicutes) 
Intestinibacter 0.092 (0.499) 0.016 (0.028) 0.436 0.057 
Peptoclostridium 0.46 (0.906) 0.336 (0.434) 0.796 0.085 
Ruminococcaceae (Clostridiales, Firmicutes) 
Anaerotruncus 0.929 (0.248) 0.82 (0.202) 0.165 0.031 
Intestinimonas 0.064 (0.040) 0.031 (0.021) 0.023 0.011 
Oscillibacter 0.908 (0.281) 0.701 (0.228) 0.043 0.015 
Papillibacter 0.071 (0.188) 0.151 (0.169) 0.063 0.019 
Ruminoclostridium 0.084 (0.836) 0.112 (0.056) 0.247 0.038 
Ruminoclostridium 5 0.343 (0.175) 0.443 (0.333) 0.19 0.033 
Ruminoclostridium 6 0.723 (0.781) 1.617 (1.084) 0.123 0.027 
Ruminoclostridium 9 3.962 (1.396) 3.133 (2.071) 0.529 0.064 
Ruminococcaceae NK4A214 group 0.239 (0.146) 0.224 (0.204) 0.436 0.057 
Ruminococcaceae UCG-002 0.004 (0.006) 0.008 (0.005) 0.023 0.010 
Ruminococcaceae UCG-003 1.392 (1.069) 1.089 (1.051) 0.28 0.42 
Ruminococcaceae UCG-005 0.324 (0.247) 0.229 (0.172) 0.247 0.038 
Ruminococcaceae UCG-009 0.081 (0.043) 0.092 (0.062) 0.28 0.42 
Ruminococcaceae UCG-010 0.282 (0.208) 0.474 (0.231) 0.089 0.022 




Ruminococcaceae UCG-013 0.067 (0.059) 0.092 (0.158) 0.165 0.031 
Ruminococcaceae UCG-014 1.134 (0.706) 1.11 (0.57) 0.912 0.093 
Ruminococcus 1 2.6 (1.577) 2.239 (2.498) 0.971 0.096 
Ruminococcus 2 0.093 (0.114) 0.062 (0.109) 0.579 0.067 
[Eubacterium] coprostanoligenes 
group 
1.339 (1.0) 0.841 (0.929) 0.353 0.049 
Ruminococcaceae uncultured 7.016 (3.051) 8.094 (2.842) 0.436 0.057 
Erysipelotrichaceae (Erysipelotrichales, Firmicutes) 
Allobaculum 0.002 (0.037) 0.037 (0.083) 0.063  0.019 
Turicibacter 0.206 (0.216) 0.159 (0.229) 0.739 0.082 
Erysipelotrichaceae uncultured 0.019 (0.088) 0.012 (0.006) 0.393 0.054 
Rhodospirillaceae (Rhodospirillales, Proteobacteria) 
Thalassospira 0.236 (0.415) 0.281 (0.254) 0.436 0.058 
Uncultured rhodospirillaceae        0 (0.0343) 0.002 (0.04) 0.436 0.058 
Alcaligenaceae (Burkholderiales, Proteobacteria) 
Parasutterella 0.039 (0.094) 0.048 (0.094) 0.971 0.097 
Desulfovibrionaceae (Deltaproteobacteria, Proteobacteria) 
Bilophila 0.089 (0.327) 0.124 (0.08) 0.631 0.073 
Desulfovibrio 1.753 (2.685) 3.152 (1.215) 0.023 0.011 
Helicobacteraceae (Campylobacterales, Proteobacteria) 
Helicobacter 0.002 (0.003) 3.515 (1.354) 0.000 0.003 
& 
Enterobacteriaceae (Enterobacteriales, Proteobacteria) 
Unknown Family (Unknown order, Saccharibacteria) 
Candidatus Saccharimonas 0.419 (0.49) 0.582 (0.36) 0.315 0.046 
Anaeroplasmataceae (Anaeroplasmatales, Tenericutes) 
Anaeroplasma 0.083 (0.277) 0.181 (1.059) 0.19 0.034 
Uncultured bacterium, (Mollicutes RF9, Tenericutes) 
Uncultured bacterium 0.062 (0.0330 0.095 (0.093) 0.315 0.046 
Uncultured rumen bacterium (Mollicutes RF9, Tenericutes) 
Uncultured rumen bacterium 0.112 (0.242) 0.128 (0.321) 0.579 0.067 
Uncultured Bacillales bacterium (NB1-n, Tenericutes) 
Uncultured Bacillales bacterium  0.042 (0.042) 0.029 (0.071) 0.19 0.034 
Verrucomicrobiaceae (Verrucomicrobiales, Verrucomicrobia) 
Akkermansia 0.041 (0.149) 0.064 (0.156) 0.739 0.082 
 
Appendix Table A.21 Relative abundance (%) of bacterial genera in the caecal samples 
from VEH and ABX-FMT rats  
VEH, autoclaved deionised water; ABX-FMT, antibiotics followed by faecal microbial 
transfer. Data in these tables are the top 45% of genera plus genera with raw p<0.05 and 
present in > two animals in each group. Data are shown as median (IQR) and were 
statistically compared using unpaired non-parametric Mann-Whitney U test and 
Benjamini-Hochberg adjustment procedure with Q = 0.1 used to correct p values for 
multiple testing.  & indicates an increase or decrease in the relative abundance  of 




Genus VEH-FMT ABX-FMT p-value (i/m)*
Q 
Bifidobacteriaceae (Bifidobacteriales, Actinobacteria) 
Bifidobacterium 0.044 (0.058) 0.052 (0.119) 0.796 0.086 
Micrococcaceae (Micrococcales, Actinobacteria) 
Rothia 0.008 (0.011) 0.002 (0.004) 0.035 0.013 
Coriobacteriaceae (Coriobacteriales, Actinobacteria) 
Gordonibacter 0.007 (0.012) 0.003 (0.003) 0.035 0.013 
Uncultured bacterium (Unknown order, Bacteroidetes) 
Bacteroidetes VC21 Bac22 
uncultured bacterium 
0.116 (0.081) 0.1 (0.062) 0.853 0.09 
Bacteroidaceae (Bacteroidales, Bacteroidetes) 
Bacteroides 1.182 (0.885) 2.17 (1.539) 0.353 0.05 
Bacteroidales S24-7 group (Bacteroidales, Bacteroidetes) 
Uncultured bacterium 14.372 (2.949) 17.353 (3.996) 0.075 0.021 
Unidentified 0.067 (0.059) 0.0429 (0.177) 0.353 0.05 
Porphyromonadaceae (Bacteroidales, Bacteroidetes) 
Odoribacter 0.296 (0.289) 0.296 (0.100) 0.631 0.074 
Parabacteroides 0.099 (0.070) 0.147 (0.129) 0.684 0.077 
Prevotellaceae (Bacteroidales, Bacteroidetes) 
Alloprevotella 0.748 (1.639) 2.173 (2.118) 0.28 0.043 
Prevotellaceae NK3B31 group 2.017 (2.704) 0.63 (2.525) 0.143 0.029 
Prevotellaceae UCG-001 2.134 (2.167) 1.379 (2.066) 0.075 0.021 
Rikenellaceae (Bacteroidales, Bacteroidetes) 
Alistipes 1.961 (1.097) 2.535 (0.804) 0.353 0.05 
Uncultured bacterium (Gastranaerophilales, Cyanobacteria) 
Uncultured bacterium 0.837 (0.685) 1.396 (1.062) 0.19 0.034 
Uncultured organism 0.491 (0.893) 0.111 (0.442) 0.089 0.023 
Lactobacillaceae (Lactobacillales, Firmicutes) 
Lactobacillus 1.441 (2.691) 1.399 (1.761) 0.075 0.021 
Streptococcaceae (Lactobacillales, Firmicutes) 
Streptococcus 0.003 (0.005) 0.001 (0.002) 0.003 0.005 ¥ 
Christensenellaceae (Clostridiales, Firmicutes) 
Christensenellaceae R-7 group 0.046 (0.045) 0.081 (0.082) 0.218 0.036 
Clostridiaceae 1 (Clostridiales, Firmicutes) 
Clostridium sensu stricto 1 0.238 (0.005) 0.139 (0.469) 0.436 0.058 
Clostridiales vadin BB60 group (Clostridiales, Firmicutes) 
Uncultured clostridiales bacterium 0.045 (0.022) 0.031 (0.051) 0.579 0.068 
Uncultured bacterium 2.147 (0.811) 2.927 (2.541) 0.579 0.068 
Uncultured rumen bacterium 0.021 (0.048) 0.077 (0.099) 0.105 0.025 
Unidentified 0.756 (1.352) 0.702 (0.868) 0.353 0.05 
Family XIII (Clostridiales, Firmicutes) 
Anaerovorax 0.038 (0.013) 0.053 (0.033) 0.052 0.017 
Lachnospiraceae (Clostridiales, Firmicutes) 




Coprococcus 1 0.127 (0.06) 0.147 (0.138) 0.28 0.043 
Coprococcus 2 0.011 (0.207) 0.155 (0.279) 0.075 0.021 
Incertae Sedis 0.913 (0.926) 0.566 (0.680) 0.436 0.058 
Lachnoclostridium 0.124 (0.040) 0.071 (0.164) 0.218 0.036 
Lachnoclostridium 10 0.313 (0.362) 0.128 (0.16) 0.853 0.09 
Lachnospiraceae NC2004 group 0.4 (0.391) 0.07 (0.223) 0.052 0.018 
Lachnospiraceae NK4A136 group 19.789 (5.348) 19.099 (7.826) 0.631 0.074 
Lachnospiraceae UCG-0001 0.303 (0.354) 0.193 (0.246) 0.105 0.025 
Lachnospiraceae UCG-0005 0.103 (0.088) 0.063 (0.052) 0.063 0.019 
Lachnospiraceae UCG-0006 0.254 (0.268) 0.346 (0.606) 0.739 0.082 
Roseburia 1.798 (1.915) 0.851 (1.281) 0.315 0.047 
Tyzzerella 0.117 (0.059) 0.177 (0.109) 0.165 0.032 
Lachnospiraceae [Eubacterium] 
oxidoreducens group 
0.292 (0.355) 0.269 (0.465) 1.000 0.1 
Lachnospiraceae [Eubacterium] 
ruminantium group 
0.035 (0.363) 0.043 (0.155) 0.684 0.078 
Lachnospiraceae [Eubacterium] 
ventriosum group 
0.014 (0.019) 0.032 (0.046) 0.035 0.04 
Lachnospiraceae uncultured 9.821 (5.779) 6.788 (4.27) 0.123 0.028 
Marvinbryantia 0.002 (0.003) 0.008 (0.029) 0.043 0.016 
Peptococcaceae (Clostridiales, Firmicutes) 
Peptococcaceae (uncultured) 0.325 (0.1) 0.301 (0.104) 0.739 0.083 
Peptococcus 0.085 (0.083) 0.09 (0.04) 0.631 0.074 
Peptostreptococcaceae (Clostridiales, Firmicutes) 
Intestinibacter 0.046 (0.093) 0.016 (0.028) 0.315 0.047 
Peptoclostridium 0.626 (0.767) 0.336 (0.434) 0.007 0.008 ¥ 
Ruminococcaceae (Clostridiales, Firmicutes) 
Anaerotruncus 0.764 (0.170) 0.82 (0.202) 0.529 0.065 
Flavonifractor 0.065 (0.169) 0.018 (0.114) 0.393 0.054 
Oscillibacter 0.586 (0.175) 0.701 (0.228) 0.247 0.039 
Papillibacter 0.161 (0.247) 0.151 (0.169) 0.579 0.069 
Ruminoclostridium 0.152 (0.094) 0.112 (0.056) 0.105 0.025 
Ruminoclostridium 5 0.407 (0.27) 0.443 (0.333) 0.912 0.094 
Ruminoclostridium 6 1.0 (0.9) 1.617 (1.084) 0.89 0.023 
Ruminoclostridium 9 2.305 (0.576) 3.133 (2.071) 0.035 0.04 
Ruminococcaceae NK4A214 group 0.234 (0.094) 0.224 (0.204) 0.579 0.069 
Ruminococcaceae UCG-003 1.429 (0.472) 1.089 (1.051) 0.579 0.07 
Ruminococcaceae UCG-005 0.417 (0.313) 0.229 (0.172) 0.005 0.007 ¥ 
Ruminococcaceae UCG-009 0.083 (0.029) 0.092 (0.062) 0.28 0.043 
Ruminococcaceae UCG-010 0.418 (0.26) 0.474 (0.231) 0.796 0.086 
Ruminococcaceae UCG-013 0.204 (0.15) 0.092 (0.158) 0.043 0.04 
Ruminococcaceae UCG-014 0.945 (0.78) 1.11 (0.57) 0.436 0.059 
Ruminococcus 1 2.413 (3.09) 2.239 (2.498) 0.971 0.098 
Ruminococcus 2 0.082 (0.045) 0.062 (0.109) 0.739 0.083 
[Eubacterium] coprostanoligenes 
group 




Ruminococcaceae uncultured 5.734 (2.825) 8.094 (2.842) 0.009 0.0087 
Erysipelotrichaceae (Erysipelotrichales, Firmicutes) 
Allobaculum 0.008 (0.003) 0.037 (0.083) 0.001 0.004 ¥ 
Turicibacter 0.297 (0.295) 0.159 (0.229) 0.105 0.026 
Rhodospirillaceae (Rhodospirillales, Proteobacteria) 
Thalassospira 0.361 (0.186) 0.281 (0.254) 0.28 0.043 
Uncultured rhodospirillaceae 0.023 (0.054) 0.002 (0.04) 0.631 0.075 
Alcaligenaceae (Burkholderiales, Proteobacteria) 
Parasutterella 0.01 (0.011) 0.048 (0.094) 0.005 0.007 ¥ 
Desulfovibrionaceae (Deltaproteobacteria, Proteobacteria) 
Bilophila 0.171 (0.128) 0.124 (0.08) 0.353 0.051 
Desulfovibrio 2.262 (1.294) 3.152 (1.215) 0.035 0.014 
Helicobacteraceae (Campylobacterales, Proteobacteria) 
Helicobacter 4.226 (1.378) 3.515 (1.354) 0.105 0.026 
Enterobacteriaceae (Enterobacteriales, Proteobacteria) 
Enterobacter 0 (0.002) 0.002 (0.004) 0.28 0.044 
Unknown Family (Unknown order, Saccharibacteria 
Candidatus Saccharimonas 0.354 (0.207) 0.582 (0.36) 0.023 0.011 
Anaeroplasmataceae (Anaeroplasmatales, Tenericutes) 
Anaeroplasma 0.217 (0.195) 0.181 (1.059) 0.739 0.084 
Uncultured bacterium, (Mollicutes RF9, Tenericutes) 
Uncultured bacterium 0.078 (0.064) 0.095 (0.093) 0.579 0.07 
Uncultured rumen bacterium (Mollicutes RF9, Tenericutes) 
Uncultured rumen bacterium 0.073 (0.079) 0.128 (0.321) 0.631 0.075 
Uncultured Bacillales bacterium (NB1-n, Tenericutes) 
Uncultured Bacillales bacterium 0.034 (0.1) 0.029 (0.071) 0.739 0.084 
Verrucomicrobiaceae (Verrucomicrobiales, Verrucomicrobia) 
Akkermansia 0.313 (1.167) 0.064 (0.156) 0.029 0.012 
 
Appendix Table A.22 Relative abundance (%) of bacterial genera in the caecal samples 
from VEH-FMT and ABX-FMT rats  
VEH-FMT, VEH followed by faecal microbial transfer; ABX-FMT, antibiotics followed by 
faecal microbial transfer. Data in these tables are the top 45% of genera plus genera with 
raw p<0.05 and present in > two animals in each group. Data are shown as median (IQR) 
and were statistically compared using unpaired non-parametric Mann-Whitney U test and 
Benjamini-Hochberg adjustment procedure with Q = 0.1 used to correct p values for 
multiple testing.  ¥ indicates an increase or decrease in the relative abundance of bacterial 





Appendix B. Chronic intermittent hypoxia disrupts cardiorespiratory 



























Appendix Figure B.1 No significant correlations are evident between noradrenaline 
concentrations of the medulla oblongata and various cardiorespiratory parameters  
Individual data points for correlations between medullary noradrenaline (NA) 
concentrations and time to expire (Te) short-term variability (SD1; a), Te long-term 
variability (SD2; b), sigh frequency (c), total breath duration (Ttotal) SD1 (d), Ttotal SD2 
(e) in sham and CIH-exposed awake guinea pigs, and for respiratory frequency ( fR; f), 
heart rate (HR; g), change in HR in response to propranolol administration (h) and 
change in HR in response to phenylephrine (PE) administration (i) in sham and CIH-
exposed anaesthetised guinea-pigs. Solid black lines represent linear regression analysis 
















Appendix Figure B.2 Faecal microbiota composition in sham and CIH-exposed guinea-
pigs 
Stacked barplot showing the relative abundance of dominant bacterial genera (0.01 cut-
off) in the faecal matter of sham and CIH-exposed animals. Genera are ordered 

















Appendix Figure B.3 Linear discriminant analysis effect size (LEfSe) analysis on the 
genus level 
Histogram plots from LEfSe analysis showing significant genera associated with sham and 
CIH-exposed faecal microbiota, ranked based on LDA scores. Taxa with LDA scores above 2 
were considered significant. Bacterial genera significantly over-represented in the sham 











 Median (IQR)   
Phylum Sham CIH p-value (i/m)*Q 
Proteobacteria 1.027 (0.885) 1.547 (2.357) 0.07 0.08 
Bacteroidetes 38.072 (16.381) 45.497 (3.958) 0.04* 0.05 
Cyanobacteria 2.961 (2.792) 3.965 (4.492) 0.32 0.12 
Verrucomicrobia 0.152 (0.497) 0.265 (1.377) 0.38 0.15 
Firmicutes 53.338 (17.573) 42.92 (4.587) 0.007* 0.03 
Actinobacteria 1.478 (1.458) 3.14 (2.295) 0.053 0.07 
Euryarchaeota 0.025 (0.072) 0.093 (0.06) 0.007* 0.02 
Saccharibacteria 0.518 (0.245) 0.687 (0.485) 0.21 0.1 
Tenericutes 0.227 (0.528) 0.328 (0.353) 0.9 0.2 
Other 0.043 (0.04) 0.058 (0.033) 0.32 0.13 
 
Appendix Table B.1 Relative abundance (%) of bacterial phyla in the faeces of sham 
and CIH-exposed guinea-pigs 
Data are shown as median (IQR) and were statistically compared using non-parametric 
Mann-Whitney U test and Benjamini-Hochberg adjustment procedure with the false 
discovery rate set at 20% to correct for multiple testing. Raw p-values < 0.05 are marked in 
bold. Significant false discovery rate adjusted p-values are in bold. CIH, chronic intermittent 









 Median (IQR)  








0.682 (1.275) 2.038 (2.612) 0.04* 0.007 
Coriobacteriaceae 
(Coriobacteriales) 
0.688 (0.298) 0.815 (0.513) 0.81 0.15 
Corynebacteriaceae 
(Corynebacteriales) 




0.333 (0.512) 0.502 (0.713) 0.32 0.06 
Porphyromonadaceae 
(Bacteroidales) 
0.057 (0.033) 0.123 (0.15) 0.1 0.03 
Prevotellaceae 
(Bacteroidales) 
0.017 (0.037) 0.025 (0.05) 1 0.19 
Rikenellaceae (Bacteroidales) 1.818 (1.848) 1.112 (1.745) 0.81 0.15 
S24-7 
(Bacteroidales) 
34.728 (14.117) 42.193 (3.255) 0.053 0.01 
Rat ANO60301C 
(Bacteroidales) 




0.973 (0.957) 1.852 (3.117) 0.17 0.04 
Uncultured organism 
(Gastranaerophilales) 
2.023 (1.818) 1.242 (1.572) 0.9 0.18 
Uncultured rumen bacterium 
(Gastranaerophilales) 




0.023 (0.023) 0.018 (0.025) 0.9 0.18 
Lactobacillaceae 
(Lactobacillales) 
0.127 (0.112) 0.22 (0.287) 0.6 0.11 
Caldicoprobacteraceae 
(Clostridiales) 
0.07 (0.005) 0.01 (0.013) 0.46 0.09 
Christensenellaceae 
(Clostridiales) 
2.865 (2.915) 2.19 (4.57) 0.81 0.16 
Clostridiaceae 1 (Clostridiales)  0.008 (0.005) 0.025 (0.028) 0.053 0.02 
Clostridiales vadinBB60 group 
(Clostridiales) 
1.418 (0.903) 1.575 (0.657) 0.81 0.16 
Defluviitaleaceae 
(Clostridiales) 
0.028 (0.023) 0.033 (0.015) 0.46 0.1 
Eubacteriaceae (Clostridiales) 0.003 (0.001) 0.048 (0.123) 0.04* 0.01 
Family XIII (Clostridiales) 0.08 (0.04) 0.063 (0.01) 0.38 0.08 
Lachnospiraceae 
(Clostridiales) 
22.257 (21.812) 15.722 (3.378) 0.053 0.02 
Peptococcaceae 
(Clostridiales) 






0.015 (0.037) 0.053 (0.06) 0.053 0.03 
Ruminococcaceae 
(Clostridiales) 
22.68 (7.375) 21.662 (4.952) 0.62 0.12 
Syntrophomonadaceae 
(Clostridiales) 
0.007 (0.018) 0.002 (0.003) 0.26 0.06 
Erysipelotrichaceae 
(Erysipelotrichales) 
0.213 (0.238) 0.335 (0.382) 0.13 0.04 
Thermoanaerobacteraceae 
(Thermoanaerobacterales) 
0 (0) 0 (0.03) 0.32 0.07 
Veillonellaceae 
(Selenomonadales) 




0.642 (0.573) 0.942 (1.278) 0.17 0.05 
Alcaligenaceae 
(Burkholderiales) 
0.265 (0.23) 0.337 (0.197) 0.13 0.04 
Oxalobacteraceae 
(Burkholderiales) 
0.018 (0.027) 0.02 (0.022) 0.71 0.14 
Desulfovibrionaceae 
(Desulfovibrionales) 
0.067 (0.108) 0.095 (0.165) 0.46 0.11 
Enterobacteriaceae 
(Enterobacteriales) 
0.002 (0.015) 0.002 (0.012) 0.81 0.16 
Saccharibacteria  
Unknown family (Unknown 
order) 
0.518 (0.243) 0.683 (0.485) 0.17 0.05 
CandidatusSaccharibacteriaor
altaxonTM7x unknown family 
(Unknown order) 




0.025 (0.028) 0.007 (0.022) 0.54 0.11 
Uncultured bacterium 
(Mollicutes RF9) 
0.23 (0.28) 0.15 (0.388) 0.9 0.19 
Uncultured rumen bacteria 
(Mollicutes RF9) 
0.033 (0.07) 0.04 (0.267) 0.81 0.17 
Uncultured bacterium 
(Mollicutes NB1-n) 




0.152 (0.497) 0.265 (1.377) 0.38 0.09 
Other 0.043 (0.04) 0.058 (0.033) 0.32 0.07 
 
Appendix Table B.2 Relative abundance (%) of bacterial families in the faeces of Sham and 
CIH-exposed guinea-pigs   
Data are shown as median (IQR) and were statistically compared using non-parametric 
Mann-Whitney U test and Benjamini-Hochberg adjustment procedure with the false 
discovery rate set at 20% to correct for multiple testing. Raw p-values < 0.05 are marked in 
bold. Significant false discovery rate adjusted p-values are in bold. CIH, chronic intermittent 




 Median (IQR)   
Genus Sham CIH p-value (i/m)*Q 
Methanobacteriaceae (Methanobacteriales, Euryarchaeota) 
Methanobrevibacter 0.025 (0.072) 0.093 (0.06) 0.007** 0.001 
Bifidobacteriaceae (Bifidobacteriales, Actinobacteria) 
Bifidobacterium 0.682 (1.275) 2.034 (2.612) 0.04* 0.008 
Coriobacteriaceae (Coriobacteriales, Actinobacteria) 
Coriobacteriaceae UCG-002 0.045 (0.032) 0.103 (0.072) 0.01 0.002 
Uncultured coriobacteriaceae 0.33 (0.228) 0.367 (0.11) 0.54 0.1 
Enterorhabdus 0.293 (0.238) 0.187 (0.265) 0.9 0.17 
Senegalimassilia 0.057 (0.037) 0.058 (0.033) 0.71 0.12 
Bacteroidaceae (Bacteroidales, Bacteroidetes) 
Bacteroides 0.333 (0.512) 0.502 (0.713) 0.32 0.06 
Bacteroidales S24-7 group (Bacteroidales, Bacteroidetes) 
Uncultured bacterium 34.587 (14.043) 42.002 (3.285) 0.053 0.01 
Unidentified  0.082 (0.073) 0.168 (0.098) 0.053 0.01 
Porphyromonadaceae (Bacteroidales, Bacteroidetes) 
Odoribacter 0.053 (0.037) 0.055 (0.125) 0.32 0.06 
Prevotellaceae (Bacteroidales, Bacteroidetes) 
Prevotellaceae UCG-001 0.015 (0.042) 0.025 (0.05) 0.9 0.17 
Rikenellaceae (Bacteroidales, Bacteroidetes) 
Alistipes 1.738 (1.762) 1.058 (1.74) 1 0.19 
Rikenella 0.078 (0.228) 0.077 (0.047) 0.62 0.11 
Uncultured bacterium (Gastranaerophilales, Cyanobacteria) 
Uncultured bacterium 0.973 (0.957) 1.852 (3.117) 0.17 0.04 
Uncultured organism 2.023 (1.818) 1.242 (1.572) 0.9 0.17 
Uncultured rumen bacterium 0.048 (0.092) 0.047 (0.083) 1 0.19 
Lactobacillaceae (Lactobacillales, Firmicutes) 
Lactobacillus 0.127 (0.112) 0.22 (0.287) 0.62 0.11 
Christensenellaceae (Clostridiales, Firmicutes) 
Christensenellaceae R-7 group 2.852 (2.885) 2.163 (4.565) 0.81 0.16 
Clostridiales vadin BB60 group (Clostridiales, Firmicutes) 
Uncultured bacterium 1.392 (0.617) 1.365 (0.515) 1 0.19 
Unidentified 0.02 (0.05) 0.023 (0.102) 0.71 0.13 
Eubacteriaceae (Clostridiales, Firmicutes) 
Uncultured  0.003 (0.012) 0.048 (0.123) 0.04 0.009 
Lachnospiraceae (Clostridiales, Firmicutes) 
Acetatifactor 0.112 (0.193) 0.085 (0.15) 0.26 0.05 




Anaerostipes 0.355 (0.537) 0.287 (0.36) 0.71 0.13 
Blautia 0.245 (0.2) 0.117 (0.108) 0.04 0.01 
Butyrivibrio 0.288 (0.383) 0.082 (0.498) 1 0.19 
Cellulosillyticum 0.038 (0.05) 0.045 (0.123) 0.62 0.11 
Coprococcus 2 0.063 (0.217) 0.28 (0.428) 0.053 0.02 
Incertae Sedia 1.878 (3.073) 1.075 (0.605) 0.38 0.08 
Lachnoclostridium 0.057 (0.06) 0.068 (0.04) 0.81 0.16 
Lachnospiraceae FCS020 group 0.728 (1.333) 0.127 (0.515) 0.21 0.05 
Lachnospiraceae NC2004 group 0.498 (1.135) 0.603 (0.343) 0.38 0.07 
Lachnospiraceae NK4A136 group 5.945 (12.397) 4.83 (2.318) 0.26 0.05 
Lachnospiraceae NK4B4 group 0.058 (0.097) 0.07 (0.055) 0.6 0.12 
Lachnospiraceae UCG-0001 0.615 (0.433) 0.313 (0.418) 0.21 0.05 
Lachnospiraceae UCG-0006 0.422 (0.237) 0.18 (0.167) 0.13 0.03 
Lachnospiraceae UCG-008 0.358 (0.888) 0.257 (0.668) 0.46 0.09 
Mobilitalea 0.073 (0.218) 0.015 (0.088) 0.32 0.06 
Pseudobutyrivibrio 0.132 (0.443) 0.043 (0.332) 0.13 0.03 
Roseburia 1.33 (2.263) 0.257 (0.253) 0.1 0.03 
Tyzzerella 3 0.325 (0.548) 0.102 (0.147) 0.32 0.06 
[Eubacterium] oxidoreducens group 0.062 (0.087) 0.043 (0.037) 1 0.2 
[Eubacterium] ruminantium group 0.113 (0.24) 0.04 (0.083) 0.71 0.14 
Lachnospiraceae uncultured 6.828 (5.173) 4.053 (2.198) 0.053 0.02 
Lachnospiraceae uncultured bacterium 0.047 (0.818) 0.087 (0.147) 0.71 0.14 
Peptococcaceae (Clostridiales, Firmicutes) 
Peptococcaceae (uncultured) 0.305 (0.192) 0.19 (0.13) 0.32 0.07 
Peptostreptococcaceae (Clostridiales, Firmicutes) 
Intestinibacter 0.015 (0.036) 0.053 (0.06) 0.053 0.02 
Ruminococcaceae (Clostridiales, Firmicutes) 
Anaerofilum 0.153 (0.168) 0.055 (0.065) 0.17 0.04 
Anaerotruncus 0.585 (0.478) 0.335 (0.267) 0.04* 0.01 
Flavonifractor 0.107 (0.078) 0.057 (0.057) 0.03* 0.007 
Oscillibacter 0.653 (0.558) 0.477 (0.293) 0.62 0.12 
Papillibacter 0.125 (0.105) 0.107 (0.073) 0.38 0.08 
Ruminoclostridium 0.097 (0.13) 0.053 (0.157) 0.26 0.05 
Ruminioclostridium 5 0.328 (0.172) 0.222 (0.095) 0.04* 0.01 
Ruminioclostridium 6 2.553 (2.06) 2.35 (2.52) 0.90 0.18 
Ruminioclostridium 9 1.00 (0.587) 0.915 (0.408) 0.71 0.15 
Ruminococcaeae NK4A214 group 0.367 (0.133) 0.41 (0.125) 0.71 0.15 
Ruminococcaceae UCG-003 0.265 (0.268) 0.158 (0.077) 0.07 0.02 
Ruminococcaceae UCG-004 0.188 (0.09) 0.208 (0.172) 0.81 0.17 
Ruminococcaceae UCG-005 0.69 (0.46) 0.697 (0.453) 0.9 0.18 
Ruminococcaceae UCG-009 0.043 (0.052) 0.053 (0.048) 0.54 0.1 
Ruminococcaceae UCG-010 1.53 (1.113) 1.44 (2.658) 0.54 0.1 




Ruminococcaceae UCG-013 0.383 (0.517) 0.325 (0.323) 0.9 0.18 
Ruminococcaceae UCG-014 3.828 (5.048) 5.265 (1.57) 0.26 0.05 
Ruminococcaceae V9D2013 group 0.205 (0.195) 0.15 (0.235) 0.71 0.15 
Ruminococcus 1 3.912 (1.217) 4.013 (1.507) 0.81 0.17 
[Eubacterium] coprostanoligenes group 0.318 (0.22) 0.448 (0.687) 0.46 0.09 
Rumiococcaceae uncultured 1.653 (1.242) 1.707 (0.555) 0.38 0.08 
Erysipelotrichaceae (Erysipelotrichales, Firmicutes) 
Allobaculum 0.083 (0.21) 0.26 (0.343) 0.13 0.03 
Rhodospirillaceae (Rhodospirillales, Proteobacteria) 
Thalassospira 0.642 (0.575) 0.942 (1.285) 0.21 0.05 
Uncultured  0 (0.002) 0.183 (0.03) 0.01** 0.004 
Alcaligenaceae (Burkholderiales, Proteobacteria) 
Parasutterella 0.265 (0.23) 0.337 (0.197) 0.13 0.04 
Desulfovibrionaceae (Deltaproteobacteria, Proteobacteria) 
Desulfovibrio 0.06 (0.103) 0.085 (0.167) 0.54 0.11 
Unknown Family (Unknown order, Saccharibacteria) 
Candidatus Saccharimonas 0.518 (0.243) 0.683 (0.485) 0.17 0.04 
Uncultured bacterium, (Mollicutes RF9, Tenericutes) 
Uncultured bacterium 0.23 (0.28) 0.15 (0.388) 0.9 0.18 
Uncultured rumen bacterium (Mollicutes RF9, Tenericutes) 
Uncultured rumen bacterium 0.033 (0.07) 0.04 (0.267) 0.81 0.17 
Verrucomicrobiaceae (Verrucomicrobiales, Verrucomicrobia) 
Akkermansia 0.152 (0.497) 0.265 (1.377) 0.38 0.08 
Other 
No blast hit 0.043 (0.04) 0.058 (0.033) 0.32 0.07 
 
Appendix Table B.3 Relative abundance (%) of bacterial genera in the faeces of Sham and 
CIH-exposed guinea-pigs.  
Only genera that had a relative abundance > 0.04% in sham or CIH-exposed animals are 
represented in this table. Data are shown as median (IQR) and were statistically compared 
using non-parametric Mann-Whitney U test and Benjamini-Hochberg adjustment procedure 
with the false discovery rate set at 20% to correct for multiple testing. Raw p-values < 0.05 
are marked in bold. Significant false discovery rate adjusted p-values are in bold. CIH, chronic 







Appendix C. Chronic intermittent hypoxia lowers Lactobacillus 
rhamnosus relative abundance and increases apnoea index and blood 






Appendix Figure C.1 Correlation analysis between the relative abundance of Lactobacillus 
rhamnosus and sigh events during hypercapnia. 
Individual data points for correlation analysis between Lactobacillus rhamnosus and sigh 
amplitude (a) and frequency (b) during hypercapnia in sham+VEH and CIH+VEH rats. CIH, 
chronic intermittent hypoxia; VEH, vehicle. Solid dark blue lines represent linear regression  























- - - - 









1025 ± 60 997  ± 38 917 ± 61 781 ± 94 <0.0005 N/A 0.074 <0.0005 0.001 0.001 
Caecum 
(g) 













1422 ± 146 1596  ±  
182 
1394 ± 112 1390  ± 244 0.015 N/A 0.206 0.024 0.908 0.035 
 




RV, right ventricle; LV, left ventricle; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean ± SD and were statistically 
compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, 
followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by the number of 























0.436 0.015 0.129 0.074 
VT (ml) 2.5 ± 0.3 2.5 ± 0.3 2.4  ± 0.4 2.3 ± 0.3 0.667 N/A - - - - 





0.055 0.353 0.188 0.108 





- - - - 
VCO2 
(ml/min) 
7.0 ± 0.9 6.6 ± 0.8 5.7 ± 1.0 5.5 ± 0.8 0.001 N/A 0.218 0.004 0.795 0.006 
 
Appendix Table C.2. Baseline ventilation in behaving rats during quiet rest  
VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; VO2, oxygen consumption; VCO2, carbon dioxide production; VE/ CIH, chronic intermittent 
hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean ± SD and were statistically compared using two-way ANOVA, followed by Fisher’s least 
significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. 
Statistical significance for multiple comparisons was accepted at p<0.05 divided by the number of comparisons made, which was four i.e.  p<0.0125. p-values 


















Hypoxia (% change from baseline)      





- - - - 





- - - - 
VE  30 ± 28 42 ± 15 28 ± 25 29 ± 38 0.815 N/A - - - - 





- - - - 





- - - - 
 SBP -25 ± 10 -18 ± 10 -20 ± 9.8 -14 ± 11 0.177 N/A - - - - 





- - - - 
Hypoxic hypercapnia (% change from baseline)       




VT  67 ± 17 63 ± 17 68 ± 28 84 ± 23 0.056 N/A - - - - 





- - - - 





0.116 0.036 0.033 0.211 





0.100 0.052 0.028 0.183 
SBP  -10 ± 7 -7 ± 12 -6 ± 10 -2 ± 5 0.173 N/A - - - - 





- - - - 
Sodium cyanide (% change from baseline)       
fR  53 ± 18 51 ± 20 62 ± 21 44 ± 24 0.213 N/A - - - - 





- - - - 
VE  110 ± 34 112 ± 38 133 ± 41 102 ± 49 0.489 N/A - - - - 
MAP  19 ± 8 18 ± 8 19 ± 8 17 ± 13 N/A Diet, p=0.383; 
Exposure, 
p=0.728; 











- - - - 
SBP  12 ± 8 8 ± 7 8 ± 8 8 ± 6 0.131 N/A - - - - 





- - - - 
 
Appendix Table C.3 Cardiorespiratory responsiveness to chemostimulation in urethane anaesthetised rats  
fR, respiratory frequency (brpm, breaths per min); VT, tidal volume; VE, minute ventilation; MAP, mean arterial pressure; DBP, diastolic blood pressure; SBP, 
systolic blood pressure; HR, heart rate (bpm, beats per min); CIH, chronic intermittent hypoxia; preb, prebiotic; VEH, vehicle. Data are shown as mean ± SD 
and were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric 
Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by 


















Phenylephrine (% change from baseline)        
SBP  43 ±  11 47 ±  16 35 ± 12 37 ± 9 0.018 N/A 0.999 0.015 0.667 0.049 
HR  -25  ±  14 -24 ± 14 -20 ± 12 -15 ± 7 0.149 N/A - - - - 
Sodium nitroprusside (% change from baseline)     
SBP  -30 ± 14 -31 ± 14 -22 ± 10 -27 ± 11 0.236 N/A - - - - 





0.013 0.245 0.842 <0.0005 
 
Appendix Table C.4 Baroreflex receptor sensitivity in urethane anaesthetised rats 
SBP, systolic blood pressure; HR, heart rate; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are show n as mean ± SD and were 
statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-
Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by the 






















0.02 ± 0.00 0.03 ± 
0.01 
0.03 ± 0.02 0.03 ± 0.03 0.222 N/A - - - - 
Max slope  
(v/s) 





0.715 0.074 0.531 0.138 
Occlusion (% change from baseline)      
Area under 
the curve 
87 ± 40 65 ± 34 96 ± 44 57 ± 41 0.073 N/A  - - - - 
Hypoxia (% change from baseline) 
 
       
Area under 
the curve 
11 ± 21 6 ± 13 12 ± 11 9 ± 12 0.974 N/A  - - - - 
Max slope  31 ± 28 19 ± 14 22 ± 17 24 ± 19 0.511 N/A - - - - 
Hypoxic hypercapnia (% change from baseline)     
Area under 
the curve 





- - - - 





- - - - 











0.511 0.063 0.989 0.015 





- - - - 
 
Appendix Table C.5 Diaphragm EMG activity during baseline and chemostimulation in urethane anaesthetised rats   
CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data are shown as mean ± SD and were statistically compared  using two-way ANOVA, 
followed by Fisher’s least significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, 
where appropriate. Statistical significance for multiple comparisons was accepted at p<0.05 divided by the number of comparisons made, which was four i.e. 


















pH 7.37  ± 0.04 7.35  ± 
0.04 





- - - - 
PaCO2 (mmHg) 41  ± 13 48  ± 5 50 ± 4 48 ± 6 0.140 N/A - - - - 





0.370 0.817 0.149 0.002 
Haematocrit 
(%) 
47.5  ± 2.5 46.5  ± 
3.0 





0.394 0.050 0.544 0.001 
[Hb] (g/dl) 16.2  ± 0.9 15.2  ± 
1.0 





0.447 0.047 0.521 0.002 
 




Pco2, partial pressure of arterial carbon dioxide; Pao2, partial pressure of arterial oxygen; [Hb], haemoglobin concentration; MAP, mean arterial blood pressure; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate (bpm, beat per min); CIH, chronic intermittent hy poxia; PREB, prebiotic; VEH, 
vehicle. Data are shown as mean ± SD and were statistically compared using two-way ANOVA, followed by Fisher’s least significant difference (LSD) post hoc 
where appropriate, or non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. Statistical significance for multiple 






 Sham+VEH CIH+VEH p-value 
Body mass 
(g) 
353 ±19 343 ±22 0.287 
RV (mg) 215 ± 17 182 ± 32 0.506 
RV 
(mg/100g) 
61 ± 6 56 ± 8 0.419 
LV (mg) 803 ± 51 787 ± 71 0.844 
LV 
(mg/100g) 
228 ± 16 244 ± 21 0.311 
RV+LV (mg) 1018 ± 42 2112 ± 100 0.634 
RV+LV (mg/100g) 290 ± 17 300 ± 27 0.172 
Caecum (g) 5.2 ±  1.0 5.0 ± 1.6 0.710 
Caecum (g/100g) 1.5 ± 0.3 1.5 ±  0.5 0.496 
 
Appendix Table C.7 Body and tissue weights in rats euthanized by pentobarbitone 
BW, body weight; RV, right ventricle; LV, left ventricle; CIH, chronic intermittent hypoxia; 
VEH, vehicle. Data are shown as mean ± SD and were statistically compared using 





 Sham+VEH CIH+VEH p-value 
Pons    
IFN-γ 7.7 ± 0.6 7.8 ± 0.7 0.097 
IL-1β 253 ± 26 275 ± 60 0.518 
IL-4 2.2 ± 0.0008 2.2 ± 0.0008 0.131 
IL-5 21 ± 0.8 20 ± 0.6 0.044 
IL-6 38 ± 11.0 36 ± 7.1 0.756 
KC/GRO 4.1 ± 0.9 4.2 ± 1.2 0.621 
IL-10 4.3 ± 1.5 4.1 ± 1.8 0.902 
IL-13 1.8 ± 0.04 1.8 ± 0.05 0.163 
TNF-α 0.6 ± 0.04 0.6 ± 0.03 0.843 
Medulla    
IFN-γ 8.1 ± 0.9 7.6 ± 1.3 0.050 
IL-1β 283 ± 27 268 ± 33 0.057 
IL-4 2.2 ± 0.0006 2.2 ± 0.0006 0.070 
IL-5 21 ± 0.5 20 ± 0.4 0.016 
IL-6 48 ± 18 33 ± 10 0.380 
KC/GRO 4.7 ± 1.2 3.6 ± 1.4 0.052 
IL-10 4.8 ± 1.8 3.0 ± 1.5 0.035 
IL-13 1.8 ± 0.08 1.8 ± 0.06 0.906 
TNF-α 0.6 ± 0.05 0.6 ± 0.04 0.373 
 
Appendix Table C.8 Cytokine concentrations in pons and medulla oblongata 
IFN-y, interferon-y; IL-β, interleukin-β; IL-4, interleukin-4; IL-5, interleukin-5;  IL-
6, interleukin-6; KC/GRO, keratinocyte chemoattractant/growth-related oncogene; IL-
10, interleukin-10; IL-13, interleukin-13; TNF-α, tumour necrosis factor; CIH, chronic 
intermittent hypoxia; VEH, vehicle. Data are shown as mean ± SD and were statistically 
compared using independent samples t-test or non-parametric Mann-Whitney U test, where 





Bacterial species p-value Statistic q-value 
Actinobacteria    
Acidimicrobium ferrooxidans 0.000104 -0.55375 0.01888 
Acidipropionibacterium sp. JS278 0.001673 -0.45942 0.04825 
Actinomyces oris 0.005244 -0.41199 0.0711 
Actinomyces sp. VUL4_3 0.00688 -0.39974 0.078342 
Arsenicicoccus sp. oral taxon 190 0.007161 -0.39789 0.080043 
Arthrobacter sp. ATCC 21022 0.005547 -0.40949 0.072506 
Arthrobacter sp. PGP41 0.011805 -0.37404 0.090492 
Arthrobacter sp. U41 0.000944 -0.48103 0.038102 
Bifidobacterium angulatum 0.0069 -0.3996 0.078342 
Bifidobacterium asteroides 0.003057 -0.43518 0.05565 
Candidatus Rhodoluna planktonica 0.000625 0.495784 0.036179 
Cellulomonas fimi 0.010572 -0.37945 0.089473 
Cellulomonas sp. PSBB021 0.005167 -0.41265 0.0711 
Coriobacterium glomerans 0.001526 -0.46298 0.047807 
Corynebacterium callunae 0.008412 -0.39038 0.084904 
Corynebacterium cystitidis 0.000753 -0.4892 0.037892 
Corynebacterium flavescens 0.007732 -0.39433 0.082378 
Corynebacterium imitans 0.012954 -0.36943 0.094512 
Corynebacterium jeikeium 0.001214 -0.47167 0.041579 
Corynebacterium provencense 0.010233 -0.38103 0.089069 
Corynebacterium sp. ATCC 6931 0.002961 -0.4365 0.05565 
Corynebacterium ulcerans 0.002466 -0.44401 0.052096 
Dermacoccus nishinomiyaensis 0.008845 -0.38801 0.0871 
Dietzia sp. JS16-p6b 0.010862 -0.37813 0.089611 
Dietzia sp. oral taxon 368 0.014346 -0.3643 0.098887 
Gordonibacter urolithinfaciens 0.012221 -0.37233 0.091368 
Mycobacterium marinum 0.008272 -0.39117 0.084428 
Mycolicibacterium vanbaalenii 0.010039 -0.38195 0.089069 
Plantactinospora sp. KBS50 0.003655 -0.42767 0.060361 
Rathayibacter toxicus 0.005213 -0.41225 0.0711 
Rhodococcus jostii 0.009556 -0.38432 0.089069 
Streptomyces autolyticus 0.010891 -0.378 0.089611 
Streptomyces coelicolor 0.013125 -0.36877 0.095382 
Streptomyces lincolnensis 3.88E-06 -0.64032 0.003521 
Streptomyces noursei 0.008272 -0.39117 0.084428 
Streptomyces sp. HNM0039 0.008507 -0.38986 0.085384 
Streptomyces sp. SAT1 0.009195 -0.38617 0.088382 
Streptomyces venezuelae 0.000904 -0.48261 0.038102 
Aquificae    
Hydrogenobacter thermophilus 0.004556 -0.41818 0.066213 
Persephonella marina 0.010345 -0.3805 0.089069 




Arcticibacterium luteifluviistationis 0.008919 0.387615 0.087114 
Aureitalea sp. RR4-38 0.014495 0.363768 0.098887 
Chryseobacterium indologenes 0.003225 0.432938 0.056344 
Croceibacter atlanticus 0.002531 0.442951 0.052249 
Flavobacterium sp. HYN0056 0.000307 0.519895 0.027919 
Polaribacter reichenbachii 0.011189 0.37668 0.089724 
Sediminicola sp. YIK13 0.012319 0.371937 0.091721 
Weeksella virosa 0.002878 0.437681 0.05565 
Winogradskyella sp. PG-2 0.001007 0.478656 0.038913 
Chlamydiae    
Chlamydia abortus 0.001112 0.474967 0.040408 
Chloroflexi    
Caldilinea aerophila 0.00194 -0.45362 0.048422 
Roseiflexus castenholzii 0.002178 -0.44901 0.049464 
Roseiflexus sp. RS-1 0.005798 -0.40751 0.073656 
Cyanobacteria    
Geminocystis sp. NIES-3709 0.008249 0.391304 0.084428 
Gloeobacter kilaueensis 0.002999 -0.43597 0.05565 
Nostoc sp. PCC 7524 0.006146 -0.40487 0.075669 
Nostocales cyanobacterium HT-58-2 0.001802 0.456522 0.048422 
Prochlorococcus marinus 0.003499 0.429513 0.05832 
Synechococcus sp. JA-3-3Ab 4.34E-05 -0.57879 0.017794 
Synechococcus sp. KORDI-49 0.006273 -0.40395 0.07569 
Firmicutes    
Anaerostipes hadrus 0.007181 0.39776 0.080043 
 Bacillus anthracis 0.009297 -0.38564 0.088893 
 Bacillus clausii 0.006291 0.403821 0.07569 
 Bacillus cytotoxicus 0.005781 0.407642 0.073656 
 Bacillus kochii 0.000494 0.503953 0.031446 
 Bacillus pumilus 0.003781 0.426219 0.060446 
 Bacillus weihaiensis 0.000759 0.488933 0.037892 
 Blautia hansenii 0.003735 0.426746 0.060446 
 Blautia sp. N6H1-15 0.004882 0.415152 0.068755 
 Blautia sp. YL58 0.009018 0.387088 0.087614 
 Brevibacillus laterosporus 0.007431 0.396179 0.082054 
 Cellulosilyticum lentocellum 0.010177 0.381291 0.089069 
 Clostridium argentinense 0.004709 0.416733 0.066841 
 Clostridium clariflavum 0.007886 0.393412 0.083039 
 Clostridium cochlearium 0.014383 0.364163 0.098887 
 Clostridium drakei 0.003984 0.423979 0.061346 
 Clostridium estertheticum 0.001455 0.464822 0.047193 
 Clostridium sp. BNL1100 0.013229 0.368379 0.095754 
 Clostridium tyrobutyricum 0.014722 0.362978 0.099432 




 Desulfosporosinus meridiei 0.008602 -0.38933 0.085867 
 Erysipelothrix rhusiopathiae 0.006058 0.405534 0.075669 
 Eubacterium eligens 0.003145 0.433992 0.05565 
 Eubacterium hallii 0.003155 0.43386 0.05565 
 Eubacterium rectale 0.002303 0.446772 0.05041 
 Ezakiella massiliensis 0.009795 0.383136 0.089069 
 Geobacillus subterraneus 0.000996 -0.47905 0.038913 
 Gottschalkia acidurici 0.006164 0.404743 0.075669 
 Lactobacillus casei 0.007754 -0.3942 0.082378 
 Lactobacillus murinus 0.010921 0.377866 0.089611 
 Lactobacillus parabuchneri 0.000853 0.484717 0.038102 
 Listeria welshimeri 0.000187 0.535837 0.024255 
 Macrococcus caseolyticus 0.010012 0.382082 0.089069 
 Megamonas hypermegale 0.002971 0.436364 0.05565 
 Oenococcus oeni 0.010345 -0.3805 0.089069 
 Paenibacillus beijingensis 0.01351 -0.36733 0.096252 
 Paenibacillus sabinae 0.006218 -0.40435 0.07569 
 Paenibacillus sp. FSL R5-0345 0.008869 0.387879 0.0871 
 Planococcus kocurii 0.007645 -0.39486 0.082182 
 Selenomonas sputigena 0.001511 -0.46337 0.047807 
 Sporosarcina ureae 0.005418 0.41054 0.072375 
 Staphylococcus condimenti 0.003466 0.429908 0.058312 
 Staphylococcus pasteuri 0.011711 0.37444 0.090492 
 Staphylococcus succinus 0.001148 0.473781 0.040895 
 Streptococcus parasanguinis 0.002087 0.450725 0.049234 
 Streptococcus pasteurianus 0.001914 0.45415 0.048422 
 Streptococcus pneumoniae 0.010261 0.380896 0.089069 
 Tepidanaerobacter acetatoxydans 0.000201 0.533597 0.024311 
 Thermincola potens 0.010572 -0.37945 0.089473 
 Thermoanaerobacterium thermosaccharolyticum 0.013369 0.367852 0.096252 
 Virgibacillus pantothenticus 0.004709 0.416733 0.066841 
Bacillus xiamenensis 0.00573 0.408037 0.073656 
Clostridia Thermoanaerobacterium xylanolyticum 6.74E-05 0.566403 0.017794 
Fusobacteria    
Fusobacterium necrophorum 0.009582 0.38419 0.089069 
Fusobacterium varium 0.011249 0.376416 0.089724 
Ilyobacter polytropus 7.02E-05 0.565217 0.017794 
Ignavibacteriae    
Ignavibacteria Ignavibacterium album 0.005244 0.411989 0.0711 
Nitrospirae    
Thermodesulfovibrio yellowstonii 0.001927 0.453887 0.048422 
Planctomycetes    
Phycisphaera mikurensis 0.014533 -0.36364 0.098887 




Proteobacteria    
Xanthomonas vasicola 0.012784 0.370092 0.094277 
 Acetobacter aceti 0.010177 0.381291 0.089069 
 Acetobacter tropicalis 0.007161 -0.39789 0.080043 
 Acidithiobacillus ferrivorans 0.01131 -0.37615 0.089724 
 Acinetobacter equi 0.012818 0.36996 0.094277 
 Aeromonas sp. ASNIH2 0.000862 -0.48432 0.038102 
 Allofrancisella guangzhouensis 0.007953 0.393017 0.083039 
 Alteromonas addita 0.001778 0.457049 0.048422 
 Alteromonas sp. MB-3u-76 0.01351 0.367325 0.096252 
 Aminobacter aminovorans 0.002597 -0.4419 0.053015 
 Antarctobacter heliothermus 0.011555 -0.3751 0.090485 
 Arcobacter bivalviorum 0.000142 0.544269 0.021549 
 Arcobacter halophilus 0.014684 0.363109 0.099432 
 Bartonella quintana 0.003096 0.434651 0.05565 
 Bordetella bronchialis 0.01376 -0.3664 0.097269 
 Bordetella sp. H567 0.000914 -0.48221 0.038102 
 Bordetella sp. HZ20 0.001864 -0.4552 0.048422 
 Bradyrhizobium diazoefficiens 0.000813 -0.48643 0.037892 
 Bradyrhizobium sp. BTAi1 0.011249 -0.37642 0.089724 
 Burkholderia sp. JP2-270 0.010094 -0.38169 0.089069 
 Burkholderiales bacterium YL45 0.007645 0.394862 0.082182 
 Calyptogena okutanii thioautotrophic gill symbiont 0.001617 0.460738 0.048041 
 Campylobacter helveticus 0.004172 0.422003 0.062827 
 Campylobacter sp. RM16704 0.000796 0.48722 0.037892 
 Candidatus Blochmannia floridanus 0.006685 0.401054 0.07785 
 Candidatus Erwinia sp. ErCipseudotaxifoliae 0.011009 -0.37747 0.089692 
 Candidatus Fokinia solitaria 0.011099 -0.37708 0.089724 
 Candidatus Kinetoplastibacterium sorsogonicusi 0.008674 0.388933 0.086115 
 Celeribacter ethanolicus 0.000718 -0.49091 0.037892 
 Chromobacterium vaccinii 0.014495 -0.36377 0.098887 
 Citrobacter koseri 0.012156 -0.3726 0.091368 
 Corallococcus coralloides 0.010572 -0.37945 0.089473 
 Croceicoccus naphthovorans 0.000481 0.504875 0.031446 
 Cronobacter dublinensis 0.007645 -0.39486 0.082182 
 Cystobacter fuscus 0.00384 -0.42556 0.060514 
 Desulfobacterium autotrophicum 0.003689 -0.42727 0.060376 
 Desulfocapsa sulfexigens 0.004184 -0.42187 0.062827 
 Desulfohalobium retbaense 0.002403 -0.44506 0.05186 
 Ehrlichia sp. HF 0.002288 0.447036 0.05041 
 Enterobacter sp. FY-07 0.00024 -0.52793 0.025635 
 Enterobacter sp. ODB01 0.001223 -0.47141 0.041579 
 Epibacterium mobile 0.003864 -0.4253 0.060514 




 Erythrobacter seohaensis 0.003793 0.426087 0.060446 
 Francisella noatunensis 0.011868 0.373781 0.090594 
 Gammaproteobacteria bacterium DM2 0.014533 0.363636 0.098887 
Gammaproteobacteria bacterium ESL0073 6.29E-05 0.568379 0.017794 
 Gemmobacter sp. HYN0069 0.000298 -0.52095 0.027919 
 Geobacter sp. M18 0.001972 -0.45296 0.048422 
 Geobacter uraniireducens 0.003423 -0.43043 0.058309 
 Gluconobacter albidus 0.000934 -0.48142 0.038102 
 Halocynthiibacter arcticus 0.001089 0.475758 0.040366 
 Halomonas sp. KO116 0.002178 -0.44901 0.049464 
 Halorhodospira halochloris 0.003028 0.435573 0.05565 
 Helicobacter cetorum 0.005482 0.410013 0.072506 
 Herbaspirillum frisingense 0.010289 -0.38076 0.089069 
 Herbaspirillum hiltneri 0.014346 -0.3643 0.098887 
 Kangiella koreensis 0.003067 -0.43505 0.05565 
 Ketogulonicigenium vulgare 0.000119 -0.5498 0.019588 
 Klebsiella oxytoca 0.013868 -0.36601 0.097277 
 Klebsiella sp. M5al 0.010687 0.37892 0.089473 
 Kosakonia oryzae 0.000352 0.515415 0.028363 
 Leisingera methylohalidivorans 0.000748 -0.48946 0.037892 
 Leminorella richardii 0.001054 -0.47694 0.039911 
 Limnobaculum parvum 0.003434 0.430303 0.058309 
 Luteibacter rhizovicinus 0.000381 -0.51278 0.028839 
 Mariprofundus aestuarium 0.008319 -0.39091 0.084428 
 Massilia armeniaca 0.01131 -0.37615 0.089724 
 Mesorhizobium japonicum 0.00537 -0.41094 0.072267 
 Methylobacterium phyllosphaerae 0.001742 -0.45784 0.048422 
 Methylobacterium sp. C1 0.007931 -0.39315 0.083039 
 Methylocella silvestris 0.006439 -0.40277 0.076956 
 Methylococcus capsulatus 0.005663 -0.40856 0.073487 
 Methylophilus sp. TWE2 0.009984 0.382213 0.089069 
 Microvirga ossetica 0.002426 0.444664 0.05186 
 Morganella morganii 0.01351 0.367325 0.096252 
 Moritella yayanosii 0.004597 0.417787 0.066285 
 Myxococcus hansupus 0.009768 -0.38327 0.089069 
 Myxococcus xanthus 0.000284 -0.52253 0.027919 
 Nitrosomonas sp. Is79A3 7.84E-05 0.562055 0.017794 
 Obesumbacterium proteus 0.000359 0.514756 0.028363 
 Oblitimonas alkaliphila 0.011679 -0.37457 0.090492 
 Octadecabacter antarcticus 0.00684 -0.4 0.078342 
 Oleiphilus messinensis 0.003106 0.434519 0.05565 
 Pandoraea pnomenusa 0.005015 -0.41397 0.070087 
 Pantoea sp. At-9b 0.001639 -0.46021 0.048041 




 Paraburkholderia terrae 0.004314 0.420553 0.064239 
 Paraburkholderia xenovorans 0.000447 0.507378 0.031244 
 Paracoccus aminovorans 0.000578 -0.49855 0.034995 
 Paracoccus sp. CBA4604 0.006762 -0.40053 0.07825 
 Phaeobacter inhibens 0.006646 -0.40132 0.07785 
 Photobacterium damselae 0.000173 0.53834 0.024108 
 Porphyrobacter neustonensis 0.003936 -0.42451 0.061115 
 Proteus mirabilis 0.000637 0.495125 0.036179 
 Providencia rettgeri 0.010658 0.379051 0.089473 
 Pseudoalteromonas phenolica 0.000502 0.503426 0.031446 
 Pseudomonas alcaligenes 0.001953 -0.45336 0.048422 
 Pseudomonas azotoformans 0.009119 -0.38656 0.088118 
 Pseudomonas cichorii 0.001864 -0.4552 0.048422 
 Pseudomonas pseudoalcaligenes 0.013868 0.366008 0.097277 
 Pseudomonas sp. NC02 0.005515 -0.40975 0.072506 
 Pseudomonas stutzeri 0.002143 -0.44967 0.049464 
 Pseudomonas syringae 0.012616 -0.37075 0.093552 
 Pseudomonas versuta 0.011493 0.375362 0.090391 
 Pseudomonas viridiflava 1.01E-06 -0.67167 0.001844 
 Pseudoxanthomonas spadix 0.011742 -0.37431 0.090492 
 Psychrobacter sp. P2G3 0.001731 0.458103 0.048422 
 Psychromonas ingrahamii 0.011932 -0.37352 0.090697 
 Psychromonas sp. CNPT3 0.010862 0.378129 0.089611 
 Rahnella sp. Y9602 0.011805 -0.37404 0.090492 
 Ralstonia pickettii 0.008021 0.392622 0.083264 
 Rhizobacter gummiphilus 5.84E-05 -0.57049 0.017794 
 Rhizobium sp. 11515TR 0.002087 -0.45072 0.049234 
 Rhodobacter capsulatus 0.006666 0.401186 0.07785 
 Rhodocyclaceae bacterium 0.006093 0.40527 0.075669 
 Rhodomicrobium vannielii 0.01095 -0.37773 0.089611 
 Rhodovulum sp. MB263 0.006005 -0.40593 0.075669 
 Rickettsia akari 0.009426 -0.38498 0.089069 
 Roseomonas sp. FDAARGOS_362 0.009957 -0.38235 0.089069 
 Serratia ficaria 0.000802 -0.48696 0.037892 
 Shewanella bicestrii 0.002273 0.447299 0.05041 
 Shinella sp. HZN7 0.003145 -0.43399 0.05565 
 Sinorhizobium americanum 0.012092 -0.37286 0.091368 
 Sinorhizobium fredii 0.010289 -0.38076 0.089069 
 Sinorhizobium medicae 0.004146 -0.42227 0.062827 
 Sphingobium cloacae 0.001302 -0.46904 0.043017 
 Sphingobium indicum 0.000103 -0.55415 0.01888 
 Sphingobium sp. TKS 0.00022 -0.5307 0.024976 
 Sphingomonas sp. Cra20 0.012886 0.369697 0.094394 




 Sulfuritalea hydrogenivorans 0.001612 -0.46087 0.048041 
 Thiocystis violascens 0.009876 -0.38274 0.089069 
 Vibrio harveyi 0.006685 -0.40105 0.07785 
 Vibrio rotiferianus 0.012188 0.372464 0.091368 
 Yersinia aleksiciae 0.000351 0.515547 0.028363 
 Yersinia frederiksenii 0.013581 0.367062 0.09638 
 Yersinia ruckeri 0.00043 -0.5087 0.031244 
Spirochaetes    
Borreliella afzelii 0.011493 -0.37536 0.090391 
Sphaerochaeta globosa 0.002523 -0.44308 0.052249 
Treponema putidum 0.003423 0.430435 0.058309 
Tenericutes    
Spiroplasma syrphidicola 0.004367 0.420026 0.064496 
Tenericutes bacterium MO-XQ 0.007452 0.396047 0.082054 
Thermotogae    
Defluviitoga tunisiensis 0.002726 0.439921 0.055018 
Fervidobacterium nodosum 0.002066 0.45112 0.049234 
Marinitoga sp. 1137 0.009688 0.383663 0.089069 
Petrotoga mobilis 0.002961 0.436495 0.05565 
Thermosipho melanesiensis 0.009478 -0.38472 0.089069 
Verrucomicrobia    
Opitutaceae bacterium TAV5 0.010658 -0.37905 0.089473 
 
Appendix Table C.9 Significant correlations between mean arterial blood pressure and 
bacterial species 
Hierarchical All-against-All association testing (HAllA) was used (version 0.8.7) with 
Spearman correlation as correlation metric, medoid as clustering method and q < 0.1 as 





Bacterial species  p-value statistic q-value 
Actinobacteria    
Arthrobacter sp. U41 0.000432 -0.50856 0.085106 
Corynebacterium jeikeium 0.000494 -0.50395 0.085106 
Streptomyces lincolnensis 5.20E-05 -0.57378 0.067098 
Cyanobacteria    
Synechococcus sp. JA-3-3Ab 0.00044 -0.50791 0.085106 
Proteobacteria    
Rhizobacter gummiphilus 0.000189 -0.53544 0.081474 
Campylobacter sp. RM16704 0.000314 0.519236 0.085106 
Gemmobacter sp. HYN0069 0.000152 -0.54216 0.078751 
Halocynthiibacter arcticus 0.000126 0.54809 0.078751 
Ketogulonicigenium vulgare 0.000433 -0.50843 0.085106 
Luteibacter rhizovicinus 0.000449 -0.50725 0.085106 
Obesumbacterium proteus 0.000422 0.509354 0.085106 
Paraburkholderia xenovorans 0.000569 0.499078 0.091873 
Pseudomonas viridiflava 8.09E-06 -0.62253 0.020898 
Sphingobium indicum 0.00012 -0.54941 0.078751 
Yersinia aleksiciae 0.000489 0.504348 0.085106 
Yersinia ruckeri 0.000483 -0.50474 0.085106 
 
Appendix Table C.10 Significant correlations between diastolic blood pressure and 
bacterial species 
Hierarchical All-against-All association testing (HAllA) was used (version 0.8.7) with 
Spearman correlation as correlation metric, medoid as clustering method and q < 0.1 as 




Actinobacteria p-value Statistical q-value 
Candidatus Rhodoluna planktonica 0.003246 0.432675 0.083956 
Corynebacterium sp. ATCC 6931 0.003466 -0.42991 0.085635 
Dietzia sp. oral taxon 368 0.003067 -0.43505 0.082224 
Mycobacterium ulcerans 0.000985 0.479447 0.063073 
Pseudarthrobacter chlorophenolicus 0.002869 -0.43781 0.080105 
Renibacterium salmoninarum 0.004433 0.419368 0.093723 
Sinomonas atrocyanea 0.00377 -0.42635 0.088936 
Streptomyces lincolnensis 0.002896 -0.43742 0.080105 
Streptomyces xiamenensis 0.001634 -0.46034 0.069792 
Bacteroidetes    
 Candidatus Cardinium hertigii 0.001901 0.454414 0.070373 
 Chryseobacterium indologenes 0.000607 0.496838 0.063073 
 Sediminicola sp. YIK13 0.004288 0.420817 0.091804 
Caldiserica    
Caldisericum exile 0.004262 0.42108 0.091804 
Cyanobacteria    
Prochlorococcus marinus 0.002674 0.440711 0.079433 
Deinococcus-Thermus    
Thermus oshimai 0.002589 -0.44203 0.077969 
Firmicutes    
Aerococcus urinae 0.002333 0.446245 0.075082 
Alkaliphilus metalliredigens 0.000721 0.490777 0.063073 
Anaerostipes hadrus 0.000739 0.489855 0.063073 
Bacillus clausii 0.002094 0.450593 0.070817 
Bacillus flexus 0.00298 0.436232 0.080897 
Bacillus simplex 0.00128 0.469697 0.063073 
Bacillus weihaiensis 0.000109 0.552306 0.039979 
Bacillus xiamenensis 0.001253 0.470487 0.063073 
Blautia hansenii 0.001298 0.46917 0.063073 
Blautia sp. N6H1-15 0.00071 0.491304 0.063073 
Blautia sp. YL58 0.001713 0.458498 0.070373 
Clostridium argentinense 0.001227 0.471278 0.063073 
Clostridium cellulosi 0.003677 0.427404 0.088936 
Clostridium cochlearium 0.00091 0.482345 0.063073 
Clostridium drakei 0.002326 0.446377 0.075082 
Clostridium estertheticum 0.001435 0.465349 0.065048 
Clostridium pasteurianum 0.003924 0.424638 0.088936 
Clostridium thermosuccinogenes 0.002442 0.444401 0.076707 
Dehalobacterium formicoaceticum 0.00145 0.464954 0.065048 
Eubacterium eligens 0.001495 0.463768 0.065748 
Eubacterium hallii 0.00384 0.42556 0.088936 
Eubacterium limosum 0.002752 0.439526 0.080105 




Geobacillus thermodenitrificans 0.001348 0.467721 0.063073 
Gottschalkia acidurici 0.003391 0.43083 0.084734 
Listeria welshimeri 0.003328 0.431621 0.084734 
Macrococcus canis 0.001325 0.468379 0.063073 
Mordavella sp. Marseille-P3756 0.000207 0.532675 0.050488 
Natranaerobius thermophilus 0.001156 0.473518 0.063073 
Paenibacillus sp. FSL R5-0345 0.001193 0.472332 0.063073 
Paenibacillus sp. lzh-N1 0.004752 -0.41634 0.096739 
Ruminococcus bicirculans 0.00176 0.457444 0.070373 
Salimicrobium jeotgali 0.001914 0.45415 0.070373 
Sporosarcina ureae 0.000598 0.497365 0.063073 
Staphylococcus succinus 0.001025 0.477997 0.063073 
Streptococcus agalactiae 0.001796 0.456653 0.070373 
Streptococcus sp. oral taxon 431 0.002841 0.438208 0.080105 
Streptococcus thermophilus 0.000454 0.506851 0.063073 
Thermoanaerobacter wiegelii 0.000614 0.496443 0.063073 
Thermoanaerobacterium xylanolyticum 0.003828 0.425692 0.088936 
Fusobacteria    
Fusobacterium mortiferum 0.004681 0.416996 0.096185 
Ilyobacter polytropus 4.98E-05 0.574967 0.036504 
Sebaldella termitidis 0.000729 0.490382 0.063073 
Proteobacteria    
Acetobacter aceti 0.000699 0.491831 0.063073 
Agrobacterium sp. H13-3 0.002012 -0.45217 0.070817 
Allofrancisella guangzhouensis 0.000399 0.511199 0.062717 
Arcobacter bivalviorum 0.002589 0.442029 0.077969 
Bordetella bronchialis 0.001808 -0.45639 0.070373 
Calyptogena okutanii thioautotrophic gill symbiont 0.004301 0.420685 0.091804 
Campylobacter hominis 0.001 0.47892 0.063073 
Candidatus Carsonella ruddii 0.000841 0.485244 0.063073 
Candidatus Fokinia solitaria 0.001214 -0.47167 0.063073 
Candidatus Nucleicultrix amoebiphila 0.000146 0.543478 0.04336 
Chromobacterium vaccinii 0.000657 -0.49407 0.063073 
Citrobacter koseri 0.004009 -0.42372 0.089942 
Desulfobacula toluolica 0.00208 0.450856 0.070817 
Gammaproteobacteria bacterium ESL0073 3.93E-05 0.581555 0.036504 
Janthinobacterium sp. 1_2014MBL_MicDiv 0.004275 -0.42095 0.091804 
Klebsiella sp. M5al 0.004197 0.421739 0.091804 
Lawsonia intracellularis 0.000319 0.518709 0.059562 
Limnobaculum parvum 0.004941 0.414625 0.098755 
Magnetospirillum gryphiswaldense 0.000258 -0.52556 0.056776 
Marinobacter hydrocarbonoclasticus 0.004824 -0.41568 0.097301 
Methylophilus sp. TWE2 0.001043 0.477339 0.063073 




Myxococcus xanthus 0.002356 -0.44585 0.075082 
Nitrobacter hamburgensis 0.002136 0.449802 0.071139 
Obesumbacterium proteus 0.002915 0.437154 0.080105 
Paraburkholderia phymatum 0.001999 -0.45244 0.070817 
Paracoccus aminovorans 0.001845 -0.4556 0.070373 
Photobacterium damselae 7.67E-06 0.623847 0.016863 
Pseudoalteromonas phenolica 0.00112 0.474704 0.063073 
Pseudomonas stutzeri 0.003246 -0.43267 0.083956 
Ralstonia pickettii 0.003912 0.424769 0.088936 
Rhodospirillum rubrum 0.002506 -0.44335 0.077615 
Rhodovulum sp. MB263 0.00192 -0.45402 0.070373 
Rickettsia australis 0.000504 0.503294 0.063073 
Shewanella bicestrii 0.000393 0.511726 0.062717 
Shewanella sp. WE21 0.001152 -0.47365 0.063073 
Sphingobium indicum 0.003381 -0.43096 0.084734 
Sphingomonas taxi 0.000834 -0.48551 0.063073 
Wolinella succinogenes 0.002787 -0.439 0.080105 
Kosakonia oryzae 0.000108 0.552569 0.039979 
Spirochaetes    
Borreliella afzelii 0.00091 -0.48235 0.063073 
Borreliella burgdorferi 0.003852 0.425428 0.088936 
Sphaerochaeta coccoides 0.003888 0.425033 0.088936 
Treponema putidum 7.29E-05 0.564163 0.039979 
Tenericutes    
Mycoplasma dispar 0.000927 0.481686 0.063073 
Thermodesulfobacteria    
Thermodesulfobacterium commune 0.004515 0.418577 0.094532 
Thermotogae    
Fervidobacterium nodosum 0.001316 0.468643 0.063073 
Petrotoga mobilis 0.000158 0.541107 0.04336 
Thermotoga profunda 0.001651 0.459947 0.069792 
Thermotoga sp. Cell2 0.002039 -0.45165 0.070817 
Thermotogae    
Opitutaceae bacterium TAV5 0.004597 -0.41779 0.095353 
Tenericutes    
Tenericutes bacterium MO-XQ 0.000325 0.51805 0.059562 
 
Appendix Table C.11 Significant correlations between systolic blood pressure and bacterial 
species 
Hierarchical All-against-All association testing (HAllA) was used (version 0.8.7) with 
Spearman correlation as correlation metric, medoid as clustering method and q < 0.1 as 
threshold for significance. 
